,Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes,cluster,ordered_cluster,sample
0,KEGG_2021_Human,PI3K-Akt signaling pathway,22/354,1.3328875802764385e-22,2.3858687686948246e-20,0,0,29.5210843373494,1486.9629761945132,PDGFRB;HSP90AA1;ITGA4;ITGB5;EGF;HGF;FLT4;ITGA1;FN1;TGFA;HSP90B1;COL1A1;COL1A2;COL4A1;ITGA11;ERBB2;COL4A3;KDR;ITGA6;ITGAV;MET;IFNAR1,1,1,A1
1,KEGG_2021_Human,ECM-receptor interaction,15/88,2.8641235334081924e-22,2.5633905624003323e-20,0,0,80.0201450443191,3969.368060222329,ITGA4;SDC4;ITGB5;ITGA1;FN1;COL1A1;COL1A2;COL4A1;ITGA11;COL4A3;SDC1;ITGA6;ITGAV;CD36;CD44,1,1,A1
2,KEGG_2021_Human,Focal adhesion,18/201,2.2651481051328864e-21,1.3515383693959556e-19,0,0,40.47336065573771,1923.9678506042917,PDGFRB;ITGA4;ITGB5;EGF;HGF;FLT4;ITGA1;FN1;COL1A1;COL1A2;COL4A1;ITGA11;ERBB2;COL4A3;KDR;ITGA6;ITGAV;MET,1,1,A1
3,KEGG_2021_Human,Proteoglycans in cancer,18/205,3.250894852259309e-21,1.4547754463860408e-19,0,0,39.599598930481285,1868.12520295132,TGFB1;SDC4;ITGB5;HGF;FN1;MMP9;DCN;COL1A1;COL1A2;PLAU;ERBB2;KDR;TIMP3;SDC1;ITGAV;MET;CD44;HBEGF,1,1,A1
4,KEGG_2021_Human,Human papillomavirus infection,20/331,2.7292793015425756e-20,9.77081989952242e-19,0,0,27.4332447923948,1235.803601454255,PDGFRB;NOTCH2;ITGA4;ITGB5;EGF;ITGA1;FN1;HLA-B;HLA-C;HLA-A;TNFRSF1A;COL1A1;COL1A2;COL4A1;ITGA11;COL4A3;GNAS;ITGA6;ITGAV;IFNAR1,1,1,A1
5,KEGG_2021_Human,Pathways in cancer,23/531,4.266993435107462e-20,1.2729863748070598e-18,0,0,20.45403772202893,912.2662900634036,PDGFRB;NOTCH2;HSP90AA1;TGFB1;EGF;TGFB3;HGF;FLT4;FN1;TGFA;MMP9;ADCY7;TGFBR1;HSP90B1;CDH1;COL4A1;ERBB2;COL4A3;GNAS;ITGA6;ITGAV;MET;IFNAR1,1,1,A1
6,KEGG_2021_Human,Dilated cardiomyopathy,10/96,6.784013618596315e-13,1.7347691967553436e-11,0,0,41.21262458471761,1154.7380655927825,TGFB1;ITGA4;ITGB5;TGFB3;ITGA1;ITGA11;GNAS;ITGA6;ITGAV;ADCY7,1,1,A1
7,KEGG_2021_Human,Human T-cell leukemia virus 1 infection,12/219,6.427645364924035e-12,1.4381856504017528e-10,0,0,21.17767042404724,545.7573098157895,TGFB1;TGFB3;CANX;ITGB2;HLA-B;HLA-C;HLA-A;CD3D;ADCY7;B2M;TGFBR1;TNFRSF1A,1,1,A1
8,KEGG_2021_Human,Amoebiasis,9/102,4.7377093147457556e-11,9.422777414883227e-10,0,0,33.68590831918506,800.8111326626716,COL1A1;TGFB1;COL1A2;TGFB3;COL4A1;COL4A3;ITGB2;FN1;GNAS,1,1,A1
9,KEGG_2021_Human,Cell adhesion molecules,10/148,5.3625450873521846e-11,9.598955706360412e-10,0,0,25.615942028985508,605.7913446698636,ITGA4;SDC4;CDH1;ITGB2;HLA-B;HLA-C;SDC1;ITGA6;ITGAV;HLA-A,1,1,A1
10,KEGG_2021_Human,Regulation of actin cytoskeleton,11/218,1.2727807640247194e-10,2.0711614250947707e-09,0,0,19.059903381642517,434.2731674530274,PDGFRB;ITGA4;ITGB5;EGF;ITGA1;ITGA11;ITGB2;FN1;ITGA6;ITGAV;ITGAE,1,1,A1
11,KEGG_2021_Human,MAPK signaling pathway,12/294,1.9743451913658224e-10,2.9450649104540183e-09,0,0,15.486209613869187,346.04886444892344,PDGFRB;TGFB1;EGF;TGFB3;HGF;FLT4;ERBB2;KDR;TGFA;MET;TGFBR1;TNFRSF1A,1,1,A1
12,KEGG_2021_Human,Malaria,7/50,2.7428803624869177e-10,3.776735268347372e-09,0,0,54.88253843121797,1208.3401955576935,TGFB1;TGFB3;HGF;ITGB2;SDC1;CD36;MET,1,1,A1
13,KEGG_2021_Human,Relaxin signaling pathway,9/129,3.9543717178440776e-10,5.055946696386357e-09,0,0,26.071052631578947,564.4651217757123,COL1A1;TGFB1;COL1A2;COL4A1;COL4A3;GNAS;MMP9;ADCY7;TGFBR1,1,1,A1
14,KEGG_2021_Human,Hypertrophic cardiomyopathy,8/90,5.680194706699291e-10,6.778365683327822e-09,0,0,33.39276703111859,710.8941232750193,TGFB1;ITGA4;ITGB5;TGFB3;ITGA1;ITGA11;ITGA6;ITGAV,1,1,A1
15,KEGG_2021_Human,Fluid shear stress and atherosclerosis,9/139,7.706038493870531e-10,8.621130565017657e-09,0,0,24.05344129554656,504.7337244750793,HSP90AA1;SDC4;KDR;SDC1;ITGAV;MMP9;ACVR2A;TNFRSF1A;HSP90B1,1,1,A1
16,KEGG_2021_Human,Prostate cancer,8/97,1.04004107983308e-09,1.0951020781771844e-08,0,0,30.75552111584657,636.1473717517874,PDGFRB;HSP90AA1;EGF;PLAU;ERBB2;TGFA;MMP9;HSP90B1,1,1,A1
17,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,8/100,1.3288448135500092e-09,1.3214623423636205e-08,0,0,29.748125937031485,608.0206321525512,COL1A1;TGFB1;COL1A2;TGFB3;COL4A1;COL4A3;FN1;TGFBR1,1,1,A1
18,KEGG_2021_Human,Rap1 signaling pathway,10/210,1.661537558197622e-09,1.5653432785124964e-08,0,0,17.619642857142857,356.1902852707889,PDGFRB;EGF;CDH1;HGF;FLT4;ITGB2;KDR;GNAS;ADCY7;MET,1,1,A1
19,KEGG_2021_Human,Gastric cancer,8/149,3.1311918035099394e-08,2.802416664141396e-07,0,0,19.36219124480313,334.56447307555425,TGFB1;EGF;TGFB3;CDH1;HGF;ERBB2;MET;TGFBR1,1,1,A1
20,KEGG_2021_Human,Phagosome,8/152,3.6581877552927266e-08,3.118169562844752e-07,0,0,18.955938697318008,324.5960513961485,ITGB5;CANX;ITGB2;HLA-B;HLA-C;ITGAV;CD36;HLA-A,1,1,A1
21,KEGG_2021_Human,Calcium signaling pathway,9/240,9.067246593272663e-08,7.377441546344576e-07,0,0,13.467532467532468,218.38966943544085,PDGFRB;EGF;HGF;FLT4;ERBB2;KDR;GNAS;ADCY7;MET,1,1,A1
22,KEGG_2021_Human,Pancreatic cancer,6/76,1.8673001390966865e-07,1.4532466299926383e-06,0,0,28.377142857142857,439.6641584387969,TGFB1;EGF;TGFB3;ERBB2;TGFA;TGFBR1,1,1,A1
23,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,6/77,2.0198975749586282e-07,1.5065069413233097e-06,0,0,27.97605633802817,431.2522749774554,ITGA4;ITGB5;ITGA1;ITGA11;ITGA6;ITGAV,1,1,A1
24,KEGG_2021_Human,Antigen processing and presentation,6/78,2.182600751107031e-07,1.562742137792634e-06,0,0,27.586111111111112,423.1041441281826,HSP90AA1;CANX;HLA-B;HLA-C;HLA-A;B2M,1,1,A1
25,KEGG_2021_Human,Bladder cancer,5/41,2.292571919971863e-07,1.5783475910575518e-06,0,0,45.30510018214936,692.6434610902426,CDH1;EGF;ERBB2;MMP9;HBEGF,1,1,A1
26,KEGG_2021_Human,Estrogen signaling pathway,7/137,3.373024746739153e-07,2.2361904802455867e-06,0,0,18.07405475880052,269.3447288248352,HSP90AA1;GNAS;TGFA;MMP9;ADCY7;HSP90B1;HBEGF,1,1,A1
27,KEGG_2021_Human,Human cytomegalovirus infection,8/225,7.424466212040289e-07,4.746355185554328e-06,0,0,12.532655331320514,176.87731071636878,HLA-B;GNAS;HLA-C;ITGAV;HLA-A;ADCY7;B2M;TNFRSF1A,1,1,A1
28,KEGG_2021_Human,Hematopoietic cell lineage,6/99,9.021038770383224e-07,5.568158413443438e-06,0,0,21.33440860215054,296.94373759193326,ITGA4;ITGA1;ITGA6;CD36;CD3D;CD44,1,1,A1
29,KEGG_2021_Human,Chagas disease,6/102,1.0757329457979094e-06,6.418539909927526e-06,0,0,20.664583333333333,283.9832083601198,TGFB1;TGFB3;GNAS;CD3D;TGFBR1;TNFRSF1A,1,1,A1
30,KEGG_2021_Human,Renal cell carcinoma,5/69,3.2020481926834043e-06,1.848924601581708e-05,0,0,25.448258196721312,321.96423446192824,TGFB1;TGFB3;HGF;TGFA;MET,1,1,A1
31,KEGG_2021_Human,Melanoma,5/72,3.956179727324752e-06,2.1459277914882743e-05,0,0,24.30511377538537,302.36124719259647,PDGFRB;EGF;CDH1;HGF;MET,1,1,A1
32,KEGG_2021_Human,Non-small cell lung cancer,5/72,3.956179727324752e-06,2.1459277914882743e-05,0,0,24.30511377538537,302.36124719259647,EGF;HGF;ERBB2;TGFA;MET,1,1,A1
33,KEGG_2021_Human,Epstein-Barr virus infection,7/202,4.544178603374085e-06,2.392376382364592e-05,0,0,12.009821816601477,147.7407875474715,HLA-B;HLA-C;HLA-A;CD3D;B2M;CD44;IFNAR1,1,1,A1
34,KEGG_2021_Human,Diabetic cardiomyopathy,7/203,4.694317504087986e-06,2.4008080949478557e-05,0,0,11.947941888619855,146.5911846844869,COL1A1;TGFB1;COL1A2;TGFB3;CD36;MMP9;TGFBR1,1,1,A1
35,KEGG_2021_Human,MicroRNAs in cancer,8/310,8.01025490458282e-06,3.982876744223124e-05,0,0,8.966430691938799,105.21916305433426,PDGFRB;NOTCH2;PLAU;ERBB2;TIMP3;MMP9;MET;CD44,1,1,A1
36,KEGG_2021_Human,Colorectal cancer,5/86,9.503444871632622e-06,4.597612518979025e-05,0,0,20.090062740335963,232.31859671927992,TGFB1;EGF;TGFB3;TGFA;TGFBR1,1,1,A1
37,KEGG_2021_Human,Ras signaling pathway,7/232,1.1237852243983946e-05,5.2936198728240165e-05,0,0,10.392693032015066,118.4374454225878,PDGFRB;EGF;HGF;FLT4;KDR;TGFA;MET,1,1,A1
38,KEGG_2021_Human,Cellular senescence,6/156,1.2628183371737249e-05,5.7960123680537614e-05,0,0,13.189333333333334,148.7701334412546,TGFB1;TGFB3;HLA-B;HLA-C;HLA-A;TGFBR1,1,1,A1
39,KEGG_2021_Human,Small cell lung cancer,5/92,1.3216701756078564e-05,5.914474035845157e-05,0,0,18.69888826078764,210.06385754484236,COL4A1;COL4A3;FN1;ITGA6;ITGAV,1,1,A1
40,KEGG_2021_Human,TGF-beta signaling pathway,5/94,1.4677662392620963e-05,6.408052605558909e-05,0,0,18.27684656474489,203.40638442961037,TGFB1;TGFB3;TGFBR1;ACVR2A;DCN,1,1,A1
41,KEGG_2021_Human,Hepatocellular carcinoma,6/168,1.9235667538369668e-05,8.198058308019453e-05,0,0,12.204938271604938,132.53030410835447,TGFB1;TGFB3;HGF;TGFA;MET;TGFBR1,1,1,A1
42,KEGG_2021_Human,Protein digestion and absorption,5/103,2.2879714991013985e-05,9.524346473003495e-05,0,0,16.590833054533288,177.2773622860712,COL1A1;COL18A1;COL1A2;COL4A1;COL4A3,1,1,A1
43,KEGG_2021_Human,Viral myocarditis,4/60,4.589496548318426e-05,0.00018670906412477232,0,0,22.90092165898617,228.7608591030963,ITGB2;HLA-B;HLA-C;HLA-A,1,1,A1
44,KEGG_2021_Human,Cytokine-cytokine receptor interaction,7/295,5.2338913861877495e-05,0.0002081925684728016,0,0,8.093338041431261,79.78226828452298,GDF9;TGFB1;TGFB3;TGFBR1;ACVR2A;TNFRSF1A;IFNAR1,1,1,A1
45,KEGG_2021_Human,Human immunodeficiency virus 1 infection,6/212,7.069449778573338e-05,0.000275093806601006,0,0,9.576699029126214,91.52588029754948,HLA-B;HLA-C;HLA-A;CD3D;B2M;TNFRSF1A,1,1,A1
46,KEGG_2021_Human,Natural killer cell mediated cytotoxicity,5/131,7.24500050594143e-05,0.00027592661501351403,0,0,12.88576632838928,122.8350341751041,ITGB2;HLA-B;HLA-C;HLA-A;IFNAR1,1,1,A1
47,KEGG_2021_Human,Adherens junction,4/71,8.899340037853198e-05,0.0003318712222449422,0,0,19.130476649013,178.428967502051,CDH1;ERBB2;MET;TGFBR1,1,1,A1
48,KEGG_2021_Human,Thyroid hormone synthesis,4/75,0.0001102293412355218,0.0004026745322685388,0,0,18.049068605179464,164.48021358108932,CANX;GNAS;ADCY7;HSP90B1,1,1,A1
49,KEGG_2021_Human,Leishmaniasis,4/77,0.0001221235207280456,0.0004372022042064033,0,0,17.552806009721607,158.15916467342342,TGFB1;ITGA4;TGFB3;ITGB2,1,1,A1
50,KEGG_2021_Human,Chemical carcinogenesis,6/239,0.0001365152977260321,0.00047914192731293617,0,0,8.455364806866953,75.24491608484311,NOTCH2;HSP90AA1;EGF;GNAS;ADCY7;HSP90B1,1,1,A1
51,KEGG_2021_Human,ErbB signaling pathway,4/85,0.00017914616946872037,0.0006166762372096336,0,0,15.812823576264435,136.42210718747486,EGF;ERBB2;TGFA;HBEGF,1,1,A1
52,KEGG_2021_Human,Hepatitis B,5/162,0.00019662135221381797,0.0006640607933259134,0,0,10.325258431659185,88.11813799629485,TGFB1;TGFB3;MMP9;TGFBR1;IFNAR1,1,1,A1
53,KEGG_2021_Human,Hippo signaling pathway,5/163,0.00020233065557460496,0.0006665134700830616,0,0,10.259389914920108,87.26234165183924,TGFB1;TGFB3;CDH1;ITGB2;TGFBR1,1,1,A1
54,KEGG_2021_Human,Gap junction,4/88,0.00020479464164563347,0.0006665134700830616,0,0,15.245775729646695,129.49003928976228,PDGFRB;EGF;GNAS;ADCY7,1,1,A1
55,KEGG_2021_Human,IL-17 signaling pathway,4/94,0.0002638791445747891,0.0008371955982174701,0,0,14.225089605734768,117.2150135403837,HSP90AA1;MMP9;S100A8;HSP90B1,1,1,A1
56,KEGG_2021_Human,Allograft rejection,3/38,0.00026659301172288154,0.0008371955982174701,0,0,27.073469387755104,222.808896244126,HLA-B;HLA-C;HLA-A,1,1,A1
57,KEGG_2021_Human,Graft-versus-host disease,3/42,0.000359387942048076,0.0011091455452863,0,0,24.29181929181929,192.66104558485847,HLA-B;HLA-C;HLA-A,1,1,A1
58,KEGG_2021_Human,Type I diabetes mellitus,3/43,0.00038543363890109416,0.0011693664637846,0,0,23.683333333333334,186.17803506279176,HLA-B;HLA-C;HLA-A,1,1,A1
59,KEGG_2021_Human,Th17 cell differentiation,4/107,0.000432459451760312,0.0012901706977515,0,0,12.421547134356404,96.21757724189833,HSP90AA1;TGFB1;CD3D;TGFBR1,1,1,A1
60,KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,5/193,0.00044071488096103577,0.0012932453064266,0,0,8.609173351935821,66.52405033402142,HLA-B;HLA-C;HLA-A;TNFRSF1A;IFNAR1,1,1,A1
61,KEGG_2021_Human,Toxoplasmosis,4/112,0.0005140888200511295,0.0014842241740185,0,0,11.843488649940262,89.69209569392353,TGFB1;TGFB3;ITGA6;TNFRSF1A,1,1,A1
62,KEGG_2021_Human,Autoimmune thyroid disease,3/53,0.0007146287435063299,0.0020110531189191,0,0,18.937142857142856,137.1758791449791,HLA-B;HLA-C;HLA-A,1,1,A1
63,KEGG_2021_Human,Lipid and atherosclerosis,5/215,0.0007190357520157985,0.0020110531189191,0,0,7.698672911787666,55.719911038716376,HSP90AA1;CD36;MMP9;TNFRSF1A;HSP90B1,1,1,A1
64,KEGG_2021_Human,Platelet activation,4/124,0.0007538852420525269,0.0020760839742677,0,0,10.65268817204301,76.59570844822865,COL1A1;COL1A2;GNAS;ADCY7,1,1,A1
65,KEGG_2021_Human,Regulation of lipolysis in adipocytes,3/55,0.0007965654826368659,0.002160382142303,0,0,18.206959706959708,129.91032109566703,ADORA1;GNAS;ADCY7,1,1,A1
66,KEGG_2021_Human,Osteoclast differentiation,4/127,0.0008243843122503263,0.0022024595804896,0,0,10.391292945187516,73.78725918273874,TGFB1;TGFBR1;TNFRSF1A;IFNAR1,1,1,A1
67,KEGG_2021_Human,FoxO signaling pathway,4/131,0.000925464631424984,0.0024133594691697,0,0,10.061976123952247,70.28506295171725,TGFB1;EGF;TGFB3;TGFBR1,1,1,A1
68,KEGG_2021_Human,Endometrial cancer,3/58,0.0009302894043168408,0.0024133594691697,0,0,17.21125541125541,120.13481806147028,CDH1;EGF;ERBB2,1,1,A1
69,KEGG_2021_Human,Breast cancer,4/147,0.0014178994464389,0.0036257714416082,0,0,8.92894202571622,58.5611695694028,NOTCH2;EGF;FLT4;ERBB2,1,1,A1
70,KEGG_2021_Human,Phospholipase D signaling pathway,4/148,0.0014537057812271,0.0036649765470375,0,0,8.866487455197133,57.930430638731885,PDGFRB;EGF;GNAS;ADCY7,1,1,A1
71,KEGG_2021_Human,Central carbon metabolism in cancer,3/70,0.0016045253863799,0.0039343841666029,0,0,14.120113717128644,90.86190489223836,PDGFRB;ERBB2;MET,1,1,A1
72,KEGG_2021_Human,Epithelial cell signaling in Helicobacter pylori infection,3/70,0.0016045253863799,0.0039343841666029,0,0,14.120113717128644,90.86190489223836,ADAM10;MET;HBEGF,1,1,A1
73,KEGG_2021_Human,Glioma,3/75,0.001956199521718,0.0047318880322639,0,0,13.136243386243386,81.92748837064639,PDGFRB;EGF;TGFA,1,1,A1
74,KEGG_2021_Human,Chronic myeloid leukemia,3/76,0.0020318217902398,0.0047854750059597,0,0,12.955642530984996,80.30972783698496,TGFB1;TGFB3;TGFBR1,1,1,A1
75,KEGG_2021_Human,Gastric acid secretion,3/76,0.0020318217902398,0.0047854750059597,0,0,12.955642530984996,80.30972783698496,GNAS;ADCY7;CFTR,1,1,A1
76,KEGG_2021_Human,Bacterial invasion of epithelial cells,3/77,0.0021092423363523,0.0049033036130788,0,0,12.77992277992278,78.74255460655293,CDH1;FN1;MET,1,1,A1
77,KEGG_2021_Human,Complement and coagulation cascades,3/85,0.0027950958671545,0.0064143866694957,0,0,11.528455284552846,67.78603595564651,PLAU;ITGB2;TFPI,1,1,A1
78,KEGG_2021_Human,Tuberculosis,4/180,0.0029618066667173,0.0067109290296506,0,0,7.242668621700879,42.16649685367765,TGFB1;TGFB3;ITGB2;TNFRSF1A,1,1,A1
79,KEGG_2021_Human,Axon guidance,4/182,0.003081643928895,0.0068951782909027,0,0,7.16056542225444,41.404480738296456,EFNB2;SEMA4D;MET;EPHB4,1,1,A1
80,KEGG_2021_Human,Bile secretion,3/90,0.0032858821043794,0.0072613937862212,0,0,10.863163656267105,62.11687486710128,GNAS;ADCY7;CFTR,1,1,A1
81,KEGG_2021_Human,Morphine addiction,3/91,0.0033899583603205,0.0074000310548461,0,0,10.73917748917749,61.073032693968216,ADORA1;GNAS;ADCY7,1,1,A1
82,KEGG_2021_Human,GnRH signaling pathway,3/93,0.0036041291653092,0.0076802276260757,0,0,10.4994708994709,59.06661200702416,GNAS;ADCY7;HBEGF,1,1,A1
83,KEGG_2021_Human,Rheumatoid arthritis,3/93,0.0036041291653092,0.0076802276260757,0,0,10.4994708994709,59.06661200702416,TGFB1;TGFB3;ITGB2,1,1,A1
84,KEGG_2021_Human,Pancreatic secretion,3/102,0.004669506170107,0.0098334306405782,0,0,9.54064454064454,51.201795737353706,GNAS;ADCY7;CFTR,1,1,A1
85,KEGG_2021_Human,"Parathyroid hormone synthesis, secretion and action",3/106,0.0051978010793919,0.0108186789908275,0,0,9.168284789644012,48.22077366115591,GNAS;ADCY7;HBEGF,1,1,A1
86,KEGG_2021_Human,cAMP signaling pathway,4/216,0.0056547947654469,0.0116345777358046,0,0,6.001825928180158,31.060958413414888,ADORA1;GNAS;ADCY7;CFTR,1,1,A1
87,KEGG_2021_Human,Herpes simplex virus 1 infection,6/498,0.0059513221221655,0.0121055302257685,0,0,3.951626016260162,20.24869235888937,HLA-B;HLA-C;HLA-A;B2M;TNFRSF1A;IFNAR1,1,1,A1
88,KEGG_2021_Human,Leukocyte transendothelial migration,3/114,0.0063589046719933,0.0127892577110876,0,0,8.504075504075503,43.01275616024597,ITGA4;ITGB2;MMP9,1,1,A1
89,KEGG_2021_Human,Endocytosis,4/252,0.0096326918059526,0.0191583537029502,0,0,5.121227887617065,23.775774536677176,HLA-B;HLA-C;HLA-A;TGFBR1,1,1,A1
90,KEGG_2021_Human,Apelin signaling pathway,3/137,0.0105076435126644,0.0206688811952411,0,0,7.036247334754798,32.054696586571794,CDH1;ADCY7;TGFBR1,1,1,A1
91,KEGG_2021_Human,Measles,3/139,0.010927140901957,0.021117768255135,0,0,6.932072829131653,31.308745708244224,RACK1;CD3D;IFNAR1,1,1,A1
92,KEGG_2021_Human,Intestinal immune network for IgA production,2/48,0.0109718013839528,0.021117768255135,0,0,13.51086956521739,60.9668100275446,TGFB1;ITGA4,1,1,A1
93,KEGG_2021_Human,Vibrio cholerae infection,2/50,0.0118650634107129,0.0225941101118895,0,0,12.946614583333334,57.4073222604629,GNAS;CFTR,1,1,A1
94,KEGG_2021_Human,Ovarian steroidogenesis,2/51,0.0123233009764115,0.0232196934187122,0,0,12.681760204081632,55.75235849108612,GNAS;ADCY7,1,1,A1
95,KEGG_2021_Human,Hepatitis C,3/157,0.0151388462105505,0.028227640330089,0,0,6.116264687693259,25.630153606912117,EGF;TNFRSF1A;IFNAR1,1,1,A1
96,KEGG_2021_Human,Necroptosis,3/159,0.0156558338887514,0.0288906625369743,0,0,6.037240537240537,25.096275577528207,HSP90AA1;TNFRSF1A;IFNAR1,1,1,A1
97,KEGG_2021_Human,JAK-STAT signaling pathway,3/162,0.0164498721583794,0.030046195064795,0,0,5.922431865828092,24.326019171177595,PDGFRB;EGF;IFNAR1,1,1,A1
98,KEGG_2021_Human,Protein processing in endoplasmic reticulum,3/171,0.0189661366164419,0.0342923076196274,0,0,5.602607709750567,22.214900800961956,HSP90AA1;CANX;HSP90B1,1,1,A1
99,KEGG_2021_Human,Cortisol synthesis and secretion,2/65,0.0195192797200375,0.0345935749493735,0,0,9.856646825396826,38.79923734134345,GNAS;ADCY7,1,1,A1
100,KEGG_2021_Human,Inflammatory bowel disease,2/65,0.0195192797200375,0.0345935749493735,0,0,9.856646825396826,38.79923734134345,TGFB1;TGFB3,1,1,A1
101,KEGG_2021_Human,Adipocytokine signaling pathway,2/69,0.0218310473790006,0.0379393930178748,0,0,9.266324626865671,35.438336973132955,CD36;TNFRSF1A,1,1,A1
102,KEGG_2021_Human,Renin secretion,2/69,0.0218310473790006,0.0379393930178748,0,0,9.266324626865671,35.438336973132955,ADORA1;GNAS,1,1,A1
103,KEGG_2021_Human,Transcriptional misregulation in cancer,3/192,0.0256243332851402,0.0441034197888472,0,0,4.9748047367094985,18.22874349225433,PLAU;MMP9;MET,1,1,A1
0,KEGG_2021_Human,ECM-receptor interaction,13/88,9.093034293990121e-25,5.36489023345417e-23,0,0,265.32,14687.35072463372,ITGB1;LAMA5;ITGB5;ITGA3;LAMB2;ITGB4;FN1;COL1A1;COMP;ITGAV;ITGA5;ITGB6;CD44,2,2,A1
1,KEGG_2021_Human,PI3K-Akt signaling pathway,14/354,1.8265937599983058e-18,5.3884515919950015e-17,0,0,67.37156862745098,2751.7296562019383,ITGB1;LAMA5;ITGB5;ITGA3;LAMB2;ITGB4;FN1;AREG;COL1A1;COMP;ERBB3;ITGAV;ITGA5;ITGB6,2,2,A1
2,KEGG_2021_Human,Focal adhesion,12/201,6.505345432977034e-18,1.2793846018188171e-16,0,0,89.72789115646259,3550.883261265264,COL1A1;ITGB1;COMP;LAMA5;ITGB5;ITGA3;LAMB2;ITGB4;FN1;ITGAV;ITGA5;ITGB6,2,2,A1
3,KEGG_2021_Human,Human papillomavirus infection,12/331,2.7153084303480788e-15,4.0050799347634175e-14,0,0,52.81236005373936,1771.319735255797,COL1A1;ITGB1;COMP;LAMA5;ITGB5;ITGA3;LAMB2;ITGB4;FN1;ITGAV;ITGA5;ITGB6,2,2,A1
4,KEGG_2021_Human,Proteoglycans in cancer,9/205,2.813073177521297e-12,3.31942634947513e-11,0,0,53.421968787515006,1420.8504049908363,COL1A1;ITGB1;ITGB5;ERBB3;GPC1;FN1;ITGAV;ITGA5;CD44,2,2,A1
5,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,7/77,5.880236527502179e-12,5.782232585377144e-11,0,0,104.7578947368421,2708.9788308675656,ITGB1;ITGB5;ITGA3;ITGB4;ITGAV;ITGA5;ITGB6,2,2,A1
6,KEGG_2021_Human,Hypertrophic cardiomyopathy,7/90,1.8072522149967674e-11,1.5232554383544182e-10,0,0,88.29232720355104,2184.0544925273757,ITGB1;ITGB5;ITGA3;ITGB4;ITGAV;ITGA5;ITGB6,2,2,A1
7,KEGG_2021_Human,Dilated cardiomyopathy,7/96,2.8687731520990796e-11,2.1157201996730706e-10,0,0,82.31519810762862,1998.164520445251,ITGB1;ITGB5;ITGA3;ITGB4;ITGAV;ITGA5;ITGB6,2,2,A1
8,KEGG_2021_Human,Regulation of actin cytoskeleton,8/218,2.31182785846761e-10,1.5155315961065443e-09,0,0,41.82857142857143,928.0844973891604,ITGB1;ITGB5;ITGA3;ITGB4;FN1;ITGAV;ITGA5;ITGB6,2,2,A1
9,KEGG_2021_Human,Small cell lung cancer,6/92,1.7163829678887675e-09,1.0126659510543728e-08,0,0,69.37674418604651,1400.234066831048,ITGB1;LAMA5;ITGA3;LAMB2;FN1;ITGAV,2,2,A1
10,KEGG_2021_Human,Phagosome,6/152,3.5435052134551716e-08,1.9006073417623189e-07,0,0,40.74246575342466,698.9599923347313,ITGB1;COMP;ITGB5;ITGAV;ITGA5;CALR,2,2,A1
11,KEGG_2021_Human,Pathways in cancer,7/531,3.7920344365039374e-06,1.8644169312811028e-05,0,0,13.675170751305746,170.7017943482004,ITGB1;LAMA5;ITGA3;LAMB2;FN1;ITGAV;LRP6,2,2,A1
12,KEGG_2021_Human,Amoebiasis,4/102,8.743668111812081e-06,3.968280143053175e-05,0,0,36.87569573283859,429.4978939955388,COL1A1;LAMA5;LAMB2;FN1,2,2,A1
13,KEGG_2021_Human,Bacterial invasion of epithelial cells,3/77,0.0001338383109174152,0.0005640328817233926,0,0,35.07638072855464,312.8419646622961,ITGB1;FN1;ITGA5,2,2,A1
14,KEGG_2021_Human,Hematopoietic cell lineage,3/99,0.00028159031963469633,0.0011075885905631,0,0,27.008152173913043,220.79319187429456,ITGA3;ITGA5;CD44,2,2,A1
15,KEGG_2021_Human,Toxoplasmosis,3/112,0.0004046284662695075,0.0014920674693688,0,0,23.77143996808935,185.71535601511485,ITGB1;LAMA5;LAMB2,2,2,A1
16,KEGG_2021_Human,Yersinia infection,3/137,0.0007283985897609024,0.002527971576229,0,0,19.312134977287474,139.523650532531,ITGB1;FN1;ITGA5,2,2,A1
17,KEGG_2021_Human,Axon guidance,3/182,0.0016519045010059,0.0054145758644082,0,0,14.424338110274473,92.39980606638925,ITGB1;PLXNA1;SEMA3F,2,2,A1
18,KEGG_2021_Human,Shigellosis,3/246,0.0038776419242105,0.0120410986067589,0,0,10.59098228663446,58.806726346392246,ITGB1;ITGA5;CD44,2,2,A1
19,KEGG_2021_Human,Pertussis,2/76,0.0043656592891775,0.0128786949030738,0,0,22.40990990990991,121.77513808303524,ITGB1;ITGA5,2,2,A1
20,KEGG_2021_Human,ErbB signaling pathway,2/85,0.0054295113427952,0.0152543413916628,0,0,19.970883534136547,104.16625407098388,ERBB3;AREG,2,2,A1
21,KEGG_2021_Human,MicroRNAs in cancer,3/310,0.0073636893637585,0.0190826388056009,0,0,8.355898597932304,41.03744072649827,ERBB3;ITGA5;CD44,2,2,A1
22,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,2/100,0.0074389947886241,0.0190826388056009,0,0,16.901360544217688,82.83389842043363,COL1A1;FN1,2,2,A1
23,KEGG_2021_Human,Protein digestion and absorption,2/103,0.0078755403387356,0.0193607033327252,0,0,16.396864686468646,79.42630566946903,COL1A1;COL18A1,2,2,A1
24,KEGG_2021_Human,Platelet activation,2/124,0.0112440495200817,0.026535956867393,0,0,13.560109289617486,60.856634450440026,COL1A1;ITGB1,2,2,A1
25,KEGG_2021_Human,Fluid shear stress and atherosclerosis,2/139,0.013973961266051,0.031710142872962,0,0,12.066301703163017,51.52986046289262,GPC1;ITGAV,2,2,A1
26,KEGG_2021_Human,Cell adhesion molecules,2/148,0.0157363858372094,0.0343869171998281,0,0,11.317351598173516,46.98715038313553,ITGB1;ITGAV,2,2,A1
27,KEGG_2021_Human,Phenylalanine metabolism,1/17,0.0218801506534414,0.0461046031626087,0,0,49.895,190.70744238188936,MIF,2,2,A1
0,KEGG_2021_Human,PI3K-Akt signaling pathway,42/354,4.1316846725532436e-41,8.222052498380955e-39,0,0,28.92751479289941,2689.891599802288,ITGB1;LAMA5;ITGB5;LAMA2;EPO;ITGB4;TNC;LAMC2;FGF1;FGF2;AREG;THBS1;EGFR;IGF1R;COMP;FGF6;ERBB3;ERBB2;ITGAV;ITGB6;HRAS;NGFR;HSP90AA1;LAMB3;ITGA3;LAMB2;INSR;ITGA2;FN1;VEGFB;LAMB1;VEGFA;COL1A1;EFNA1;EFNA3;COL1A2;COL6A2;COL6A1;ITGA7;FGFR4;FGFR3;FGFR2,3,3,A1
1,KEGG_2021_Human,ECM-receptor interaction,28/88,2.800729343512528e-40,2.786725696794965e-38,0,0,88.03111111111112,8017.303497907275,ITGB1;LAMA5;ITGB5;LAMA2;SDC4;ITGB4;TNC;LAMC2;THBS1;COMP;ITGAV;CD36;ITGB6;LAMB3;ITGA3;LAMB2;ITGA2;FN1;LAMB1;HSPG2;COL1A1;COL1A2;COL6A2;COL6A1;ITGA7;SDC1;AGRN;CD44,3,3,A1
2,KEGG_2021_Human,Pathways in cancer,44/531,3.0015811574164685e-36,1.99104883441959e-34,0,0,19.673765083173752,1609.1944488692789,RET;ITGB1;NOTCH3;LAMA5;NOTCH1;LAMA2;EPO;LRP5;CXCR4;LAMC2;FGF1;FGF2;EGFR;IGF1R;GNAI2;FGF6;CDH1;ERBB2;ITGAV;HRAS;FZD1;JAG2;HSP90AA1;TGFB1;FZD2;LAMB3;TGFB3;FZD4;WNT3A;ITGA3;LAMB2;ITGA2;WNT7B;FN1;VEGFB;LAMB1;ESR1;VEGFA;ADCY9;GNAS;CALM3;FGFR4;FGFR3;FGFR2,3,3,A1
3,KEGG_2021_Human,Proteoglycans in cancer,30/205,5.39606709029062e-32,2.684543377419584e-30,0,0,32.77447988904299,2359.665952646837,ITGB1;SDC4;ITGB5;FGF2;THBS1;EGFR;IGF1R;ERBB3;PLAU;GPC1;ERBB2;GPC3;ITGAV;HRAS;FZD1;TGFB1;FZD2;LUM;FZD4;WNT3A;ITGA2;WNT7B;FN1;ESR1;HSPG2;VEGFA;COL1A1;COL1A2;SDC1;CD44,3,3,A1
4,KEGG_2021_Human,Human papillomavirus infection,34/331,6.213623069476907e-31,2.473021981651809e-29,0,0,22.62966363976465,1573.9699051583634,ITGB1;NOTCH3;LAMA5;NOTCH1;ITGB5;LAMA2;ITGB4;TNC;LAMC2;THBS1;EGFR;COMP;ITGAV;ITGB6;HRAS;FZD1;FZD2;LAMB3;FZD4;WNT3A;ITGA3;LAMB2;ITGA2;WNT7B;FN1;LAMB1;VEGFA;COL1A1;COL1A2;MFNG;COL6A2;COL6A1;GNAS;ITGA7,3,3,A1
5,KEGG_2021_Human,Focal adhesion,28/201,3.031955113716507e-29,1.005598446049308e-27,0,0,30.35684007707129,1993.4049758714416,ITGB1;LAMA5;ITGB5;LAMA2;ITGB4;TNC;LAMC2;THBS1;EGFR;IGF1R;COMP;ERBB2;ITGAV;ITGB6;HRAS;LAMB3;ITGA3;LAMB2;ITGA2;FN1;VEGFB;LAMB1;VEGFA;COL1A1;COL1A2;COL6A2;COL6A1;ITGA7,3,3,A1
6,KEGG_2021_Human,Rap1 signaling pathway,24/210,5.187761555890345e-23,1.4748064994602553e-21,0,0,23.29801716484167,1195.4947621085478,FARP2;ITGB1;NGFR;INSR;ITGB2;VEGFB;FGF1;FGF2;THBS1;EGFR;IGF1R;VEGFA;GNAI2;EFNA1;FGF6;EFNA3;ADCY9;CDH1;GNAS;CALM3;FGFR4;FGFR3;HRAS;FGFR2,3,3,A1
7,KEGG_2021_Human,Axon guidance,19/182,1.2549582779643549e-17,3.121708716436333e-16,0,0,20.14723926380368,784.0669725678016,EPHB6;ITGB1;BMPR2;SEMA4D;SEMA4C;CXCR4;SEMA3F;NTN1;GNAI2;EFNA1;EFNB1;EFNA3;PLXNB2;PLXNA1;PLXNB1;HRAS;NEO1;EPHB4;EPHB3,3,3,A1
8,KEGG_2021_Human,Breast cancer,17/147,1.2347147498812027e-16,2.730091502515104e-15,0,0,22.249933687002653,815.0266746570863,FZD1;JAG2;NOTCH3;FZD2;NOTCH1;FZD4;WNT3A;WNT7B;LRP5;FGF1;ESR1;FGF2;EGFR;IGF1R;FGF6;ERBB2;HRAS,3,3,A1
9,KEGG_2021_Human,Amoebiasis,15/102,2.0937973471139567e-16,4.1666567207567735e-15,0,0,28.901227352425483,1043.4031547131492,LAMA5;TGFB1;LAMA2;LAMB3;TGFB3;LAMB2;ITGB2;FN1;LAMC2;LAMB1;COL1A1;COL3A1;COL1A2;GNAS;CD14,3,3,A1
10,KEGG_2021_Human,Regulation of actin cytoskeleton,19/218,3.753203650749242e-16,6.789886604537266e-15,0,0,16.472361809045225,585.0777291030586,ITGB1;ITGB5;ITGA3;ITGB4;ITGA2;ITGB2;FN1;CXCR4;FGF1;FGF2;EGFR;FGF6;ITGA7;ITGAV;ITGB6;FGFR4;FGFR3;HRAS;FGFR2,3,3,A1
11,KEGG_2021_Human,MAPK signaling pathway,21/294,5.365041296935676e-16,8.897026817418327e-15,0,0,13.457417582417582,473.1824152317044,NGFR;TGFB1;TGFB3;INSR;VEGFB;FGF1;FGF2;AREG;EGFR;IGF1R;VEGFA;EFNA1;FGF6;EFNA3;ERBB3;ERBB2;CD14;FGFR4;FGFR3;HRAS;FGFR2,3,3,A1
12,KEGG_2021_Human,Gastric cancer,16/149,3.369386934210033e-15,5.1577538454445893e-14,0,0,20.290726817042607,676.1691054186743,FZD1;TGFB1;FZD2;TGFB3;FZD4;WNT3A;WNT7B;LRP5;FGF1;FGF2;EGFR;FGF6;CDH1;ERBB2;HRAS;FGFR2,3,3,A1
13,KEGG_2021_Human,Dilated cardiomyopathy,13/96,6.909189166346737e-14,9.820918886450001e-13,0,0,25.82248995983936,782.5076674149926,ITGB1;TGFB1;ITGB5;LAMA2;ITGB4;ITGA3;TGFB3;ITGA2;ADCY9;GNAS;ITGA7;ITGAV;ITGB6,3,3,A1
14,KEGG_2021_Human,Ras signaling pathway,16/232,3.4443568388528558e-12,4.5695134062114546e-11,0,0,12.44127888572333,328.3786472748138,NGFR;INSR;VEGFB;FGF1;FGF2;EGFR;IGF1R;VEGFA;EFNA1;FGF6;EFNA3;CALM3;FGFR4;FGFR3;HRAS;FGFR2,3,3,A1
15,KEGG_2021_Human,Calcium signaling pathway,16/240,5.770431656302797e-12,7.176974372526603e-11,0,0,11.992063492063492,310.3339076042756,RET;VEGFB;CXCR4;FGF1;FGF2;EGFR;VEGFA;FGF6;ADCY9;ERBB3;ERBB2;GNAS;CALM3;FGFR4;FGFR3;FGFR2,3,3,A1
16,KEGG_2021_Human,Hypertrophic cardiomyopathy,11/90,1.9687708837176212e-11,2.3046200344694507e-10,0,0,22.58435360033202,556.7275011603164,ITGB1;TGFB1;ITGB5;LAMA2;ITGB4;ITGA3;TGFB3;ITGA2;ITGA7;ITGAV;ITGB6,3,3,A1
17,KEGG_2021_Human,Small cell lung cancer,11/92,2.5152234927948607e-11,2.780719305923207e-10,0,0,22.02448896984416,537.5313155257273,ITGB1;LAMA5;LAMA2;LAMB3;ITGA3;LAMB2;ITGA2;FN1;LAMC2;ITGAV;LAMB1,3,3,A1
18,KEGG_2021_Human,Relaxin signaling pathway,12/129,6.107519706310172e-11,6.396823271345915e-10,0,0,16.740834922653104,393.7262781320063,COL1A1;COL3A1;ADCY9;TGFB1;COL1A2;GNAS;VEGFB;INSL3;HRAS;EGFR;GNAI2;VEGFA,3,3,A1
19,KEGG_2021_Human,Signaling pathways regulating pluripotency of stem cells,12/143,2.0501278974835017e-10,2.039877257996084e-09,0,0,14.941139360292723,333.30617111183307,FZD1;FZD2;BMPR2;FZD4;WNT3A;WNT7B;FGFR4;FGFR3;FGF2;HRAS;FGFR2;IGF1R,3,3,A1
20,KEGG_2021_Human,Toxoplasmosis,11/112,2.1949463493759566e-10,2.07997296917055e-09,0,0,17.645349780879727,392.4271677551745,ITGB1;LAMA5;TGFB1;LAMA2;LAMB3;TGFB3;LAMB2;LAMC2;LAMB1;CCR5;GNAI2,3,3,A1
21,KEGG_2021_Human,MicroRNAs in cancer,16/310,2.6394632154034684e-10,2.387514453933137e-09,0,0,9.10425024710739,200.79674615499383,NOTCH3;NOTCH1;BMPR2;WNT3A;TNC;THBS1;EGFR;VEGFA;EFNA1;EFNA3;ERBB3;PLAU;ERBB2;FGFR3;HRAS;CD44,3,3,A1
22,KEGG_2021_Human,Hippo signaling pathway,12/163,9.357760985232655e-10,8.096497548092602e-09,0,0,12.949044934595808,269.2060457130548,FZD1;TGFB1;FZD2;BMPR2;TGFB3;CDH1;FZD4;WNT3A;WNT7B;ITGB2;FGF1;AREG,3,3,A1
23,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,10/100,1.25201690239574e-09,1.0381306815698013e-08,0,0,17.865401987353206,366.2141224359433,COL1A1;COL3A1;TGFB1;VCAM1;COL1A2;TGFB3;FN1;VEGFB;HRAS;VEGFA,3,3,A1
24,KEGG_2021_Human,Malaria,8/50,1.312701502432974e-09,1.0449103959366473e-08,0,0,30.20952380952381,617.8203670786149,COMP;TGFB1;VCAM1;TGFB3;ITGB2;SDC1;CD36;THBS1,3,3,A1
25,KEGG_2021_Human,Melanogenesis,10/101,1.3818329480241464e-09,1.0576336794492509e-08,0,0,17.66818547306352,360.42842169080114,FZD1;ADCY9;FZD2;FZD4;WNT3A;WNT7B;GNAS;CALM3;HRAS;GNAI2,3,3,A1
26,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,9/77,2.130060102385194e-09,1.569933186572791e-08,0,0,21.13270872865275,421.959238982878,ITGB1;ITGB5;LAMA2;ITGB4;ITGA3;ITGA2;ITGA7;ITGAV;ITGB6,3,3,A1
27,KEGG_2021_Human,Phagosome,11/152,5.783421283397684e-09,4.1103601264147824e-08,0,0,12.613998372282293,239.2657320998764,COMP;ITGB1;MRC2;ITGB5;ITGA2;ITGB2;ITGAV;CD14;CALR;CD36;THBS1,3,3,A1
28,KEGG_2021_Human,Bladder cancer,7/41,9.13398628086982e-09,6.267804378941702e-08,0,0,32.40686274509804,599.8919795067917,CDH1;ERBB2;THBS1;HRAS;FGFR3;EGFR;VEGFA,3,3,A1
29,KEGG_2021_Human,Hepatocellular carcinoma,11/168,1.6480219886291696e-08,1.0931879191240161e-07,0,0,11.319306672235564,202.854483060068,FZD1;TGFB1;FZD2;TGFB3;FZD4;WNT3A;WNT7B;LRP5;HRAS;EGFR;IGF1R,3,3,A1
30,KEGG_2021_Human,Human cytomegalovirus infection,11/225,3.243416708570093e-07,2.082064274211124e-06,0,0,8.280335529339666,123.7203711322618,ADCY9;GNAS;CXCR4;CALM3;ITGAV;CALR;CCR5;HRAS;EGFR;VEGFA;GNAI2,3,3,A1
31,KEGG_2021_Human,Fluid shear stress and atherosclerosis,9/139,3.825908181378666e-07,2.379236650294858e-06,0,0,11.019416873449131,162.82620710989832,HSP90AA1;VCAM1;BMPR2;SDC4;GPC1;SDC1;CALM3;ITGAV;VEGFA,3,3,A1
32,KEGG_2021_Human,Protein digestion and absorption,8/103,4.329441511484855e-07,2.6107844266226854e-06,0,0,13.320084210526316,195.1746264592408,COL1A1;COL18A1;COL3A1;COL16A1;COL1A2;COL6A2;COL7A1;COL6A1,3,3,A1
33,KEGG_2021_Human,Adherens junction,7/71,4.5791532651062693e-07,2.680151469871022e-06,0,0,17.190104166666668,250.91675726223892,FARP2;CDH1;INSR;ERBB2;SORBS1;EGFR;IGF1R,3,3,A1
34,KEGG_2021_Human,Melanoma,7/72,5.04441258509275e-07,2.868108869809878e-06,0,0,16.924786324786325,245.40626112908748,FGF6;CDH1;FGF1;FGF2;HRAS;EGFR;IGF1R,3,3,A1
35,KEGG_2021_Human,Cell adhesion molecules,9/148,6.504988401404713e-07,3.5958130329987164e-06,0,0,10.301229983754933,146.74644288279504,ITGB1;VCAM1;PTPRC;SDC4;CDH1;ITGB2;SDC1;ITGAV;NEO1,3,3,A1
36,KEGG_2021_Human,mTOR signaling pathway,9/154,9.084505170512232e-07,4.885990618734958e-06,0,0,9.871968854282535,137.33414563455833,FZD1;FZD2;FZD4;WNT3A;INSR;WNT7B;LRP5;HRAS;IGF1R,3,3,A1
37,KEGG_2021_Human,Cushing syndrome,9/155,9.590797134444745e-07,5.022549025669747e-06,0,0,9.80385550154662,135.85488492149244,FZD1;ADCY9;FZD2;FZD4;WNT3A;WNT7B;GNAS;EGFR;GNAI2,3,3,A1
38,KEGG_2021_Human,Alzheimer disease,13/369,1.129230160257912e-06,5.76196927926473e-06,0,0,5.937336142322097,81.30572932430272,FZD1;APP;FZD2;FZD4;WNT3A;INSR;WNT7B;LRP5;LPL;RTN4;CALM3;APOE;HRAS,3,3,A1
39,KEGG_2021_Human,Platelet activation,8/124,1.7839008347640869e-06,8.874906652951331e-06,0,0,10.897103448275862,144.24177760287964,COL1A1;ITGB1;COL3A1;ADCY9;COL1A2;ITGA2;GNAS;GNAI2,3,3,A1
40,KEGG_2021_Human,Estrogen signaling pathway,8/137,3.767846650725957e-06,1.816139570523822e-05,0,0,9.792496124031008,122.29855165996062,HSP90AA1;ADCY9;GNAS;CALM3;ESR1;HRAS;EGFR;GNAI2,3,3,A1
41,KEGG_2021_Human,Prostate cancer,7/97,3.833058390050278e-06,1.816139570523822e-05,0,0,12.208024691358023,152.25662269283464,HSP90AA1;PLAU;ERBB2;HRAS;FGFR2;EGFR;IGF1R,3,3,A1
42,KEGG_2021_Human,Chemical carcinogenesis,10/239,4.595676763318495e-06,2.1268364555822803e-05,0,0,6.9719884971775485,85.68848929208076,FGF6;HSP90AA1;ADCY9;GNAS;ESR1;FGF2;HRAS;EGFR;VEGFA;GNAI2,3,3,A1
43,KEGG_2021_Human,Central carbon metabolism in cancer,6/70,7.141998337112339e-06,3.23013106610308e-05,0,0,14.618356299212598,173.22047524457565,RET;ERBB2;HRAS;FGFR3;EGFR;FGFR2,3,3,A1
44,KEGG_2021_Human,HIF-1 signaling pathway,7/109,8.322584817739489e-06,3.680431952733685e-05,0,0,10.76525054466231,125.91615858906992,EPO;INSR;ERBB2;TIMP1;EGFR;IGF1R;VEGFA,3,3,A1
45,KEGG_2021_Human,FoxO signaling pathway,7/131,2.762003217630821e-05,0.00011948666093663772,0,0,8.845430107526882,92.85020779768112,TGFB1;TGFB3;INSR;HRAS;S1PR4;EGFR;IGF1R,3,3,A1
46,KEGG_2021_Human,Hematopoietic cell lineage,6/99,5.214899626215887e-05,0.0002208010692802046,0,0,10.04521209042418,99.0599110011037,EPO;ITGA3;ITGA2;CD14;CD36;CD44,3,3,A1
47,KEGG_2021_Human,Basal cell carcinoma,5/63,6.221068148615759e-05,0.00025791511699469496,0,0,13.34119073275862,129.209216718356,FZD1;FZD2;FZD4;WNT3A;WNT7B,3,3,A1
48,KEGG_2021_Human,Pancreatic cancer,5/76,0.00015261311944556752,0.0006074002153933587,0,0,10.891285211267606,95.70830660694708,TGFB1;TGFB3;ERBB2;EGFR;VEGFA,3,3,A1
49,KEGG_2021_Human,Pertussis,5/76,0.00015261311944556752,0.0006074002153933587,0,0,10.891285211267606,95.70830660694708,ITGB1;ITGB2;CALM3;CD14;GNAI2,3,3,A1
50,KEGG_2021_Human,ErbB signaling pathway,5/85,0.00025833605715186496,0.0010080171641808,0,0,9.66162109375,79.81706024177689,ERBB3;ERBB2;AREG;HRAS;EGFR,3,3,A1
51,KEGG_2021_Human,Colorectal cancer,5/86,0.0002728334873384258,0.0010441127688528,0,0,9.541859567901234,78.30669118713566,TGFB1;TGFB3;AREG;HRAS;EGFR,3,3,A1
52,KEGG_2021_Human,Endocytosis,8/252,0.0002874625524629982,0.0010793405271723,0,0,5.147016393442623,41.97092291144961,CXCR4;FGFR4;CCR5;FGFR3;HRAS;EGFR;FGFR2;IGF1R,3,3,A1
53,KEGG_2021_Human,Gap junction,5/88,0.0003036735450067032,0.0011190932491913,0,0,9.310993975903614,75.41492921543828,ADCY9;GNAS;HRAS;EGFR;GNAI2,3,3,A1
54,KEGG_2021_Human,Apelin signaling pathway,6/137,0.0003113960526928284,0.0011266875361067,0,0,7.117629380296928,57.47090678113976,NOTCH3;ADCY9;CDH1;CALM3;HRAS;GNAI2,3,3,A1
55,KEGG_2021_Human,Ovarian steroidogenesis,4/51,0.00036662280797180593,0.0013028203354712,0,0,13.076034966188356,103.44682720153146,ADCY9;INSR;GNAS;IGF1R,3,3,A1
56,KEGG_2021_Human,GnRH signaling pathway,5/93,0.000392334457260126,0.0013697290700835,0,0,8.779740767045455,68.86298251275844,ADCY9;GNAS;CALM3;HRAS;EGFR,3,3,A1
57,KEGG_2021_Human,TGF-beta signaling pathway,5/94,0.00041218849275715823,0.0014142329320461,0,0,8.68065308988764,67.65726892287765,BMPR2;TGFB1;TGFB3;NEO1;THBS1,3,3,A1
58,KEGG_2021_Human,Diabetic cardiomyopathy,7/203,0.0004233801894494165,0.0014280111474649,0,0,5.575680272108843,43.30764677855783,COL1A1;COL3A1;TGFB1;COL1A2;TGFB3;INSR;CD36,3,3,A1
59,KEGG_2021_Human,Regulation of lipolysis in adipocytes,4/55,0.0004901951038975145,0.00162581376126,0,0,12.048031615747076,91.8145197726138,ADCY9;INSR;GNAS;GNAI2,3,3,A1
60,KEGG_2021_Human,Oxytocin signaling pathway,6/154,0.0005802924531825535,0.0018930852161201,0,0,6.2946371568418815,46.90749982572365,ADCY9;GNAS;CALM3;HRAS;EGFR;GNAI2,3,3,A1
61,KEGG_2021_Human,Chagas disease,5/102,0.000599541669692648,0.0018968032902708,0,0,7.961501288659794,59.06912540350254,TGFB1;TGFB3;GNAS;CALR;GNAI2,3,3,A1
62,KEGG_2021_Human,Endometrial cancer,4/58,0.0006004955140053391,0.0018968032902708,0,0,11.376973873097905,84.39160923384428,CDH1;ERBB2;HRAS;EGFR,3,3,A1
63,KEGG_2021_Human,Notch signaling pathway,4/59,0.0006408763291536351,0.001992724835962,0,0,11.169556025369978,82.12610478127006,JAG2;NOTCH3;NOTCH1;MFNG,3,3,A1
64,KEGG_2021_Human,Long-term depression,4/60,0.0006831451971050027,0.0020914752957522,0,0,10.96954595791805,79.95486095353179,GNAS;HRAS;IGF1R;GNAI2,3,3,A1
65,KEGG_2021_Human,"Parathyroid hormone synthesis, secretion and action",5/106,0.00071420234364374,0.0021534282785621,0,0,7.644647277227722,55.38045647966366,ADCY9;GNAS;LRP5;EGFR;GNAI2,3,3,A1
66,KEGG_2021_Human,Cytokine-cytokine receptor interaction,8/295,0.0008129022513158369,0.0024144410151022,0,0,4.366271777003484,31.065585702740997,NGFR;TGFB1;BMPR2;TGFB3;EPO;CXCR4;CCR5;CXCL14,3,3,A1
67,KEGG_2021_Human,Wnt signaling pathway,6/166,0.0008594243133829289,0.0025150799759294,0,0,5.818996062992126,41.0777351320866,FZD1;FZD2;FZD4;WNT3A;WNT7B;LRP5,3,3,A1
68,KEGG_2021_Human,Leukocyte transendothelial migration,5/114,0.00099180104152774,0.0028604116994785,0,0,7.0807052752293576,48.97007295414482,ITGB1;VCAM1;ITGB2;CXCR4;GNAI2,3,3,A1
69,KEGG_2021_Human,Renal cell carcinoma,4/69,0.0011565992786047,0.0032880465206048,0,0,9.4463923673226,63.87906738914685,TGFB1;TGFB3;HRAS;VEGFA,3,3,A1
70,KEGG_2021_Human,Thyroid hormone signaling pathway,5/121,0.0012943473466172,0.0035571981036255,0,0,6.651064116379311,44.227904897108544,NOTCH3;NOTCH1;ITGAV;ESR1;HRAS,3,3,A1
71,KEGG_2021_Human,Pathways of neurodegeneration,10/475,0.0012999166684402,0.0035571981036255,0,0,3.3922545677069675,22.543075477743653,FZD1;APP;FZD2;FZD4;WNT3A;WNT7B;LRP5;CALM3;HRAS;SPTBN2,3,3,A1
72,KEGG_2021_Human,Tuberculosis,6/180,0.0013049018169078,0.0035571981036255,0,0,5.346999728482215,35.51278031686087,MRC2;TGFB1;TGFB3;ITGB2;CALM3;CD14,3,3,A1
73,KEGG_2021_Human,Non-small cell lung cancer,4/72,0.0013554546093618,0.0036450738819324,0,0,9.028271773825807,59.61926138785479,RET;ERBB2;HRAS;EGFR,3,3,A1
74,KEGG_2021_Human,Glioma,4/75,0.001577030437094,0.0041843874264227,0,0,8.645485314990719,55.78250124701372,CALM3;HRAS;EGFR;IGF1R,3,3,A1
75,KEGG_2021_Human,Gastric acid secretion,4/76,0.0016561650685219,0.0043365374820509,0,0,8.524978466838933,54.587573047381774,ADCY9;GNAS;CALM3;GNAI2,3,3,A1
76,KEGG_2021_Human,Leishmaniasis,4/77,0.0017380184067351,0.0044917618563674,0,0,8.407773176170755,53.431479765747,ITGB1;TGFB1;TGFB3;ITGB2,3,3,A1
77,KEGG_2021_Human,Chemokine signaling pathway,6/192,0.0018114860032848,0.0046216117263292,0,0,4.998983997967996,31.56162423290987,ADCY9;CXCR4;CCR5;CXCL14;HRAS;GNAI2,3,3,A1
78,KEGG_2021_Human,Thyroid cancer,3/37,0.0018934793703531,0.0047696505658263,0,0,13.46131221719457,84.39353244292744,RET;CDH1;HRAS,3,3,A1
79,KEGG_2021_Human,Human immunodeficiency virus 1 infection,6/212,0.0029708026014114,0.0073898714710109,0,0,4.509058940447978,26.237867347366148,CXCR4;CALM3;CALR;CCR5;HRAS;GNAI2,3,3,A1
80,KEGG_2021_Human,Phospholipase D signaling pathway,5/148,0.0031218694316893,0.0076697779864961,0,0,5.387893356643357,31.084498571411327,ADCY9;INSR;GNAS;HRAS;EGFR,3,3,A1
81,KEGG_2021_Human,Lipid and atherosclerosis,6/215,0.0031837544154601,0.0077264283984946,0,0,4.443657461477603,25.549671287743763,HSP90AA1;VCAM1;CALM3;CD14;CD36;HRAS,3,3,A1
82,KEGG_2021_Human,Rheumatoid arthritis,4/93,0.0034561929524582,0.0081594183353277,0,0,6.890688964375926,39.05358331925753,TGFB1;TGFB3;ITGB2;VEGFA,3,3,A1
83,KEGG_2021_Human,Salivary secretion,4/93,0.0034561929524582,0.0081594183353277,0,0,6.890688964375926,39.05358331925753,ADCY9;TRPV6;GNAS;CALM3,3,3,A1
84,KEGG_2021_Human,Human T-cell leukemia virus 1 infection,6/219,0.0034851786859439,0.0081594183353277,0,0,4.3593212820228455,24.67042777443805,TGFB1;ADCY9;TGFB3;ITGB2;CALR;HRAS,3,3,A1
85,KEGG_2021_Human,Circadian entrainment,4/97,0.0040188533372333,0.0092994396989469,0,0,6.592981578728016,36.37188819681642,ADCY9;GNAS;CALM3;GNAI2,3,3,A1
86,KEGG_2021_Human,Progesterone-mediated oocyte maturation,4/100,0.0044793892906002,0.0101437726441395,0,0,6.385981912144703,34.53710520599195,HSP90AA1;ADCY9;IGF1R;GNAI2,3,3,A1
87,KEGG_2021_Human,Cholesterol metabolism,3/50,0.0044856884054486,0.0101437726441395,0,0,9.731587561374797,52.6173636813508,LPL;CD36;APOE,3,3,A1
88,KEGG_2021_Human,Longevity regulating pathway,4/102,0.004805407221609,0.0107446745741596,0,0,6.255022939408321,33.389396834552066,ADCY9;INSR;HRAS;IGF1R,3,3,A1
89,KEGG_2021_Human,Endocrine and other factor-regulated calcium reabsorption,3/53,0.0052843835705361,0.0116843592281855,0,0,9.146307692307692,47.95408486507544,ADCY9;GNAS;ESR1,3,3,A1
90,KEGG_2021_Human,Serotonergic synapse,4/113,0.0068857374411452,0.0150578214372297,0,0,5.620652869639428,27.98131329111859,APP;GNAS;HRAS;GNAI2,3,3,A1
91,KEGG_2021_Human,"Growth hormone synthesis, secretion and action",4/119,0.0082378825988742,0.0176272971739353,0,0,5.325783619817998,25.558499150677157,ADCY9;GNAS;HRAS;GNAI2,3,3,A1
92,KEGG_2021_Human,Sphingolipid signaling pathway,4/119,0.0082378825988742,0.0176272971739353,0,0,5.325783619817998,25.558499150677157,S1PR3;HRAS;S1PR4;GNAI2,3,3,A1
93,KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,5/193,0.0094521609015553,0.020010425738399,0,0,4.088887965425532,19.060399895454207,CALM3;CCR5;FGF2;HRAS;VEGFA,3,3,A1
94,KEGG_2021_Human,Renin secretion,3/69,0.0109446234389426,0.0229261059405219,0,0,6.923426573426574,31.258626778042032,GNAS;CALM3;GNAI2,3,3,A1
95,KEGG_2021_Human,Vascular smooth muscle contraction,4/133,0.0120409078605147,0.0249597985858587,0,0,4.74442641668169,20.96773368430215,ADCY9;RAMP3;GNAS;CALM3,3,3,A1
96,KEGG_2021_Human,PPAR signaling pathway,3/74,0.0132208568565304,0.0270136318138383,0,0,6.434236186348862,27.83424600161923,LPL;CD36;SORBS1,3,3,A1
97,KEGG_2021_Human,Insulin signaling pathway,4/137,0.0133031955666138,0.0270136318138383,0,0,4.600804336422452,19.874329153528432,INSR;CALM3;SORBS1;HRAS,3,3,A1
98,KEGG_2021_Human,Chronic myeloid leukemia,3/76,0.0142012181190962,0.02854588288586,0,0,6.257323498419389,26.621329387197687,TGFB1;TGFB3;HRAS,3,3,A1
99,KEGG_2021_Human,Bacterial invasion of epithelial cells,3/77,0.0147064841889393,0.0292659035359893,0,0,6.172453222453222,26.04446133044011,ITGB1;CDH1;FN1,3,3,A1
100,KEGG_2021_Human,Adrenergic signaling in cardiomyocytes,4/150,0.0179760565725434,0.0354181708706549,0,0,4.188382712116385,16.831914742957764,ADCY9;GNAS;CALM3;GNAI2,3,3,A1
101,KEGG_2021_Human,Cellular senescence,4/156,0.020437002886116,0.0398721919052655,0,0,4.021827825377397,15.646551766779885,TGFB1;TGFB3;CALM3;HRAS,3,3,A1
102,KEGG_2021_Human,Morphine addiction,3/91,0.022846937450436,0.0441411704139492,0,0,5.186800699300699,19.60059929345622,ADCY9;GNAS;GNAI2,3,3,A1
103,KEGG_2021_Human,Hepatitis B,4/162,0.0230959315436796,0.0441931767037716,0,0,3.867922676871749,14.574714799596686,TGFB1;TGFB3;HSPG2;HRAS,3,3,A1
104,KEGG_2021_Human,Th1 and Th2 cell differentiation,3/92,0.023505001331951,0.0445475739529357,0,0,5.128262748487468,19.233765121852983,JAG2;NOTCH3;NOTCH1,3,3,A1
105,KEGG_2021_Human,cGMP-PKG signaling pathway,4/167,0.0254654194738346,0.0475332136277965,0,0,3.748323583963475,13.757973749154976,ADCY9;INSR;CALM3;GNAI2,3,3,A1
106,KEGG_2021_Human,Salmonella infection,5/249,0.0255580595888152,0.0475332136277965,0,0,3.14148949795082,11.519221759326769,HSP90AA1;PTPRC;CD14;HRAS;S100A10,3,3,A1
0,KEGG_2021_Human,PI3K-Akt signaling pathway,29/354,3.7159670484018916e-27,7.24613574438369e-25,0,0,23.92484720758693,1455.9982199741262,CSF1R;CSF1;ITGB5;LAMA1;FLT4;TNC;PDGFB;FASLG;IL2RG;AREG;ERBB3;ERBB2;ITGAV;ITGB7;EGF;ITGA3;ITGA1;FN1;NGF;EREG;VEGFA;COL1A1;EFNA1;COL1A2;COL4A1;IL2RA;IL2RB;ITGA6;ITGA5,1,1,B1
1,KEGG_2021_Human,Human papillomavirus infection,26/331,7.410386545721467e-24,7.225126882078429e-22,0,0,21.97661777394305,1170.4561941168572,NOTCH2;ITGB5;LAMA1;TRADD;TNC;FASLG;PSEN1;ITGAV;ITGB7;FADD;EGF;ITGA3;ITGA1;HLA-B;FN1;HLA-C;HLA-A;TNFRSF1A;VEGFA;COL1A1;COL1A2;COL4A1;GNAS;FAS;ITGA6;ITGA5,1,1,B1
2,KEGG_2021_Human,Pathways in cancer,30/531,2.351821175380885e-23,1.5286837639975748e-21,0,0,16.131902860944777,840.5409761850211,NOTCH2;CSF1R;LAMA1;FLT4;PDGFB;CXCR4;FASLG;IL2RG;ADCY7;GNAI2;ERBB2;ITGAV;FADD;TGFB1;EGF;IL15;ITGA3;FN1;ESR1;VEGFA;ADCY9;COL4A1;IL2RA;IL2RB;GNAS;FAS;CALM3;ITGA6;IL6ST;CALM1,1,1,B1
3,KEGG_2021_Human,Cytokine-cytokine receptor interaction,24/295,2.140929487528682e-22,1.0437031251702324e-20,0,0,22.28441669032075,1111.8950538723727,IL10;CSF1R;CXCL9;TGFB1;CSF1;IL15;IL10RA;EBI3;CXCR4;FASLG;IL27;CXCL13;IL2RG;NGF;IL27RA;TNFRSF1A;CXCL10;CXCL11;IL2RA;CCL5;CXCR3;IL2RB;FAS;IL6ST,1,1,B1
4,KEGG_2021_Human,Viral protein interaction with cytokine and cytokine receptor,16/100,5.822120279579246e-20,2.2706269090359063e-18,0,0,43.88482834994463,1943.6606869489224,IL10;CSF1R;CXCL9;CSF1;IL10RA;CXCR4;CXCL13;IL2RG;TNFRSF1A;CXCL10;CXCL11;CCL5;CXCR3;IL2RA;IL2RB;IL6ST,1,1,B1
5,KEGG_2021_Human,Human cytomegalovirus infection,20/225,1.6545895754327068e-19,5.377416120156297e-18,0,0,23.4301011302796,1013.2479327893536,IL10RA;TRADD;HLA-B;HLA-C;CXCR4;FASLG;HLA-A;ADCY7;TNFRSF1A;VEGFA;GNAI2;ADCY9;CCL5;GNAS;FAS;CALM3;ITGAV;FADD;CALM1;B2M,1,1,B1
6,KEGG_2021_Human,ECM-receptor interaction,15/88,3.290382397286777e-19,9.166065249584595e-18,0,0,46.82333490788852,1992.7127770487452,ITGB5;SDC4;ITGA3;LAMA1;ITGA1;TNC;FN1;COL1A1;COL1A2;COL4A1;ITGAV;ITGB7;ITGA6;ITGA5;CD44,1,1,B1
7,KEGG_2021_Human,Focal adhesion,19/201,4.479811708320133e-19,1.0919541039030324e-17,0,0,24.798358268237788,1047.7191242134736,ITGB5;EGF;ITGA3;LAMA1;FLT4;ITGA1;TNC;PDGFB;FN1;VEGFA;COL1A1;COL1A2;COL4A1;ERBB2;ITGA6;ITGAV;ITGB7;ITGA5;VCL,1,1,B1
8,KEGG_2021_Human,Proteoglycans in cancer,18/205,1.5606141864552493e-17,3.381330737319707e-16,0,0,22.58708938120703,874.0947707682997,TGFB1;SDC4;ITGB5;SDC2;FN1;FASLG;ESR1;VEGFA;COL1A1;COL1A2;ERBB3;PLAU;GPC1;ERBB2;FAS;ITGAV;ITGA5;CD44,1,1,B1
9,KEGG_2021_Human,Rap1 signaling pathway,18/210,2.4051184416387366e-17,4.689980961195535e-16,0,0,21.993303571428573,841.6033956081059,FARP2;CSF1R;ITGAM;CSF1;EGF;FLT4;ITGB2;PDGFB;NGF;ITGAL;ADCY7;VEGFA;GNAI2;EFNA1;ADCY9;GNAS;CALM3;CALM1,1,1,B1
10,KEGG_2021_Human,Human T-cell leukemia virus 1 infection,18/219,5.0961712858893107e-17,9.034121824985598e-16,0,0,20.998933901918974,787.7846029218532,NRP1;TGFB1;IL15;ITGB2;HLA-B;HLA-C;CD3G;HLA-A;IL2RG;ITGAL;ADCY7;ICAM1;TNFRSF1A;ADCY9;IL2RA;IL2RB;CANX;B2M,1,1,B1
11,KEGG_2021_Human,Regulation of actin cytoskeleton,16/218,1.8926421738009185e-14,3.0755435324264925e-13,0,0,18.14045590605572,573.206070788841,ITGAM;ITGB5;EGF;ITGA3;ITGA1;ITGB2;PDGFB;FN1;CXCR4;ITGAL;ITGAX;ITGA6;ITGAV;ITGB7;ITGA5;VCL,1,1,B1
12,KEGG_2021_Human,Cell adhesion molecules,14/148,2.6889875177493312e-14,4.033481276623997e-13,0,0,23.46472184531886,733.2027868787504,ITGAM;SDC4;SDC2;ITGB2;HLA-B;HLA-C;HLA-A;ITGAL;ICAM1;PECAM1;ITGA6;MADCAM1;ITGAV;ITGB7,1,1,B1
13,KEGG_2021_Human,Dilated cardiomyopathy,12/96,6.97340026744898e-14,9.712950372518225e-13,0,0,31.45079365079365,952.7731216244453,ADCY9;TGFB1;ITGB5;ITGA3;LAMA1;ITGA1;GNAS;ITGAV;ITGB7;ITGA6;ITGA5;ADCY7,1,1,B1
14,KEGG_2021_Human,MAPK signaling pathway,17/294,1.37367963994485e-13,1.785783531928305e-12,0,0,14.166787003610107,419.565167593502,CSF1R;TGFB1;CSF1;EGF;TRADD;FLT4;PDGFB;FASLG;NGF;AREG;EREG;TNFRSF1A;VEGFA;EFNA1;ERBB3;ERBB2;FAS,1,1,B1
15,KEGG_2021_Human,Chagas disease,12/102,1.4709021766700718e-13,1.7926620278166497e-12,0,0,29.345185185185183,867.0836165973132,IL10;TGFB1;CCL5;SERPINE1;GNAS;FAS;CD3G;FASLG;FADD;CD247;TNFRSF1A;GNAI2,1,1,B1
16,KEGG_2021_Human,Human immunodeficiency virus 1 infection,15/212,2.25519212383174e-13,2.5868380243952308e-12,0,0,17.242254507264136,502.1008488272776,TRADD;HLA-B;HLA-C;CXCR4;FASLG;CD3G;HLA-A;TNFRSF1A;GNAI2;FAS;CALM3;CD247;FADD;CALM1;B2M,1,1,B1
17,KEGG_2021_Human,Amoebiasis,11/102,4.237106043613417e-12,4.590198213914535e-11,0,0,26.31046975003019,688.995971032911,COL1A1;IL10;TGFB1;COL1A2;ITGAM;COL4A1;LAMA1;ITGB2;FN1;GNAS;VCL,1,1,B1
18,KEGG_2021_Human,Tuberculosis,13/180,7.652871889002572e-12,7.85426325450264e-11,0,0,17.257821435780127,441.7301642135983,IL10;TGFB1;ITGAM;IL10RA;TRADD;ITGB2;TNFRSF1A;MRC2;FCGR2A;ITGAX;CALM3;FADD;CALM1,1,1,B1
19,KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,13/193,1.8506226840776862e-11,1.8043571169757442e-10,0,0,16.000873907615482,395.4282184754372,TRADD;HLA-B;PDGFB;HLA-C;HLA-A;ICAM1;TNFRSF1A;VEGFA;FAS;CALM3;FADD;IL6ST;CALM1,1,1,B1
20,KEGG_2021_Human,Calcium signaling pathway,14/240,2.047864726914433e-11,1.901588674991974e-10,0,0,13.847948511665326,340.8207009251013,EGF;FLT4;PDGFB;HTR2C;CXCR4;NGF;ADCY7;VEGFA;ADCY9;ERBB3;ERBB2;GNAS;CALM3;CALM1,1,1,B1
21,KEGG_2021_Human,Epstein-Barr virus infection,13/202,3.285077082774074e-11,2.9117728688224744e-10,0,0,15.23197193983711,367.6852698976388,TRADD;HLA-B;HLA-C;CD3G;HLA-A;ITGAL;ICAM1;CXCL10;FAS;CD247;FADD;B2M;CD44,1,1,B1
22,KEGG_2021_Human,Hematopoietic cell lineage,10/99,8.112276193385457e-11,6.87779938134854e-10,0,0,24.192721055202732,562.1192655044885,CSF1R;ITGAM;CSF1;ITGA3;IL2RA;ITGA1;CD3G;ITGA6;ITGA5;CD44,1,1,B1
23,KEGG_2021_Human,Fluid shear stress and atherosclerosis,11/139,1.2725175580026267e-10,1.0339205158771343e-09,0,0,18.670157967032967,425.3968171356442,SDC4;GPC1;SDC2;PDGFB;PECAM1;CALM3;ITGAV;CALM1;ICAM1;TNFRSF1A;VEGFA,1,1,B1
24,KEGG_2021_Human,Phagosome,11/152,3.3386918425811266e-10,2.604179637213279e-09,0,0,16.937651001480788,369.5841495825804,MRC2;FCGR2A;ITGAM;ITGB5;CANX;ITGB2;HLA-B;HLA-C;ITGAV;HLA-A;ITGA5,1,1,B1
25,KEGG_2021_Human,Hypertrophic cardiomyopathy,9/90,8.174283529305191e-10,6.130712646978893e-09,0,0,23.676224611708484,495.4216346300178,TGFB1;ITGB5;ITGA3;LAMA1;ITGA1;ITGAV;ITGB7;ITGA6;ITGA5,1,1,B1
26,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,8/77,5.45080575477706e-09,3.936693045116766e-08,0,0,24.457600986740676,465.3670613337002,ITGB5;ITGA3;LAMA1;ITGA1;ITGAV;ITGB7;ITGA6;ITGA5,1,1,B1
27,KEGG_2021_Human,TNF signaling pathway,9/112,5.798906760962578e-09,4.038524351384653e-08,0,0,18.59849671155653,352.7315827737513,CXCL10;CSF1;IL15;TRADD;CCL5;FAS;FADD;ICAM1;TNFRSF1A,1,1,B1
28,KEGG_2021_Human,Malaria,7/50,6.077512721286986e-09,4.086603381555042e-08,0,0,34.02325581395349,643.6747598402659,IL10;TGFB1;SDC2;ITGB2;PECAM1;ITGAL;ICAM1,1,1,B1
29,KEGG_2021_Human,JAK-STAT signaling pathway,10/162,1.0330356360872428e-08,6.714731634567079e-08,0,0,14.120423340961098,259.6488727506422,IL10;EGF;IL15;IL10RA;IL2RA;IL2RB;PDGFB;IL6ST;IL2RG;IL27RA,1,1,B1
30,KEGG_2021_Human,Relaxin signaling pathway,9/129,2.0138853366760828e-08,1.266798840812375e-07,0,0,15.95,282.6438074062884,COL1A1;TGFB1;COL1A2;ADCY9;COL4A1;GNAS;ADCY7;VEGFA;GNAI2,1,1,B1
31,KEGG_2021_Human,Viral myocarditis,7/60,2.2541549374095482e-08,1.36138544541704e-07,0,0,27.58987090367428,485.7998421626386,LAMA1;ITGB2;HLA-B;HLA-C;HLA-A;ITGAL;ICAM1,1,1,B1
32,KEGG_2021_Human,Natural killer cell mediated cytotoxicity,9/131,2.3038830614749912e-08,1.36138544541704e-07,0,0,15.686938127974615,275.8718234959832,ITGB2;HLA-B;FAS;HLA-C;FASLG;HLA-A;CD247;ITGAL;ICAM1,1,1,B1
33,KEGG_2021_Human,Rheumatoid arthritis,8/93,2.467322023587213e-08,1.415081748822078e-07,0,0,19.8377972465582,347.5095532302249,TGFB1;CSF1;IL15;CCL5;ITGB2;ITGAL;ICAM1;VEGFA,1,1,B1
34,KEGG_2021_Human,Ras signaling pathway,11/232,2.846829177168702e-08,1.5860905415654198e-07,0,0,10.762617473024712,186.9948275572036,EFNA1;CSF1R;CSF1;EGF;FLT4;PDGFB;CALM3;FASLG;CALM1;NGF;VEGFA,1,1,B1
35,KEGG_2021_Human,Allograft rejection,6/38,3.6675860300028995e-08,1.986609099584904e-07,0,0,38.80078125,664.3138816610085,IL10;HLA-B;HLA-C;FAS;FASLG;HLA-A,1,1,B1
36,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,8/100,4.378260995248776e-08,2.307461875874355e-07,0,0,18.321924144310824,310.44721644543296,COL1A1;TGFB1;COL1A2;COL4A1;SERPINE1;FN1;ICAM1;VEGFA,1,1,B1
37,KEGG_2021_Human,Chemokine signaling pathway,10/192,5.2100557543120026e-08,2.673581242344317e-07,0,0,11.774964166268514,197.4672110151428,CXCL10;CXCL11;CXCL9;ADCY9;CCL5;CXCR3;CXCR4;CXCL13;ADCY7;GNAI2,1,1,B1
38,KEGG_2021_Human,Th17 cell differentiation,8/107,7.447609559641583e-08,3.7238047798207916e-07,0,0,17.020416935310553,279.35248849120853,TGFB1;IL2RA;IL2RB;CD3G;CD247;IL6ST;IL2RG;IL27RA,1,1,B1
39,KEGG_2021_Human,Pertussis,7/76,1.193860341630988e-07,5.808061122345319e-07,0,0,21.175133485888637,337.5507618197533,IL10;ITGAM;ITGB2;CALM3;ITGA5;CALM1;GNAI2,1,1,B1
40,KEGG_2021_Human,Leukocyte transendothelial migration,8/114,1.2211820821341442e-07,5.808061122345319e-07,0,0,15.890806904857486,252.95425560142803,ITGAM;ITGB2;PECAM1;CXCR4;ITGAL;VCL;ICAM1;GNAI2,1,1,B1
41,KEGG_2021_Human,Intestinal immune network for IgA production,6/48,1.5645529104313487e-07,7.263995655574118e-07,0,0,29.547619047619047,463.025832740191,IL10;TGFB1;IL15;CXCR4;ITGB7;MADCAM1,1,1,B1
42,KEGG_2021_Human,Autoimmune thyroid disease,6/53,2.8673615140906244e-07,1.3003151052271437e-06,0,0,26.39760638297872,397.6721100250711,IL10;HLA-B;HLA-C;FAS;FASLG;HLA-A,1,1,B1
43,KEGG_2021_Human,Gap junction,7/88,3.298055695782981e-07,1.461638319722003e-06,0,0,18.02716049382716,269.0510896267516,ADCY9;EGF;PDGFB;GNAS;HTR2C;ADCY7;GNAI2,1,1,B1
44,KEGG_2021_Human,Axon guidance,9/182,3.885854290333182e-07,1.683870192477712e-06,0,0,11.03393622972217,162.8692050621465,EFNB2;EFNA1;NRP1;SEMA3C;PLXNA1;CXCR4;EPHA1;PLXNA3;GNAI2,1,1,B1
45,KEGG_2021_Human,Measles,8/139,5.626496379690633e-07,2.3851452044340725e-06,0,0,12.841968491148286,184.80374368890853,TRADD;IL2RA;IL2RB;FAS;FASLG;CD3G;FADD;IL2RG,1,1,B1
46,KEGG_2021_Human,Inflammatory mediator regulation of TRP channels,7/98,6.894561431963229e-07,2.8605095302826164e-06,0,0,16.038056680161944,227.53772790106387,ADCY9;GNAS;HTR2C;CALM3;CALM1;NGF;ADCY7,1,1,B1
47,KEGG_2021_Human,Toxoplasmosis,7/112,1.7034262873447566e-06,6.920169292338074e-06,0,0,13.88982456140351,184.4967183053063,IL10;TGFB1;LAMA1;IL10RA;ITGA6;TNFRSF1A;GNAI2,1,1,B1
48,KEGG_2021_Human,Graft-versus-host disease,5/42,2.2885941857114306e-06,9.107670739055691e-06,0,0,27.66926720534968,359.35662275005984,HLA-B;HLA-C;FAS;FASLG;HLA-A,1,1,B1
49,KEGG_2021_Human,Gastric acid secretion,6/76,2.484115136889144e-06,9.68804903386766e-06,0,0,17.70357142857143,228.47510597835625,ADCY9;GNAS;CALM3;CALM1;ADCY7;GNAI2,1,1,B1
50,KEGG_2021_Human,Type I diabetes mellitus,5/43,2.579288471332235e-06,9.861985331564427e-06,0,0,26.93977211068909,346.66090625307965,HLA-B;HLA-C;FAS;FASLG;HLA-A,1,1,B1
51,KEGG_2021_Human,Influenza A,8/172,2.804007076921449e-06,1.0515026538455434e-05,0,0,10.240788790866633,130.92296557099266,CXCL10;TRADD;CCL5;FAS;FASLG;FADD;ICAM1;TNFRSF1A,1,1,B1
52,KEGG_2021_Human,Platelet activation,7/124,3.367309190488429e-06,1.2389156455570634e-05,0,0,12.457669815564552,156.98403796228388,COL1A1;COL1A2;ADCY9;FCGR2A;GNAS;ADCY7;GNAI2,1,1,B1
53,KEGG_2021_Human,MicroRNAs in cancer,10/310,4.188283938973929e-06,1.5124358668516966e-05,0,0,7.100724637681159,87.92983157753557,EFNA1;NOTCH2;ERBB3;PLAU;ERBB2;TNC;PDGFB;ITGA5;CD44;VEGFA,1,1,B1
54,KEGG_2021_Human,ErbB signaling pathway,6/85,4.789111502842195e-06,1.6979577146440507e-05,0,0,15.679588607594935,192.06187823722152,ERBB3;EGF;ERBB2;NRG2;AREG;EREG,1,1,B1
55,KEGG_2021_Human,Estrogen signaling pathway,7/137,6.518544446022708e-06,2.2698502981686217e-05,0,0,11.204534412955466,133.7917706437393,ADCY9;GNAS;CALM3;CALM1;ADCY7;ESR1;GNAI2,1,1,B1
56,KEGG_2021_Human,Small cell lung cancer,6/92,7.586921735014321e-06,2.5507754109099877e-05,0,0,14.398255813953488,169.74225613267856,ITGA3;COL4A1;LAMA1;FN1;ITGAV;ITGA6,1,1,B1
57,KEGG_2021_Human,Th1 and Th2 cell differentiation,6/92,7.586921735014321e-06,2.5507754109099877e-05,0,0,14.398255813953488,169.74225613267856,NOTCH2;IL2RA;IL2RB;CD3G;CD247;IL2RG,1,1,B1
58,KEGG_2021_Human,Salivary secretion,6/93,8.076917655891452e-06,2.669489733726836e-05,0,0,14.232040229885058,166.8920231208256,ADCY9;GNAS;CALM3;LYZ;CALM1;ADCY7,1,1,B1
59,KEGG_2021_Human,Staphylococcus aureus infection,6/95,9.133924108477334e-06,2.968525335255133e-05,0,0,13.910814606741573,161.41434806488027,IL10;ITGAM;FCGR2A;ITGB2;ITGAL;ICAM1,1,1,B1
60,KEGG_2021_Human,Circadian entrainment,6/97,1.030029745843715e-05,3.292718039992204e-05,0,0,13.603708791208792,156.21598316034618,ADCY9;GNAS;CALM3;CALM1;ADCY7;GNAI2,1,1,B1
61,KEGG_2021_Human,Melanogenesis,6/101,1.2995045549883887e-05,4.087151422947351e-05,0,0,13.028289473684213,146.580534239505,ADCY9;GNAS;CALM3;CALM1;ADCY7;GNAI2,1,1,B1
62,KEGG_2021_Human,Cellular senescence,7/156,1.5243541335418977e-05,4.71823898477254e-05,0,0,9.76637230660544,108.32229902941268,TGFB1;SERPINE1;HLA-B;HLA-C;CALM3;HLA-A;CALM1,1,1,B1
63,KEGG_2021_Human,Hepatitis C,7/157,1.5888839093291964e-05,4.841130661237395e-05,0,0,9.700771929824562,107.19249804108912,CXCL10;EGF;TRADD;FAS;FASLG;FADD;TNFRSF1A,1,1,B1
64,KEGG_2021_Human,Chemical carcinogenesis,8/239,3.0867346942574483e-05,9.260204082772344e-05,0,0,7.245832182002394,75.25384840605803,NOTCH2;ADCY9;EGF;GNAS;ADCY7;ESR1;VEGFA;GNAI2,1,1,B1
65,KEGG_2021_Human,Neurotrophin signaling pathway,6/119,3.30483187253415e-05,9.764275987032715e-05,0,0,10.943030973451329,112.90515829720157,MAGED1;CALM3;FASLG;PSEN1;CALM1;NGF,1,1,B1
66,KEGG_2021_Human,African trypanosomiasis,4/37,3.6999406111556855e-05,0.00010768483868288937,0,0,24.570191713048857,250.72919202935265,IL10;FAS;FASLG;ICAM1,1,1,B1
67,KEGG_2021_Human,Leishmaniasis,5/77,4.61574352153805e-05,0.00013236323333822348,0,0,14.193871706758303,141.7038439788246,IL10;ITGAM;TGFB1;FCGR2A;ITGB2,1,1,B1
68,KEGG_2021_Human,Herpes simplex virus 1 infection,11/498,4.726189558483419e-05,0.0001335662266527923,0,0,4.818038224609066,47.9867268719345,TRADD;CCL5;HLA-B;FAS;HLA-C;FASLG;HLA-A;ITGA5;FADD;B2M;TNFRSF1A,1,1,B1
69,KEGG_2021_Human,Antigen processing and presentation,5/78,4.9120661950872667e-05,0.00013683612972028813,0,0,13.998728993080071,138.88462121924852,CANX;HLA-B;HLA-C;HLA-A;B2M,1,1,B1
70,KEGG_2021_Human,Apelin signaling pathway,6/137,7.27023586749745e-05,0.0001996754921354933,0,0,9.430820610687023,89.86757907537377,ADCY9;SERPINE1;CALM3;CALM1;ADCY7;GNAI2,1,1,B1
71,KEGG_2021_Human,Complement and coagulation cascades,5/85,7.420052784284086e-05,0.000200959762907694,0,0,12.769329896907216,121.42022894917062,ITGAM;PLAU;ITGB2;SERPINE1;ITGAX,1,1,B1
72,KEGG_2021_Human,Apoptosis,6/142,8.867020666338293e-05,0.0002368587712241051,0,0,9.081801470588236,84.73853523131964,TRADD;FAS;FASLG;FADD;NGF;TNFRSF1A,1,1,B1
73,KEGG_2021_Human,Alzheimer disease,9/369,0.00011379523168225725,0.0002959846753094487,0,0,5.252150537634408,47.69535644323013,NCSTN;CSF1;FAS;ADAM10;CALM3;PSEN1;FADD;CALM1;TNFRSF1A,1,1,B1
74,KEGG_2021_Human,GnRH signaling pathway,5/93,0.00011384025973440336,0.0002959846753094487,0,0,11.603795688847235,105.37075370836816,ADCY9;GNAS;CALM3;CALM1;ADCY7,1,1,B1
75,KEGG_2021_Human,Lipid and atherosclerosis,7/215,0.00011708365125208846,0.00030041199992312173,0,0,6.975202429149798,63.14387034146463,CCL5;FAS;CALM3;FASLG;CALM1;ICAM1;TNFRSF1A,1,1,B1
76,KEGG_2021_Human,Adrenergic signaling in cardiomyocytes,6/150,0.00011991535704284434,0.00030368174835525513,0,0,8.573784722222221,77.41033951084553,ADCY9;GNAS;CALM3;CALM1;ADCY7;GNAI2,1,1,B1
77,KEGG_2021_Human,Oxytocin signaling pathway,6/154,0.00013851432945122895,0.0003462858236280724,0,0,8.340371621621621,74.10033839736161,ADCY9;GNAS;CALM3;CALM1;ADCY7;GNAI2,1,1,B1
78,KEGG_2021_Human,Aldosterone synthesis and secretion,5/98,0.00014579360712820756,0.00035987029607595535,0,0,10.977164394191332,96.96479026707432,ADCY9;GNAS;CALM3;CALM1;ADCY7,1,1,B1
79,KEGG_2021_Human,Necroptosis,6/159,0.00016490220899256224,0.00040194913441937046,0,0,8.06576797385621,70.25411289947829,TRADD;FAS;FASLG;HMGB1;FADD;TNFRSF1A,1,1,B1
80,KEGG_2021_Human,Regulation of lipolysis in adipocytes,4/55,0.00017808846839781445,0.0004287314979947385,0,0,15.883953581432571,137.12982644692147,ADCY9;GNAS;ADCY7;GNAI2,1,1,B1
81,KEGG_2021_Human,Toll-like receptor signaling pathway,5/104,0.00019272366380918132,0.00045830627369256537,0,0,10.3087576798917,88.18372325568018,CXCL10;CXCL11;CXCL9;CCL5;FADD,1,1,B1
82,KEGG_2021_Human,Endocytosis,7/252,0.00030979387357880765,0.000727828980094789,0,0,5.910676691729323,47.75592352780444,IL2RA;IL2RB;HLA-B;HLA-C;CXCR4;HLA-A;IL2RG,1,1,B1
83,KEGG_2021_Human,Renin secretion,4/69,0.0004274341262938596,0.000992257793182174,0,0,12.454003139717424,96.6145493299227,GNAS;CALM3;CALM1;GNAI2,1,1,B1
84,KEGG_2021_Human,Osteoclast differentiation,5/127,0.0004857908869663441,0.0011144614465698,0,0,8.355585600811223,63.750881347182016,CSF1R;TGFB1;FCGR2A;CSF1;TNFRSF1A,1,1,B1
85,KEGG_2021_Human,Pathogenic Escherichia coli infection,6/197,0.000520282904348477,0.0011797112366041,0,0,6.448625654450262,48.75894750025316,FCGR2A;TRADD;FAS;FASLG;FADD;TNFRSF1A,1,1,B1
86,KEGG_2021_Human,FoxO signaling pathway,5/131,0.0005596156122192783,0.0012543108549742,0,0,8.088692521682212,60.57023603273839,IL10;TGFB1;EGF;S1PR1;FASLG,1,1,B1
87,KEGG_2021_Human,Glioma,4/75,0.0005870751929339996,0.0012862883440688,0,0,11.398102903133084,84.80596212338662,EGF;PDGFB;CALM3;CALM1,1,1,B1
88,KEGG_2021_Human,Thyroid hormone synthesis,4/75,0.0005870751929339996,0.0012862883440688,0,0,11.398102903133084,84.80596212338662,ADCY9;CANX;GNAS;ADCY7,1,1,B1
89,KEGG_2021_Human,Vascular smooth muscle contraction,5/133,0.000599541669692648,0.0012990069510007,0,0,7.961501288659794,59.06912540350254,ADCY9;GNAS;CALM3;CALM1;ADCY7,1,1,B1
90,KEGG_2021_Human,Pancreatic cancer,4/76,0.0006172831748383996,0.0013227496603679,0,0,11.239229024943311,83.059955732762,TGFB1;EGF;ERBB2;VEGFA,1,1,B1
91,KEGG_2021_Human,Pathways of neurodegeneration,9/475,0.0007243736178479885,0.0015353571247864,0,0,4.035442336979094,29.177068307816477,CSF1;FAS;CALM3;FASLG;PSEN1;FADD;CALM1;TNFRSF1A;SPTBN2,1,1,B1
92,KEGG_2021_Human,cAMP signaling pathway,6/216,0.0008422604238994454,0.0017660299210794,0,0,5.859523809523809,41.48203766207477,ADCY9;GNAS;CALM3;CALM1;ADCY7;GNAI2,1,1,B1
93,KEGG_2021_Human,Breast cancer,5/147,0.0009418187760324082,0.0019537729928331,0,0,7.171482503267025,49.96872202905329,NOTCH2;EGF;FLT4;ERBB2;ESR1,1,1,B1
94,KEGG_2021_Human,Phospholipase D signaling pathway,5/148,0.000970854814248488,0.0019928072502995,0,0,7.120971811693461,49.40055717583537,ADCY9;EGF;GNAS;PDGFB;ADCY7,1,1,B1
95,KEGG_2021_Human,Colorectal cancer,4/86,0.0009827396138021671,0.0019961898405356,0,0,9.8636137381782,68.30716606958924,TGFB1;EGF;AREG;EREG,1,1,B1
96,KEGG_2021_Human,Bladder cancer,3/41,0.0011925956804552,0.0023974861617398,0,0,15.83732057416268,106.61087307041784,EGF;ERBB2;VEGFA,1,1,B1
97,KEGG_2021_Human,Morphine addiction,4/91,0.0012130627874591,0.0024137473832096,0,0,9.294393619516772,62.40819941956118,ADCY9;GNAS;ADCY7;GNAI2,1,1,B1
98,KEGG_2021_Human,Prostate cancer,4/97,0.0015364003833846,0.0030262431793939,0,0,8.69212201009436,56.31028711952232,PLAU;EGF;ERBB2;PDGFB,1,1,B1
99,KEGG_2021_Human,Shigellosis,6/246,0.0016404929940542,0.0031989613384057,0,0,5.119270833333333,32.82864742836224,TRADD;CCL5;ITGA5;VCL;CD44;TNFRSF1A,1,1,B1
100,KEGG_2021_Human,cGMP-PKG signaling pathway,5/167,0.001658923609257,0.0032028723149022,0,0,6.279750540918926,40.20036512494168,ADCY9;CALM3;CALM1;ADCY7;GNAI2,1,1,B1
101,KEGG_2021_Human,NF-kappa B signaling pathway,4/104,0.0019843119674809,0.00379353758489,0,0,8.080816326530613,50.28274254771109,PLAU;TRADD;ICAM1;TNFRSF1A,1,1,B1
102,KEGG_2021_Human,"Parathyroid hormone synthesis, secretion and action",4/106,0.0021272401450174,0.0040272993036737,0,0,7.921568627450981,48.74085603481362,ADCY9;GNAS;ADCY7;GNAI2,1,1,B1
103,KEGG_2021_Human,Ovarian steroidogenesis,3/51,0.0022455053639155,0.0042103225573417,0,0,12.531565656565656,76.42782186394092,ADCY9;GNAS;ADCY7,1,1,B1
104,KEGG_2021_Human,HIF-1 signaling pathway,4/109,0.0023547342489843,0.0043730778909708,0,0,7.694071914480077,46.55934821923256,EGF;SERPINE1;ERBB2;VEGFA,1,1,B1
105,KEGG_2021_Human,Endocrine and other factor-regulated calcium reabsorption,3/53,0.0025074370984639,0.004612738058495,0,0,12.02909090909091,72.03614022376087,ADCY9;GNAS;ESR1,1,1,B1
106,KEGG_2021_Human,Glutamatergic synapse,4/114,0.0027702339227821,0.0050485571489955,0,0,7.3424860853432286,43.23860470831561,ADCY9;GNAS;ADCY7;GNAI2,1,1,B1
107,KEGG_2021_Human,Neutrophil extracellular trap formation,5/189,0.0028411191258285,0.0051297984216348,0,0,5.52274764679516,32.38294698241226,FCGR2A;ITGAM;ITGB2;HMGB1;ITGAL,1,1,B1
108,KEGG_2021_Human,Transcriptional misregulation in cancer,5/192,0.0030398792754914,0.0054383161350534,0,0,5.433320469706158,31.4911857314544,CSF1R;ITGAM;PLAU;IL2RB;ITGB7,1,1,B1
109,KEGG_2021_Human,"Growth hormone synthesis, secretion and action",4/119,0.0032334126438381,0.0056803195094454,0,0,7.021472937000888,40.26265055762221,ADCY9;GNAS;ADCY7;GNAI2,1,1,B1
110,KEGG_2021_Human,Sphingolipid signaling pathway,4/119,0.0032334126438381,0.0056803195094454,0,0,7.021472937000888,40.26265055762221,TRADD;S1PR1;TNFRSF1A;GNAI2,1,1,B1
111,KEGG_2021_Human,Notch signaling pathway,3/59,0.0034037095339937,0.0059261014207927,0,0,10.737012987012989,61.01725732055938,NOTCH2;NCSTN;PSEN1,1,1,B1
112,KEGG_2021_Human,Viral carcinogenesis,5/203,0.0038551362080895,0.0066526686776766,0,0,5.1286056440695615,28.506579744126757,TRADD;HLA-B;HLA-C;HLA-A;IL6ST,1,1,B1
113,KEGG_2021_Human,Oocyte meiosis,4/129,0.0043129341491207,0.007377387360338,0,0,6.456489795918367,35.16292686640224,ADCY9;CALM3;CALM1;ADCY7,1,1,B1
114,KEGG_2021_Human,Cortisol synthesis and secretion,3/65,0.0044736431463163,0.0075203483925145,0,0,9.6950146627566,52.445687711406286,ADCY9;GNAS;ADCY7,1,1,B1
115,KEGG_2021_Human,Inflammatory bowel disease,3/65,0.0044736431463163,0.0075203483925145,0,0,9.6950146627566,52.445687711406286,IL10;TGFB1;IL2RG,1,1,B1
116,KEGG_2021_Human,Dopaminergic synapse,4/132,0.0046789146393352,0.0077981910655588,0,0,6.3042091836734695,33.8201223587293,GNAS;CALM3;CALM1;GNAI2,1,1,B1
117,KEGG_2021_Human,Amphetamine addiction,3/69,0.0052879500889933,0.0086651282970898,0,0,9.105601469237833,47.73451871673548,GNAS;CALM3;CALM1,1,1,B1
118,KEGG_2021_Human,Renal cell carcinoma,3/69,0.0052879500889933,0.0086651282970898,0,0,9.105601469237833,47.73451871673548,TGFB1;PDGFB;VEGFA,1,1,B1
119,KEGG_2021_Human,Yersinia infection,4/137,0.0053343692004392,0.0086683499507138,0,0,6.065674390056775,31.745220314113237,IL10;FCGR2A;FN1;ITGA5,1,1,B1
120,KEGG_2021_Human,RIG-I-like receptor signaling pathway,3/70,0.005504504862005,0.0088708962652147,0,0,8.969244685662597,46.65970116437159,CXCL10;TRADD;FADD,1,1,B1
121,KEGG_2021_Human,Adherens junction,3/71,0.0057263215771157,0.0091527271109636,0,0,8.836898395721924,45.622095514768695,FARP2;ERBB2;VCL,1,1,B1
122,KEGG_2021_Human,Coronavirus disease,5/232,0.0067395098377833,0.0106845887672174,0,0,4.466824106453517,22.333084591186736,CXCL10;NRP1;FCGR2A;IL6ST;TNFRSF1A,1,1,B1
123,KEGG_2021_Human,Bacterial invasion of epithelial cells,3/77,0.0071695468054091,0.0112746905407643,0,0,8.117936117936118,40.08566093767435,FN1;ITGA5;VCL,1,1,B1
124,KEGG_2021_Human,Cushing syndrome,4/155,0.0081969016668737,0.0126856811511141,0,0,5.337748344370861,25.64253793074891,ADCY9;GNAS;ADCY7;GNAI2,1,1,B1
125,KEGG_2021_Human,Non-alcoholic fatty liver disease,4/155,0.0081969016668737,0.0126856811511141,0,0,5.337748344370861,25.64253793074891,TGFB1;FAS;FASLG;TNFRSF1A,1,1,B1
126,KEGG_2021_Human,Phototransduction,2/28,0.0089298779982146,0.0137112299972586,0,0,15.286153846153846,72.12546292162165,CALM3;CALM1,1,1,B1
127,KEGG_2021_Human,Hepatitis B,4/162,0.0095373572602879,0.0145295677012198,0,0,5.099457504520796,23.72542414676911,TGFB1;FAS;FASLG;FADD,1,1,B1
128,KEGG_2021_Human,Insulin secretion,3/86,0.0097057997603937,0.0146096730154411,0,0,7.234392113910186,33.531636479489684,ADCY9;GNAS;ADCY7,1,1,B1
129,KEGG_2021_Human,Hippo signaling pathway,4/163,0.0097397820102941,0.0146096730154411,0,0,5.067128738287768,23.468591916685664,TGFB1;SERPINE1;ITGB2;AREG,1,1,B1
130,KEGG_2021_Human,GABAergic synapse,3/89,0.0106529385437983,0.0157372955760657,0,0,6.980972515856236,31.707015235591296,ADCY9;ADCY7;GNAI2,1,1,B1
131,KEGG_2021_Human,PD-L1 expression and PD-1 checkpoint pathway in cancer,3/89,0.0106529385437983,0.0157372955760657,0,0,6.980972515856236,31.707015235591296,EGF;CD3G;CD247,1,1,B1
132,KEGG_2021_Human,Bile secretion,3/90,0.0109801354135365,0.0160986947792453,0,0,6.900383141762452,31.132234428843127,ADCY9;GNAS;ADCY7,1,1,B1
133,KEGG_2021_Human,IL-17 signaling pathway,3/94,0.0123468147388916,0.0179673796573423,0,0,6.595737595737596,28.98402676264153,CXCL10;TRADD;FADD,1,1,B1
134,KEGG_2021_Human,Progesterone-mediated oocyte maturation,3/100,0.0145721785315227,0.0210487023233105,0,0,6.185879412683536,26.15786422245009,ADCY9;ADCY7;GNAI2,1,1,B1
135,KEGG_2021_Human,Alcoholism,4/186,0.0151891060893728,0.0217784977016742,0,0,4.421619197129401,18.514101376950865,GNAS;CALM3;CALM1;GNAI2,1,1,B1
136,KEGG_2021_Human,Pancreatic secretion,3/102,0.0153611383807227,0.0218643940455543,0,0,6.060299969390878,25.30729415703534,ADCY9;GNAS;ADCY7,1,1,B1
137,KEGG_2021_Human,Protein digestion and absorption,3/103,0.0157645113382288,0.0222759399344538,0,0,5.999393939393939,24.897448750666197,COL1A1;COL1A2;COL4A1,1,1,B1
138,KEGG_2021_Human,Primary immunodeficiency,2/38,0.0160686315537379,0.022368056037204,0,0,11.034444444444444,45.58203492237632,CD79A;IL2RG,1,1,B1
139,KEGG_2021_Human,C-type lectin receptor signaling pathway,3/104,0.0161738251345936,0.022368056037204,0,0,5.93969396939694,24.497442610017814,IL10;CALM3;CALM1,1,1,B1
140,KEGG_2021_Human,T cell receptor signaling pathway,3/104,0.0161738251345936,0.022368056037204,0,0,5.93969396939694,24.497442610017814,IL10;CD3G;CD247,1,1,B1
141,KEGG_2021_Human,Glucagon signaling pathway,3/107,0.0174374916920784,0.0239458512672908,0,0,5.7674825174825175,23.35330203422757,GNAS;CALM3;CALM1,1,1,B1
142,KEGG_2021_Human,Cholinergic synapse,3/113,0.0201261590001613,0.0272541736460518,0,0,5.451239669421487,21.291096846681032,ADCY9;ADCY7;GNAI2,1,1,B1
143,KEGG_2021_Human,Serotonergic synapse,3/113,0.0201261590001613,0.0272541736460518,0,0,5.451239669421487,21.291096846681032,GNAS;HTR2C;GNAI2,1,1,B1
144,KEGG_2021_Human,Vasopressin-regulated water reabsorption,2/44,0.0212003867195719,0.0285108648987347,0,0,9.455238095238096,36.43799007445939,ADCY9;GNAS,1,1,B1
145,KEGG_2021_Human,Thyroid hormone signaling pathway,3/121,0.0240468548328491,0.0321173746055177,0,0,5.079609655880843,18.93552031548243,NOTCH2;ITGAV;ESR1,1,1,B1
146,KEGG_2021_Human,Cocaine addiction,2/49,0.0259258637518775,0.0343914519157559,0,0,8.447234042553191,30.853642359468505,GNAS;GNAI2,1,1,B1
147,KEGG_2021_Human,Vibrio cholerae infection,2/50,0.0269177264019109,0.0354659232998151,0,0,8.270833333333334,29.898816321570965,ADCY9;GNAS,1,1,B1
148,KEGG_2021_Human,Legionellosis,2/57,0.0342756665277342,0.0448574159255582,0,0,7.215636363636364,24.340647624266385,ITGAM;ITGB2,1,1,B1
149,KEGG_2021_Human,Endometrial cancer,2/58,0.0353839947507074,0.0459991931759197,0,0,7.086428571428572,23.679270506020032,EGF;ERBB2,1,1,B1
150,KEGG_2021_Human,Long-term depression,2/60,0.037641852242917,0.0486103389891975,0,0,6.841379310344828,22.437252731021232,GNAS;GNAI2,1,1,B1
151,KEGG_2021_Human,Parkinson disease,4/249,0.0386920340723464,0.0496378068691286,0,0,3.2741357767596835,10.647887478125767,GNAS;CALM3;CALM1;GNAI2,1,1,B1
0,KEGG_2021_Human,Pathways in cancer,20/531,5.349737971017039e-16,1.0057507385512033e-13,0,0,15.835779517286367,556.8543218853523,PDGFRB;CSF1R;NOTCH3;LAMB3;LAMB2;MMP2;GSTP1;LAMB1;TRAF2;MMP9;GNAI2;EDNRA;CXCL12;ERBB2;GNAS;CALM3;ITGAV;MET;FGFR1;IFNAR1,2,2,B1
1,KEGG_2021_Human,ECM-receptor interaction,11/88,7.833794164617872e-15,7.363766514740799e-13,0,0,49.76190476190476,1616.2830599615183,ITGA4;LAMB3;SDC4;LAMB2;ITGB4;COL6A2;ITGA1;SDC1;LAMB1;ITGAV;HSPG2,2,2,B1
2,KEGG_2021_Human,Human papillomavirus infection,15/331,2.8031761007803945e-13,1.756657023155714e-11,0,0,17.568664915213756,507.78454143402354,PDGFRB;NOTCH3;ITGA4;LAMB3;LAMB2;ITGB4;ITGA1;LAMB1;HLA-F;TNFRSF1A;HLA-E;COL6A2;GNAS;ITGAV;IFNAR1,2,2,B1
3,KEGG_2021_Human,PI3K-Akt signaling pathway,15/354,7.401760556884618e-13,3.4788274617357696e-11,0,0,16.357488729337117,456.8955484475718,PDGFRB;CSF1R;ITGA4;LAMB3;LAMB2;ITGB4;ITGA1;LAMB1;COL6A2;ERBB2;ITGAV;TLR4;MET;FGFR1;IFNAR1,2,2,B1
4,KEGG_2021_Human,Proteoglycans in cancer,12/205,4.285733260241117e-12,1.6114357058506602e-10,0,0,21.9159881569208,573.6669767551859,SDC4;MMP2;GPC1;ERBB2;SDC1;ITGAV;MMP9;TLR4;HSPG2;MET;DCN;FGFR1,2,2,B1
5,KEGG_2021_Human,Human immunodeficiency virus 1 infection,12/212,6.366310160881299e-12,1.9947771837428067e-10,0,0,21.14142857142857,545.026051124787,CD4;CALM3;TRAF2;CALR;TNFRSF1B;HLA-F;TLR4;CD3D;B2M;TNFRSF1A;HLA-E;GNAI2,2,2,B1
6,KEGG_2021_Human,Human cytomegalovirus infection,12/225,1.2806795961645416e-11,3.4395394868419114e-10,0,0,19.838028169014084,497.55848022169374,CXCL12;CCL5;GNAS;CALM3;TRAF2;ITGAV;CALR;HLA-F;B2M;TNFRSF1A;HLA-E;GNAI2,2,2,B1
7,KEGG_2021_Human,Fluid shear stress and atherosclerosis,10/139,3.909503948452509e-11,9.187334278863395e-10,0,0,26.467522052927023,634.2948415657256,SDC4;MMP2;GPC1;GSTP1;PECAM1;SDC1;CALM3;ITGAV;MMP9;TNFRSF1A,2,2,B1
8,KEGG_2021_Human,Focal adhesion,11/201,7.463961864144231e-11,1.5591387005101283e-09,0,0,20.05189289012004,467.5770499312978,PDGFRB;ITGA4;LAMB3;LAMB2;ITGB4;COL6A2;ITGA1;ERBB2;LAMB1;ITGAV;MET,2,2,B1
9,KEGG_2021_Human,Cell adhesion molecules,9/148,1.7699974834163405e-09,3.3275952688227204e-08,0,0,21.721375442019266,437.7354074114267,CD4;ITGA4;SDC4;ITGB2;PECAM1;SDC1;ITGAV;HLA-F;HLA-E,2,2,B1
10,KEGG_2021_Human,Chagas disease,8/102,1.9883258406322427e-09,3.398229618535105e-08,0,0,28.139007092198582,563.7923817989547,C3;CCL5;GNAS;CALR;TLR4;CD3D;TNFRSF1A;GNAI2,2,2,B1
11,KEGG_2021_Human,Regulation of actin cytoskeleton,9/218,5.1964001740057535e-08,8.14102693927568e-07,0,0,14.395182872435326,241.4462943995204,PDGFRB;CXCL12;ITGA4;ITGB4;ITGA1;ITGB2;ITGAX;ITGAV;FGFR1,2,2,B1
12,KEGG_2021_Human,Leukocyte transendothelial migration,7/114,1.181001316313088e-07,1.677375177651383e-06,0,0,21.261682242990656,339.1606782533533,CXCL12;ITGA4;MMP2;ITGB2;PECAM1;MMP9;GNAI2,2,2,B1
13,KEGG_2021_Human,Renin secretion,6/69,1.2491091748467748e-07,1.677375177651383e-06,0,0,30.52073732718894,485.1474165280813,EDNRA;ADORA1;GNAS;CALM3;AQP1;GNAI2,2,2,B1
14,KEGG_2021_Human,Antigen processing and presentation,6/78,2.613100183455878e-07,3.275085563264701e-06,0,0,26.693548387096776,404.6090165721795,CD4;KLRD1;CALR;HLA-F;B2M;HLA-E,2,2,B1
15,KEGG_2021_Human,Rap1 signaling pathway,8/210,5.567284863934915e-07,6.541559715123525e-06,0,0,13.023102310231025,187.548146965454,PDGFRB;CSF1R;ITGB2;GNAS;CALM3;MET;FGFR1;GNAI2,2,2,B1
16,KEGG_2021_Human,Cytokine-cytokine receptor interaction,9/295,6.727435137987484e-07,7.439751799656747e-06,0,0,10.478487614080834,148.91923581768916,CSF1R;CD4;CXCL12;IL34;CCL5;LEPR;TNFRSF1B;TNFRSF1A;IFNAR1,2,2,B1
17,KEGG_2021_Human,Malaria,5/50,7.361800479386748e-07,7.565244621469476e-06,0,0,35.07407407407408,495.3087477237293,ITGB2;PECAM1;SDC1;MET;TLR4,2,2,B1
18,KEGG_2021_Human,Human T-cell leukemia virus 1 infection,8/219,7.64572594722979e-07,7.565244621469476e-06,0,0,12.461927330173776,175.51314720223388,CD4;ITGB2;CALR;HLA-F;CD3D;B2M;TNFRSF1A;HLA-E,2,2,B1
19,KEGG_2021_Human,Phagosome,7/152,8.383131575243383e-07,7.88014368072878e-06,0,0,15.659581684567552,219.1068955448172,C3;ITGB2;ITGAV;CALR;HLA-F;TLR4;HLA-E,2,2,B1
20,KEGG_2021_Human,Viral protein interaction with cytokine and cytokine receptor,6/100,1.1438701789268336e-06,1.0240361601821176e-05,0,0,20.42347288949897,279.41543507643144,CSF1R;CXCL12;IL34;CCL5;TNFRSF1B;TNFRSF1A,2,2,B1
21,KEGG_2021_Human,Amoebiasis,6/102,1.2852728090784564e-06,1.0983240368488629e-05,0,0,19.995967741935484,271.23609546327725,LAMB3;LAMB2;ITGB2;GNAS;LAMB1;TLR4,2,2,B1
22,KEGG_2021_Human,Toxoplasmosis,6/112,2.2236614504891345e-06,1.817601533443293e-05,0,0,18.100426049908705,235.6015786948364,LAMB3;LAMB2;LAMB1;TLR4;TNFRSF1A;GNAI2,2,2,B1
23,KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,7/193,4.119964824716563e-06,3.227305779361307e-05,0,0,12.18244315177155,151.0582253215618,C3;CALM3;TRAF2;HLA-F;TNFRSF1A;HLA-E;IFNAR1,2,2,B1
24,KEGG_2021_Human,Epstein-Barr virus infection,7/202,5.561073003059689e-06,4.181926898300886e-05,0,0,11.614880201765448,140.53679226024892,TRAF2;CALR;HLA-F;CD3D;B2M;HLA-E;IFNAR1,2,2,B1
25,KEGG_2021_Human,Pertussis,5/76,5.996047992936821e-06,4.3356039333543167e-05,0,0,22.20098367985692,266.9537295837368,C3;ITGB2;CALM3;TLR4;GNAI2,2,2,B1
26,KEGG_2021_Human,Lipid and atherosclerosis,7/215,8.365037184518926e-06,5.824544409961326e-05,0,0,10.881778058007566,127.22376166363964,ABCA1;CCL5;CALM3;TRAF2;MMP9;TLR4;TNFRSF1A,2,2,B1
27,KEGG_2021_Human,Small cell lung cancer,5/92,1.530497203072602e-05,0.00010276195506344612,0,0,18.103448275862068,200.7189560979294,LAMB3;LAMB2;LAMB1;TRAF2;ITGAV,2,2,B1
28,KEGG_2021_Human,Calcium signaling pathway,7/240,1.7075274134571934e-05,0.00011069488059653527,0,0,9.70189263350454,106.50620435144806,PDGFRB;EDNRA;ERBB2;GNAS;CALM3;MET;FGFR1,2,2,B1
29,KEGG_2021_Human,Dilated cardiomyopathy,5/96,1.882475565591017e-05,0.00011796846877703706,0,0,17.30420373277516,188.2755813518832,ITGA4;ITGB4;ITGA1;GNAS;ITGAV,2,2,B1
30,KEGG_2021_Human,Prostate cancer,5/97,1.9795901711578827e-05,0.00012005256521860707,0,0,17.115251897860592,185.3587878009673,PDGFRB;GSTP1;ERBB2;MMP9;FGFR1,2,2,B1
31,KEGG_2021_Human,Hematopoietic cell lineage,5/99,2.185495632713609e-05,0.00012839786842192455,0,0,16.749408983451538,179.73929512065823,CSF1R;CD4;ITGA4;ITGA1;CD3D,2,2,B1
32,KEGG_2021_Human,Tuberculosis,6/180,3.36932666072514e-05,0.0001919495188534322,0,0,10.988876529477198,113.16578612591768,C3;ITGB2;ITGAX;CALM3;TLR4;TNFRSF1A,2,2,B1
33,KEGG_2021_Human,TNF signaling pathway,5/112,3.962024423066749e-05,0.0002190766445695732,0,0,14.704791573950452,149.0502723898783,CCL5;TRAF2;TNFRSF1B;MMP9;TNFRSF1A,2,2,B1
34,KEGG_2021_Human,Herpes simplex virus 1 infection,9/498,4.5768650232374e-05,0.0002458430355338946,0,0,6.065197046896121,60.60291026644949,C3;CCL5;TRAF2;CALR;HLA-F;B2M;TNFRSF1A;HLA-E;IFNAR1,2,2,B1
35,KEGG_2021_Human,MAPK signaling pathway,7/294,6.21949943245057e-05,0.0003247960814724187,0,0,7.854858056777289,76.07615432923801,PDGFRB;CSF1R;ERBB2;TRAF2;MET;TNFRSF1A;FGFR1,2,2,B1
36,KEGG_2021_Human,Osteoclast differentiation,5/127,7.219196072807823e-05,0.0003668132058615866,0,0,12.887067395264117,122.89341839447226,CSF1R;TREM2;TRAF2;TNFRSF1A;IFNAR1,2,2,B1
37,KEGG_2021_Human,Adipocytokine signaling pathway,4/69,8.944984121176644e-05,0.0004425413196792656,0,0,19.10288461538461,178.0738910941142,LEPR;TRAF2;TNFRSF1B;TNFRSF1A,2,2,B1
38,KEGG_2021_Human,Central carbon metabolism in cancer,4/70,9.462924261679654e-05,0.0004561614772296859,0,0,18.8125,174.30804670887434,PDGFRB;ERBB2;MET;FGFR1,2,2,B1
39,KEGG_2021_Human,Estrogen signaling pathway,5/137,0.0001033385766050644,0.0004856913100438027,0,0,11.904761904761903,109.25595010834712,MMP2;GNAS;CALM3;MMP9;GNAI2,2,2,B1
40,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,4/77,0.00013719418568415212,0.0006141073073481095,0,0,17.002568493150687,151.22276924231187,ITGA4;ITGB4;ITGA1;ITGAV,2,2,B1
41,KEGG_2021_Human,Leishmaniasis,4/77,0.00013719418568415212,0.0006141073073481095,0,0,17.002568493150687,151.22276924231187,C3;ITGA4;ITGB2;TLR4,2,2,B1
42,KEGG_2021_Human,Hypertrophic cardiomyopathy,4/90,0.0002505985293132387,0.0010956400816485,0,0,14.42296511627907,119.59029963115674,ITGA4;ITGB4;ITGA1;ITGAV,2,2,B1
43,KEGG_2021_Human,Rheumatoid arthritis,4/93,0.0002841704034356708,0.0012141826328615,0,0,13.934691011235955,113.78980177265366,CXCL12;CCL5;ITGB2;TLR4,2,2,B1
44,KEGG_2021_Human,Bladder cancer,3/41,0.0003653066704852594,0.0015261700900273,0,0,24.16275303643725,191.24271413457677,MMP2;ERBB2;MMP9,2,2,B1
45,KEGG_2021_Human,Axon guidance,5/182,0.0003871875156241871,0.001569811502209,0,0,8.857949959644875,69.5933824596618,CXCL12;EFNB3;MET;GNAI2;EPHB3,2,2,B1
46,KEGG_2021_Human,Graft-versus-host disease,3/42,0.0003924528755522668,0.001569811502209,0,0,23.542011834319528,184.6422138900429,KLRD1;HLA-F;HLA-E,2,2,B1
47,KEGG_2021_Human,NF-kappa B signaling pathway,4/104,0.0004351603687657273,0.001704378110999,0,0,12.395,95.93477056457326,CXCL12;TRAF2;TLR4;TNFRSF1A,2,2,B1
48,KEGG_2021_Human,Sphingolipid signaling pathway,4/119,0.0007233598283595462,0.0027753397496243,0,0,10.770108695652176,77.88515866509948,ADORA1;TRAF2;TNFRSF1A;GNAI2,2,2,B1
49,KEGG_2021_Human,cAMP signaling pathway,5/216,0.0008416115440570646,0.0031644594056545,0,0,7.4178138870082,52.51954653492173,EDNRA;ADORA1;GNAS;CALM3;GNAI2,2,2,B1
50,KEGG_2021_Human,Regulation of lipolysis in adipocytes,3/55,0.0008690133722139896,0.0032034218426711,0,0,17.644970414201183,124.36443430473982,ADORA1;GNAS;GNAI2,2,2,B1
51,KEGG_2021_Human,Legionellosis,3/57,0.0009645260399673188,0.003468145066083,0,0,16.98974358974359,117.97463415100592,C3;ITGB2;TLR4,2,2,B1
52,KEGG_2021_Human,Relaxin signaling pathway,4/129,0.0009777217473531951,0.003468145066083,0,0,9.9035,68.63408185820364,MMP2;GNAS;MMP9;GNAI2,2,2,B1
53,KEGG_2021_Human,Natural killer cell mediated cytotoxicity,4/131,0.001035258015484,0.0036042316094631,0,0,9.746555118110235,66.98909274830557,ITGB2;KLRD1;HLA-E;IFNAR1,2,2,B1
54,KEGG_2021_Human,Viral myocarditis,3/60,0.0011198555544262,0.0038278698951295,0,0,16.09311740890688,109.3455805495442,ITGB2;HLA-F;HLA-E,2,2,B1
55,KEGG_2021_Human,Ras signaling pathway,5/232,0.0011576408102789,0.003886365577365,0,0,6.88937836514929,46.58164397524769,PDGFRB;CSF1R;CALM3;MET;FGFR1,2,2,B1
56,KEGG_2021_Human,Yersinia infection,4/137,0.0012221180270729,0.0040308454226265,0,0,9.30404135338346,62.40378553441278,CD4;ITGA4;TRAF2;TLR4,2,2,B1
57,KEGG_2021_Human,Measles,4/139,0.0012893260314654,0.0041791947226811,0,0,9.165277777777778,60.9824189952134,RACK1;TLR4;CD3D;IFNAR1,2,2,B1
58,KEGG_2021_Human,Shigellosis,5/246,0.00149985371235,0.0047791948800307,0,0,6.484555094513601,42.16509129127003,C3;CCL5;TRAF2;TLR4;TNFRSF1A,2,2,B1
59,KEGG_2021_Human,Adherens junction,3/71,0.0018212460905116,0.0057065710836031,0,0,13.48235294117647,85.0498419026256,ERBB2;MET;FGFR1,2,2,B1
60,KEGG_2021_Human,Melanoma,3/72,0.001895838132275,0.0058429109650445,0,0,13.28628762541806,83.2797030961845,PDGFRB;MET;FGFR1,2,2,B1
61,KEGG_2021_Human,Necroptosis,4/159,0.002109838938756,0.0063975761368732,0,0,7.974596774193548,49.13263641021332,TRAF2;TLR4;TNFRSF1A;IFNAR1,2,2,B1
62,KEGG_2021_Human,Gastric acid secretion,3/76,0.002213182258085,0.0066044168971427,0,0,12.555742887249735,76.75732261509744,GNAS;CALM3;GNAI2,2,2,B1
63,KEGG_2021_Human,Hepatitis B,4/162,0.0022580107771253,0.0066329066578056,0,0,7.8219936708860756,47.66152751302382,MMP9;TLR4;HSPG2;IFNAR1,2,2,B1
64,KEGG_2021_Human,cGMP-PKG signaling pathway,4/167,0.0025206780657329,0.0072905765593505,0,0,7.580138036809816,45.35368914242863,EDNRA;ADORA1;CALM3;GNAI2,2,2,B1
65,KEGG_2021_Human,Influenza A,4/172,0.0028036539481298,0.0079861657916426,0,0,7.352678571428571,43.210454736961424,CCL5;TLR4;TNFRSF1A;IFNAR1,2,2,B1
66,KEGG_2021_Human,Complement and coagulation cascades,3/85,0.0030425730309443,0.0085373691017541,0,0,11.172607879924954,64.74584062086394,C3;ITGB2;ITGAX,2,2,B1
67,KEGG_2021_Human,Gap junction,3/88,0.0033559768153867,0.0091727840773291,0,0,10.776651583710407,61.39471769003036,PDGFRB;GNAS;GNAI2,2,2,B1
68,KEGG_2021_Human,NOD-like receptor signaling pathway,4/181,0.0033666069219984,0.0091727840773291,0,0,6.975635593220339,39.71822195445093,CCL5;TRAF2;TLR4;IFNAR1,2,2,B1
69,KEGG_2021_Human,PD-L1 expression and PD-1 checkpoint pathway in cancer,3/89,0.0034646715994478,0.0093051180099455,0,0,10.650805008944545,60.338274087322745,CD4;TLR4;CD3D,2,2,B1
70,KEGG_2021_Human,Morphine addiction,3/91,0.003688481510957,0.0097666834374636,0,0,10.407692307692308,58.30951683558848,ADORA1;GNAS;GNAI2,2,2,B1
71,KEGG_2021_Human,Th1 and Th2 cell differentiation,3/92,0.0038036226138706,0.0099316812695511,0,0,10.290233362143477,57.3351361074206,NOTCH3;CD4;CD3D,2,2,B1
72,KEGG_2021_Human,GnRH signaling pathway,3/93,0.0039209381308341,0.010097758473929,0,0,10.175384615384615,56.38612392284474,MMP2;GNAS;CALM3,2,2,B1
73,KEGG_2021_Human,MicroRNAs in cancer,5/310,0.0040699753541861,0.0103399373863107,0,0,5.107207910486599,28.110676700911814,PDGFRB;NOTCH3;ERBB2;MMP9;MET,2,2,B1
74,KEGG_2021_Human,Circadian entrainment,3/97,0.0044121911590111,0.0110598925052545,0,0,9.740425531914894,52.82606653617872,GNAS;CALM3;GNAI2,2,2,B1
75,KEGG_2021_Human,Melanogenesis,3/101,0.0049391987418177,0.0122180179402859,0,0,9.340973312401884,49.60572599087418,GNAS;CALM3;GNAI2,2,2,B1
76,KEGG_2021_Human,Viral carcinogenesis,4/203,0.0050568729068937,0.0123466507337145,0,0,6.197550251256281,32.76649149502447,C3;TRAF2;HLA-F;HLA-E,2,2,B1
77,KEGG_2021_Human,Toll-like receptor signaling pathway,3/104,0.0053583527040772,0.0129150039534169,0,0,9.062147753236864,47.38686487674727,CCL5;TLR4;IFNAR1,2,2,B1
78,KEGG_2021_Human,"Parathyroid hormone synthesis, secretion and action",3/106,0.005649328918916,0.0134439726171671,0,0,8.885287528005975,45.99218982503616,GNAS;FGFR1;GNAI2,2,2,B1
79,KEGG_2021_Human,Allograft rejection,2/38,0.0073995057127876,0.0171741614074576,0,0,16.747474747474747,82.16884002986536,HLA-F;HLA-E,2,2,B1
80,KEGG_2021_Human,Primary immunodeficiency,2/38,0.0073995057127876,0.0171741614074576,0,0,16.747474747474747,82.16884002986536,CD4;CD3D,2,2,B1
81,KEGG_2021_Human,Coronavirus disease,4/232,0.0080480785843256,0.0184516923640635,0,0,5.401315789473684,26.04688342697596,C3;TLR4;TNFRSF1A;IFNAR1,2,2,B1
82,KEGG_2021_Human,Type I diabetes mellitus,2/43,0.0094014859803731,0.0212949321001223,0,0,14.70140428677014,68.60980018036983,HLA-F;HLA-E,2,2,B1
83,KEGG_2021_Human,Dopaminergic synapse,3/132,0.0103064858583601,0.0230668969210917,0,0,7.085152057245081,32.41444232807527,GNAS;CALM3;GNAI2,2,2,B1
84,KEGG_2021_Human,Vascular smooth muscle contraction,3/133,0.0105190560674097,0.0232656769490944,0,0,7.030295857988166,32.019952130981245,EDNRA;GNAS;CALM3,2,2,B1
85,KEGG_2021_Human,Apelin signaling pathway,3/137,0.0113947838178035,0.0249095274156634,0,0,6.819058553386912,30.512556594459877,NOTCH3;CALM3;GNAI2,2,2,B1
86,KEGG_2021_Human,Intestinal immune network for IgA production,2/48,0.0116167597830401,0.0251028832093281,0,0,13.100131752305666,58.36510102971351,CXCL12;ITGA4,2,2,B1
87,KEGG_2021_Human,Cocaine addiction,2/49,0.0120847413708695,0.0258174020195848,0,0,12.820760799484203,56.61406510399833,GNAS;GNAI2,2,2,B1
88,KEGG_2021_Human,Cholesterol metabolism,2/50,0.0125608922452035,0.0265331206977333,0,0,12.553030303030305,54.94671101969335,ABCA1;APOE,2,2,B1
89,KEGG_2021_Human,Breast cancer,3/147,0.0137639696368881,0.0287514032414997,0,0,6.342307692307692,27.181234400391325,NOTCH3;ERBB2;FGFR1,2,2,B1
90,KEGG_2021_Human,Autoimmune thyroid disease,2/53,0.0140377695733921,0.0290011063714034,0,0,11.81283422459893,50.39359516285688,HLA-F;HLA-E,2,2,B1
91,KEGG_2021_Human,Adrenergic signaling in cardiomyocytes,3/150,0.0145253110910678,0.0296821574469647,0,0,6.211930926216641,26.288037904781717,GNAS;CALM3;GNAI2,2,2,B1
92,KEGG_2021_Human,Oxytocin signaling pathway,3/154,0.0155770400878652,0.0314890702851469,0,0,6.046153846153846,25.163833762737035,GNAS;CALM3;GNAI2,2,2,B1
93,KEGG_2021_Human,Non-alcoholic fatty liver disease,3/155,0.0158465297474571,0.0316930594949143,0,0,6.006072874493927,24.893999355075604,LEPR;TRAF2;TNFRSF1A,2,2,B1
94,KEGG_2021_Human,Cellular senescence,3/156,0.0161186479423977,0.0318979559281133,0,0,5.9665158371040725,24.62845531476212,CALM3;HLA-F;HLA-E,2,2,B1
95,KEGG_2021_Human,Hepatitis C,3/157,0.0163933972403876,0.0321037362624257,0,0,5.927472527472528,24.36710830305253,TRAF2;TNFRSF1A;IFNAR1,2,2,B1
96,KEGG_2021_Human,Long-term depression,2/60,0.0177588230505749,0.0341597761231869,0,0,10.383490073145246,41.85452784289615,GNAS;GNAI2,2,2,B1
97,KEGG_2021_Human,JAK-STAT signaling pathway,3/162,0.0178066918088953,0.0341597761231869,0,0,5.739622641509434,23.1202385733152,PDGFRB;LEPR;IFNAR1,2,2,B1
98,KEGG_2021_Human,Amphetamine addiction,2/69,0.0230828770826961,0.0438341504196653,0,0,8.984622342831297,33.86002446746899,GNAS;CALM3,2,2,B1
99,KEGG_2021_Human,Epithelial cell signaling in Helicobacter pylori infection,2/70,0.0237103597045097,0.0445754762444783,0,0,8.85204991087344,33.122982836017705,CCL5;MET,2,2,B1
100,KEGG_2021_Human,Non-small cell lung cancer,2/72,0.0249862294254293,0.0465090211087199,0,0,8.598268398268399,31.722713064037848,ERBB2;MET,2,2,B1
101,KEGG_2021_Human,Alcoholism,3/186,0.0255130506399481,0.0470240541206887,0,0,4.980832282471627,18.272507818804595,GNAS;CALM3;GNAI2,2,2,B1
102,KEGG_2021_Human,Neutrophil extracellular trap formation,3/189,0.0265839510168534,0.0485221630210528,0,0,4.899751861042184,17.77359308244188,C3;ITGB2;TLR4,2,2,B1
103,KEGG_2021_Human,Glioma,2/75,0.0269515004105609,0.0487200199729371,0,0,8.243669572436696,29.79028318252327,PDGFRB;CALM3,2,2,B1
104,KEGG_2021_Human,Transcriptional misregulation in cancer,3/192,0.0276787340857232,0.049090584982226,0,0,4.821245421245421,17.29424549610241,CSF1R;MMP9;MET,2,2,B1
105,KEGG_2021_Human,Chemokine signaling pathway,3/192,0.0276787340857232,0.049090584982226,0,0,4.821245421245421,17.29424549610241,CXCL12;CCL5;GNAI2,2,2,B1
0,KEGG_2021_Human,Human immunodeficiency virus 1 infection,14/212,3.276135923676152e-16,5.569431070249458e-14,0,0,34.90808080808081,1244.6370382001603,HLA-B;HLA-C;CXCR4;TRAF2;HLA-A;HLA-F;CD3D;TNFRSF1A;HLA-E;GNAI2;CD4;CALM3;CALR;B2M,3,3,B1
1,KEGG_2021_Human,Human cytomegalovirus infection,13/225,2.4067399552483452e-14,2.0457289619610933e-12,0,0,29.5147261849977,925.5203689861676,HLA-B;HLA-C;CXCR4;TRAF2;HLA-A;HLA-F;TNFRSF1A;HLA-E;GNAI2;CCL5;CALM3;CALR;B2M,3,3,B1
2,KEGG_2021_Human,Antigen processing and presentation,9/78,5.98372495006707e-13,3.3907774717046726e-11,0,0,57.61449275362319,1621.5347171879614,CD4;HLA-B;HLA-C;KLRD1;CALR;HLA-A;HLA-F;B2M;HLA-E,3,3,B1
3,KEGG_2021_Human,Epstein-Barr virus infection,11/202,5.559283064387953e-12,2.36269530236488e-10,0,0,26.458663095093144,685.6908582656754,CD19;HLA-B;HLA-C;TRAF2;CALR;HLA-A;HLA-F;CD3D;B2M;HLA-E;IFNAR1,3,3,B1
4,KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,10/193,9.173203699075832e-11,3.1188892576857833e-09,0,0,24.54421261798311,567.2695096753592,C3;HLA-B;HLA-C;CALM3;TRAF2;HLA-A;HLA-F;TNFRSF1A;HLA-E;IFNAR1,3,3,B1
5,KEGG_2021_Human,Cell adhesion molecules,9/148,2.0852314289878544e-10,5.908155715465588e-09,0,0,28.49928057553957,635.2766392165444,CD4;ITGA4;SDC4;HLA-B;HLA-C;SDC1;HLA-A;HLA-F;HLA-E,3,3,B1
6,KEGG_2021_Human,Viral protein interaction with cytokine and cytokine receptor,8/100,2.5284766366334225e-10,6.140586117538313e-09,0,0,37.53119092627599,829.3730367023828,CSF1R;IL34;CCL5;CXCR4;CCR7;CCL19;CXCL14;TNFRSF1A,3,3,B1
7,KEGG_2021_Human,Human T-cell leukemia virus 1 infection,10/219,3.170024943026216e-10,6.736303003930709e-09,0,0,21.462592431491952,469.4322141744584,CD4;HLA-B;HLA-C;CALR;HLA-A;HLA-F;CD3D;B2M;TNFRSF1A;HLA-E,3,3,B1
8,KEGG_2021_Human,Herpes simplex virus 1 infection,13/498,5.284691593022042e-10,9.982195231263861e-09,0,0,12.722806135277848,271.7723283688195,HLA-B;HLA-C;TRAF2;HLA-A;HLA-F;TNFRSF1A;HLA-E;C3;CCL5;ITGA5;CALR;B2M;IFNAR1,3,3,B1
9,KEGG_2021_Human,Human papillomavirus infection,11/331,1.0970832758162344e-09,1.8650415688875992e-08,0,0,15.689389534883722,323.6816883399005,COL1A1;ITGA4;ITGA3;HLA-B;HLA-C;ITGA5;HLA-A;HLA-F;TNFRSF1A;HLA-E;IFNAR1,3,3,B1
10,KEGG_2021_Human,Graft-versus-host disease,6/42,1.416032685305158e-09,2.1884141500170627e-08,0,0,69.13194444444444,1408.5914881029669,HLA-B;HLA-C;KLRD1;HLA-A;HLA-F;HLA-E,3,3,B1
11,KEGG_2021_Human,Cytokine-cytokine receptor interaction,10/295,5.647746216141039e-09,8.000973806199806e-08,0,0,15.678628389154705,297.7686557260208,CSF1R;CD4;IL34;CCL5;CXCR4;CCR7;CCL19;CXCL14;TNFRSF1A;IFNAR1,3,3,B1
12,KEGG_2021_Human,Phagosome,8/152,7.156624855778174e-09,9.358663272940689e-08,0,0,23.915458937198068,448.5398696895218,C3;HLA-B;HLA-C;ITGA5;CALR;HLA-A;HLA-F;HLA-E,3,3,B1
13,KEGG_2021_Human,Hematopoietic cell lineage,7/99,8.596445461590558e-09,1.0438540917645677e-07,0,0,32.14107308048104,596.921342748405,CSF1R;CD4;ITGA4;ITGA3;CD19;ITGA5;CD3D,3,3,B1
14,KEGG_2021_Human,Pathways in cancer,12/531,1.347499641357698e-08,1.5271662602053914e-07,0,0,10.69474263693917,193.81472465948343,AR;CSF1R;ITGA3;GSTP1;ERBB2;CXCR4;CALM3;TRAF2;MMP9;HSP90B1;IFNAR1;GNAI2,3,3,B1
15,KEGG_2021_Human,Allograft rejection,5/38,5.566538224051328e-08,5.914446863054535e-07,0,0,61.573902288188,1028.524761277321,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E,3,3,B1
16,KEGG_2021_Human,Fluid shear stress and atherosclerosis,7/139,9.072506656894356e-08,9.072506656894356e-07,0,0,22.35622179239201,362.5157976071941,SDC4;GSTP1;SDC1;CALM3;MMP9;TNFRSF1A;HSP90B1,3,3,B1
17,KEGG_2021_Human,Type I diabetes mellitus,5/43,1.0566821481570493e-07,9.979775843705464e-07,0,0,53.45864661654135,858.7041931669773,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E,3,3,B1
18,KEGG_2021_Human,ECM-receptor interaction,6/88,1.3307272074965484e-07,1.190650659339017e-06,0,0,30.28048780487805,479.4118892992211,COL1A1;ITGA4;SDC4;ITGA3;SDC1;ITGA5,3,3,B1
19,KEGG_2021_Human,Autoimmune thyroid disease,5/53,3.0865156941739245e-07,2.6006265787948237e-06,0,0,42.300170068027214,634.124083080028,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E,3,3,B1
20,KEGG_2021_Human,Chagas disease,6/102,3.212538714981841e-07,2.6006265787948237e-06,0,0,25.846354166666668,386.42972378470006,C3;CCL5;CALR;CD3D;TNFRSF1A;GNAI2,3,3,B1
21,KEGG_2021_Human,PI3K-Akt signaling pathway,9/354,4.060697002669668e-07,3.137811320244744e-06,0,0,11.362898550724635,167.22483516828714,COL1A1;CSF1R;ITGA4;ITGA3;CD19;ERBB2;ITGA5;HSP90B1;IFNAR1,3,3,B1
22,KEGG_2021_Human,Viral myocarditis,5/60,5.790838605870985e-07,4.280185056513337e-06,0,0,36.90352504638219,530.0017299413302,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E,3,3,B1
23,KEGG_2021_Human,Viral carcinogenesis,7/203,1.1831172382833533e-06,8.380413771173751e-06,0,0,15.00759878419453,204.81407145766784,C3;HLA-B;HLA-C;TRAF2;HLA-A;HLA-F;HLA-E,3,3,B1
24,KEGG_2021_Human,Natural killer cell mediated cytotoxicity,6/131,1.4045884460256614e-06,9.551201432974496e-06,0,0,19.821,267.10316222811656,HLA-B;HLA-C;KLRD1;HLA-A;HLA-E;IFNAR1,3,3,B1
25,KEGG_2021_Human,Cellular senescence,6/156,3.876969795638476e-06,2.5349417894559263e-05,0,0,16.496666666666666,205.5560005286868,HLA-B;HLA-C;CALM3;HLA-A;HLA-F;HLA-E,3,3,B1
26,KEGG_2021_Human,Prostate cancer,5/97,6.336200870880731e-06,3.989459807591572e-05,0,0,22.020851818988465,263.5726666610983,AR;GSTP1;ERBB2;MMP9;HSP90B1,3,3,B1
27,KEGG_2021_Human,Chemokine signaling pathway,6/192,1.2745577524436024e-05,7.738386354121872e-05,0,0,13.279569892473118,149.6650845815889,CCL5;CXCR4;CCR7;CCL19;CXCL14;GNAI2,3,3,B1
28,KEGG_2021_Human,Sphingolipid signaling pathway,5/119,1.716839727934695e-05,0.0001006423288789304,0,0,17.7515216612961,194.7775104494966,ADORA1;TRAF2;S1PR4;TNFRSF1A;GNAI2,3,3,B1
29,KEGG_2021_Human,Proteoglycans in cancer,6/205,1.8477480278096965e-05,0.0001047057215758828,0,0,12.40389447236181,135.18952302559038,COL1A1;SDC4;ERBB2;SDC1;ITGA5;MMP9,3,3,B1
30,KEGG_2021_Human,Lipid and atherosclerosis,6/215,2.4172014360272416e-05,0.00013255620778213905,0,0,11.804425837320574,125.48476534443007,CCL5;CALM3;TRAF2;MMP9;TNFRSF1A;HSP90B1,3,3,B1
31,KEGG_2021_Human,Renin secretion,4/69,3.602036909984236e-05,0.00019135821084291253,0,0,24.46892307692308,250.35197505624168,ADORA1;CALM3;AQP1;GNAI2,3,3,B1
32,KEGG_2021_Human,Pertussis,4/76,5.271485603870497e-05,0.00027156137959332864,0,0,22.08222222222222,217.52343067641664,C3;CALM3;ITGA5;GNAI2,3,3,B1
33,KEGG_2021_Human,Endocytosis,6/252,5.868451911852015e-05,0.00029342259559260073,0,0,10.010162601626016,97.53236357527976,HLA-B;HLA-C;CXCR4;HLA-A;HLA-F;HLA-E,3,3,B1
34,KEGG_2021_Human,Primary immunodeficiency,3/38,0.00014679430265700233,0.0007130008986197255,0,0,33.463865546218486,295.3680814974974,CD4;CD19;CD3D,3,3,B1
35,KEGG_2021_Human,Focal adhesion,5/201,0.00020681644046154708,0.0009766331910684167,0,0,10.282174094127448,87.23066360547598,COL1A1;ITGA4;ITGA3;ERBB2;ITGA5,3,3,B1
36,KEGG_2021_Human,TNF signaling pathway,4/112,0.000237512437843815,0.0010912733630661,0,0,14.694814814814816,122.63249944307556,CCL5;TRAF2;MMP9;TNFRSF1A,3,3,B1
37,KEGG_2021_Human,Leukocyte transendothelial migration,4/114,0.00025416740647699895,0.0011370647131865,0,0,14.42618181818182,119.41297141121431,ITGA4;CXCR4;MMP9;GNAI2,3,3,B1
38,KEGG_2021_Human,Osteoclast differentiation,4/127,0.0003835804449152849,0.0016720173239897,0,0,12.8930081300813,101.41590162586878,CSF1R;TRAF2;TNFRSF1A;IFNAR1,3,3,B1
39,KEGG_2021_Human,Yersinia infection,4/137,0.0005109791323191884,0.002116934523451,0,0,11.917593984962409,90.3256114966778,CD4;ITGA4;TRAF2;ITGA5,3,3,B1
40,KEGG_2021_Human,Estrogen signaling pathway,4/137,0.0005109791323191884,0.002116934523451,0,0,11.917593984962409,90.3256114966778,CALM3;MMP9;HSP90B1;GNAI2,3,3,B1
41,KEGG_2021_Human,Shigellosis,5/246,0.0005230073528526149,0.002116934523451,0,0,8.343212803793717,63.04060706444421,C3;CCL5;TRAF2;ITGA5;TNFRSF1A,3,3,B1
42,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,3/77,0.0011817409235949,0.0046719990002591,0,0,15.796502384737678,106.4805351789864,ITGA4;ITGA3;ITGA5,3,3,B1
43,KEGG_2021_Human,Axon guidance,4/182,0.0014713926415247,0.0056849261149821,0,0,8.884494382022472,57.9406383680362,PLXNB2;CXCR4;SEMA4G;GNAI2,3,3,B1
44,KEGG_2021_Human,Hypertrophic cardiomyopathy,3/90,0.001851578265349,0.006994851224652,0,0,13.42731575388776,84.480869278287,ITGA4;ITGA3;ITGA5,3,3,B1
45,KEGG_2021_Human,IL-17 signaling pathway,3/94,0.0020966534414301,0.0077485018487636,0,0,12.834518422753716,79.15577326267173,TRAF2;MMP9;HSP90B1,3,3,B1
46,KEGG_2021_Human,Dilated cardiomyopathy,3/96,0.0022263925859746,0.0080529093535252,0,0,12.557242251739403,76.69175823690271,ITGA4;ITGA3;ITGA5,3,3,B1
47,KEGG_2021_Human,Rap1 signaling pathway,4/210,0.0024781204527065,0.0087766766033358,0,0,7.666019417475728,45.998070482101895,CSF1R;FPR1;CALM3;GNAI2,3,3,B1
48,KEGG_2021_Human,Protein digestion and absorption,3/103,0.0027193737367265,0.0094345619437452,0,0,11.674117647058823,68.96314171509846,COL1A1;COL18A1;SLC1A5,3,3,B1
49,KEGG_2021_Human,NF-kappa B signaling pathway,3/104,0.0027948406111328,0.0094519752018589,0,0,11.557949912638325,67.96051664386877,TRAF2;CCL19;TNFRSF1A,3,3,B1
50,KEGG_2021_Human,Regulation of actin cytoskeleton,4/218,0.0028355925605576,0.0094519752018589,0,0,7.376448598130841,43.26659132198892,ITGA4;ITGA3;CXCR4;ITGA5,3,3,B1
51,KEGG_2021_Human,Chemical carcinogenesis,4/239,0.0039391659846683,0.0128780426421851,0,0,6.710127659574468,37.15254260890263,AR;GSTP1;HSP90B1;GNAI2,3,3,B1
52,KEGG_2021_Human,Relaxin signaling pathway,3/129,0.0051158757030462,0.0164094126324124,0,0,9.253034547152197,48.813520364788914,COL1A1;MMP9;GNAI2,3,3,B1
53,KEGG_2021_Human,Bladder cancer,2/41,0.0054847089319639,0.0172666762672939,0,0,19.63214990138067,102.20087423124885,ERBB2;MMP9,3,3,B1
54,KEGG_2021_Human,Measles,3/139,0.0062909637531997,0.0194447970553447,0,0,8.568339100346021,43.42983486679253,RACK1;CD3D;IFNAR1,3,3,B1
55,KEGG_2021_Human,Intestinal immune network for IgA production,2/48,0.0074544435169343,0.0226295606764077,0,0,16.638795986622075,81.51254605805195,ITGA4;CXCR4,3,3,B1
56,KEGG_2021_Human,MAPK signaling pathway,4/294,0.0081291066385937,0.0242447040098411,0,0,5.422344827586207,26.09397303713418,CSF1R;ERBB2;TRAF2;TNFRSF1A,3,3,B1
57,KEGG_2021_Human,Hepatitis C,3/157,0.0087840397576845,0.025746323427696,0,0,7.559969442322384,35.795085957594694,TRAF2;TNFRSF1A;IFNAR1,3,3,B1
58,KEGG_2021_Human,Necroptosis,3/159,0.0090918731152449,0.0261969225354516,0,0,7.462292609351433,35.075568614523775,TRAF2;TNFRSF1A;IFNAR1,3,3,B1
59,KEGG_2021_Human,Regulation of lipolysis in adipocytes,2/55,0.0096962918823686,0.0274728270000445,0,0,14.436139332365748,66.92611152225938,ADORA1;GNAI2,3,3,B1
60,KEGG_2021_Human,cGMP-PKG signaling pathway,3/167,0.010386182725111,0.0289450993978504,0,0,7.095408895265424,32.40671162022782,ADORA1;CALM3;GNAI2,3,3,B1
61,KEGG_2021_Human,Protein processing in endoplasmic reticulum,3/171,0.0110714669407465,0.0303484828222157,0,0,6.925070028011205,31.186249743550285,TRAF2;CALR;HSP90B1,3,3,B1
62,KEGG_2021_Human,Influenza A,3/172,0.0112467906929387,0.0303484828222157,0,0,6.883745214061956,30.891993837858266,CCL5;TNFRSF1A;IFNAR1,3,3,B1
63,KEGG_2021_Human,Tuberculosis,3/180,0.0127074180300098,0.0337313648007514,0,0,6.569956796277833,28.68160208099708,C3;CALM3;TNFRSF1A,3,3,B1
64,KEGG_2021_Human,NOD-like receptor signaling pathway,3/181,0.0128972865414637,0.0337313648007514,0,0,6.532716457369465,28.42213992513552,CCL5;TRAF2;IFNAR1,3,3,B1
65,KEGG_2021_Human,Neuroactive ligand-receptor interaction,4/341,0.0134484354858189,0.0346399095846852,0,0,4.654955489614244,20.057702799160083,C3;FPR1;ADORA1;S1PR4,3,3,B1
66,KEGG_2021_Human,Adipocytokine signaling pathway,2/69,0.0149545644899604,0.0379444173625861,0,0,11.411595866819749,47.959955677421554,TRAF2;TNFRSF1A,3,3,B1
67,KEGG_2021_Human,Central carbon metabolism in cancer,2/70,0.0153680475323007,0.0384201188307518,0,0,11.243212669683258,46.94563829797736,ERBB2;SLC1A5,3,3,B1
68,KEGG_2021_Human,Gastric acid secretion,2/76,0.0179508142227228,0.0442266437371432,0,0,10.328482328482329,41.52173635894564,CALM3;GNAI2,3,3,B1
69,KEGG_2021_Human,Leishmaniasis,2/77,0.0183979906866827,0.0446808345248009,0,0,10.19025641025641,40.71531033833909,C3;ITGA4,3,3,B1
70,KEGG_2021_Human,cAMP signaling pathway,3/216,0.0205797433948673,0.0492754419313724,0,0,5.449599558133112,21.16323659921621,ADORA1;CALM3;GNAI2,3,3,B1
0,KEGG_2021_Human,Pathways in cancer,53/531,1.6032654099485732e-41,3.4470206313894325e-39,0,0,17.87826011157601,1679.3755267253232,RET;FLT4;FASLG;FGF1;FGF2;IGF1R;EDNRA;CDH1;BDKRB2;ITGAV;HRAS;PDGFRB;HSP90AA1;ITGA3;TRAF2;TGFBR1;AR;ADCY9;COL4A2;COL4A1;COL4A5;ITGA6;IL6ST;NOTCH2;NOTCH3;LAMA5;NOTCH1;PTGER2;LRP5;PDGFB;CXCR4;IL2RG;HSP90B1;GNAI2;RXRA;ERBB2;FADD;TGFB3;WNT7B;FZD6;FN1;VEGFB;ESR1;VEGFA;BMP4;BMP2;GNAS;FAS;CALM3;CALM1;FGFR4;CALM2;FGFR3,4,4,B1
1,KEGG_2021_Human,PI3K-Akt signaling pathway,44/354,2.0174096316813907e-38,2.168715354057495e-36,0,0,21.47406851712928,1863.8722530677333,LAMA5;ITGB5;FLT4;TNC;PDGFB;FASLG;IL2RG;FGF1;EFNA4;FGF2;AREG;THBS1;HSP90B1;IGF1R;RXRA;ERBB3;PDGFC;ERBB2;ITGAV;ITGB7;HRAS;PDGFRB;HSP90AA1;ITGA3;INSR;ITGA1;OSM;FN1;VEGFB;OSMR;VEGFA;COL1A1;EFNA1;EFNA3;COL1A2;COL4A2;COL4A1;COL6A1;COL4A5;ITGA6;FGFR4;FGFR3;EPHA2;ITGA9,4,4,B1
2,KEGG_2021_Human,Human papillomavirus infection,35/331,5.029039301847489e-28,3.6041448329907007e-26,0,0,16.73484625930278,1051.9048023227326,NOTCH2;NOTCH3;LAMA5;NOTCH1;ITGB5;TRADD;TNC;FASLG;PSEN1;TNF;THBS1;ITGAV;ITGB7;FADD;HRAS;PDGFRB;ITGA3;WNT7B;FZD6;ITGA1;HLA-B;FN1;TNFRSF1A;VEGFA;COL1A1;COL1A2;PKM;COL4A2;COL4A1;COL6A1;GNAS;FAS;COL4A5;ITGA6;ITGA9,4,4,B1
3,KEGG_2021_Human,Focal adhesion,28/201,7.220892411269639e-26,3.881229671057431e-24,0,0,21.937891170021924,1269.9896504451965,LAMA5;ITGB5;FLT4;TNC;PDGFB;THBS1;IGF1R;PDGFC;ERBB2;ITGAV;ITGB7;HRAS;PDGFRB;ITGA3;ITGA1;FN1;VEGFB;VEGFA;COL1A1;COL1A2;COL4A2;COL4A1;COL6A1;COL4A5;ITGA6;TLN1;VCL;ITGA9,4,4,B1
4,KEGG_2021_Human,Rap1 signaling pathway,28/210,2.5238274754475657e-25,1.0852458144424536e-23,0,0,20.843501326259947,1180.5519604364597,FLT4;ITGB2;PDGFB;FGF1;EFNA4;FGF2;THBS1;IGF1R;GNAI2;CDH1;PDGFC;HRAS;PDGFRB;FARP2;INSR;VEGFB;VEGFA;EFNA1;EFNA3;ADCY9;GNAS;CALM3;TLN1;CALM1;FGFR4;CALM2;FGFR3;EPHA2,4,4,B1
5,KEGG_2021_Human,Proteoglycans in cancer,27/205,2.693211520837775e-24,9.65067461633536e-23,0,0,20.41415268585501,1107.9027654504205,SDC4;ITGB5;SDC2;FASLG;TNF;FGF2;THBS1;IGF1R;ERBB3;PLAU;GPC1;ERBB2;GPC3;TIMP3;ITGAV;HRAS;WNT7B;FZD6;FN1;ESR1;VEGFA;COL1A1;COL1A2;FAS;SDC1;CD44;HBEGF,4,4,B1
6,KEGG_2021_Human,ECM-receptor interaction,20/88,3.305575894011206e-23,1.0152840245891561e-21,0,0,37.98346789696271,1966.1703991510144,LAMA5;ITGB5;SDC4;ITGA3;ITGA1;TNC;FN1;THBS1;COL1A1;COL1A2;COL4A2;COL4A1;COL6A1;COL4A5;SDC1;ITGAV;ITGB7;ITGA6;CD44;ITGA9,4,4,B1
7,KEGG_2021_Human,Axon guidance,25/182,5.1501398926189924e-23,1.3841000961413545e-21,0,0,21.16328111551041,1086.108756071085,NRP1;BMPR2;SEMA3C;SEMA3B;CXCR4;SEMA3F;NTN1;EFNA4;GNAI2;EFNB2;EFNB1;PLXNA1;EPHB2;HRAS;NEO1;EPHB4;PLXNA3;SEMA4A;SEMA4D;SEMA4C;EFNA1;EFNA3;PLXNB2;EPHA1;EPHA2,4,4,B1
8,KEGG_2021_Human,MAPK signaling pathway,28/294,2.9961233128164147e-21,7.157405691728103e-20,0,0,14.200362976406534,671.0660949149371,TRADD;FLT4;PDGFB;FASLG;FGF1;TNF;EFNA4;FGF2;AREG;IGF1R;ERBB3;PDGFC;ERBB2;HRAS;PDGFRB;TGFB3;INSR;VEGFB;TRAF2;TGFBR1;TNFRSF1A;VEGFA;EFNA1;EFNA3;FAS;FGFR4;FGFR3;EPHA2,4,4,B1
9,KEGG_2021_Human,Fluid shear stress and atherosclerosis,20/139,5.245308166379659e-19,1.1277412557716266e-17,0,0,21.64881638930082,911.2372767391066,ACVR1;HSP90AA1;BMPR2;SDC4;SDC2;PDGFB;TNF;ACVR2A;ICAM1;HSP90B1;TNFRSF1A;VEGFA;BMP4;GPC1;PECAM1;SDC1;CALM3;ITGAV;CALM1;CALM2,4,4,B1
10,KEGG_2021_Human,Cytokine-cytokine receptor interaction,25/295,7.90814827089496e-18,1.5456835256749242e-16,0,0,12.23536036036036,481.8118266660696,BMPR2;IL20;EBI3;IL20RA;CXCR4;FASLG;CXCL13;IL2RG;TNF;CXCR3;ACVR1;TGFB3;GDF15;OSM;INHBB;OSMR;TGFBR1;ACVR2A;TNFRSF1A;BMP4;CXCL10;GDF9;BMP2;FAS;IL6ST,4,4,B1
11,KEGG_2021_Human,Regulation of actin cytoskeleton,22/218,2.055972521568661e-17,3.683617434477184e-16,0,0,14.592580078388972,560.6935878222829,PDGFRB;ITGB5;ITGA3;ITGA1;ITGB2;PDGFB;FN1;CXCR4;ITGAE;FGF1;FGF2;PDGFC;BDKRB2;ITGAX;ITGA6;ITGAV;ITGB7;FGFR4;FGFR3;HRAS;VCL;ITGA9,4,4,B1
12,KEGG_2021_Human,Calcium signaling pathway,22/240,1.6102006041417043e-16,2.6630240760805115e-15,0,0,13.105231180509143,476.5717674969317,PDGFRB;RET;FLT4;PDGFB;VEGFB;HTR2C;CXCR4;FGF1;FGF2;VEGFA;EDNRA;ADCY9;ERBB3;PDGFC;ERBB2;GNAS;BDKRB2;CALM3;CALM1;FGFR4;CALM2;FGFR3,4,4,B1
13,KEGG_2021_Human,Ras signaling pathway,21/232,1.0564033463263388e-15,1.6223337104297346e-14,0,0,12.844100773260164,442.9147679043044,PDGFRB;INSR;FLT4;PDGFB;VEGFB;FASLG;FGF1;EFNA4;FGF2;IGF1R;VEGFA;EFNA1;EFNA3;PDGFC;CALM3;CALM1;FGFR4;CALM2;FGFR3;HRAS;EPHA2,4,4,B1
14,KEGG_2021_Human,Human cytomegalovirus infection,20/225,7.486163884315493e-15,1.073016823418554e-13,0,0,12.51203570859238,406.9629687559056,TRADD;PTGER2;HLA-B;CXCR4;TRAF2;FASLG;TNF;TNFRSF1A;VEGFA;GNAI2;ADCY9;GNAS;FAS;CALM3;ITGAV;CALR;FADD;CALM1;CALM2;HRAS,4,4,B1
15,KEGG_2021_Human,Cell adhesion molecules,17/148,1.2193102907616316e-14,1.6384482032109428e-13,0,0,16.384419651595223,524.9224956543106,SDC4;SDC2;ITGB2;HLA-B;PTPRM;PTPRF;ICAM1;VCAN;CDH1;PECAM1;SDC1;ITGAV;ITGB7;MADCAM1;ITGA6;NEO1;ITGA9,4,4,B1
16,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,14/100,1.787211048710181e-13,2.260296326309935e-12,0,0,20.211642533274823,593.2713302206525,TGFB3;SERPINE1;FN1;VEGFB;TNF;TGFBR1;ICAM1;VEGFA;COL1A1;COL1A2;COL4A2;COL4A1;COL4A5;HRAS,4,4,B1
17,KEGG_2021_Human,Chagas disease,13/102,4.618783163729922e-12,5.516879890010741e-11,0,0,18.019241573033707,470.3182391179217,ACE;TGFB3;SERPINE1;FASLG;TNF;TGFBR1;TNFRSF1A;GNAI2;GNAS;BDKRB2;FAS;FADD;CALR,4,4,B1
18,KEGG_2021_Human,MicroRNAs in cancer,19/310,2.72414760692802e-11,3.0825880815238126e-10,0,0,8.28276877761414,201.48895617473505,PDGFRB;NOTCH2;NOTCH3;NOTCH1;BMPR2;TNC;PDGFB;EFNA4;THBS1;VEGFA;EFNA1;EFNA3;ERBB3;PLAU;ERBB2;TIMP3;FGFR3;HRAS;CD44,4,4,B1
19,KEGG_2021_Human,TGF-beta signaling pathway,12/94,3.084987001962809e-11,3.3163610271100195e-10,0,0,17.947280715043174,434.3580881595037,ACVR1;BMP4;BMP2;BMPR2;TGFB3;INHBB;TNF;NEO1;LTBP1;THBS1;TGFBR1;ACVR2A,4,4,B1
20,KEGG_2021_Human,Amoebiasis,12/102,8.221944666057632e-11,8.417705253344718e-10,0,0,16.345341614906832,379.5654631824333,COL1A1;LAMA5;COL1A2;COL4A2;COL4A1;TGFB3;ITGB2;FN1;GNAS;COL4A5;TNF;VCL,4,4,B1
21,KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,15/193,1.3634684595775739e-10,1.3324805400417202e-09,0,0,10.479839283174512,238.05813376092087,TRADD;HLA-B;PDGFB;TRAF2;FGF2;ICAM1;TNFRSF1A;VEGFA;FAS;CALM3;FADD;IL6ST;CALM1;CALM2;HRAS,4,4,B1
22,KEGG_2021_Human,Signaling pathways regulating pluripotency of stem cells,13/143,3.480621697679466e-10,3.2536246304395004e-09,0,0,12.310625,268.1086700912577,ACVR1;BMPR2;WNT7B;FZD6;INHBB;FGF2;ACVR2A;IGF1R;BMP4;IL6ST;FGFR4;FGFR3;HRAS,4,4,B1
23,KEGG_2021_Human,Renin secretion,10/69,3.952916546663696e-10,3.5411544063862273e-09,0,0,20.55526671519185,445.0502453791764,EDNRA;EDN2;ACE;PTGER2;ADORA1;GNAS;CALM3;CALM1;CALM2;GNAI2,4,4,B1
24,KEGG_2021_Human,Breast cancer,13/147,4.912335331640929e-10,4.211970975539238e-09,0,0,11.94071828358209,255.9385673577729,NOTCH2;NOTCH3;NOTCH1;FLT4;WNT7B;FZD6;LRP5;FGF1;FGF2;ESR1;IGF1R;ERBB2;HRAS,4,4,B1
25,KEGG_2021_Human,Human immunodeficiency virus 1 infection,15/212,5.093546296000939e-10,4.211970975539238e-09,0,0,9.459937030135578,202.4225654388331,TRADD;HLA-B;CXCR4;TRAF2;FASLG;TNF;TNFRSF1A;GNAI2;FAS;CALM3;CALR;FADD;CALM1;CALM2;HRAS,4,4,B1
26,KEGG_2021_Human,Dilated cardiomyopathy,11/96,6.879562266001544e-10,5.478169952556786e-09,0,0,15.770660856935368,332.7182987027137,ADCY9;ITGB5;ITGA3;TGFB3;ITGA1;GNAS;ITGAV;ITGB7;ITGA6;TNF;ITGA9,4,4,B1
27,KEGG_2021_Human,Relaxin signaling pathway,12/129,1.30158346380725e-09,9.994301597091388e-09,0,0,12.556139512661252,256.8946500115233,COL1A1;ADCY9;COL1A2;COL4A2;COL4A1;GNAS;VEGFB;COL4A5;HRAS;TGFBR1;GNAI2;VEGFA,4,4,B1
28,KEGG_2021_Human,Alzheimer disease,18/369,3.6278002447096157e-09,2.6895760434916115e-08,0,0,6.443672456575682,125.23045038328044,APP;INSR;WNT7B;FZD6;LRP5;ADAM10;TRAF2;PSEN1;TNF;TNFRSF1A;NCSTN;FAS;CALM3;APOE;FADD;CALM1;CALM2;HRAS,4,4,B1
29,KEGG_2021_Human,Hypertrophic cardiomyopathy,10/90,5.689792507338205e-09,3.99200307774777e-08,0,0,15.14340490797546,287.4913645117485,ACE;ITGB5;ITGA3;TGFB3;ITGA1;ITGAV;ITGB7;ITGA6;TNF;ITGA9,4,4,B1
30,KEGG_2021_Human,Lipid and atherosclerosis,14/215,5.755911414427017e-09,3.99200307774777e-08,0,0,8.597390406458274,163.11861864966158,ABCA1;HSP90AA1;TRAF2;FASLG;TNF;HSP90B1;ICAM1;TNFRSF1A;RXRA;FAS;CALM3;CALM1;CALM2;HRAS,4,4,B1
31,KEGG_2021_Human,Small cell lung cancer,10/92,7.066038622448984e-09,4.7474946994579114e-08,0,0,14.7725572347748,277.25084928679456,LAMA5;RXRA;COL4A2;ITGA3;COL4A1;FN1;COL4A5;ITGAV;TRAF2;ITGA6,4,4,B1
32,KEGG_2021_Human,Human T-cell leukemia virus 1 infection,14/219,7.289963261174628e-09,4.749521518644076e-08,0,0,8.42791839239147,157.91194599916886,NRP1;TGFB3;ITGB2;HLA-B;IL2RG;TNF;TGFBR1;ICAM1;TNFRSF1A;ADCY9;CANX;CALR;TLN1;HRAS,4,4,B1
33,KEGG_2021_Human,Adherens junction,9/71,1.0342343512648748e-08,6.447773444211302e-08,0,0,17.49459087332809,321.6733808771192,FARP2;CDH1;INSR;ERBB2;PTPRM;PTPRF;TGFBR1;VCL;IGF1R,4,4,B1
34,KEGG_2021_Human,Malaria,8/50,1.0496375374297466e-08,6.447773444211302e-08,0,0,22.83982683982684,419.61868528778615,TGFB3;SDC2;ITGB2;PECAM1;SDC1;TNF;THBS1;ICAM1,4,4,B1
35,KEGG_2021_Human,Prostate cancer,10/97,1.1874996832975703e-08,7.0920119974716e-08,0,0,13.92003384810662,254.02434178018663,PDGFRB;AR;HSP90AA1;PLAU;PDGFC;ERBB2;PDGFB;HRAS;IGF1R;HSP90B1,4,4,B1
36,KEGG_2021_Human,Viral protein interaction with cytokine and cytokine receptor,10/100,1.5984711822713666e-08,9.288413626711994e-08,0,0,13.45398773006135,241.5210512275778,CXCL10;IL20;CXCR3;IL20RA;CXCR4;CXCL13;IL6ST;IL2RG;TNF;TNFRSF1A,4,4,B1
37,KEGG_2021_Human,Hippo signaling pathway,12/163,1.8726887666448825e-08,1.0595475916543417e-07,0,0,9.712146764838964,172.81119447351762,BMP4;BMP2;BMPR2;CDH1;TGFB3;WNT7B;SERPINE1;FZD6;ITGB2;FGF1;AREG;TGFBR1,4,4,B1
38,KEGG_2021_Human,Estrogen signaling pathway,11/137,3.043134898792091e-08,1.6776256493341016e-07,0,0,10.6168430335097,183.75411668733256,HSP90AA1;ADCY9;GNAS;CALM3;CALM1;ESR1;CALM2;HRAS;HSP90B1;HBEGF;GNAI2,4,4,B1
39,KEGG_2021_Human,Bladder cancer,7/41,5.628814270899616e-08,3.025487670608544e-07,0,0,24.548369950389795,409.7805863939009,CDH1;ERBB2;THBS1;HRAS;FGFR3;VEGFA;HBEGF,4,4,B1
40,KEGG_2021_Human,Gastric cancer,11/149,7.251240432997307e-08,3.802479739254686e-07,0,0,9.68773483628556,159.2615962370849,RXRA;CDH1;TGFB3;WNT7B;FZD6;ERBB2;LRP5;FGF1;FGF2;HRAS;TGFBR1,4,4,B1
41,KEGG_2021_Human,Melanoma,8/72,1.991030103055671e-07,1.0192177908499267e-06,0,0,14.971969696969698,231.00916061929613,PDGFRB;CDH1;PDGFC;PDGFB;FGF1;FGF2;HRAS;IGF1R,4,4,B1
42,KEGG_2021_Human,Melanogenesis,9/101,2.3234285450682413e-07,1.161714272534121e-06,0,0,11.771937963944858,179.81696142085713,ADCY9;WNT7B;FZD6;GNAS;CALM3;CALM1;CALM2;HRAS;GNAI2,4,4,B1
43,KEGG_2021_Human,Apelin signaling pathway,10/137,3.2173984161530064e-07,1.572137862438401e-06,0,0,9.51644848074972,142.2663612850675,NOTCH3;ADCY9;CDH1;SERPINE1;CALM3;CALM1;CALM2;HRAS;TGFBR1;GNAI2,4,4,B1
44,KEGG_2021_Human,Gap junction,8/88,9.508443553516628e-07,4.542923031124612e-06,0,0,11.967878787878789,165.94559541238348,PDGFRB;ADCY9;PDGFC;PDGFB;GNAS;HTR2C;HRAS;GNAI2,4,4,B1
45,KEGG_2021_Human,Hepatitis C,10/157,1.1320608703942471e-06,5.2911540681470255e-06,0,0,8.213346688368599,112.4527964131777,CXCL10;RXRA;TRADD;FAS;FASLG;TRAF2;FADD;TNF;HRAS;TNFRSF1A,4,4,B1
46,KEGG_2021_Human,Chemical carcinogenesis,12/239,1.1996995159363445e-06,5.487987147368384e-06,0,0,6.435548745451063,87.73866405797207,NOTCH2;AR;HSP90AA1;ADCY9;RXRA;GNAS;ESR1;FGF2;HRAS;HSP90B1;VEGFA;GNAI2,4,4,B1
47,KEGG_2021_Human,Inflammatory mediator regulation of TRP channels,8/98,2.163397054483045e-06,9.690215973205308e-06,0,0,10.632727272727273,138.69149613950196,ADCY9;PTGER2;GNAS;BDKRB2;HTR2C;CALM3;CALM1;CALM2,4,4,B1
48,KEGG_2021_Human,Glioma,7/75,3.8822212670032255e-06,1.6564784650424e-05,0,0,12.2531006378455,152.66264385541132,PDGFRB;PDGFB;CALM3;CALM1;HRAS;CALM2;IGF1R,4,4,B1
49,KEGG_2021_Human,Tuberculosis,10/180,3.89123124872903e-06,1.6564784650424e-05,0,0,7.093828942619993,88.36630149702802,TGFB3;TRADD;ITGB2;ITGAX;CALM3;FADD;CALM1;CALM2;TNF;TNFRSF1A,4,4,B1
50,KEGG_2021_Human,Pathways of neurodegeneration,16/475,3.929321010100577e-06,1.6564784650424e-05,0,0,4.300237292369177,53.5252424358395,APP;WNT7B;FZD6;LRP5;TRAF2;FASLG;PSEN1;TNF;TNFRSF1A;FAS;CALM3;FADD;CALM1;CALM2;HRAS;SPTBN2,4,4,B1
51,KEGG_2021_Human,Apoptosis,9/142,4.105666794447148e-06,1.697535309242571e-05,0,0,8.126077388593435,100.78889495173198,TRADD;FAS;FASLG;TRAF2;FADD;TNF;HRAS;SPTAN1;TNFRSF1A,4,4,B1
52,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,7/77,4.63595076500126e-06,1.880621536745794e-05,0,0,11.901807228915663,146.17405989481196,ITGB5;ITGA3;ITGA1;ITGAV;ITGB7;ITGA6;ITGA9,4,4,B1
53,KEGG_2021_Human,TNF signaling pathway,8/112,5.899769132285061e-06,2.348982154520904e-05,0,0,9.194871794871794,110.7117488560272,CXCL10;TRADD;FAS;TRAF2;FADD;TNF;ICAM1;TNFRSF1A,4,4,B1
54,KEGG_2021_Human,ErbB signaling pathway,7/85,8.979162185771003e-06,3.510036127165028e-05,0,0,10.67678405931418,124.07067930978872,ERBB3;NRG4;ERBB2;NRG2;AREG;HRAS;HBEGF,4,4,B1
55,KEGG_2021_Human,Sphingolipid signaling pathway,8/119,9.244691921859724e-06,3.549301362856858e-05,0,0,8.611957411957412,99.82516862454206,TRADD;ADORA1;BDKRB2;TRAF2;TNF;HRAS;TNFRSF1A;GNAI2,4,4,B1
56,KEGG_2021_Human,Necroptosis,9/159,1.030806188230614e-05,3.874513694863651e-05,0,0,7.198902439024391,82.66200384903631,HSP90AA1;TRADD;FAS;FASLG;TRAF2;FADD;HMGB1;TNF;TNFRSF1A,4,4,B1
57,KEGG_2021_Human,Thyroid hormone signaling pathway,8/121,1.045217647916706e-05,3.874513694863651e-05,0,0,8.45867524805578,97.01001157254896,NOTCH2;BMP4;NOTCH3;NOTCH1;RXRA;ITGAV;ESR1;HRAS,4,4,B1
58,KEGG_2021_Human,Epstein-Barr virus infection,10/202,1.0772900668244778e-05,3.9257180401230975e-05,0,0,6.2739647239263805,71.76459977885594,CXCL10;TRADD;HLA-B;FAS;TRAF2;CALR;FADD;TNF;CD44;ICAM1,4,4,B1
59,KEGG_2021_Human,JAK-STAT signaling pathway,9/162,1.1981917670667997e-05,4.293520498656032e-05,0,0,7.056671449067432,79.96699054054699,PDGFRB;IL20;IL20RA;PDGFB;OSM;IL6ST;OSMR;IL2RG;HRAS,4,4,B1
60,KEGG_2021_Human,cGMP-PKG signaling pathway,9/167,1.5287488882160413e-05,5.388213294531949e-05,0,0,6.831622414325409,75.75227970805608,EDNRA;ADCY9;INSR;ADORA1;BDKRB2;CALM3;CALM1;CALM2;GNAI2,4,4,B1
61,KEGG_2021_Human,GnRH signaling pathway,7/93,1.6263831117492834e-05,5.639876919775741e-05,0,0,9.679672177080414,106.73355249684958,ADCY9;GNAS;CALM3;CALM1;HRAS;CALM2;HBEGF,4,4,B1
62,KEGG_2021_Human,IL-17 signaling pathway,7/94,1.744563386852715e-05,5.9536687011640265e-05,0,0,9.567926879933529,104.8302364168101,CXCL10;HSP90AA1;TRADD;TRAF2;FADD;TNF;HSP90B1,4,4,B1
63,KEGG_2021_Human,cAMP signaling pathway,10/216,1.9266858960362932e-05,6.472460431996924e-05,0,0,5.843409375186134,63.44262069718162,EDNRA;ADCY9;EDN2;PTGER2;ADORA1;GNAS;CALM3;CALM1;CALM2;GNAI2,4,4,B1
64,KEGG_2021_Human,Protein digestion and absorption,7/103,3.163976937481978e-05,0.0001037251793116861,0,0,8.666980421686747,89.79941361491694,COL1A1;COL18A1;COL1A2;COL4A2;COL4A1;COL6A1;COL4A5,4,4,B1
65,KEGG_2021_Human,Central carbon metabolism in cancer,6/70,3.184121783521527e-05,0.0001037251793116861,0,0,11.094498502994012,114.8807467149584,RET;PDGFRB;PKM;ERBB2;HRAS;FGFR3,4,4,B1
66,KEGG_2021_Human,Phospholipase D signaling pathway,8/148,4.491026974642373e-05,0.00014411504470867318,0,0,6.818008658008658,68.25402150576926,PDGFRB;ARF1;ADCY9;INSR;PDGFC;PDGFB;GNAS;HRAS,4,4,B1
67,KEGG_2021_Human,Gastric acid secretion,6/76,5.0867932486399416e-05,0.0001585015287619692,0,0,10.140461933276304,100.2514241291191,ADCY9;GNAS;CALM3;CALM1;CALM2;GNAI2,4,4,B1
68,KEGG_2021_Human,Pertussis,6/76,5.0867932486399416e-05,0.0001585015287619692,0,0,10.140461933276304,100.2514241291191,ITGB2;CALM3;CALM1;TNF;CALM2;GNAI2,4,4,B1
69,KEGG_2021_Human,mTOR signaling pathway,8/154,5.952504806354056e-05,0.00018282693333801747,0,0,6.53582399335824,63.5877725202358,INSR;WNT7B;FZD6;LRP5;TNF;HRAS;IGF1R;TNFRSF1A,4,4,B1
70,KEGG_2021_Human,Cellular senescence,8/156,6.519820378185334e-05,0.0001974311804661756,0,0,6.446846846846847,62.13521688201139,TGFB3;SERPINE1;HLA-B;CALM3;CALM1;CALM2;HRAS;TGFBR1,4,4,B1
71,KEGG_2021_Human,Regulation of lipolysis in adipocytes,5/55,0.00011205181842452147,0.0003345991800176683,0,0,11.772023809523809,107.08479293298336,ADCY9;INSR;ADORA1;GNAS;GNAI2,4,4,B1
72,KEGG_2021_Human,Influenza A,8/172,0.00012889847184050366,0.0003796324855576478,0,0,5.813155949741316,52.06544699331077,CXCL10;TRADD;FAS;FASLG;FADD;TNF;ICAM1;TNFRSF1A,4,4,B1
73,KEGG_2021_Human,Natural killer cell mediated cytotoxicity,7/131,0.000145570509383223,0.0004229413448296344,0,0,6.700398367664206,59.19701443923668,ITGB2;HLA-B;FAS;FASLG;TNF;HRAS;ICAM1,4,4,B1
74,KEGG_2021_Human,Notch signaling pathway,5/59,0.0001568264017163816,0.0004495690182536273,0,0,10.89781746031746,95.46892497909457,NOTCH2;NOTCH3;NCSTN;NOTCH1;PSEN1,4,4,B1
75,KEGG_2021_Human,Vascular smooth muscle contraction,7/133,0.00015993775271232644,0.00045245548464671294,0,0,6.593373493975903,57.630870229650704,EDNRA;ADCY9;EDN2;GNAS;CALM3;CALM1;CALM2,4,4,B1
76,KEGG_2021_Human,Circadian entrainment,6/97,0.00019800490505720485,0.0005528708387960914,0,0,7.7920642232019475,66.44463618082676,ADCY9;GNAS;CALM3;CALM1;CALM2;GNAI2,4,4,B1
77,KEGG_2021_Human,African trypanosomiasis,4/37,0.00028576547120654183,0.0007774770513124436,0,0,14.19688004303389,115.8513555161933,FAS;FASLG;TNF;ICAM1,4,4,B1
78,KEGG_2021_Human,Thyroid cancer,4/37,0.00028576547120654183,0.0007774770513124436,0,0,14.19688004303389,115.8513555161933,RET;RXRA;CDH1;HRAS,4,4,B1
79,KEGG_2021_Human,NF-kappa B signaling pathway,6/104,0.0002892937865348627,0.0007774770513124436,0,0,7.232921911279482,58.93433829733358,PLAU;TRADD;TRAF2;TNF;ICAM1;TNFRSF1A,4,4,B1
80,KEGG_2021_Human,Allograft rejection,4/38,0.0003172435038372023,0.000830638427091274,0,0,13.778628611207797,110.99844029867738,HLA-B;FAS;FASLG;TNF,4,4,B1
81,KEGG_2021_Human,"Parathyroid hormone synthesis, secretion and action",6/106,0.0003206502552586817,0.000830638427091274,0,0,7.08754491017964,57.02042980661179,ADCY9;RXRA;GNAS;LRP5;HBEGF;GNAI2,4,4,B1
82,KEGG_2021_Human,Pathogenic Escherichia coli infection,8/197,0.0003249921631941913,0.000830638427091274,0,0,5.0378066378066375,40.46219937749487,ARF1;TRADD;FAS;TRAF2;FASLG;FADD;TNF;TNFRSF1A,4,4,B1
83,KEGG_2021_Human,Salmonella infection,9/249,0.0003278291117484599,0.000830638427091274,0,0,4.478734756097561,35.93296995108294,HSP90AA1;ARF1;TRADD;TRAF2;FADD;TNF;HRAS;HSP90B1;TNFRSF1A,4,4,B1
84,KEGG_2021_Human,Adipocytokine signaling pathway,5/69,0.000328391936291899,0.000830638427091274,0,0,9.19038318452381,73.71884577573003,RXRA;TRADD;TRAF2;TNF;TNFRSF1A,4,4,B1
85,KEGG_2021_Human,RIG-I-like receptor signaling pathway,5/70,0.0003512036547664209,0.0008780091369160522,0,0,9.0485347985348,71.97335139834395,CXCL10;TRADD;TRAF2;FADD;TNF,4,4,B1
86,KEGG_2021_Human,Endocytosis,9/252,0.00035782308715553686,0.0008842754452694302,0,0,4.4227642276422765,35.0967210880678,ARF1;HLA-B;CXCR4;IL2RG;FGFR4;FGFR3;HRAS;TGFBR1;IGF1R,4,4,B1
87,KEGG_2021_Human,Phagosome,7/152,0.0003624577417343835,0.000885550164464687,0,0,5.723888658080599,45.34809553661952,ITGB5;ITGB2;CANX;HLA-B;ITGAV;CALR;THBS1,4,4,B1
88,KEGG_2021_Human,Oxytocin signaling pathway,7/154,0.0003922335904907752,0.0009475305837698502,0,0,5.645438898450947,44.28086376084028,ADCY9;GNAS;CALM3;CALM1;CALM2;HRAS;GNAI2,4,4,B1
89,KEGG_2021_Human,Non-alcoholic fatty liver disease,7/155,0.0004078382536008025,0.000974280272490806,0,0,5.607009117551287,43.76068707522485,RXRA;INSR;FAS;FASLG;TRAF2;TNF;TNFRSF1A,4,4,B1
90,KEGG_2021_Human,Toxoplasmosis,6/112,0.0004309425686001151,0.0010181610137255,0,0,6.6843294542989495,51.80044992546448,LAMA5;TGFB3;ITGA6;TNF;TNFRSF1A;GNAI2,4,4,B1
91,KEGG_2021_Human,Graft-versus-host disease,4/42,0.0004682904979067628,0.0010943745331516,0,0,12.325755216443476,94.49443766194976,HLA-B;FAS;FASLG;TNF,4,4,B1
92,KEGG_2021_Human,Leukocyte transendothelial migration,6/114,0.0004736245898328877,0.0010949385678932,0,0,6.559880239520958,50.21651006054396,ITGB2;PECAM1;CXCR4;VCL;ICAM1;GNAI2,4,4,B1
93,KEGG_2021_Human,Type I diabetes mellitus,4/43,0.0005128628756916422,0.0011730374284436,0,0,12.00910332271279,90.97498680829952,HLA-B;FAS;FASLG;TNF,4,4,B1
94,KEGG_2021_Human,Hepatitis B,7/162,0.0005315040625358804,0.0012028776152127,0,0,5.351884959191605,40.35214069902793,TGFB3;FAS;FASLG;FADD;TNF;HRAS;TGFBR1,4,4,B1
95,KEGG_2021_Human,Antigen processing and presentation,5/78,0.0005794965052968449,0.0012978307149877,0,0,8.05365296803653,60.02670180499774,HSP90AA1;CANX;HLA-B;CALR;TNF,4,4,B1
96,KEGG_2021_Human,Neurotrophin signaling pathway,6/119,0.0005948004203063868,0.0013183720656275,0,0,6.268030311059297,46.55444523197462,CALM3;FASLG;PSEN1;CALM1;CALM2;HRAS,4,4,B1
97,KEGG_2021_Human,Hepatocellular carcinoma,7/168,0.000659767204812522,0.0014474484595376,0,0,5.150864326872708,37.72299105609864,TGFB3;WNT7B;FZD6;LRP5;HRAS;TGFBR1;IGF1R,4,4,B1
98,KEGG_2021_Human,Platelet activation,6/124,0.0007387737305756499,0.0016044075967046,0,0,6.000913427382523,43.269699488294975,COL1A1;ADCY9;COL1A2;GNAS;TLN1;GNAI2,4,4,B1
99,KEGG_2021_Human,Complement and coagulation cascades,5/85,0.0008577360363153253,0.0018441324780779,0,0,7.346354166666667,51.87418003513125,PLAU;ITGB2;SERPINE1;BDKRB2;ITGAX,4,4,B1
100,KEGG_2021_Human,Oocyte meiosis,6/129,0.0009083285631271672,0.0019335707036865,0,0,5.755513363516869,40.31106532006951,AR;ADCY9;CALM3;CALM1;CALM2;IGF1R,4,4,B1
101,KEGG_2021_Human,FoxO signaling pathway,6/131,0.0009839643191885143,0.0020544824897062,0,0,5.662850299401198,39.2091276693307,TGFB3;INSR;FASLG;HRAS;TGFBR1;IGF1R,4,4,B1
102,KEGG_2021_Human,Ovarian steroidogenesis,4/51,0.0009842404485569634,0.0020544824897062,0,0,9.960971924965378,68.96618697032198,ADCY9;INSR;GNAS;IGF1R,4,4,B1
103,KEGG_2021_Human,Endocrine and other factor-regulated calcium reabsorption,4/53,0.0011379464378541,0.0023524854244101,0,0,9.553435575413598,64.7582497589396,ADCY9;BDKRB2;GNAS;ESR1,4,4,B1
104,KEGG_2021_Human,Insulin signaling pathway,6/137,0.0012401808406612,0.0025394179118301,0,0,5.401837546281483,36.15178735702487,INSR;CALM3;CALM1;CALM2;HRAS;PTPRF,4,4,B1
105,KEGG_2021_Human,Rheumatoid arthritis,5/93,0.0012857756458951,0.0025835678866117,0,0,6.67579816017316,44.43673699231751,TGFB3;ITGB2;TNF;ICAM1;VEGFA,4,4,B1
106,KEGG_2021_Human,Salivary secretion,5/93,0.0012857756458951,0.0025835678866117,0,0,6.67579816017316,44.43673699231751,ADCY9;GNAS;CALM3;CALM1;CALM2,4,4,B1
107,KEGG_2021_Human,Shigellosis,8/246,0.0013855185128922,0.002758208150665,0,0,3.990628978864273,26.265046257276424,ARF1;TRADD;TRAF2;TLN1;TNF;VCL;CD44;TNFRSF1A,4,4,B1
108,KEGG_2021_Human,Chemokine signaling pathway,7/192,0.0014369576923017,0.0028343660903199,0,0,4.47717355910127,29.30411777312031,CXCL10;ADCY9;CXCR3;CXCR4;CXCL13;HRAS;GNAI2,4,4,B1
109,KEGG_2021_Human,Aldosterone synthesis and secretion,5/98,0.001623018366858,0.0031722631715862,0,0,6.315284178187404,40.56602377010225,ADCY9;GNAS;CALM3;CALM1;CALM2,4,4,B1
110,KEGG_2021_Human,Hematopoietic cell lineage,5/99,0.0016975751069508,0.0032880959278777,0,0,6.247783687943262,39.85182846963321,ITGA3;ITGA1;ITGA6;TNF;CD44,4,4,B1
111,KEGG_2021_Human,Phototransduction,3/28,0.0017773040502781,0.0034117890250874,0,0,13.977882352941176,88.51714349164372,CALM3;CALM1;CALM2,4,4,B1
112,KEGG_2021_Human,Long-term depression,4/60,0.0018082506675976,0.0034404769339247,0,0,8.35629754860524,52.77332295776591,GNAS;HRAS;IGF1R;GNAI2,4,4,B1
113,KEGG_2021_Human,Adrenergic signaling in cardiomyocytes,6/150,0.0019681702360914,0.0037119000066636,0,0,4.910928143712575,30.59827926122385,ADCY9;GNAS;CALM3;CALM1;CALM2;GNAI2,4,4,B1
114,KEGG_2021_Human,C-type lectin receptor signaling pathway,5/104,0.0021085948188688,0.0039421555309287,0,0,5.93073593073593,36.54361435876632,CALM3;CALM1;TNF;CALM2;HRAS,4,4,B1
115,KEGG_2021_Human,Basal cell carcinoma,4/63,0.0021649918761783,0.004012700460158,0,0,7.930197572961589,48.65444782915839,BMP4;BMP2;WNT7B;FZD6,4,4,B1
116,KEGG_2021_Human,Glucagon signaling pathway,5/107,0.0023875776323614,0.0043502473809975,0,0,5.755427170868347,34.74825324100523,PKM;GNAS;CALM3;CALM1;CALM2,4,4,B1
117,KEGG_2021_Human,Th17 cell differentiation,5/107,0.0023875776323614,0.0043502473809975,0,0,5.755427170868347,34.74825324100523,HSP90AA1;RXRA;IL6ST;IL2RG;TGFBR1,4,4,B1
118,KEGG_2021_Human,HIF-1 signaling pathway,5/109,0.0025878839316188,0.0046755886159499,0,0,5.644173534798535,33.621860592448435,INSR;SERPINE1;ERBB2;IGF1R;VEGFA,4,4,B1
119,KEGG_2021_Human,Long-term potentiation,4/67,0.002712397774671,0.0048597126796189,0,0,7.4251901944209635,43.88229672254312,CALM3;CALM1;HRAS;CALM2,4,4,B1
120,KEGG_2021_Human,Amphetamine addiction,4/69,0.0030187144532158,0.0052870074028258,0,0,7.195994538006373,41.75781096254862,GNAS;CALM3;CALM1;CALM2,4,4,B1
121,KEGG_2021_Human,Renal cell carcinoma,4/69,0.0030187144532158,0.0052870074028258,0,0,7.195994538006373,41.75781096254862,TGFB3;PDGFB;HRAS;VEGFA,4,4,B1
122,KEGG_2021_Human,Serotonergic synapse,5/113,0.0030246600490584,0.0052870074028258,0,0,5.434027777777778,31.522559162380023,APP;GNAS;HTR2C;HRAS;GNAI2,4,4,B1
123,KEGG_2021_Human,Non-small cell lung cancer,4/72,0.0035212371670713,0.0061053708945189,0,0,6.877479986077272,38.85049162173263,RET;RXRA;ERBB2;HRAS,4,4,B1
124,KEGG_2021_Human,Thyroid hormone synthesis,4/75,0.0040777907034707,0.0070138000099696,0,0,6.585882156846404,36.23684035209868,ADCY9;CANX;GNAS;HSP90B1,4,4,B1
125,KEGG_2021_Human,Coronavirus disease,7/232,0.0041382268900525,0.0070612601695341,0,0,3.673734939759036,20.159575920673092,CXCL10;NRP1;ACE;IL6ST;TNF;TNFRSF1A;HBEGF,4,4,B1
126,KEGG_2021_Human,Pancreatic cancer,4/76,0.0042757675100053,0.0072385040523713,0,0,6.494082840236686,35.423868904606366,TGFB3;ERBB2;TGFBR1;VEGFA,4,4,B1
127,KEGG_2021_Human,Alcoholism,6/186,0.0056645237666658,0.0095146297643214,0,0,3.921556886227545,20.288301820861424,GNAS;CALM3;CALM1;CALM2;HRAS;GNAI2,4,4,B1
128,KEGG_2021_Human,Dopaminergic synapse,5/132,0.0058487685930834,0.0097479476551391,0,0,4.616610423697038,23.736413923662784,GNAS;CALM3;CALM1;CALM2;GNAI2,4,4,B1
129,KEGG_2021_Human,Colorectal cancer,4/86,0.0066219372794551,0.0109516655006374,0,0,5.699235098859864,28.595155885248023,TGFB3;AREG;HRAS;TGFBR1,4,4,B1
130,KEGG_2021_Human,Measles,5/139,0.0072461476134007,0.0118925323426042,0,0,4.373889481165601,21.551401410015742,TRADD;FAS;FASLG;FADD;IL2RG,4,4,B1
131,KEGG_2021_Human,Type II diabetes mellitus,3/46,0.007351256790784,0.011973637954686,0,0,8.119288645690835,39.88912318486773,PKM;INSR;TNF,4,4,B1
132,KEGG_2021_Human,Morphine addiction,4/91,0.0080623339487877,0.0130330962330026,0,0,5.370332585186697,25.88796851836009,ADCY9;ADORA1;GNAS;GNAI2,4,4,B1
133,KEGG_2021_Human,Intestinal immune network for IgA production,3/48,0.0082713713264588,0.0132712301133481,0,0,7.75764705882353,37.19756827591976,CXCR4;ITGB7;MADCAM1,4,4,B1
134,KEGG_2021_Human,Th1 and Th2 cell differentiation,4/92,0.008373118300844,0.0133349661828257,0,0,5.309037116729424,25.39168528657977,NOTCH2;NOTCH3;NOTCH1;IL2RG,4,4,B1
135,KEGG_2021_Human,Diabetic cardiomyopathy,6/203,0.008556755358281,0.0134284846863535,0,0,3.58004802577586,17.04473111562238,COL1A1;COL1A2;ACE;TGFB3;INSR;TGFBR1,4,4,B1
136,KEGG_2021_Human,Viral carcinogenesis,6/203,0.008556755358281,0.0134284846863535,0,0,3.58004802577586,17.04473111562238,PKM;TRADD;HLA-B;TRAF2;IL6ST;HRAS,4,4,B1
137,KEGG_2021_Human,Vibrio cholerae infection,3/50,0.0092562394453228,0.0144209527590174,0,0,7.426783479349186,34.77559741127963,ARF1;ADCY9;GNAS,4,4,B1
138,KEGG_2021_Human,Choline metabolism in cancer,4/98,0.0104031192053093,0.0160911556053345,0,0,4.968651642956062,22.68512235746034,PDGFRB;PDGFC;PDGFB;HRAS,4,4,B1
139,KEGG_2021_Human,Autoimmune thyroid disease,3/53,0.0108568891404164,0.0166730797513537,0,0,6.980117647058823,31.57076119996346,HLA-B;FAS;FASLG,4,4,B1
140,KEGG_2021_Human,Progesterone-mediated oocyte maturation,4/100,0.0111444641085547,0.0169933317967323,0,0,4.864644970414201,21.87539580935677,HSP90AA1;ADCY9;IGF1R;GNAI2,4,4,B1
141,KEGG_2021_Human,Cushing syndrome,5/155,0.0112831342347699,0.0170836187357431,0,0,3.904166666666667,17.508025426436667,ADCY9;WNT7B;FZD6;GNAS;GNAI2,4,4,B1
142,KEGG_2021_Human,Longevity regulating pathway,4/102,0.0119190487218572,0.0179202480783168,0,0,4.764883468180171,21.106610842284937,ADCY9;INSR;HRAS;IGF1R,4,4,B1
143,KEGG_2021_Human,Legionellosis,3/57,0.0132252235006093,0.0197459934210487,0,0,6.461764705882353,27.951199397491777,ARF1;ITGB2;TNF,4,4,B1
144,KEGG_2021_Human,Endometrial cancer,3/58,0.0138596297971176,0.0205504855612434,0,0,6.343957219251337,27.14436552378812,CDH1;ERBB2;HRAS,4,4,B1
145,KEGG_2021_Human,Insulin resistance,4/108,0.0144472154658007,0.0212750090763503,0,0,4.488620846609012,19.019424770954927,INSR;TNF;PTPRF;TNFRSF1A,4,4,B1
146,KEGG_2021_Human,Viral myocarditis,3/60,0.0151796644767043,0.0222015500849757,0,0,6.120743034055727,25.632439171672065,ITGB2;HLA-B;ICAM1,4,4,B1
147,KEGG_2021_Human,Protein processing in endoplasmic reticulum,5/171,0.0166354382988178,0.0241663461773367,0,0,3.524992828456684,14.439146200867302,HSP90AA1;CANX;TRAF2;CALR;HSP90B1,4,4,B1
148,KEGG_2021_Human,Inflammatory bowel disease,3/65,0.0187806670804482,0.0270996202838682,0,0,5.625711574952562,22.36179443705682,TGFB3;IL2RG;TNF,4,4,B1
149,KEGG_2021_Human,"Growth hormone synthesis, secretion and action",4/119,0.0199111264057691,0.0285392811816024,0,0,4.057010547980448,15.88918682693717,ADCY9;GNAS;HRAS;GNAI2,4,4,B1
150,KEGG_2021_Human,Osteoclast differentiation,4/127,0.0245876506270726,0.0350089065219908,0,0,3.7916005195554914,14.049817315738144,TRAF2;TNF;TGFBR1;TNFRSF1A,4,4,B1
151,KEGG_2021_Human,p53 signaling pathway,3/73,0.0254429314912842,0.0359883570435928,0,0,4.980756302521009,18.28593685809585,SERPINE1;FAS;THBS1,4,4,B1
152,KEGG_2021_Human,Chronic myeloid leukemia,3/76,0.0282274143747146,0.0396659744481284,0,0,4.7753424657534245,17.035851027733788,TGFB3;HRAS;TGFBR1,4,4,B1
153,KEGG_2021_Human,Neuroactive ligand-receptor interaction,7/341,0.0291664921197602,0.0402300057697285,0,0,2.461059808094654,8.699193647083868,VIPR1;EDNRA;EDN2;PTGER2;ADORA1;BDKRB2;HTR2C,4,4,B1
154,KEGG_2021_Human,Bacterial invasion of epithelial cells,3/77,0.0291901437212914,0.0402300057697285,0,0,4.710572337042925,16.64680543867054,CDH1;FN1;VCL,4,4,B1
155,KEGG_2021_Human,Leishmaniasis,3/77,0.0291901437212914,0.0402300057697285,0,0,4.710572337042925,16.64680543867054,TGFB3;ITGB2;TNF,4,4,B1
156,KEGG_2021_Human,Herpes simplex virus 1 infection,9/498,0.0295645753752828,0.0404865204183809,0,0,2.1702079904234624,7.641689525916647,TRADD;HLA-B;FAS;TRAF2;FASLG;CALR;FADD;TNF;TNFRSF1A,4,4,B1
0,KEGG_2021_Human,PI3K-Akt signaling pathway,8/354,9.316349311007835e-10,8.384714379907051e-08,0,0,37.83044315992293,786.6492646355089,HSP90AA1;ERBB3;ERBB2;FN1;TNC;ITGB6;EGFR;HSP90B1,1,1,C1
1,KEGG_2021_Human,ECM-receptor interaction,5/88,2.163115980700099e-08,9.734021913150445e-07,0,0,79.90763052208835,1410.300237235799,SDC4;FN1;TNC;SDC1;ITGB6,1,1,C1
2,KEGG_2021_Human,Proteoglycans in cancer,6/205,3.7057773503436564e-08,1.1117332051030968e-06,0,0,42.60086145010768,728.934295941749,SDC4;ERBB3;ERBB2;FN1;SDC1;EGFR,1,1,C1
3,KEGG_2021_Human,Pathways in cancer,7/531,5.132309293581073e-07,1.1547695910557414e-05,0,0,19.99295361127422,289.5487491612717,HSP90AA1;TGFB3;CDH1;ERBB2;FN1;EGFR;HSP90B1,1,1,C1
4,KEGG_2021_Human,Adherens junction,4/71,6.766045606126773e-07,1.2178882091028192e-05,0,0,74.30223880597015,1055.55089270016,CDH1;ERBB2;EGFR;PTPRF,1,1,C1
5,KEGG_2021_Human,Focal adhesion,5/201,1.337589882385776e-06,2.006384823578664e-05,0,0,33.64625850340136,455.0535725896941,ERBB2;FN1;TNC;ITGB6;EGFR,1,1,C1
6,KEGG_2021_Human,Prostate cancer,4/97,2.372919648928384e-06,3.050896691479351e-05,0,0,53.45967741935484,692.3771016818831,HSP90AA1;ERBB2;EGFR;HSP90B1,1,1,C1
7,KEGG_2021_Human,Bladder cancer,3/41,8.896823842210735e-06,9.927726204035276e-05,0,0,92.60990712074305,1077.0361996489462,CDH1;ERBB2;EGFR,1,1,C1
8,KEGG_2021_Human,Fluid shear stress and atherosclerosis,4/139,9.927726204035276e-06,9.927726204035276e-05,0,0,36.75,423.36658150610407,HSP90AA1;SDC4;SDC1;HSP90B1,1,1,C1
9,KEGG_2021_Human,Cell adhesion molecules,4/148,1.2720072301986945e-05,0.00010687573538571372,0,0,34.4375,388.1908408180275,SDC4;CDH1;SDC1;PTPRF,1,1,C1
10,KEGG_2021_Human,Gastric cancer,4/149,1.306258988047612e-05,0.00010687573538571372,0,0,34.19827586206897,384.5855394049781,TGFB3;CDH1;ERBB2;EGFR,1,1,C1
11,KEGG_2021_Human,Endometrial cancer,3/58,2.5474983887326053e-05,0.0001910623791549454,0,0,63.93048128342246,676.2447150996445,CDH1;ERBB2;EGFR,1,1,C1
12,KEGG_2021_Human,Pancreatic cancer,3/76,5.737834681405649e-05,0.0003729085563810871,0,0,48.12328767123287,469.9644989426725,TGFB3;ERBB2;EGFR,1,1,C1
13,KEGG_2021_Human,Regulation of actin cytoskeleton,4/218,5.800799765928021e-05,0.0003729085563810871,0,0,23.0911214953271,225.25226610167212,FN1;ITGB6;ITGAE;EGFR,1,1,C1
14,KEGG_2021_Human,ErbB signaling pathway,3/85,8.015427688190231e-05,0.0004809256612914139,0,0,42.82209469153515,403.8790406182925,ERBB3;ERBB2;EGFR,1,1,C1
15,KEGG_2021_Human,MAPK signaling pathway,4/294,0.0001840618711733036,0.0010353480253498,0,0,16.974137931034484,145.9816362446964,ERBB3;TGFB3;ERBB2;EGFR,1,1,C1
16,KEGG_2021_Human,MicroRNAs in cancer,4/310,0.0002254316380915369,0.0011934616134257,0,0,16.073529411764707,134.9773603969322,ERBB3;ERBB2;TNC;EGFR,1,1,C1
17,KEGG_2021_Human,Human papillomavirus infection,4/331,0.00028943581432784484,0.0014471790716392,0,0,15.025229357798166,122.41921310075315,FN1;TNC;ITGB6;EGFR,1,1,C1
18,KEGG_2021_Human,Estrogen signaling pathway,3/137,0.0003291166829116823,0.0015589737611606,0,0,26.13608428446005,209.58782672203765,HSP90AA1;EGFR;HSP90B1,1,1,C1
19,KEGG_2021_Human,Malaria,2/50,0.0011307590059983,0.0050884155269924,0,0,46.138888888888886,313.0461870363529,TGFB3;SDC1,1,1,C1
20,KEGG_2021_Human,Chemical carcinogenesis,3/239,0.0016529134522188,0.0068431511136058,0,0,14.76370887337986,94.56474163053548,HSP90AA1;EGFR;HSP90B1,1,1,C1
21,KEGG_2021_Human,Calcium signaling pathway,3/240,0.0016727702722147,0.0068431511136058,0,0,14.700670141474312,93.98541486301065,ERBB3;ERBB2;EGFR,1,1,C1
22,KEGG_2021_Human,Salmonella infection,3/249,0.0018582659430686,0.0072714754293991,0,0,14.15638450502152,89.01692441369535,HSP90AA1;HSP90B1;S100A10,1,1,C1
23,KEGG_2021_Human,Central carbon metabolism in cancer,2/70,0.0022026761035863,0.008060159849552,0,0,32.5359477124183,199.05760409273051,ERBB2;EGFR,1,1,C1
24,KEGG_2021_Human,Melanoma,2/72,0.0023284906232039,0.008060159849552,0,0,31.603174603174605,191.59535285451057,CDH1;EGFR,1,1,C1
25,KEGG_2021_Human,Non-small cell lung cancer,2/72,0.0023284906232039,0.008060159849552,0,0,31.603174603174605,191.59535285451057,ERBB2;EGFR,1,1,C1
26,KEGG_2021_Human,Bacterial invasion of epithelial cells,2/77,0.0026575929845639,0.0088586432818797,0,0,29.488888888888887,174.87897393163863,CDH1;FN1,1,1,C1
27,KEGG_2021_Human,Colorectal cancer,2/86,0.0033018930995042,0.0106132278198351,0,0,26.31746031746032,150.3584751342039,TGFB3;EGFR,1,1,C1
28,KEGG_2021_Human,Hypertrophic cardiomyopathy,2/90,0.0036094335277519,0.0112016902585405,0,0,25.116161616161616,141.25842758872437,TGFB3;ITGB6,1,1,C1
29,KEGG_2021_Human,Salivary secretion,2/93,0.0038485584136363,0.011409305309522,0,0,24.284493284493283,135.02315810678772,TRPV6;AQP5,1,1,C1
30,KEGG_2021_Human,IL-17 signaling pathway,2/94,0.0039298718288353,0.011409305309522,0,0,24.019323671497585,133.04659989721253,HSP90AA1;HSP90B1,1,1,C1
31,KEGG_2021_Human,Dilated cardiomyopathy,2/96,0.0040948972210907,0.0115168984343177,0,0,23.505910165484632,129.23581519530129,TGFB3;ITGB6,1,1,C1
32,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,2/100,0.004434499847536,0.0120940904932801,0,0,22.54195011337869,122.13995997533476,TGFB3;FN1,1,1,C1
33,KEGG_2021_Human,Amoebiasis,2/102,0.0046090529183839,0.0122004341957221,0,0,22.08888888888889,118.83232192165296,TGFB3;FN1,1,1,C1
34,KEGG_2021_Human,HIF-1 signaling pathway,2/109,0.005244730259552,0.0134864492388482,0,0,20.63655244029076,108.3528679492363,ERBB2;EGFR,1,1,C1
35,KEGG_2021_Human,FoxO signaling pathway,2/131,0.0074882334108293,0.0187205835270734,0,0,17.098191214470283,83.68576954910893,TGFB3;EGFR,1,1,C1
36,KEGG_2021_Human,Breast cancer,2/147,0.0093473086864774,0.0227366968049452,0,0,15.199233716475096,71.02095504803928,ERBB2;EGFR,1,1,C1
37,KEGG_2021_Human,Hippo signaling pathway,2/163,0.0113913007147331,0.026979396429631,0,0,13.677708764665288,61.2064515808089,TGFB3;CDH1,1,1,C1
38,KEGG_2021_Human,Hepatocellular carcinoma,2/168,0.0120670598354949,0.0278470611588345,0,0,13.262382864792505,58.583603758242354,TGFB3;EGFR,1,1,C1
39,KEGG_2021_Human,Protein processing in endoplasmic reticulum,2/171,0.0124808418461157,0.0280818941537604,0,0,13.024983563445105,57.09580297600449,HSP90AA1;HSP90B1,1,1,C1
40,KEGG_2021_Human,Rap1 signaling pathway,2/210,0.018410850055187,0.0404140610967519,0,0,10.561965811965813,42.19310063010437,CDH1;EGFR,1,1,C1
41,KEGG_2021_Human,Lipid and atherosclerosis,2/215,0.0192427883471784,0.0412345464582396,0,0,10.311424100156495,40.736507139702006,HSP90AA1;HSP90B1,1,1,C1
0,KEGG_2021_Human,Epstein-Barr virus infection,13/202,1.3542771798386561e-18,1.191763918258017e-16,0,0,75.58495002939448,3109.8115390122684,HLA-B;HLA-C;HLA-A;HLA-F;ITGAL;CD3D;HLA-E;ICAM1;VIM;CALR;CD247;B2M;CD44,2,2,C1
1,KEGG_2021_Human,Cell adhesion molecules,11/148,1.8625930188876784e-16,8.195409283105785e-15,0,0,79.61751824817519,2883.6980935339425,PTPRC;ITGB2;HLA-B;PECAM1;HLA-C;SDC1;HLA-A;HLA-F;ITGAL;HLA-E;ICAM1,2,2,C1
2,KEGG_2021_Human,Human T-cell leukemia virus 1 infection,11/219,1.4729673586439724e-14,4.3207042520223197e-13,0,0,52.25264423076923,1664.1898848270605,ITGB2;HLA-B;HLA-C;HLA-A;CALR;HLA-F;ITGAL;CD3D;B2M;HLA-E;ICAM1,2,2,C1
3,KEGG_2021_Human,Viral myocarditis,8/60,3.016997393350662e-14,6.637394265371458e-13,0,0,133.22408026755852,4147.52263538776,ITGB2;HLA-B;HLA-C;HLA-A;HLA-F;ITGAL;HLA-E;ICAM1,2,2,C1
4,KEGG_2021_Human,Antigen processing and presentation,8/78,2.71435982230864e-13,4.395125884753718e-12,0,0,98.87701863354036,2861.0114855496563,HLA-B;HLA-C;KLRD1;HLA-A;CALR;HLA-F;B2M;HLA-E,2,2,C1
5,KEGG_2021_Human,Natural killer cell mediated cytotoxicity,9/131,2.996676739604808e-13,4.395125884753718e-12,0,0,66.551043219076,1919.0726896205424,ITGB2;HLA-B;HLA-C;KLRD1;HLA-A;CD247;ITGAL;HLA-E;ICAM1,2,2,C1
6,KEGG_2021_Human,Phagosome,9/152,1.1638870722082377e-12,1.4631723193474988e-11,0,0,56.7177368086459,1558.561197499903,C3;ITGB2;HLA-B;HLA-C;HLA-A;CALR;CD14;HLA-F;HLA-E,2,2,C1
7,KEGG_2021_Human,Human immunodeficiency virus 1 infection,9/212,2.3467767422774067e-11,2.5814544165051467e-10,0,0,39.83296014330497,974.9273632339105,HLA-B;HLA-C;HLA-A;CALR;CD247;HLA-F;CD3D;B2M;HLA-E,2,2,C1
8,KEGG_2021_Human,Graft-versus-host disease,6/42,4.182559365027822e-11,4.0896136013605365e-10,0,0,132.88666666666666,3175.660801069704,HLA-B;HLA-C;KLRD1;HLA-A;HLA-F;HLA-E,2,2,C1
9,KEGG_2021_Human,Human papillomavirus infection,9/331,1.222809010472382e-09,1.0760719292156962e-08,0,0,24.96089779785432,512.250419035109,COL1A1;COL6A2;ITGA1;FN1;HLA-B;HLA-C;HLA-A;HLA-F;HLA-E,2,2,C1
10,KEGG_2021_Human,Human cytomegalovirus infection,8/225,1.4299899761060802e-09,1.1439919808848642e-08,0,0,31.66018833901022,644.7786810571106,CCL5;HLA-B;HLA-C;HLA-A;CALR;HLA-F;B2M;HLA-E,2,2,C1
11,KEGG_2021_Human,Allograft rejection,5/38,3.086755994461379e-09,2.263621062605012e-08,0,0,116.17715617715618,2276.6244141078014,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E,2,2,C1
12,KEGG_2021_Human,ECM-receptor interaction,6/88,4.113083161754804e-09,2.78424090949556e-08,0,0,58.20585365853658,1123.9022372845222,COL1A1;COL6A2;ITGA1;FN1;SDC1;CD44,2,2,C1
13,KEGG_2021_Human,Type I diabetes mellitus,5/43,5.887671657247697e-09,3.700822184555695e-08,0,0,100.8653846153846,1911.4399113151069,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E,2,2,C1
14,KEGG_2021_Human,Malaria,5/50,1.2861415497107111e-08,7.545363758302838e-08,0,0,85.14529914529915,1547.007839745968,ITGB2;PECAM1;SDC1;ITGAL;ICAM1,2,2,C1
15,KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,7/193,1.5102942147427492e-08,8.30661818108512e-08,0,0,31.021729390681003,558.6509753485016,C3;HLA-B;HLA-C;HLA-A;HLA-F;HLA-E;ICAM1,2,2,C1
16,KEGG_2021_Human,Autoimmune thyroid disease,5/53,1.7363214125518957e-08,8.98801672379805e-08,0,0,79.81169871794872,1426.1482209114415,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E,2,2,C1
17,KEGG_2021_Human,Herpes simplex virus 1 infection,9/498,4.238033985052438e-08,2.071927726025637e-07,0,0,16.29670942554378,276.6624119150514,C3;CCL5;HLA-B;HLA-C;HLA-A;CALR;HLA-F;B2M;HLA-E,2,2,C1
18,KEGG_2021_Human,Chagas disease,5/102,4.778904272322638e-07,2.213387241917853e-06,0,0,39.39730372720064,573.383802638559,C3;CCL5;CALR;CD247;CD3D,2,2,C1
19,KEGG_2021_Human,Viral carcinogenesis,6/203,6.050687100070247e-07,2.662302324030909e-06,0,0,24.08771573604061,344.8860787885266,C3;HLA-B;HLA-C;HLA-A;HLA-F;HLA-E,2,2,C1
20,KEGG_2021_Human,Leukocyte transendothelial migration,5/114,8.313977597999793e-07,3.4839525172570563e-06,0,0,35.03881439661256,490.5489203278189,MMP2;ITGB2;PECAM1;ITGAL;ICAM1,2,2,C1
21,KEGG_2021_Human,Cellular senescence,5/156,3.904878141373169e-06,1.5619512565492675e-05,0,0,25.23942944472746,314.31378239243963,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E,2,2,C1
22,KEGG_2021_Human,Rheumatoid arthritis,4/93,1.2519804516771964e-05,4.790186075982316e-05,0,0,33.09196837286725,373.5487178777872,CCL5;ITGB2;ITGAL;ICAM1,2,2,C1
23,KEGG_2021_Human,Staphylococcus aureus infection,4/95,1.362156690340497e-05,4.994574531248489e-05,0,0,32.36141636141636,362.5726559745327,C3;ITGB2;ITGAL;ICAM1,2,2,C1
24,KEGG_2021_Human,Proteoglycans in cancer,5/205,1.4737130933015142e-05,5.18747008842133e-05,0,0,19.008653846153845,211.4739416203225,COL1A1;MMP2;FN1;SDC1;CD44,2,2,C1
25,KEGG_2021_Human,Hematopoietic cell lineage,4/99,1.6037364154075088e-05,5.428030944456184e-05,0,0,30.992592592592597,342.1764861129013,ITGA1;CD14;CD3D;CD44,2,2,C1
26,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,4/100,1.6687556029356314e-05,5.438907150308724e-05,0,0,30.66820987654321,337.37629271966244,COL1A1;MMP2;FN1;ICAM1,2,2,C1
27,KEGG_2021_Human,Amoebiasis,4/102,1.804589519159232e-05,5.671567060214728e-05,0,0,30.039304610733183,328.1070776067066,COL1A1;ITGB2;FN1;CD14,2,2,C1
28,KEGG_2021_Human,Regulation of actin cytoskeleton,5/218,1.9818655286251648e-05,6.013936776517741e-05,0,0,17.836764174792343,193.152301512472,ITGA1;ITGB2;FN1;ITGAX;ITGAL,2,2,C1
29,KEGG_2021_Human,Primary immunodeficiency,3/38,2.7416160670176023e-05,8.042073796584968e-05,0,0,61.02244897959184,641.0028652557249,CD79A;PTPRC;CD3D,2,2,C1
30,KEGG_2021_Human,Endocytosis,5/252,3.9670873774892926e-05,0.00011261409329647024,0,0,15.355029585798816,155.62158643345558,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E,2,2,C1
31,KEGG_2021_Human,Fluid shear stress and atherosclerosis,4/139,6.076054784716012e-05,0.00016709150657969032,0,0,21.765706447187927,211.31388167533805,MMP2;PECAM1;SDC1;ICAM1,2,2,C1
32,KEGG_2021_Human,Legionellosis,3/57,9.321611427381588e-05,0.0002485763047301757,0,0,39.513888888888886,366.7122001583965,C3;ITGB2;CD14,2,2,C1
33,KEGG_2021_Human,Tuberculosis,4/180,0.00016510494393906486,0.0004273304431364032,0,0,16.660774410774412,145.09750579970583,C3;ITGB2;ITGAX;CD14,2,2,C1
34,KEGG_2021_Human,Pertussis,3/76,0.000219544191344744,0.0005519968239524991,0,0,29.201565557729943,245.9927331283584,C3;ITGB2;CD14,2,2,C1
35,KEGG_2021_Human,Focal adhesion,4/201,0.00025184831701023343,0.0006156292193583485,0,0,14.868960330889266,123.21436925173585,COL1A1;COL6A2;ITGA1;FN1,2,2,C1
36,KEGG_2021_Human,Complement and coagulation cascades,3/85,0.00030555948951030155,0.0007267360831596361,0,0,25.98475609756097,210.3041433362322,C3;ITGB2;ITGAX,2,2,C1
37,KEGG_2021_Human,Shigellosis,4/246,0.0005412481777456293,0.0012461342437979,0,0,12.07652280379553,90.83516816400598,C3;CCL5;CD14;CD44,2,2,C1
38,KEGG_2021_Human,T cell receptor signaling pathway,3/104,0.0005522640398650075,0.0012461342437979,0,0,21.07637906647808,158.1041265197237,PTPRC;CD247;CD3D,2,2,C1
39,KEGG_2021_Human,PI3K-Akt signaling pathway,4/354,0.0020812597391039,0.0045787714260286,0,0,8.304338624338625,51.27748003496079,COL1A1;COL6A2;ITGA1;FN1,2,2,C1
40,KEGG_2021_Human,Neutrophil extracellular trap formation,3/189,0.0030727909454141,0.0065952586145474,0,0,11.39573732718894,65.92626663221358,C3;ITGB2;ITGAL,2,2,C1
41,KEGG_2021_Human,Lipid and atherosclerosis,3/215,0.0044108011379613,0.0092416785747761,0,0,9.985006738544474,54.15567048455993,CCL5;CD14;ICAM1,2,2,C1
42,KEGG_2021_Human,Leishmaniasis,2/77,0.0063285917152504,0.0129515365335357,0,0,18.293333333333333,92.61324789757649,C3;ITGB2,2,2,C1
43,KEGG_2021_Human,PD-L1 expression and PD-1 checkpoint pathway in cancer,2/89,0.0083727822480647,0.0167455644961295,0,0,15.760602457391991,75.37932152498767,CD247;CD3D,2,2,C1
44,KEGG_2021_Human,Th1 and Th2 cell differentiation,2/92,0.0089243322904424,0.0174520275901984,0,0,15.23295019157088,71.88389235582319,CD247;CD3D,2,2,C1
45,KEGG_2021_Human,Protein digestion and absorption,2/103,0.0110815660431143,0.0206947099370595,0,0,13.566404916353704,61.08236191260247,COL1A1;COL6A2,2,2,C1
46,KEGG_2021_Human,Toll-like receptor signaling pathway,2/104,0.0112880236020324,0.0206947099370595,0,0,13.432724814063556,60.23251233622612,CCL5;CD14,2,2,C1
47,KEGG_2021_Human,NF-kappa B signaling pathway,2/104,0.0112880236020324,0.0206947099370595,0,0,13.432724814063556,60.23251233622612,CD14;ICAM1,2,2,C1
48,KEGG_2021_Human,Th17 cell differentiation,2/107,0.0119175782685405,0.0214029977067666,0,0,13.046962233169127,57.79466096438427,CD247;CD3D,2,2,C1
49,KEGG_2021_Human,TNF signaling pathway,2/112,0.0130004527316697,0.0228807968077387,0,0,12.450783699059562,54.07090357846781,CCL5;ICAM1,2,2,C1
50,KEGG_2021_Human,Relaxin signaling pathway,2/129,0.0169882631483111,0.0293130815108113,0,0,10.774911756720066,43.9102713988681,COL1A1;MMP2,2,2,C1
51,KEGG_2021_Human,Influenza A,2/172,0.0290431384335684,0.049149926579885,0,0,8.032048681541582,28.425203596038617,CCL5;ICAM1,2,2,C1
0,KEGG_2021_Human,PI3K-Akt signaling pathway,15/354,1.6810292710178004e-21,1.2439616605531722e-19,0,0,108.61725663716814,5195.693511651339,HSP90AA1;FN1;TNC;THBS2;THBS1;HSP90B1;VEGFA;COL1A1;COMP;COL1A2;ERBB3;ERBB2;ITGA6;ITGAV;ITGB6,1,1,D1
1,KEGG_2021_Human,ECM-receptor interaction,11/88,8.097903471077164e-21,2.9962242842985513e-19,0,0,236.9047619047619,10959.849606345972,COL1A1;COMP;COL1A2;FN1;TNC;ITGA6;ITGAV;ITGB6;CD36;THBS2;THBS1,1,1,D1
2,KEGG_2021_Human,Focal adhesion,12/201,9.34946984193407e-19,2.3062025610104036e-17,0,0,114.2164502164502,4741.558542805127,COL1A1;COMP;COL1A2;ERBB2;FN1;TNC;ITGA6;ITGAV;ITGB6;THBS2;THBS1;VEGFA,1,1,D1
3,KEGG_2021_Human,Human papillomavirus infection,11/331,2.447998114168978e-14,4.52879651121261e-13,0,0,56.30911458333333,1764.779495272689,COL1A1;COMP;COL1A2;FN1;TNC;ITGA6;ITGAV;ITGB6;THBS2;THBS1;VEGFA,1,1,D1
4,KEGG_2021_Human,Proteoglycans in cancer,8/205,4.5647293830507475e-11,6.755799486915106e-10,0,0,53.54991539763113,1275.0275977941076,COL1A1;COL1A2;ERBB3;ERBB2;FN1;ITGAV;THBS1;VEGFA,1,1,D1
5,KEGG_2021_Human,Pathways in cancer,8/531,8.08237653023932e-08,9.96826438729516e-07,0,0,19.83836838750797,323.98029077127273,HSP90AA1;CDH1;ERBB2;FN1;ITGA6;ITGAV;HSP90B1;VEGFA,1,1,D1
6,KEGG_2021_Human,Bladder cancer,4/41,1.3080277991363168e-07,1.3827722448012491e-06,0,0,113.4566145092461,1798.2391373600997,CDH1;ERBB2;THBS1;VEGFA,1,1,D1
7,KEGG_2021_Human,Malaria,4/50,2.954348855055349e-07,2.732772690926198e-06,0,0,91.21739130434784,1371.4368199585128,COMP;CD36;THBS2;THBS1,1,1,D1
8,KEGG_2021_Human,Phagosome,5/152,7.15108363357357e-07,5.879779876493824e-06,0,0,37.471655328798185,530.2550898990866,COMP;ITGAV;CD36;THBS2;THBS1,1,1,D1
9,KEGG_2021_Human,IL-17 signaling pathway,4/94,3.7832954285928487e-06,2.7996386171587083e-05,0,0,46.51929824561404,580.7894901142499,HSP90AA1;S100A9;S100A8;HSP90B1,1,1,D1
10,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,4/100,4.842628966725328e-06,3.257768577615221e-05,0,0,43.59868421052632,533.5629998044093,COL1A1;COL1A2;FN1;VEGFA,1,1,D1
11,KEGG_2021_Human,Fluid shear stress and atherosclerosis,4/139,1.7853102916840882e-05,0.00011009413465385212,0,0,30.94269005847953,338.3067415029087,HSP90AA1;ITGAV;HSP90B1;VEGFA,1,1,D1
12,KEGG_2021_Human,Cell adhesion molecules,4/148,2.2849945278900783e-05,0.0001224969649086887,0,0,28.99561403508772,309.8634223420353,CDH1;ITGA6;ITGAV;PTPRF,1,1,D1
13,KEGG_2021_Human,MicroRNAs in cancer,5/310,2.317510146921137e-05,0.0001224969649086887,0,0,17.916211293260474,191.20954794560285,ERBB3;ERBB2;TNC;THBS1;VEGFA,1,1,D1
14,KEGG_2021_Human,Adherens junction,3/71,7.214845142834683e-05,0.00035593236037984434,0,0,43.91691176470588,418.82613377865886,CDH1;ERBB2;PTPRF,1,1,D1
15,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,3/77,9.19251078780767e-05,0.0004251536239361047,0,0,40.34391891891892,374.9780211851579,ITGA6;ITGAV;ITGB6,1,1,D1
16,KEGG_2021_Human,Regulation of actin cytoskeleton,4/218,0.00010333416435093748,0.0004498075389393749,0,0,19.44220363994097,178.43165033685762,FN1;ITGA6;ITGAV;ITGB6,1,1,D1
17,KEGG_2021_Human,Hypertrophic cardiomyopathy,3/90,0.0001462017178205663,0.0006010515065956614,0,0,34.293103448275865,302.8260476890999,ITGA6;ITGAV;ITGB6,1,1,D1
18,KEGG_2021_Human,Small cell lung cancer,3/92,0.00015604795273537798,0.0006077657106535775,0,0,33.519101123595505,293.80655946915306,FN1;ITGA6;ITGAV,1,1,D1
19,KEGG_2021_Human,Dilated cardiomyopathy,3/96,0.0001770138224423282,0.0006431881387859536,0,0,32.07096774193548,277.0701579251247,ITGA6;ITGAV;ITGB6,1,1,D1
20,KEGG_2021_Human,Prostate cancer,3/97,0.00018252636370952736,0.0006431881387859536,0,0,31.728191489361706,273.1358148977517,HSP90AA1;ERBB2;HSP90B1,1,1,D1
21,KEGG_2021_Human,Amoebiasis,3/102,0.00021176457605655307,0.0007122990285538603,0,0,30.118181818181817,254.80088408363127,COL1A1;COL1A2;FN1,1,1,D1
22,KEGG_2021_Human,Relaxin signaling pathway,3/129,0.00042242449056089054,0.0013591048826741,0,0,23.632142857142856,183.60993032952388,COL1A1;COL1A2;VEGFA,1,1,D1
23,KEGG_2021_Human,Diabetic cardiomyopathy,3/203,0.0015708011443582,0.0048433035284379,0,0,14.83275,95.76274825111696,COL1A1;COL1A2;CD36,1,1,D1
24,KEGG_2021_Human,Rap1 signaling pathway,3/210,0.0017307368346105,0.0051229810304473,0,0,14.326086956521738,91.10256742999076,CDH1;THBS1;VEGFA,1,1,D1
25,KEGG_2021_Human,Lipid and atherosclerosis,3/215,0.0018510094419256,0.0052682576424037,0,0,13.984669811320757,87.99188010453639,HSP90AA1;CD36;HSP90B1,1,1,D1
26,KEGG_2021_Human,Endometrial cancer,2/58,0.0020107980652784,0.0055110761789113,0,0,33.87925170068027,210.3638488142028,CDH1;ERBB2,1,1,D1
27,KEGG_2021_Human,Chemical carcinogenesis,3/239,0.0025009205400295,0.0064576062312549,0,0,12.547245762711864,75.17175890473285,HSP90AA1;HSP90B1;VEGFA,1,1,D1
28,KEGG_2021_Human,Calcium signaling pathway,3/240,0.0025306835230593,0.0064576062312549,0,0,12.49367088607595,74.70297961420843,ERBB3;ERBB2;VEGFA,1,1,D1
29,KEGG_2021_Human,Pancreatic cancer,2/76,0.0034236166206592,0.0083845870227587,0,0,25.615186615186616,145.4188948501949,ERBB2;VEGFA,1,1,D1
30,KEGG_2021_Human,Bacterial invasion of epithelial cells,2/77,0.0035124621311556,0.0083845870227587,0,0,25.272380952380956,142.8252947103709,CDH1;FN1,1,1,D1
31,KEGG_2021_Human,ErbB signaling pathway,2/85,0.004261697129685,0.0098551746123967,0,0,22.82730923694779,124.5934582992268,ERBB3;ERBB2,1,1,D1
32,KEGG_2021_Human,MAPK signaling pathway,3/294,0.004478253739899,0.0100421447500766,0,0,10.14742268041237,54.88255981230941,ERBB3;ERBB2;VEGFA,1,1,D1
33,KEGG_2021_Human,TGF-beta signaling pathway,2/94,0.0051852594222442,0.0112855646248845,0,0,20.58488612836439,108.3163411335794,THBS1;FBN1,1,1,D1
34,KEGG_2021_Human,Hematopoietic cell lineage,2/99,0.0057346613696212,0.0121247126100564,0,0,19.518900343642613,100.74146719605557,ITGA6;CD36,1,1,D1
35,KEGG_2021_Human,Protein digestion and absorption,2/103,0.0061926086844652,0.0127292511847341,0,0,18.74210278170674,95.2923257506366,COL1A1;COL1A2,1,1,D1
36,KEGG_2021_Human,Insulin resistance,2/108,0.0067878351896843,0.013456114745515,0,0,17.853548966756513,89.13604298019607,CD36;PTPRF,1,1,D1
37,KEGG_2021_Human,HIF-1 signaling pathway,2/109,0.0069098967612104,0.013456114745515,0,0,17.68580329327993,87.98334451309246,ERBB2;VEGFA,1,1,D1
38,KEGG_2021_Human,Platelet activation,2/124,0.0088595818473312,0.0168104886333978,0,0,15.49960967993755,73.25511876869098,COL1A1;COL1A2,1,1,D1
39,KEGG_2021_Human,Estrogen signaling pathway,2/137,0.0107255248408576,0.0198422209555866,0,0,13.997883597883598,63.48220615181043,HSP90AA1;HSP90B1,1,1,D1
40,KEGG_2021_Human,Gastric cancer,2/149,0.012588796477888,0.0227212424235053,0,0,12.847424684159378,56.20681529957356,CDH1;ERBB2,1,1,D1
41,KEGG_2021_Human,Protein processing in endoplasmic reticulum,2/171,0.0163435131593669,0.0287957136617416,0,0,11.162581008734854,45.92201224705961,HSP90AA1;HSP90B1,1,1,D1
42,KEGG_2021_Human,Axon guidance,2/182,0.0183795718145744,0.0316299607971746,0,0,10.474603174603176,41.86191350995017,SEMA4C;PLXNB2,1,1,D1
43,KEGG_2021_Human,Human cytomegalovirus infection,2/225,0.0272945994138449,0.0459045535596483,0,0,8.436472346786248,30.38029727152017,ITGAV;VEGFA,1,1,D1
0,KEGG_2021_Human,Epstein-Barr virus infection,8/202,2.1183764215379164e-12,1.588782316153437e-10,0,0,90.6712485681558,2437.2768150115044,HLA-B;HLA-A;VIM;CALR;HLA-F;CD3D;B2M;CD44,2,2,D1
1,KEGG_2021_Human,Cell adhesion molecules,7/148,1.9248852249960337e-11,7.218319593735127e-10,0,0,98.5063829787234,2430.504104384872,PTPRC;ITGB2;HLA-B;SDC1;ITGB7;HLA-A;HLA-F,2,2,D1
2,KEGG_2021_Human,Human T-cell leukemia virus 1 infection,7/219,3.03810658248456e-10,7.595266456211401e-09,0,0,65.2816037735849,1430.621307499867,ITGB2;HLA-B;HLA-A;CALR;HLA-F;CD3D;B2M,2,2,D1
3,KEGG_2021_Human,Phagosome,6/152,2.0152922357678227e-09,3.778672942064668e-08,0,0,74.11083437110834,1483.8843013963158,C3;ITGB2;HLA-B;HLA-A;CALR;HLA-F,2,2,D1
4,KEGG_2021_Human,Antigen processing and presentation,5/78,4.7245116283029905e-09,7.086767442454484e-08,0,0,113.64155251141553,2178.5655688413235,HLA-B;HLA-A;CALR;HLA-F;B2M,2,2,D1
5,KEGG_2021_Human,Human immunodeficiency virus 1 infection,6/212,1.4836444968544534e-08,1.854555621068067e-07,0,0,52.36628420123566,943.9640222788408,HLA-B;HLA-A;CALR;HLA-F;CD3D;B2M,2,2,D1
6,KEGG_2021_Human,Human cytomegalovirus infection,6/225,2.1160989367740866e-08,2.2672488608293786e-07,0,0,49.22540473225405,869.8673682759802,CCL5;HLA-B;HLA-A;CALR;HLA-F;B2M,2,2,D1
7,KEGG_2021_Human,Herpes simplex virus 1 infection,7/498,8.913890895767031e-08,8.356772714781591e-07,0,0,27.78900203665988,451.10081276667006,C3;CCL5;HLA-B;HLA-A;CALR;HLA-F;B2M,2,2,D1
8,KEGG_2021_Human,Viral myocarditis,4/60,1.6911545713738753e-07,1.409295476144896e-06,0,0,109.489010989011,1707.2275691988784,ITGB2;HLA-B;HLA-A;HLA-F,2,2,D1
9,KEGG_2021_Human,ECM-receptor interaction,4/88,7.970231753397781e-07,5.977673815048336e-06,0,0,72.89010989010988,1023.5507729564172,FN1;SDC1;ITGB7;CD44,2,2,D1
10,KEGG_2021_Human,Chagas disease,4/102,1.4419258597038886e-06,9.83131267979924e-06,0,0,62.43328100470958,839.6983442670211,C3;CCL5;CALR;CD3D,2,2,D1
11,KEGG_2021_Human,Allograft rejection,3/38,4.224310552457084e-06,2.6401940952856776e-05,0,0,122.13061224489796,1511.324129588408,HLA-B;HLA-A;HLA-F,2,2,D1
12,KEGG_2021_Human,Graft-versus-host disease,3/42,5.736541405782683e-06,3.164924322957009e-05,0,0,109.58241758241758,1322.5122901516588,HLA-B;HLA-A;HLA-F,2,2,D1
13,KEGG_2021_Human,Type I diabetes mellitus,3/43,6.16354838092779e-06,3.164924322957009e-05,0,0,106.8375,1281.7143070022444,HLA-B;HLA-A;HLA-F,2,2,D1
14,KEGG_2021_Human,Human papillomavirus infection,5/331,6.329848645914019e-06,3.164924322957009e-05,0,0,25.123977505112475,300.7398955930849,FN1;HLA-B;ITGB7;HLA-A;HLA-F,2,2,D1
15,KEGG_2021_Human,Autoimmune thyroid disease,3/53,1.1638584417883092e-05,5.4555864458827e-05,0,0,85.42714285714285,970.5535515233738,HLA-B;HLA-A;HLA-F,2,2,D1
16,KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,4/193,1.8131177579082284e-05,7.999048931948067e-05,0,0,32.224664224664224,351.8249391692548,C3;HLA-B;HLA-A;HLA-F,2,2,D1
17,KEGG_2021_Human,Viral carcinogenesis,4/203,2.2109905158735974e-05,9.212460482806656e-05,0,0,30.589872439118672,327.90767425480453,C3;HLA-B;HLA-A;HLA-F,2,2,D1
18,KEGG_2021_Human,Regulation of actin cytoskeleton,4/218,2.923615824778048e-05,0.0001154058878201861,0,0,28.424155283968368,296.7511463324173,ITGB2;FN1;ITGAX;ITGB7,2,2,D1
19,KEGG_2021_Human,Complement and coagulation cascades,3/85,4.825383601649229e-05,0.0001809518850618461,0,0,52.00609756097561,516.8904358545194,C3;ITGB2;ITGAX,2,2,D1
20,KEGG_2021_Human,Natural killer cell mediated cytotoxicity,3/131,0.00017460923476053026,0.0006236044098590367,0,0,33.23939732142857,287.6191762775354,ITGB2;HLA-B;HLA-A,2,2,D1
21,KEGG_2021_Human,Cellular senescence,3/156,0.0002921027277521554,0.0009958047537005298,0,0,27.77310924369748,226.02881141760892,HLA-B;HLA-A;HLA-F,2,2,D1
22,KEGG_2021_Human,Tuberculosis,3/180,0.0004442497644527196,0.0014486405362588,0,0,23.97820823244552,185.09075355975585,C3;ITGB2;ITGAX,2,2,D1
23,KEGG_2021_Human,Primary immunodeficiency,2/38,0.0004695231348152325,0.0014672597962976,0,0,73.87777777777778,566.183995087973,PTPRC;CD3D,2,2,D1
24,KEGG_2021_Human,Proteoglycans in cancer,3/205,0.0006490166739074251,0.0019470500217222,0,0,20.984087694483733,154.02429799556998,FN1;SDC1;CD44,2,2,D1
25,KEGG_2021_Human,Malaria,2/50,0.0008132713373134499,0.0023459750114811,0,0,55.375,393.9624337310239,ITGB2;SDC1,2,2,D1
26,KEGG_2021_Human,Legionellosis,2/57,0.0010558796227944,0.0029329989522068,0,0,48.31030303030303,331.08891742177576,C3;ITGB2,2,2,D1
27,KEGG_2021_Human,Shigellosis,3/246,0.0011002914852443,0.0029472093354759,0,0,17.40740740740741,118.58239516357604,C3;CCL5;CD44,2,2,D1
28,KEGG_2021_Human,Endocytosis,3/252,0.0011794003606244,0.0030501733464425,0,0,16.982788296041306,114.5106811546426,HLA-B;HLA-A;HLA-F,2,2,D1
29,KEGG_2021_Human,Pertussis,2/76,0.0018677011427961,0.0046368139320593,0,0,35.87207207207207,225.3859126556908,C3;ITGB2,2,2,D1
30,KEGG_2021_Human,Leishmaniasis,2/77,0.0019165497585845,0.0046368139320593,0,0,35.392,221.4558385121911,C3;ITGB2,2,2,D1
31,KEGG_2021_Human,Rheumatoid arthritis,2/93,0.0027798364268155,0.0065152416253489,0,0,29.145787545787545,171.53354523215606,CCL5;ITGB2,2,2,D1
32,KEGG_2021_Human,Staphylococcus aureus infection,2/95,0.0028984552384914,0.0065873982692988,0,0,28.516129032258064,166.63620601613766,C3;ITGB2,2,2,D1
33,KEGG_2021_Human,Hematopoietic cell lineage,2/99,0.003142749862972,0.0069325364624384,0,0,27.334707903780068,157.5205488452212,CD3D;CD44,2,2,D1
34,KEGG_2021_Human,Amoebiasis,2/102,0.0033321166769984,0.0071402500221395,0,0,26.510666666666665,151.2207540022897,ITGB2;FN1,2,2,D1
35,KEGG_2021_Human,T cell receptor signaling pathway,2/104,0.0034612740273215,0.0072109875569198,0,0,25.988235294117647,147.2524218660231,PTPRC;CD3D,2,2,D1
36,KEGG_2021_Human,Neutrophil extracellular trap formation,2/189,0.0110050718155102,0.0223075780044127,0,0,14.114795008912656,63.64924303911214,C3;ITGB2,2,2,D1
37,KEGG_2021_Human,Focal adhesion,2/201,0.0123767346179499,0.0244277656933222,0,0,13.255611390284756,58.217807593481794,FN1;ITGB7,2,2,D1
0,KEGG_2021_Human,PI3K-Akt signaling pathway,18/354,4.662437641359414e-19,7.086905214866306e-17,0,0,30.90126050420168,1304.329176567144,HSP90AA1;ITGA3;INSR;FN1;TNC;TGFA;AREG;THBS1;VEGFA;HSP90B1;COL1A1;EFNA1;COL1A2;ERBB3;ERBB2;ITGAV;ITGB6;FGFR3,1,1,F1
1,KEGG_2021_Human,ECM-receptor interaction,10/88,2.1833942527220428e-14,1.6593796320687526e-12,0,0,60.65323565323565,1907.8663687522092,COL1A1;COL1A2;ITGA3;FN1;TNC;SDC1;ITGAV;ITGB6;THBS1;CD44,1,1,F1
2,KEGG_2021_Human,Proteoglycans in cancer,11/205,4.1922985218139695e-12,2.1240979177190782e-10,0,0,27.318833291425697,715.6925647596388,COL1A1;COL1A2;ERBB3;GPC1;ERBB2;FN1;SDC1;ITGAV;THBS1;CD44;VEGFA,1,1,F1
3,KEGG_2021_Human,Human papillomavirus infection,12/331,3.947679970680305e-11,1.5001183888585156e-09,0,0,18.45987460815047,442.21198124780585,COL1A1;NOTCH2;COL1A2;PKM;ITGA3;FN1;TNC;GNAS;ITGAV;ITGB6;THBS1;VEGFA,1,1,F1
4,KEGG_2021_Human,Pathways in cancer,14/531,5.1119971247875815e-11,1.5540471259354246e-09,0,0,13.846788150259597,328.1252045677484,NOTCH2;HSP90AA1;ITGA3;FN1;TGFA;VEGFA;HSP90B1;AR;CDH1;ERBB2;GNAS;CALM3;ITGAV;FGFR3,1,1,F1
5,KEGG_2021_Human,Focal adhesion,10/201,9.202303391746096e-11,2.331250192575678e-09,0,0,24.628521565694346,569.1400665120829,COL1A1;COL1A2;ITGA3;ERBB2;FN1;TNC;ITGAV;ITGB6;THBS1;VEGFA,1,1,F1
6,KEGG_2021_Human,Rap1 signaling pathway,9/210,3.251508944905665e-09,7.06041942322373e-08,0,0,20.562651856994098,401.8794835625547,FARP2;EFNA1;CDH1;INSR;GNAS;CALM3;FGFR3;THBS1;VEGFA,1,1,F1
7,KEGG_2021_Human,Axon guidance,8/182,2.1548387928010223e-08,4.094193706321943e-07,0,0,20.66248693834901,364.7541552089504,EFNB2;EFNA1;SEMA4C;PLXNB2;SEMA3F;EPHA1;EPHB4;PLXNA3,1,1,F1
8,KEGG_2021_Human,Bladder cancer,5/41,6.808562516970364e-08,1.053843211059491e-06,0,0,58.84160756501182,971.033612967181,CDH1;ERBB2;THBS1;FGFR3;VEGFA,1,1,F1
9,KEGG_2021_Human,Fluid shear stress and atherosclerosis,7/139,6.933179020128231e-08,1.053843211059491e-06,0,0,23.35218855218855,384.9459366592832,HSP90AA1;GPC1;SDC1;CALM3;ITGAV;VEGFA;HSP90B1,1,1,F1
10,KEGG_2021_Human,MicroRNAs in cancer,9/310,9.425019985732149e-08,1.3023663980284422e-06,0,0,13.661670400988951,221.0091166784683,EFNA1;NOTCH2;ERBB3;ERBB2;TNC;FGFR3;THBS1;CD44;VEGFA,1,1,F1
11,KEGG_2021_Human,MAPK signaling pathway,8/294,8.5114952716997e-07,1.0781227344152954e-05,0,0,12.499682136045772,174.7040325204216,EFNA1;ERBB3;INSR;ERBB2;TGFA;AREG;FGFR3;VEGFA,1,1,F1
12,KEGG_2021_Human,Prostate cancer,5/97,5.247125683876754e-06,6.135100799609743e-05,0,0,22.960222016651247,279.1464787976019,AR;HSP90AA1;ERBB2;TGFA;HSP90B1,1,1,F1
13,KEGG_2021_Human,Estrogen signaling pathway,5/137,2.812528091527834e-05,0.0003016318217464166,0,0,15.970341715022569,167.35068287660204,HSP90AA1;GNAS;TGFA;CALM3;HSP90B1,1,1,F1
14,KEGG_2021_Human,Ras signaling pathway,6/232,2.976629819865953e-05,0.0003016318217464166,0,0,11.382454790303964,118.6294660841273,EFNA1;INSR;TGFA;CALM3;FGFR3;VEGFA,1,1,F1
15,KEGG_2021_Human,Adherens junction,4/71,3.470331957366553e-05,0.0003038985474761284,0,0,24.72761194029851,253.91981574966715,FARP2;CDH1;INSR;ERBB2,1,1,F1
16,KEGG_2021_Human,Chemical carcinogenesis,6/239,3.515761072238073e-05,0.0003038985474761284,0,0,11.03657398768427,113.18745458856704,NOTCH2;AR;HSP90AA1;GNAS;VEGFA;HSP90B1,1,1,F1
17,KEGG_2021_Human,Calcium signaling pathway,6/240,3.5987985885330994e-05,0.0003038985474761284,0,0,10.988851727982162,112.44150665981678,ERBB3;ERBB2;GNAS;CALM3;FGFR3;VEGFA,1,1,F1
18,KEGG_2021_Human,ErbB signaling pathway,4/85,7.04039172528728e-05,0.0005632313380229824,0,0,20.439300411522638,195.42549925011676,ERBB3;ERBB2;TGFA;AREG,1,1,F1
19,KEGG_2021_Human,Dilated cardiomyopathy,4/96,0.00011310014961873378,0.0008595611371023767,0,0,17.985507246376812,163.43856425036432,ITGA3;GNAS;ITGAV;ITGB6,1,1,F1
20,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,4/100,0.0001324843517277032,0.0009589343553624232,0,0,17.23263888888889,153.8710256794273,COL1A1;COL1A2;FN1;VEGFA,1,1,F1
21,KEGG_2021_Human,Amoebiasis,4/102,0.00014302947487450634,0.0009882036445874984,0,0,16.87925170068027,149.42289765660155,COL1A1;COL1A2;FN1;GNAS,1,1,F1
22,KEGG_2021_Human,Regulation of actin cytoskeleton,5/218,0.0002517636807237974,0.0016638295421746,0,0,9.85665767655579,81.6823161973188,ITGA3;FN1;ITGAV;ITGB6;FGFR3,1,1,F1
23,KEGG_2021_Human,Human cytomegalovirus infection,5/225,0.00029128138018197553,0.0018447820744858,0,0,9.539651837524175,77.66441211489001,GNAS;CALM3;ITGAV;CALR;VEGFA,1,1,F1
24,KEGG_2021_Human,Relaxin signaling pathway,4/129,0.0003518915640671267,0.0021395007095281,0,0,13.215333333333334,105.09080836263654,COL1A1;COL1A2;GNAS;VEGFA,1,1,F1
25,KEGG_2021_Human,Regulation of lipolysis in adipocytes,3/55,0.0003953067687192971,0.0023110241863589,0,0,23.425431711146,183.55813311140764,INSR;ADORA1;GNAS,1,1,F1
26,KEGG_2021_Human,Renin secretion,3/69,0.0007694991105943972,0.0043319949929758,0,0,18.44341372912801,132.23504847906776,ADORA1;GNAS;CALM3,1,1,F1
27,KEGG_2021_Human,Central carbon metabolism in cancer,3/70,0.0008024853276700178,0.0043563489216372,0,0,18.167225098994823,129.49229231194715,PKM;ERBB2;FGFR3,1,1,F1
28,KEGG_2021_Human,Pancreatic cancer,3/76,0.0010193504080019,0.0053428021384932,0,0,16.668996365669557,114.82587683164716,ERBB2;TGFA;VEGFA,1,1,F1
29,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,3/77,0.0010587385407208,0.0053642752729857,0,0,16.442912300055156,112.64508333437377,ITGA3;ITGAV;ITGB6,1,1,F1
30,KEGG_2021_Human,Hypertrophic cardiomyopathy,3/90,0.0016604484777634,0.0081415538264528,0,0,13.976776917663615,89.460702411426,ITGA3;ITGAV;ITGB6,1,1,F1
31,KEGG_2021_Human,Small cell lung cancer,3/92,0.0017684646463304,0.0084002070700694,0,0,13.66131621187801,86.58055244199267,ITGA3;FN1;ITGAV,1,1,F1
32,KEGG_2021_Human,Alzheimer disease,5/369,0.0026556916108198,0.0121586542959628,0,0,5.723638064063596,33.947184481364914,APP;NCSTN;INSR;ADAM10;CALM3,1,1,F1
33,KEGG_2021_Human,Glucagon signaling pathway,3/107,0.0027196989872548,0.0121586542959628,0,0,11.68210361067504,69.00892047283637,PKM;GNAS;CALM3,1,1,F1
34,KEGG_2021_Human,HIF-1 signaling pathway,3/109,0.0028661094172388,0.012447103754866,0,0,11.460531382364266,67.09911653159489,INSR;ERBB2;VEGFA,1,1,F1
35,KEGG_2021_Human,Platelet activation,3/124,0.0041198441521441,0.0173948975312753,0,0,10.032214538708043,55.09631974674811,COL1A1;COL1A2;GNAS,1,1,F1
36,KEGG_2021_Human,Type II diabetes mellitus,2/46,0.0063783787113196,0.0262030693005564,0,0,18.09454545454545,91.4650562908582,PKM;INSR,1,1,F1
37,KEGG_2021_Human,Cell adhesion molecules,3/148,0.0067325064198606,0.0269300256794426,0,0,8.361576354679803,41.81463608517468,CDH1;SDC1;ITGAV,1,1,F1
38,KEGG_2021_Human,Phagosome,3/152,0.0072444025886545,0.0282345947044998,0,0,8.135460895767704,40.087696428572585,ITGAV;CALR;THBS1,1,1,F1
39,KEGG_2021_Human,Malaria,2/50,0.007499481830469,0.0284980309557824,0,0,16.583333333333332,81.14094572244915,SDC1;THBS1,1,1,F1
40,KEGG_2021_Human,Ovarian steroidogenesis,2/51,0.0077926822984508,0.028889944130842,0,0,16.24408163265306,78.85803384874593,INSR;GNAS,1,1,F1
41,KEGG_2021_Human,cGMP-PKG signaling pathway,3/167,0.009366602657838,0.0338981810474138,0,0,7.3857640617222495,34.49598526311465,INSR;ADORA1;CALM3,1,1,F1
42,KEGG_2021_Human,Endometrial cancer,2/58,0.0099867571525234,0.0345022841343971,0,0,14.208571428571428,65.45171819277833,CDH1;ERBB2,1,1,F1
43,KEGG_2021_Human,Protein processing in endoplasmic reticulum,3/171,0.0099875033020623,0.0345022841343971,0,0,7.208454810495627,33.20517500189737,HSP90AA1;CALR;HSP90B1,1,1,F1
44,KEGG_2021_Human,Notch signaling pathway,2/59,0.0103201087179194,0.0348590338916389,0,0,13.95859649122807,63.841888167545946,NOTCH2;NCSTN,1,1,F1
45,KEGG_2021_Human,Amphetamine addiction,2/69,0.013918599590371,0.0450133433560936,0,0,11.869253731343283,50.73547205180672,GNAS;CALM3,1,1,F1
46,KEGG_2021_Human,Renal cell carcinoma,2/69,0.013918599590371,0.0450133433560936,0,0,11.869253731343283,50.73547205180672,TGFA;VEGFA,1,1,F1
47,KEGG_2021_Human,Non-small cell lung cancer,2/72,0.015089708714097,0.0477840775946407,0,0,11.358857142857143,47.63611978903658,ERBB2;TGFA,1,1,F1
48,KEGG_2021_Human,Diabetic cardiomyopathy,3/203,0.0158134061409639,0.048585875749743,0,0,6.04530612244898,25.06926308539757,COL1A1;COL1A2;INSR,1,1,F1
49,KEGG_2021_Human,Thyroid hormone synthesis,2/75,0.0163018398897164,0.048585875749743,0,0,10.89041095890411,44.8301295094724,GNAS;HSP90B1,1,1,F1
50,KEGG_2021_Human,Glioma,2/75,0.0163018398897164,0.048585875749743,0,0,10.89041095890411,44.8301295094724,TGFA;CALM3,1,1,F1
51,KEGG_2021_Human,Gastric acid secretion,2/76,0.0167148812767848,0.0488588837321403,0,0,10.742702702702704,43.95329394594533,GNAS;CALM3,1,1,F1
52,KEGG_2021_Human,Bacterial invasion of epithelial cells,2/77,0.0171323795475224,0.0491343715325172,0,0,10.598933333333331,43.10358378674535,CDH1;FN1,1,1,F1
53,KEGG_2021_Human,Antigen processing and presentation,2/78,0.0175543096775161,0.0494121309441194,0,0,10.458947368421052,42.27983238386785,HSP90AA1;CALR,1,1,F1
0,KEGG_2021_Human,Viral myocarditis,6/60,7.274519676858001e-11,5.6356180496596e-09,0,0,122.9753086419753,2870.742766510662,ITGB2;HLA-B;HLA-C;HLA-A;ITGAL;ICAM1,2,2,F1
1,KEGG_2021_Human,Human T-cell leukemia virus 1 infection,8/219,1.1501261325835919e-10,5.6356180496596e-09,0,0,46.83649289099526,1071.8990074001752,ITGB2;HLA-B;HLA-C;HLA-A;ITGAL;CD3D;B2M;ICAM1,2,2,F1
2,KEGG_2021_Human,Phagosome,7/152,3.957354140053517e-10,1.2927356857508154e-08,0,0,56.31521298174442,1219.2398631931749,C3;ITGB2;HLA-B;HLA-C;ITGA5;HLA-A;CD14,2,2,F1
3,KEGG_2021_Human,Epstein-Barr virus infection,7/202,2.890403497366563e-09,7.08148856854808e-08,0,0,41.76983408748114,821.273036308944,HLA-B;HLA-C;HLA-A;ITGAL;CD3D;B2M;ICAM1,2,2,F1
4,KEGG_2021_Human,Natural killer cell mediated cytotoxicity,6/131,8.596379307130442e-09,1.684890344197567e-07,0,0,52.936,983.1234076732696,ITGB2;HLA-B;HLA-C;HLA-A;ITGAL;ICAM1,2,2,F1
5,KEGG_2021_Human,Cell adhesion molecules,6/148,1.788177591512422e-08,2.920690066136956e-07,0,0,46.55868544600939,830.5829123433186,ITGB2;HLA-B;HLA-C;HLA-A;ITGAL;ICAM1,2,2,F1
6,KEGG_2021_Human,Proteoglycans in cancer,6/205,1.2436098806180058e-07,1.7410538328652077e-06,0,0,33.12730318257957,526.7266815626461,COL1A1;ERBB2;FN1;ITGA5;MMP9;HBEGF,2,2,F1
7,KEGG_2021_Human,Pertussis,4/76,1.9307927960598157e-06,2.1003775274871595e-05,0,0,55.28888888888889,727.4679711602033,C3;ITGB2;ITGA5;CD14,2,2,F1
8,KEGG_2021_Human,Human papillomavirus infection,6/331,2.055301648873251e-06,2.1003775274871595e-05,0,0,20.154871794871795,263.9298184324996,COL1A1;FN1;HLA-B;HLA-C;ITGA5;HLA-A,2,2,F1
9,KEGG_2021_Human,Antigen processing and presentation,4/78,2.143242374986897e-06,2.1003775274871595e-05,0,0,53.78918918918919,702.1205466173179,HLA-B;HLA-C;HLA-A;B2M,2,2,F1
10,KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,5/193,2.909176876669103e-06,2.591812126487019e-05,0,0,27.698768197088462,353.0939358636023,C3;HLA-B;HLA-C;HLA-A;ICAM1,2,2,F1
11,KEGG_2021_Human,Human immunodeficiency virus 1 infection,5/212,4.604158391083381e-06,3.557184198404903e-05,0,0,25.13221459445716,308.83849236180305,HLA-B;HLA-C;HLA-A;CD3D;B2M,2,2,F1
12,KEGG_2021_Human,Staphylococcus aureus infection,4/95,4.718713732577933e-06,3.557184198404903e-05,0,0,43.7032967032967,535.9761080223569,C3;ITGB2;ITGAL;ICAM1,2,2,F1
13,KEGG_2021_Human,Regulation of actin cytoskeleton,5/218,5.275372908857361e-06,3.692761036200152e-05,0,0,24.41685198912775,296.72484611828395,ITGB2;FN1;ITGAX;ITGA5;ITGAL,2,2,F1
14,KEGG_2021_Human,Amoebiasis,4/102,6.263603083003844e-06,4.0922206808958446e-05,0,0,40.56734693877551,486.027443296844,COL1A1;ITGB2;FN1;CD14,2,2,F1
15,KEGG_2021_Human,Leukocyte transendothelial migration,4/114,9.741342129381876e-06,5.966572054246399e-05,0,0,36.12,416.7934353489221,ITGB2;ITGAL;MMP9;ICAM1,2,2,F1
16,KEGG_2021_Human,Allograft rejection,3/38,1.245869713851705e-05,7.1820724680863e-05,0,0,81.39183673469388,919.165468843585,HLA-B;HLA-C;HLA-A,2,2,F1
17,KEGG_2021_Human,Bladder cancer,3/41,1.570609485653805e-05,8.551096088559607e-05,0,0,74.95488721804512,829.1106152036315,ERBB2;MMP9;HBEGF,2,2,F1
18,KEGG_2021_Human,Graft-versus-host disease,3/42,1.6900953383655097e-05,8.71733385051684e-05,0,0,73.02930402930403,802.4562550725676,HLA-B;HLA-C;HLA-A,2,2,F1
19,KEGG_2021_Human,Type I diabetes mellitus,3/43,1.8154235584669403e-05,8.895575436488008e-05,0,0,71.2,777.2623941159866,HLA-B;HLA-C;HLA-A,2,2,F1
20,KEGG_2021_Human,Herpes simplex virus 1 infection,6/498,2.124943879552395e-05,9.916404771244512e-05,0,0,13.200542005420054,142.02700849177256,C3;HLA-B;HLA-C;ITGA5;HLA-A;B2M,2,2,F1
21,KEGG_2021_Human,Malaria,3/50,2.867422295491e-05,0.00012773062952641727,0,0,60.57446808510638,633.5793754459056,ITGB2;ITGAL;ICAM1,2,2,F1
22,KEGG_2021_Human,Autoimmune thyroid disease,3/53,3.419074218146609e-05,0.00014568229277320334,0,0,56.93142857142857,585.4575137768635,HLA-B;HLA-C;HLA-A,2,2,F1
23,KEGG_2021_Human,Legionellosis,3/57,4.2571383289240295e-05,0.00017383314843106453,0,0,52.7037037037037,530.4273758667708,C3;ITGB2;CD14,2,2,F1
24,KEGG_2021_Human,Tuberculosis,4/180,5.856681903157289e-05,0.00022958193060376573,0,0,22.5,219.27020062228087,C3;ITGB2;ITGAX;CD14,2,2,F1
25,KEGG_2021_Human,Focal adhesion,4/201,8.986036981700472e-05,0.0003387044708487101,0,0,20.08020304568528,187.09234288825863,COL1A1;ERBB2;FN1;ITGA5,2,2,F1
26,KEGG_2021_Human,Viral carcinogenesis,4/203,9.336867306873018e-05,0.0003388937022494651,0,0,19.87638190954774,184.43204684381155,C3;HLA-B;HLA-C;HLA-A,2,2,F1
27,KEGG_2021_Human,Human cytomegalovirus infection,4/225,0.0001388537720102983,0.00045920328573663166,0,0,17.877828054298643,158.79246309616622,HLA-B;HLA-C;HLA-A;B2M,2,2,F1
28,KEGG_2021_Human,Complement and coagulation cascades,3/85,0.00014057243440917296,0.00045920328573663166,0,0,34.65853658536585,307.41385993287514,C3;ITGB2;ITGAX,2,2,F1
29,KEGG_2021_Human,ErbB signaling pathway,3/85,0.00014057243440917296,0.00045920328573663166,0,0,34.65853658536585,307.41385993287514,NRG4;ERBB2;HBEGF,2,2,F1
30,KEGG_2021_Human,ECM-receptor interaction,3/88,0.0001558113728712707,0.0004925649852059525,0,0,33.430252100840335,293.07848804835965,COL1A1;FN1;ITGA5,2,2,F1
31,KEGG_2021_Human,Rheumatoid arthritis,3/93,0.00018352808462724924,0.0005620547591709508,0,0,31.565079365079367,271.5588869264088,ITGB2;ITGAL;ICAM1,2,2,F1
32,KEGG_2021_Human,IL-17 signaling pathway,3/94,0.00018942937215793472,0.0005625478324690182,0,0,31.21664050235479,267.5732564184208,MMP9;S100A9;S100A8,2,2,F1
33,KEGG_2021_Human,Hematopoietic cell lineage,3/99,0.0002207869375035619,0.0006363858786867371,0,0,29.58333333333333,249.04174198623195,ITGA5;CD14;CD3D,2,2,F1
34,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,3/100,0.00022743640782365407,0.0006368219419062314,0,0,29.276877761413843,245.59318448881905,COL1A1;FN1;ICAM1,2,2,F1
35,KEGG_2021_Human,PI3K-Akt signaling pathway,4/354,0.0007747619076066085,0.0021090740818179,0,0,11.214857142857143,80.33151471081355,COL1A1;ERBB2;FN1;ITGA5,2,2,F1
36,KEGG_2021_Human,Cellular senescence,3/156,0.0008353133639175971,0.0022124516125385,0,0,18.50887021475257,131.1853863748443,HLA-B;HLA-C;HLA-A,2,2,F1
37,KEGG_2021_Human,Primary immunodeficiency,2/38,0.0009449004432908564,0.0024368485116448,0,0,50.35353535353536,350.6837219229394,CD79A;CD3D,2,2,F1
38,KEGG_2021_Human,Neutrophil extracellular trap formation,3/189,0.0014523438778403,0.0036494794879066,0,0,15.199692780337942,99.32355616389044,C3;ITGB2;ITGAL,2,2,F1
39,KEGG_2021_Human,Lipid and atherosclerosis,3/215,0.0020987902961872,0.0051420362256587,0,0,13.318059299191376,82.12440294746015,CD14;MMP9;ICAM1,2,2,F1
40,KEGG_2021_Human,Shigellosis,3/246,0.0030736609529192,0.0073467993508802,0,0,11.60082304526749,67.10943806934256,C3;ITGA5;CD14,2,2,F1
41,KEGG_2021_Human,Endocytosis,3/252,0.003289527901934,0.0076755651045126,0,0,11.31784279977051,64.7042342651742,HLA-B;HLA-C;HLA-A,2,2,F1
42,KEGG_2021_Human,Bacterial invasion of epithelial cells,2/77,0.0038222540446578,0.0085132021903742,0,0,24.12242424242424,134.2874845394686,FN1;ITGA5,2,2,F1
43,KEGG_2021_Human,Leishmaniasis,2/77,0.0038222540446578,0.0085132021903742,0,0,24.12242424242424,134.2874845394686,C3;ITGB2,2,2,F1
44,KEGG_2021_Human,MicroRNAs in cancer,3/310,0.0058644363317775,0.0127698149619231,0,0,9.152629129827828,47.0339782147195,ERBB2;ITGA5;MMP9,2,2,F1
45,KEGG_2021_Human,Prostate cancer,2/97,0.0059939947780455,0.0127698149619231,0,0,19.02488038277512,97.35025929294416,ERBB2;MMP9,2,2,F1
46,KEGG_2021_Human,Chagas disease,2/102,0.0066070951989085,0.0137764963721922,0,0,18.06909090909091,90.69981068989615,C3;CD3D,2,2,F1
47,KEGG_2021_Human,NF-kappa B signaling pathway,2/104,0.006860029074594,0.0140058926939629,0,0,17.71301247771836,88.24700043316875,CD14;ICAM1,2,2,F1
48,KEGG_2021_Human,TNF signaling pathway,2/112,0.0079152128017673,0.0158304256035346,0,0,16.418181818181818,79.44706793117858,MMP9;ICAM1,2,2,F1
49,KEGG_2021_Human,Relaxin signaling pathway,2/129,0.0103834277603468,0.0203515184102797,0,0,14.208303507516106,64.89705468059547,COL1A1;MMP9,2,2,F1
50,KEGG_2021_Human,Yersinia infection,2/137,0.0116485087629211,0.0219529588224283,0,0,13.36094276094276,59.49062791002039,FN1;ITGA5,2,2,F1
51,KEGG_2021_Human,Estrogen signaling pathway,2/137,0.0116485087629211,0.0219529588224283,0,0,13.36094276094276,59.49062791002039,MMP9;HBEGF,2,2,F1
52,KEGG_2021_Human,Fluid shear stress and atherosclerosis,2/139,0.0119749131057109,0.0221422921577295,0,0,13.164565361645652,58.25243017669269,MMP9;ICAM1,2,2,F1
53,KEGG_2021_Human,Transcriptional misregulation in cancer,2/192,0.0220283558432485,0.0399773865303398,0,0,9.466985645933017,36.12057137527057,CD14;MMP9,2,2,F1
54,KEGG_2021_Human,Diabetic cardiomyopathy,2/203,0.0244359367200017,0.0435403963374576,0,0,8.943916779737675,33.197139612521894,COL1A1;MMP9,2,2,F1
55,KEGG_2021_Human,Pathways in cancer,3/531,0.024892585864842,0.0435620252634736,0,0,5.261904761904762,19.433189191863587,ERBB2;FN1;MMP9,2,2,F1
56,KEGG_2021_Human,Rap1 signaling pathway,2/210,0.0260221263770835,0.0447397962272664,0,0,8.63986013986014,31.52519156066381,ITGB2;ITGAL,2,2,F1
0,KEGG_2021_Human,Cell adhesion molecules,17/148,1.2588097392441784e-20,1.9637431932209185e-18,0,0,41.422063531149966,1898.0225436725357,SELPLG;SDC4;ITGB2;HLA-B;ICAM2;HLA-C;ICAM3;HLA-A;L1CAM;ITGAL;HLA-G;PTPRF;ICAM1;CD4;PTPRC;PECAM1;SDC1,3,3,F1
1,KEGG_2021_Human,Viral protein interaction with cytokine and cytokine receptor,14/100,2.260004231018248e-18,1.7628033001942335e-16,0,0,49.67620751341681,2018.4021834795292,CSF1R;CXCL9;CCL11;CCL21;CSF1;TNFSF14;IL34;IL2RG;TNFRSF1A;CXCL12;CCL5;CXCR3;LTBR;CCL19,3,3,F1
2,KEGG_2021_Human,Cytokine-cytokine receptor interaction,18/295,7.960269511643737e-17,4.139340146054743e-15,0,0,20.92631828135172,775.7278149206059,CSF1R;CXCL9;CCL11;CCL21;CSF1;TNFSF14;IL34;IL16;IL2RG;TNFRSF1A;CD4;CXCL12;CCL5;CXCR3;LTBR;LTB;CCL19;IFNAR1,3,3,F1
3,KEGG_2021_Human,ECM-receptor interaction,11/88,4.4416001724462336e-14,1.732224067254031e-12,0,0,41.6890756302521,1281.737992176039,COL1A1;SDC4;COL4A2;ITGB5;LAMB2;ITGB4;ITGA11;FN1;SDC1;ITGA5;HSPG2,3,3,F1
4,KEGG_2021_Human,Human papillomavirus infection,16/331,1.8541814582571722e-13,5.785046149762376e-12,0,0,15.807306626354244,463.4095756360124,NOTCH3;JAG1;ITGB5;LAMB2;ITGB4;FN1;HLA-B;HLA-C;HLA-A;HLA-G;TNFRSF1A;COL1A1;COL4A2;ITGA11;ITGA5;IFNAR1,3,3,F1
5,KEGG_2021_Human,Human T-cell leukemia virus 1 infection,13/219,3.1775856189348225e-12,8.261722609230538e-11,0,0,18.850764930862017,499.0721060404631,ITGB2;HLA-B;HLA-C;HLA-A;IL2RG;ITGAL;CD3D;HLA-G;TNFRSF1A;ICAM1;CD4;LTBR;B2M,3,3,F1
6,KEGG_2021_Human,Natural killer cell mediated cytotoxicity,11/131,3.8486940536784695e-12,8.577089605340589e-11,0,0,26.69252450980392,701.5672886386238,ITGB2;HLA-B;ICAM2;HLA-C;FYN;CD247;HLA-A;ITGAL;HLA-G;IFNAR1;ICAM1,3,3,F1
7,KEGG_2021_Human,Viral myocarditis,8/60,8.929419135240712e-11,1.7412367313719386e-09,0,0,43.05308775731311,996.2090432058736,ITGB2;HLA-B;HLA-C;FYN;HLA-A;ITGAL;HLA-G;ICAM1,3,3,F1
8,KEGG_2021_Human,NF-kappa B signaling pathway,9/104,2.973521310940697e-10,5.1541036056305425e-09,0,0,26.83218045112782,588.593502340697,CXCL12;CCL21;TNFSF14;LTBR;LTB;CCL19;CD14;TNFRSF1A;ICAM1,3,3,F1
9,KEGG_2021_Human,Proteoglycans in cancer,11/205,4.929237622159692e-10,7.689610690569118e-09,0,0,16.449135839902972,352.5159459506192,COL1A1;SDC4;ITGB5;MMP2;ERBB2;FN1;SDC1;ITGA5;MMP9;HSPG2;HBEGF,3,3,F1
10,KEGG_2021_Human,Leukocyte transendothelial migration,9/114,6.796943611470376e-10,9.639301848994354e-09,0,0,24.26448979591837,512.2082843543114,CXCL12;MMP2;ITGB2;PECAM1;THY1;ITGAL;MMP9;ICAM1;GNAI2,3,3,F1
11,KEGG_2021_Human,PI3K-Akt signaling pathway,13/354,1.2381192768708336e-09,1.6095550599320838e-08,0,0,11.30987292277615,231.96178763718896,CSF1R;CSF1;ITGB5;LAMB2;ITGB4;FN1;IL2RG;COL1A1;COL4A2;ITGA11;ERBB2;ITGA5;IFNAR1,3,3,F1
12,KEGG_2021_Human,Focal adhesion,10/201,6.6246923204200884e-09,7.741820496360294e-08,0,0,14.97078685787996,281.9367732391011,COL1A1;COL4A2;ITGB5;LAMB2;ITGB4;ITGA11;ERBB2;FN1;FYN;ITGA5,3,3,F1
13,KEGG_2021_Human,Epstein-Barr virus infection,10/202,6.947787624938725e-09,7.741820496360294e-08,0,0,14.892059178743962,279.74498699830883,HLA-B;HLA-C;CD247;HLA-A;ITGAL;CD3D;B2M;HLA-G;IFNAR1;ICAM1,3,3,F1
14,KEGG_2021_Human,Phagosome,9/152,8.719027058036349e-09,9.067788140357805e-08,0,0,17.782417582417583,330.00180537098163,C3;ITGB5;ITGB2;HLA-B;HLA-C;ITGA5;HLA-A;CD14;HLA-G,3,3,F1
15,KEGG_2021_Human,Human immunodeficiency virus 1 infection,10/212,1.1033293440113968e-08,1.075746110411112e-07,0,0,14.147653895824366,259.21824455574125,CD4;HLA-B;HLA-C;CD247;HLA-A;CD3D;B2M;HLA-G;TNFRSF1A;GNAI2,3,3,F1
16,KEGG_2021_Human,Pathways in cancer,14/531,1.863427024921178e-08,1.7099683287511985e-07,0,0,8.08379705400982,143.87754976491192,JAG2;CSF1R;NOTCH3;JAG1;LAMB2;MMP2;FN1;IL2RG;MMP9;GNAI2;CXCL12;COL4A2;ERBB2;IFNAR1,3,3,F1
17,KEGG_2021_Human,Th1 and Th2 cell differentiation,7/92,7.654008207340164e-08,6.633473779694808e-07,0,0,22.688235294117646,371.7569741465591,JAG2;NOTCH3;CD4;JAG1;CD247;IL2RG;CD3D,3,3,F1
18,KEGG_2021_Human,Rheumatoid arthritis,7/93,8.250952785524552e-08,6.77446649758858e-07,0,0,22.42328811369509,365.7317235022864,CXCL12;CSF1;CCL5;ITGB2;LTB;ITGAL;ICAM1,3,3,F1
19,KEGG_2021_Human,Regulation of actin cytoskeleton,9/218,1.956627810232138e-07,1.5261696919810676e-06,0,0,12.126315789473685,187.31366195228605,CXCL12;ITGB5;ITGB4;ITGA11;ITGB2;FN1;ITGAX;ITGA5;ITGAL,3,3,F1
20,KEGG_2021_Human,Human cytomegalovirus infection,9/225,2.556908853306447e-07,1.8994180053133604e-06,0,0,11.729166666666666,178.04049971864475,CXCL12;CCL5;HLA-B;HLA-C;HLA-A;B2M;HLA-G;TNFRSF1A;GNAI2,3,3,F1
21,KEGG_2021_Human,Primary immunodeficiency,5/38,3.832887953460218e-07,2.7178660033627e-06,0,0,40.72072072072072,601.6273556641139,CD79A;CD4;PTPRC;IL2RG;CD3D,3,3,F1
22,KEGG_2021_Human,Axon guidance,8/182,6.061600017587784e-07,4.111346098885627e-06,0,0,12.787437267281852,183.06651014975617,EFNB1;CXCL12;EFNB3;FYN;SLIT2;L1CAM;EPHB4;GNAI2,3,3,F1
23,KEGG_2021_Human,Antigen processing and presentation,6/78,6.414645783030259e-07,4.1695197589696684e-06,0,0,22.65867579908676,323.10165654732555,CD4;HLA-B;HLA-C;HLA-A;B2M;HLA-G,3,3,F1
24,KEGG_2021_Human,Chemokine signaling pathway,8/192,9.08375166695986e-07,5.667981222381852e-06,0,0,12.086344151867728,168.14048639934305,CXCL9;CXCL12;CCL11;CCL21;CCL5;CXCR3;CCL19;GNAI2,3,3,F1
25,KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,8/193,9.44663537063642e-07,5.667981222381852e-06,0,0,12.020403502093645,166.75229051719288,C3;HLA-B;HLA-C;HLA-A;HLA-G;TNFRSF1A;IFNAR1;ICAM1,3,3,F1
26,KEGG_2021_Human,Fluid shear stress and atherosclerosis,7/139,1.285345899899635e-06,7.426442977197891e-06,0,0,14.57523148148148,197.7054751775929,SDC4;MMP2;PECAM1;SDC1;MMP9;TNFRSF1A;ICAM1,3,3,F1
27,KEGG_2021_Human,Malaria,5/50,1.5591711049333395e-06,8.686810441771464e-06,0,0,29.84384384384384,399.0526670371581,ITGB2;PECAM1;SDC1;ITGAL;ICAM1,3,3,F1
28,KEGG_2021_Human,Hematopoietic cell lineage,6/99,2.6205389414849194e-06,1.409669223695336e-05,0,0,17.52364118426867,225.21612436032453,CSF1R;CD4;CSF1;ITGA5;CD14;CD3D,3,3,F1
29,KEGG_2021_Human,Amoebiasis,6/102,3.1197215451299705e-06,1.5699243904525012e-05,0,0,16.973458904109588,215.18555391964583,COL1A1;COL4A2;LAMB2;ITGB2;FN1;CD14,3,3,F1
30,KEGG_2021_Human,Chagas disease,6/102,3.1197215451299705e-06,1.5699243904525012e-05,0,0,16.973458904109588,215.18555391964583,C3;CCL5;CD247;CD3D;TNFRSF1A;GNAI2,3,3,F1
31,KEGG_2021_Human,Herpes simplex virus 1 infection,11/498,4.007671620588932e-06,1.9537399150371043e-05,0,0,6.455308612151226,80.22205754548145,C3;TNFSF14;CCL5;HLA-B;HLA-C;ITGA5;HLA-A;B2M;HLA-G;TNFRSF1A;IFNAR1,3,3,F1
32,KEGG_2021_Human,TNF signaling pathway,6/112,5.3722014365144325e-06,2.539586133625005e-05,0,0,15.364435254587749,186.43624852848325,JAG1;CSF1;CCL5;MMP9;TNFRSF1A;ICAM1,3,3,F1
33,KEGG_2021_Human,Osteoclast differentiation,6/127,1.107635080480157e-05,5.082090369261896e-05,0,0,13.449564134495642,153.4689183448445,CSF1R;CSF1;TREM2;FYN;TNFRSF1A;IFNAR1,3,3,F1
34,KEGG_2021_Human,Pertussis,5/76,1.2549324401995578e-05,5.593413162032315e-05,0,0,18.89036924248192,213.1937552036205,C3;ITGB2;ITGA5;CD14;GNAI2,3,3,F1
35,KEGG_2021_Human,Allograft rejection,4/38,1.5026003998990327e-05,6.511268399562476e-05,0,0,31.19529411764706,346.4464593952086,HLA-B;HLA-C;HLA-A;HLA-G,3,3,F1
36,KEGG_2021_Human,Bladder cancer,4/41,2.0430428884941975e-05,8.613910556894455e-05,0,0,28.66162162162162,309.5020956410204,MMP2;ERBB2;MMP9;HBEGF,3,3,F1
37,KEGG_2021_Human,Graft-versus-host disease,4/42,2.251348048131413e-05,9.242376197592115e-05,0,0,27.9059649122807,298.6327895390783,HLA-B;HLA-C;HLA-A;HLA-G,3,3,F1
38,KEGG_2021_Human,Type I diabetes mellitus,4/43,2.4748338722715323e-05,9.899335489086128e-05,0,0,27.18905982905983,288.38761998154285,HLA-B;HLA-C;HLA-A;HLA-G,3,3,F1
39,KEGG_2021_Human,Staphylococcus aureus infection,5/95,3.712252785270956e-05,0.00014477785862556725,0,0,14.88813813813814,151.8781633860772,C3;SELPLG;ITGB2;ITGAL;ICAM1,3,3,F1
40,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,5/100,4.7500912444494767e-05,0.00018073517905710203,0,0,14.10099573257468,140.37205137271638,COL1A1;COL4A2;MMP2;FN1;ICAM1,3,3,F1
41,KEGG_2021_Human,Autoimmune thyroid disease,4/53,5.699085382879935e-05,0.0002079247647567552,0,0,21.62938775510204,211.37578221868387,HLA-B;HLA-C;HLA-A;HLA-G,3,3,F1
42,KEGG_2021_Human,T cell receptor signaling pathway,5/104,5.731259541372098e-05,0.0002079247647567552,0,0,13.528528528528527,132.13300478947832,CD4;PTPRC;FYN;CD247;CD3D,3,3,F1
43,KEGG_2021_Human,Viral carcinogenesis,6/203,0.00015247419462895124,0.0005405903264117362,0,0,8.229191294068563,72.32237270401191,C3;HLA-B;HLA-C;HLA-A;LTBR;HLA-G,3,3,F1
44,KEGG_2021_Human,Relaxin signaling pathway,5/129,0.00015885232727163903,0.0005506880678750153,0,0,10.787380122057542,94.36299107244996,COL1A1;COL4A2;MMP2;MMP9;GNAI2,3,3,F1
45,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,4/77,0.0002451494487117808,0.0008313763912834305,0,0,14.50082191780822,120.5546499412606,ITGB5;ITGB4;ITGA11;ITGA5,3,3,F1
46,KEGG_2021_Human,Hypertrophic cardiomyopathy,4/90,0.0004452681520364764,0.0014779113131423,0,0,12.300775193798447,94.92303862351852,ITGB5;ITGB4;ITGA11;ITGA5,3,3,F1
47,KEGG_2021_Human,IL-17 signaling pathway,4/94,0.0005251068972949929,0.0017065974162087,0,0,11.751703703703704,88.74779346572205,CCL11;MMP9;S100A9;S100A8,3,3,F1
48,KEGG_2021_Human,Dilated cardiomyopathy,4/96,0.0005686228582336353,0.0018103095078458,0,0,11.495072463768116,85.89455132922436,ITGB5;ITGB4;ITGA11;ITGA5,3,3,F1
49,KEGG_2021_Human,Tuberculosis,5/180,0.000734939746434349,0.0022930120088751,0,0,7.623938223938224,55.01221907217975,C3;ITGB2;ITGAX;CD14;TNFRSF1A,3,3,F1
50,KEGG_2021_Human,Toll-like receptor signaling pathway,4/104,0.0007685276514000617,0.002350790463106,0,0,10.5712,75.80643477546607,CXCL9;CCL5;CD14;IFNAR1,3,3,F1
51,KEGG_2021_Human,Th17 cell differentiation,4/107,0.0008548697333356204,0.0025646092000068,0,0,10.261747572815532,72.49474640805043,CD4;CD247;IL2RG;CD3D,3,3,F1
52,KEGG_2021_Human,Sphingolipid signaling pathway,4/119,0.001269265917503,0.0037359525118958,0,0,9.185391304347826,61.26028236686801,FYN;S1PR4;TNFRSF1A;GNAI2,3,3,F1
53,KEGG_2021_Human,Rap1 signaling pathway,5/210,0.0014609849175557,0.004220623095161,0,0,6.498352010547133,42.42542991541516,CSF1R;CSF1;ITGB2;ITGAL;GNAI2,3,3,F1
54,KEGG_2021_Human,Legionellosis,3/57,0.0014886116303266,0.0042222438969265,0,0,14.522660818713453,94.5412350062638,C3;ITGB2;CD14,3,3,F1
55,KEGG_2021_Human,Lipid and atherosclerosis,5/215,0.0016203032170359,0.0045009299839761,0,0,6.342020592020592,40.748382719984725,CCL5;CD14;MMP9;TNFRSF1A;ICAM1,3,3,F1
56,KEGG_2021_Human,Notch signaling pathway,3/59,0.0016445705710681,0.0045009299839761,0,0,14.002584586466163,89.76043163067887,JAG2;NOTCH3;JAG1,3,3,F1
57,KEGG_2021_Human,Estrogen signaling pathway,4/137,0.0021278926688268,0.0057232975230514,0,0,7.935037593984962,48.82129596795805,MMP2;MMP9;HBEGF;GNAI2,3,3,F1
58,KEGG_2021_Human,Breast cancer,4/147,0.0027464115432499,0.0072616983177456,0,0,7.376410256410256,43.50208526269565,JAG2;NOTCH3;JAG1;ERBB2,3,3,F1
59,KEGG_2021_Human,Adherens junction,3/71,0.0027949269347894,0.0072668100304524,0,0,11.524574303405572,67.76391277078733,ERBB2;FYN;PTPRF,3,3,F1
60,KEGG_2021_Human,Shigellosis,5/246,0.0029079033055414,0.0074366051748273,0,0,5.517550745766513,32.22427836445089,C3;CCL5;ITGA5;CD14;TNFRSF1A,3,3,F1
61,KEGG_2021_Human,Endocytosis,5/252,0.0032239721268411,0.0081119298675357,0,0,5.381879855564066,30.87660411405826,HLA-B;HLA-C;HLA-A;IL2RG;HLA-G,3,3,F1
62,KEGG_2021_Human,Cellular senescence,4/156,0.0033997448921017,0.0084184159232996,0,0,6.936491228070175,39.42739682823685,HLA-B;HLA-C;HLA-A;HLA-G,3,3,F1
63,KEGG_2021_Human,Complement and coagulation cascades,3/85,0.004642898789618,0.0113170657996939,0,0,9.550224646983311,51.30778321793274,C3;ITGB2;ITGAX,3,3,F1
64,KEGG_2021_Human,Influenza A,4/172,0.0048091134020727,0.0115418721649745,0,0,6.27079365079365,33.46874660591191,CCL5;TNFRSF1A;IFNAR1;ICAM1,3,3,F1
65,KEGG_2021_Human,PD-L1 expression and PD-1 checkpoint pathway in cancer,3/89,0.0052785115580057,0.0124764818643771,0,0,9.104192166462669,47.7433954051535,CD4;CD247;CD3D,3,3,F1
66,KEGG_2021_Human,Small cell lung cancer,3/92,0.0057879313803045,0.0134763775422015,0,0,8.795978710821998,45.31670926425605,COL4A2;LAMB2;FN1,3,3,F1
67,KEGG_2021_Human,MAPK signaling pathway,5/294,0.0061675704669393,0.0141491322476844,0,0,4.589918638361545,23.355572799361067,CSF1R;CSF1;ERBB2;CD14;TNFRSF1A,3,3,F1
68,KEGG_2021_Human,Neutrophil extracellular trap formation,4/189,0.0066889426366445,0.0151228268306746,0,0,5.689657657657658,28.48981976603004,C3;SELPLG;ITGB2;ITGAL,3,3,F1
69,KEGG_2021_Human,Protein digestion and absorption,3/103,0.0079027297232522,0.0176117976689622,0,0,7.824078947368421,37.87282222542942,COL1A1;COL18A1;COL4A2,3,3,F1
70,KEGG_2021_Human,Toxoplasmosis,3/112,0.0099306953871887,0.021819556061992,0,0,7.174794785127958,33.09104878012383,LAMB2;TNFRSF1A;GNAI2,3,3,F1
71,KEGG_2021_Human,Platelet activation,3/124,0.0130655869600803,0.0283087717468407,0,0,6.45933014354067,28.01911083291832,COL1A1;FYN;GNAI2,3,3,F1
72,KEGG_2021_Human,Coronavirus disease,4/232,0.0134594540570999,0.0287626689439396,0,0,4.60654970760234,19.84535479537586,C3;TNFRSF1A;HBEGF;IFNAR1,3,3,F1
73,KEGG_2021_Human,Intestinal immune network for IgA production,2/48,0.0154516244035897,0.0325736946886486,0,0,11.222473178994916,46.7981748688665,CXCL12;LTBR,3,3,F1
74,KEGG_2021_Human,Apelin signaling pathway,3/137,0.0170313483987776,0.0349590835553856,0,0,5.828849175176748,23.739151760115348,NOTCH3;JAG1;GNAI2,3,3,F1
75,KEGG_2021_Human,Yersinia infection,3/137,0.0170313483987776,0.0349590835553856,0,0,5.828849175176748,23.739151760115348,CD4;FN1;ITGA5,3,3,F1
76,KEGG_2021_Human,Measles,3/139,0.0176947621360876,0.0358491284835023,0,0,5.742550309597523,23.168242318180575,IL2RG;CD3D;IFNAR1,3,3,F1
0,KEGG_2021_Human,ECM-receptor interaction,23/88,4.7698406076462833e-33,9.014998748451476e-31,0,0,81.57388193202146,6070.972621844749,ITGB5;VWF;LAMA2;ITGA3;LAMA4;ITGA1;FN1;LAMB1;THBS2;HSPG2;THBS1;COL1A1;COL1A2;COL4A2;COL4A1;COL6A2;COL6A1;ITGA11;COL6A3;SDC1;ITGAV;ITGB7;ITGA5,1,1,G2
1,KEGG_2021_Human,PI3K-Akt signaling pathway,33/354,8.925474580416753e-32,8.434573478493832e-30,0,0,26.47196261682243,1892.5815576517164,CSF1R;CHRM1;CSF1;ITGB5;LAMA2;FLT4;LAMA4;THBS2;THBS1;IGF1R;CD19;ERBB2;ITGAV;ITGB7;PDGFRB;VWF;ITGA3;F2R;ITGA1;FN1;LAMB1;COL1A1;COL1A2;COL4A2;COL4A1;COL6A2;ITGA11;COL6A1;COL6A3;ITGA5;TLR4;IFNAR1;TLR2,1,1,G2
2,KEGG_2021_Human,Human papillomavirus infection,31/331,7.167156874859709e-30,4.5153088311616165e-28,0,0,25.95388888888889,1741.714710896795,NOTCH3;ITGB5;LAMA2;NOTCH4;LAMA4;THBS2;THBS1;ITGAV;ITGB7;PDGFRB;VWF;ITGA3;ITGA1;HLA-B;FN1;FZD8;HLA-C;LAMB1;HLA-A;HLA-F;TNFRSF1A;COL1A1;COL1A2;COL4A2;COL4A1;COL6A2;ITGA11;COL6A1;COL6A3;ITGA5;IFNAR1,1,1,G2
3,KEGG_2021_Human,Focal adhesion,26/201,9.560764131410773e-29,4.517461052091591e-27,0,0,35.29197934595525,2276.9432205706253,ITGB5;LAMA2;FLT4;LAMA4;THBS2;THBS1;IGF1R;ERBB2;ITGAV;ITGB7;PDGFRB;VWF;ITGA3;ITGA1;FN1;LAMB1;COL1A1;COL1A2;COL4A2;COL4A1;COL6A2;ITGA11;COL6A1;COL6A3;ITGA5;TLN1,1,1,G2
4,KEGG_2021_Human,Pathways in cancer,27/531,5.4042988994273855e-19,2.0428249839835522e-17,0,0,12.66572299651568,532.744653228566,CSF1R;NOTCH3;LAMA2;NOTCH4;FLT4;LAMA4;CXCR4;IGF1R;GNAI2;EDNRB;ERBB2;ITGAV;PDGFRB;TGFB1;ITGA3;MMP2;F2R;FN1;FZD8;LAMB1;MMP9;TGFBR2;COL4A2;COL4A1;CALM3;CALM1;IFNAR1,1,1,G2
5,KEGG_2021_Human,Proteoglycans in cancer,19/205,2.445444427336252e-18,7.703149946109192e-17,0,0,22.365292712066907,906.9641669475576,TGFB1;ITGB5;MMP2;FN1;FZD8;HSPG2;MMP9;THBS1;IGF1R;COL1A1;COL1A2;GPC1;ERBB2;SDC1;ITGAV;ITGA5;TLR4;TLR2;HBEGF,1,1,G2
6,KEGG_2021_Human,Human immunodeficiency virus 1 infection,17/212,1.950914633423709e-15,5.2674695102440144e-14,0,0,18.663991081382385,632.1583009849554,HLA-B;HLA-C;CXCR4;CD3G;HLA-A;HLA-F;TNFRSF1B;CD3D;TNFRSF1A;GNAI2;CALM3;RIPK1;CALR;CALM1;B2M;TLR4;TLR2,1,1,G2
7,KEGG_2021_Human,Phagosome,15/152,4.440279203462802e-15,1.0490159618180869e-13,0,0,23.00900760987731,760.403044169866,ITGB5;ITGB2;HLA-B;HLA-C;HLA-A;HLA-F;THBS2;THBS1;C3;ITGAV;CD14;ITGA5;CALR;TLR4;TLR2,1,1,G2
8,KEGG_2021_Human,Amoebiasis,13/102,1.1200587134099343e-14,2.352123298160862e-13,0,0,30.12944756554307,967.8425254370698,TGFB1;LAMA2;LAMA4;ITGB2;FN1;LAMB1;COL1A1;COL1A2;COL4A2;COL4A1;CD14;TLR4;TLR2,1,1,G2
9,KEGG_2021_Human,Chagas disease,12/102,3.313600748628919e-13,6.262705414908657e-12,0,0,27.21786941580756,782.1210128429545,C3;TGFB1;CCL5;SERPINE1;CD3G;CALR;CD3D;TLR4;TGFBR2;TNFRSF1A;TLR2;GNAI2,1,1,G2
10,KEGG_2021_Human,Cell adhesion molecules,13/148,1.4870555798543177e-12,2.5550318599315093e-11,0,0,19.81697530864197,539.6999261674225,SELPLG;ITGB2;HLA-B;ICAM2;HLA-C;ICAM3;HLA-A;HLA-F;PTPRC;PECAM1;SDC1;ITGAV;ITGB7,1,1,G2
11,KEGG_2021_Human,Regulation of actin cytoskeleton,14/218,1.4148316237256683e-11,2.2283598073679279e-10,0,0,14.221775025799792,355.28021318171403,PDGFRB;CHRM1;ITGB5;ITGA3;F2R;ITGA1;ITGB2;FN1;CXCR4;ITGA11;ITGAX;ITGAV;ITGB7;ITGA5,1,1,G2
12,KEGG_2021_Human,Human cytomegalovirus infection,14/225,2.1635366267768742e-11,3.145449403544841e-10,0,0,13.74507358443502,337.53353595978245,HLA-B;HLA-C;CXCR4;HLA-A;HLA-F;TNFRSF1A;GNAI2;CCL5;CALM3;RIPK1;ITGAV;CALR;CALM1;B2M,1,1,G2
13,KEGG_2021_Human,Viral protein interaction with cytokine and cytokine receptor,10/100,1.7456828486444698e-10,2.3566718456700342e-09,0,0,22.22334455667789,499.3297759254109,CSF1R;CSF1;CCL21;CCL5;CXCR4;CCL19;TNFRSF1B;CXCL14;CCR10;TNFRSF1A,1,1,G2
14,KEGG_2021_Human,Human T-cell leukemia virus 1 infection,13/219,2.1100539915314718e-10,2.658668029329655e-09,0,0,12.94018001618123,288.2960484884644,TGFB1;ITGB2;HLA-B;HLA-C;CD3G;HLA-A;HLA-F;CD3D;TGFBR2;TNFRSF1A;CALR;TLN1;B2M,1,1,G2
15,KEGG_2021_Human,Protein digestion and absorption,10/103,2.3471014358051783e-10,2.7725135710448664e-09,0,0,21.503204083849244,476.7834436783618,COL1A1;COL18A1;COL1A2;COL4A2;COL5A1;COL4A1;COL6A2;COL5A2;COL6A1;COL6A3,1,1,G2
16,KEGG_2021_Human,Malaria,8/50,2.6623585760588884e-10,2.95991629926547e-09,0,0,37.43328618576143,825.2781290517049,TGFB1;ITGB2;PECAM1;SDC1;THBS2;TLR4;THBS1;TLR2,1,1,G2
17,KEGG_2021_Human,Epstein-Barr virus infection,12/202,1.0800784084682547e-09,1.1340823288916674e-08,0,0,12.827563754747692,264.8408598153235,CD19;HLA-B;HLA-C;CD3G;RIPK1;HLA-A;CALR;HLA-F;B2M;CD3D;IFNAR1;TLR2,1,1,G2
18,KEGG_2021_Human,Hypertrophic cardiomyopathy,9/90,1.4831489733071179e-09,1.4753429260791857e-08,0,0,22.011111111111116,447.4660420162904,TGFB1;ITGB5;LAMA2;ITGA3;ITGA1;ITGA11;ITGAV;ITGB7;ITGA5,1,1,G2
19,KEGG_2021_Human,Rap1 signaling pathway,12/210,1.6820428203512423e-09,1.5895304652319242e-08,0,0,12.304279912527337,248.58652702993427,PDGFRB;CSF1R;CSF1;FLT4;F2R;ITGB2;CALM3;TLN1;CALM1;THBS1;IGF1R;GNAI2,1,1,G2
20,KEGG_2021_Human,Relaxin signaling pathway,10/129,2.175633738961214e-09,1.958070365065093e-08,0,0,16.782955606485018,334.7519235723449,COL1A1;TGFB1;COL1A2;EDNRB;COL4A2;COL4A1;MMP2;MMP9;TGFBR2;GNAI2,1,1,G2
21,KEGG_2021_Human,Dilated cardiomyopathy,9/96,2.650090078721113e-09,2.2766682949013202e-08,0,0,20.486896551724136,404.5890045091307,TGFB1;ITGB5;LAMA2;ITGA3;ITGA1;ITGA11;ITGAV;ITGB7;ITGA5,1,1,G2
22,KEGG_2021_Human,Hematopoietic cell lineage,9/99,3.490621895853824e-09,2.8683806013755344e-08,0,0,19.801,385.5885544603782,CSF1R;CSF1;ITGA3;CD19;ITGA1;CD3G;CD14;ITGA5;CD3D,1,1,G2
23,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,9/100,3.818588495870414e-09,3.007138440497951e-08,0,0,19.582417582417584,379.5735389626876,COL1A1;TGFB1;COL1A2;COL4A2;COL4A1;MMP2;SERPINE1;FN1;TGFBR2,1,1,G2
24,KEGG_2021_Human,Cytokine-cytokine receptor interaction,13/295,7.927417949954143e-09,5.993127970165332e-08,0,0,9.4162603427896,175.6409246938401,CSF1R;TGFB1;CSF1;CCL21;CXCR4;TNFRSF1B;CXCL14;TGFBR2;TNFRSF1A;CCL5;CCL19;CCR10;IFNAR1,1,1,G2
25,KEGG_2021_Human,Pertussis,8/76,8.31917062909799e-09,6.047397111152e-08,0,0,23.09027373325568,429.5876912553435,C3;ITGB2;CALM3;ITGA5;CD14;CALM1;TLR4;GNAI2,1,1,G2
26,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,8/77,9.242076124324638e-09,6.469453287027248e-08,0,0,22.75448414406658,420.9465632163202,ITGB5;LAMA2;ITGA3;ITGA1;ITGA11;ITGAV;ITGB7;ITGA5,1,1,G2
27,KEGG_2021_Human,Small cell lung cancer,8/92,3.821743849643638e-08,2.579677098509456e-07,0,0,18.67703913248468,319.00334129235046,COL4A2;LAMA2;ITGA3;COL4A1;LAMA4;FN1;ITGAV;LAMB1,1,1,G2
28,KEGG_2021_Human,Tuberculosis,10/180,5.3608142758569466e-08,3.493772062541252e-07,0,0,11.717765894236482,196.1737377709778,C3;TGFB1;ITGB2;ITGAX;CALM3;CD14;CALM1;TLR4;TNFRSF1A;TLR2,1,1,G2
29,KEGG_2021_Human,Fluid shear stress and atherosclerosis,9/139,6.898926166686838e-08,4.346323485012707e-07,0,0,13.680692307692308,225.5852445030796,GPC1;MMP2;PECAM1;SDC1;CALM3;ITGAV;CALM1;MMP9;TNFRSF1A,1,1,G2
30,KEGG_2021_Human,Toxoplasmosis,8/112,1.7844765020890645e-07,1.0879550286930103e-06,0,0,15.07006854531607,234.1733513857071,TGFB1;LAMA2;LAMA4;LAMB1;TLR4;TNFRSF1A;TLR2;GNAI2,1,1,G2
31,KEGG_2021_Human,Cellular senescence,9/156,1.858777913705131e-07,1.097840705282093e-06,0,0,12.088163265306122,187.34448681683816,TGFB1;SERPINE1;HLA-B;HLA-C;CALM3;HLA-A;CALM1;HLA-F;TGFBR2,1,1,G2
32,KEGG_2021_Human,Osteoclast differentiation,8/127,4.702382017444421e-07,2.693182428172714e-06,0,0,13.160495881520925,191.74877319950343,CSF1R;TGFB1;CSF1;SIRPA;TREM2;IFNAR1;TGFBR2;TNFRSF1A,1,1,G2
33,KEGG_2021_Human,Calcium signaling pathway,10/240,7.743597445047931e-07,4.304529167982527e-06,0,0,8.634606938954764,121.49953402521786,PDGFRB;CHRM1;EDNRB;TBXA2R;FLT4;F2R;ERBB2;CXCR4;CALM3;CALM1,1,1,G2
34,KEGG_2021_Human,Viral myocarditis,6/60,8.9897230780434e-07,4.8544504621434365e-06,0,0,21.39913700107875,297.9190764916989,LAMA2;ITGB2;HLA-B;HLA-C;HLA-A;HLA-F,1,1,G2
35,KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,9/193,1.1182474496586128e-06,5.870799110707717e-06,0,0,9.63929347826087,132.09444752201512,C3;HLA-B;HLA-C;CALM3;HLA-A;CALM1;HLA-F;IFNAR1;TNFRSF1A,1,1,G2
36,KEGG_2021_Human,Lipid and atherosclerosis,9/215,2.7285006236445472e-06,1.393747615861674e-05,0,0,8.600242718446601,110.1842312171568,ABCA1;CCL5;CALM3;CD14;CALM1;MMP9;TLR4;TNFRSF1A;TLR2,1,1,G2
37,KEGG_2021_Human,Bladder cancer,5/41,2.8096937898855003e-06,1.3974529639167358e-05,0,0,26.51575854700855,338.9359614850301,MMP2;ERBB2;THBS1;MMP9;HBEGF,1,1,G2
38,KEGG_2021_Human,Antigen processing and presentation,6/78,4.260198848794109e-06,2.064557903646376e-05,0,0,16.034789644012946,198.28933104255347,HLA-B;HLA-C;HLA-A;CALR;HLA-F;B2M,1,1,G2
39,KEGG_2021_Human,MAPK signaling pathway,10/294,4.783026500938173e-06,2.2599800216932863e-05,0,0,6.973609332764262,85.42976216065846,PDGFRB;CSF1R;TGFB1;CSF1;FLT4;ERBB2;CD14;IGF1R;TGFBR2;TNFRSF1A,1,1,G2
40,KEGG_2021_Human,Platelet activation,7/124,5.242233657943961e-06,2.416541856954655e-05,0,0,11.598625775096364,141.02494053161556,COL1A1;COL1A2;VWF;TBXA2R;F2R;TLN1;GNAI2,1,1,G2
41,KEGG_2021_Human,Complement and coagulation cascades,6/85,7.033671801610244e-06,3.16515231072461e-05,0,0,14.608823890868871,173.33079829954502,C3;VWF;ITGB2;SERPINE1;F2R;ITGAX,1,1,G2
42,KEGG_2021_Human,Rheumatoid arthritis,6/93,1.1834181777993705e-05,5.201535711722813e-05,0,0,13.260127217944426,150.429757915386,TGFB1;CSF1;CCL5;ITGB2;TLR4;TLR2,1,1,G2
43,KEGG_2021_Human,Legionellosis,5/57,1.4648578318090828e-05,6.292230232089014e-05,0,0,18.34227071005917,204.17088339159855,C3;ITGB2;CD14;TLR4;TLR2,1,1,G2
44,KEGG_2021_Human,Herpes simplex virus 1 infection,12/498,1.7475342409545404e-05,7.33964381200907e-05,0,0,4.939544355351916,54.111323738985575,C3;CCL5;HLA-B;HLA-C;HLA-A;ITGA5;CALR;HLA-F;B2M;IFNAR1;TNFRSF1A;TLR2,1,1,G2
45,KEGG_2021_Human,Toll-like receptor signaling pathway,6/104,2.2444159899980376e-05,9.025417491694236e-05,0,0,11.765207053695264,125.94042496341316,CCL5;RIPK1;CD14;TLR4;IFNAR1;TLR2,1,1,G2
46,KEGG_2021_Human,NF-kappa B signaling pathway,6/104,2.2444159899980376e-05,9.025417491694236e-05,0,0,11.765207053695264,125.94042496341316,CCL21;RIPK1;CD14;CCL19;TLR4;TNFRSF1A,1,1,G2
47,KEGG_2021_Human,Hepatitis B,7/162,2.995447865027034e-05,0.00011794575968543948,0,0,8.738266919671094,91.0163176462339,TGFB1;HSPG2;MMP9;TLR4;IFNAR1;TGFBR2;TLR2,1,1,G2
48,KEGG_2021_Human,TNF signaling pathway,6/112,3.416283631554384e-05,0.00013177094007424053,0,0,10.872870489100569,111.82064658105318,CSF1;CCL5;RIPK1;TNFRSF1B;MMP9;TNFRSF1A,1,1,G2
49,KEGG_2021_Human,Leukocyte transendothelial migration,6/114,3.7749249352227154e-05,0.00014269216255141862,0,0,10.67044228694714,108.67359929107116,MMP2;ITGB2;PECAM1;CXCR4;MMP9;GNAI2,1,1,G2
50,KEGG_2021_Human,Allograft rejection,4/38,5.341383225597328e-05,0.0001979453783603716,0,0,22.24873949579832,218.87065798781487,HLA-B;HLA-C;HLA-A;HLA-F,1,1,G2
51,KEGG_2021_Human,Shigellosis,8/246,6.098387015429537e-05,0.0002216529126761889,0,0,6.540643980364423,63.4763033028506,C3;CCL5;RIPK1;CD14;ITGA5;TLN1;TLR4;TNFRSF1A,1,1,G2
52,KEGG_2021_Human,Leishmaniasis,5/77,6.3400946839546e-05,0.00022609016891838104,0,0,13.233840811965813,127.9187256250869,C3;TGFB1;ITGB2;TLR4;TLR2,1,1,G2
53,KEGG_2021_Human,Graft-versus-host disease,4/42,7.96489344068322e-05,0.0002787712704239128,0,0,19.902756892230578,187.8398690361294,HLA-B;HLA-C;HLA-A;HLA-F,1,1,G2
54,KEGG_2021_Human,Natural killer cell mediated cytotoxicity,6/131,8.208995415381219e-05,0.00028209093336491826,0,0,9.211339805825244,86.65747460638198,ITGB2;HLA-B;ICAM2;HLA-C;HLA-A;IFNAR1,1,1,G2
55,KEGG_2021_Human,Type I diabetes mellitus,4/43,8.745114868656312e-05,0.00029148043741917374,0,0,19.39145299145299,181.20207936696363,HLA-B;HLA-C;HLA-A;HLA-F,1,1,G2
56,KEGG_2021_Human,Chemokine signaling pathway,7/192,8.790679858673493e-05,0.00029148043741917374,0,0,7.310121886592475,68.27093456690109,CCL21;CCL5;CXCR4;CCL19;CXCL14;CCR10;GNAI2,1,1,G2
57,KEGG_2021_Human,Estrogen signaling pathway,6/137,0.00010514176339912888,0.0003426171255592303,0,0,8.786778329504187,80.48865555985329,MMP2;CALM3;CALM1;MMP9;HBEGF;GNAI2,1,1,G2
58,KEGG_2021_Human,Measles,6/139,0.00011387487442930606,0.0003647856146972686,0,0,8.653770348200599,78.57978544769323,RACK1;CD3G;TLR4;CD3D;IFNAR1;TLR2,1,1,G2
59,KEGG_2021_Human,Intestinal immune network for IgA production,4/48,0.0001350285458039176,0.0004253399192823404,0,0,17.183549783549783,153.10584701627923,TGFB1;CXCR4;ITGB7;CCR10,1,1,G2
60,KEGG_2021_Human,Breast cancer,6/147,0.00015474018871302928,0.0004794409125698776,0,0,8.159471183639743,71.58926677280245,NOTCH3;NOTCH4;FLT4;ERBB2;FZD8;IGF1R,1,1,G2
61,KEGG_2021_Human,Autoimmune thyroid disease,4/53,0.00019900045113034623,0.000606630407477991,0,0,15.426239067055391,131.46554804854838,HLA-B;HLA-C;HLA-A;HLA-F,1,1,G2
62,KEGG_2021_Human,Melanogenesis,5/101,0.0002291864362178714,0.0006875593086536142,0,0,9.913361378205128,83.08363143484277,EDNRB;FZD8;CALM3;CALM1;GNAI2,1,1,G2
63,KEGG_2021_Human,Coronavirus disease,7/232,0.0002821752203243292,0.000820478717558434,0,0,5.998344226579521,49.02436138098267,C3;VWF;TLR4;IFNAR1;TNFRSF1A;TLR2;HBEGF,1,1,G2
64,KEGG_2021_Human,Ras signaling pathway,7/232,0.0002821752203243292,0.000820478717558434,0,0,5.998344226579521,49.02436138098267,PDGFRB;CSF1R;CSF1;FLT4;CALM3;CALM1;IGF1R,1,1,G2
65,KEGG_2021_Human,Endocytosis,7/252,0.0004640310956997681,0.0013288163195038,0,0,5.503081232492997,42.2392246344068,HLA-B;HLA-C;CXCR4;HLA-A;HLA-F;IGF1R;TGFBR2,1,1,G2
66,KEGG_2021_Human,Renin secretion,4/69,0.0005495332730270277,0.0015501759492851,0,0,11.6196336996337,87.22209753264885,CALM3;CALM1;AQP1;GNAI2,1,1,G2
67,KEGG_2021_Human,Neutrophil extracellular trap formation,6/189,0.0005950667096425244,0.0016539354135652,0,0,6.273436256565335,46.59178876873366,C3;SELPLG;VWF;ITGB2;TLR4;TLR2,1,1,G2
68,KEGG_2021_Human,Transcriptional misregulation in cancer,6/192,0.000646319520448468,0.0017703534690544,0,0,6.171312245537113,45.32345360767052,CSF1R;ITGB7;CD14;MMP9;IGF1R;TGFBR2,1,1,G2
69,KEGG_2021_Human,Glioma,4/75,0.0007535315325474209,0.002034535137878,0,0,10.634473507712944,76.46973076253701,PDGFRB;CALM3;CALM1;IGF1R,1,1,G2
70,KEGG_2021_Human,Diabetic cardiomyopathy,6/203,0.0008641409661618795,0.0023003189099238,0,0,5.823468532847075,41.07743469569753,COL1A1;TGFB1;COL1A2;MMP2;MMP9;TGFBR2,1,1,G2
71,KEGG_2021_Human,Apelin signaling pathway,5/137,0.0009259009099018712,0.0024258383927774,0,0,7.196605477855478,50.26644216614845,NOTCH3;SERPINE1;CALM3;CALM1;GNAI2,1,1,G2
72,KEGG_2021_Human,Alzheimer disease,8/369,0.0009369640353055902,0.0024258383927774,0,0,4.285126573599189,29.87961193069236,CHRM1;CSF1;FZD8;LPL;CALM3;APOE;CALM1;TNFRSF1A,1,1,G2
73,KEGG_2021_Human,Primary immunodeficiency,3/38,0.00115616923282,0.0029529187162566,0,0,16.056064690026954,108.58143547890288,PTPRC;CD19;CD3D,1,1,G2
74,KEGG_2021_Human,PD-L1 expression and PD-1 checkpoint pathway in cancer,4/89,0.0014280106722413,0.0035985868940482,0,0,8.876638655462186,58.15505796303778,CD3G;CD3D;TLR4;TLR2,1,1,G2
75,KEGG_2021_Human,MicroRNAs in cancer,7/310,0.0015545395540412,0.0038658944172867,0,0,4.436549537306672,28.68928424578638,PDGFRB;NOTCH3;NOTCH4;ERBB2;ITGA5;MMP9;THBS1,1,1,G2
76,KEGG_2021_Human,GnRH signaling pathway,4/93,0.001679475079262,0.004122347921825,0,0,8.47597645799893,54.15533589930299,MMP2;CALM3;CALM1;HBEGF,1,1,G2
77,KEGG_2021_Human,TGF-beta signaling pathway,4/94,0.001746843712783,0.0042327366886666,0,0,8.381375661375662,53.22127206169404,TGFB1;THBS1;TGFBR2;FBN1,1,1,G2
78,KEGG_2021_Human,Prostate cancer,4/97,0.001960178154015,0.0046895401406182,0,0,8.109779825908857,50.56220578657347,PDGFRB;ERBB2;MMP9;IGF1R,1,1,G2
79,KEGG_2021_Human,Hippo signaling pathway,5/163,0.0019983125351017,0.0047210133641778,0,0,6.004442551119766,37.32032558615654,TGFB1;SERPINE1;ITGB2;FZD8;TGFBR2,1,1,G2
80,KEGG_2021_Human,cGMP-PKG signaling pathway,5/167,0.0022208727752166,0.0051820364755054,0,0,5.85499762583096,35.77318662671917,EDNRB;CALM3;CALM1;ADRA2A;GNAI2,1,1,G2
81,KEGG_2021_Human,Salmonella infection,6/249,0.0024411124621055,0.0056264665285116,0,0,4.710056334651804,28.3324085415681,PTPRC;RIPK1;CD14;TLR4;TNFRSF1A;TLR2,1,1,G2
82,KEGG_2021_Human,Cholesterol metabolism,3/50,0.0025619933727431,0.0058339367162464,0,0,11.94941790445604,71.30181411758254,ABCA1;LPL;APOE,1,1,G2
83,KEGG_2021_Human,Neuroactive ligand-receptor interaction,7/341,0.0026581061489495,0.0059807388351365,0,0,4.018404367735118,23.829706038115663,C3;CHRM1;EDNRB;TBXA2R;F2R;S1PR4;ADRA2A,1,1,G2
84,KEGG_2021_Human,Th17 cell differentiation,4/107,0.0028008411515157,0.0062277526780761,0,0,7.318723994452149,43.0182556775278,TGFB1;CD3G;CD3D;TGFBR2,1,1,G2
85,KEGG_2021_Human,HIF-1 signaling pathway,4/109,0.0029944321622174,0.0065807869611522,0,0,7.17859410430839,41.71481508262489,SERPINE1;ERBB2;TLR4;IGF1R,1,1,G2
86,KEGG_2021_Human,Viral carcinogenesis,5/203,0.0051091370533098,0.0110991598054661,0,0,4.781711344211344,25.23177466016369,C3;HLA-B;HLA-C;HLA-A;HLA-F,1,1,G2
87,KEGG_2021_Human,Inflammatory bowel disease,3/65,0.0053825017417089,0.0115601457861702,0,0,9.051582471089471,47.29091592813019,TGFB1;TLR4;TLR2,1,1,G2
88,KEGG_2021_Human,FoxO signaling pathway,4/131,0.0057576662967854,0.0122269542707016,0,0,5.9284589426321705,30.574385069492838,TGFB1;S1PR4;IGF1R;TGFBR2,1,1,G2
89,KEGG_2021_Human,cAMP signaling pathway,5/216,0.0066130093436452,0.013887319621655,0,0,4.484141450966096,22.504634497137666,CHRM1;F2R;CALM3;CALM1;GNAI2,1,1,G2
90,KEGG_2021_Human,Adherens junction,3/71,0.0068791373778713,0.0142874391694251,0,0,8.250416204217537,41.08098402202539,ERBB2;IGF1R;TGFBR2,1,1,G2
91,KEGG_2021_Human,Gastric acid secretion,3/76,0.0082971427241474,0.0168619352135898,0,0,7.683380718531921,36.81756236092534,CALM3;CALM1;GNAI2,1,1,G2
92,KEGG_2021_Human,Pancreatic cancer,3/76,0.0082971427241474,0.0168619352135898,0,0,7.683380718531921,36.81756236092534,TGFB1;ERBB2;TGFBR2,1,1,G2
93,KEGG_2021_Human,Gastric cancer,4/149,0.0089970932732119,0.0180899003046496,0,0,5.187783251231527,24.4388880455413,TGFB1;ERBB2;FZD8;TGFBR2,1,1,G2
94,KEGG_2021_Human,Phototransduction,2/28,0.0101428056254797,0.0201788448759543,0,0,14.281092739036664,65.5643629537502,CALM3;CALM1,1,1,G2
95,KEGG_2021_Human,Necroptosis,4/159,0.011225057438618,0.0219282281690277,0,0,4.850629800307219,21.777420188149684,RIPK1;TLR4;IFNAR1;TNFRSF1A,1,1,G2
96,KEGG_2021_Human,ErbB signaling pathway,3/85,0.0112541700126756,0.0219282281690277,0,0,6.83697653014266,30.677626851043605,NRG4;ERBB2;HBEGF,1,1,G2
97,KEGG_2021_Human,Hepatocellular carcinoma,4/168,0.0135103694857307,0.0260557125796236,0,0,4.582346109175377,19.723782177258915,TGFB1;FZD8;IGF1R;TGFBR2,1,1,G2
98,KEGG_2021_Human,Th1 and Th2 cell differentiation,3/92,0.0139233853286011,0.0265810083546021,0,0,6.297010811956752,26.91459202087005,NOTCH3;CD3G;CD3D,1,1,G2
99,KEGG_2021_Human,Influenza A,4/172,0.0146143497964267,0.027594742870225,0,0,4.472335600907029,18.89897829349244,CCL5;TLR4;IFNAR1;TNFRSF1A,1,1,G2
100,KEGG_2021_Human,IL-17 signaling pathway,3/94,0.0147463969835594,0.027594742870225,0,0,6.157992950445781,25.966756790503847,MMP9;S100A9;S100A8,1,1,G2
101,KEGG_2021_Human,Staphylococcus aureus infection,3/95,0.0151680392023028,0.028020668511316,0,0,6.0907506152584086,25.511503321612132,C3;SELPLG;ITGB2,1,1,G2
102,KEGG_2021_Human,Pathways of neurodegeneration,7/475,0.0152705230511404,0.028020668511316,0,0,2.8481858555387967,11.91063163907518,CHRM1;CSF1;FZD8;CALM3;CALM1;TNFRSF1B;TNFRSF1A,1,1,G2
103,KEGG_2021_Human,Circadian entrainment,3/97,0.0160316567202627,0.0291344530781698,0,0,5.960558008831795,24.63611855665516,CALM3;CALM1;GNAI2,1,1,G2
104,KEGG_2021_Human,NOD-like receptor signaling pathway,4/181,0.01730289207954,0.031145205743172,0,0,4.242991659940812,17.21331487572773,CCL5;RIPK1;TLR4;IFNAR1,1,1,G2
105,KEGG_2021_Human,T cell receptor signaling pathway,3/104,0.0192688225178686,0.0343566741120488,0,0,5.545488511115263,21.900614237030467,PTPRC;CD3G;CD3D,1,1,G2
106,KEGG_2021_Human,Pathogenic Escherichia coli infection,4/197,0.0228048553466879,0.0402814734628412,0,0,3.888082901554404,14.6999931173216,F2R;RIPK1;TLR4;TNFRSF1A,1,1,G2
107,KEGG_2021_Human,Sphingolipid signaling pathway,3/119,0.0273355572175063,0.0478372251306361,0,0,4.824739752765127,17.36697381468537,S1PR4;TNFRSF1A;GNAI2,1,1,G2
108,KEGG_2021_Human,Thyroid hormone signaling pathway,3/121,0.0285275690753433,0.0494652344517422,0,0,4.742484809721778,16.868469873180715,NOTCH3;NOTCH4;ITGAV,1,1,G2
0,KEGG_2021_Human,ECM-receptor interaction,30/88,2.4579594911570744e-44,3.258134464192695e-42,0,0,100.45638945233266,10087.269334868884,ITGB1;LAMA5;ITGB5;SDC4;ITGB4;LAMA1;TNC;LAMC2;THBS1;CHAD;ITGB8;ITGAV;ITGB7;CD36;ITGB6;LAMB3;ITGA3;LAMB2;ITGA2;FN1;LAMB1;COL1A1;COL4A1;COL6A2;COL6A1;SDC1;ITGA6;COL9A3;ITGA5;CD44,2,2,G2
1,KEGG_2021_Human,PI3K-Akt signaling pathway,44/354,3.0737117586723537e-44,3.258134464192695e-42,0,0,31.545161290322586,3160.5367823193287,ITGB1;CSF1R;LAMA5;CSF3;ITGB5;ITGB4;LAMA1;TNC;LPAR2;TGFA;LAMC2;AREG;THBS1;HSP90B1;IGF1R;RXRA;ERBB3;CHAD;ERBB2;ITGB8;ITGAV;ITGB7;ITGB6;NGFR;HSP90AA1;LAMB3;ITGA3;LAMB2;INSR;ITGA2;FN1;LAMB1;EREG;VEGFA;COL1A1;EFNA1;COL4A1;COL6A2;COL6A1;COL9A3;ITGA6;ITGA5;FGFR3;FGFR1,2,2,G2
2,KEGG_2021_Human,Pathways in cancer,44/531,2.057776434701376e-36,1.4541620138556387e-34,0,0,19.89835728952772,1635.0766193562258,NOTCH2;RET;ITGB1;CSF1R;NOTCH3;LAMA5;NOTCH1;LAMA1;GSTP1;LRP5;LPAR2;TGFA;LAMC2;PLD1;HSP90B1;IGF1R;GNAI2;RXRA;CDH1;ERBB2;ITGAV;HSP90AA1;TGFB1;LAMB3;ITGA3;LAMB2;ITGA2;FN1;TRAF2;LAMB1;ESR1;TGFBR1;VEGFA;AR;BMP2;CXCL12;COL4A1;GNAS;CALM3;ITGA6;CALM1;CALM2;FGFR3;FGFR1,2,2,G2
3,KEGG_2021_Human,Human papillomavirus infection,35/331,1.9900520418843403e-32,1.0547275821987004e-30,0,0,23.858317079966564,1741.52740974011,NOTCH2;ITGB1;NOTCH3;LAMA5;NOTCH1;ITGB5;ITGB4;LAMA1;TNC;LAMC2;PSEN1;THBS1;CHAD;ITGB8;ITGAV;ITGB7;ITGB6;LAMB3;ITGA3;LAMB2;ITGA2;FN1;LAMB1;HLA-A;HLA-F;VEGFA;COL1A1;PKM;COL4A1;COL6A2;COL6A1;GNAS;COL9A3;ITGA6;ITGA5,2,2,G2
4,KEGG_2021_Human,Focal adhesion,29/201,7.590052580687243e-31,3.218182294211391e-29,0,0,32.24113795439151,2236.0292923806533,ITGB1;LAMA5;ITGB5;ITGB4;LAMA1;TNC;LAMC2;THBS1;IGF1R;CHAD;ERBB2;ITGB8;ITGAV;ITGB7;ITGB6;LAMB3;ITGA3;LAMB2;ITGA2;FN1;LAMB1;VEGFA;COL1A1;COL4A1;COL6A2;COL6A1;COL9A3;ITGA6;ITGA5,2,2,G2
5,KEGG_2021_Human,Proteoglycans in cancer,20/205,5.467939238481175e-18,1.9320051975966814e-16,0,0,18.99903474903475,755.1666010405006,ITGB1;TGFB1;SDC4;ITGB5;ITGA2;FN1;ESR1;THBS1;IGF1R;VEGFA;COL1A1;ERBB3;GPC1;ERBB2;SDC1;TIMP3;ITGAV;ITGA5;CD44;FGFR1,2,2,G2
6,KEGG_2021_Human,Small cell lung cancer,15/92,3.701824776863375e-17,1.121124075278622e-15,0,0,32.952047952047955,1246.744711574208,ITGB1;LAMA5;LAMB3;ITGA3;LAMA1;LAMB2;ITGA2;FN1;LAMC2;TRAF2;LAMB1;RXRA;COL4A1;ITGAV;ITGA6,2,2,G2
7,KEGG_2021_Human,Rap1 signaling pathway,19/210,1.6148655989525674e-16,4.2793938372243026e-15,0,0,17.32210536070055,629.8682963161684,FARP2;ITGB1;NGFR;CSF1R;INSR;ITGB2;LPAR2;THBS1;IGF1R;VEGFA;GNAI2;EFNA1;CDH1;GNAS;CALM3;CALM1;CALM2;FGFR3;FGFR1,2,2,G2
8,KEGG_2021_Human,Dilated cardiomyopathy,14/96,2.2241777776722783e-15,5.2391743207391456e-14,0,0,28.627945431996693,965.8893896547064,ITGB1;TGFB1;ITGB5;ITGB4;ITGA3;LAMA1;ITGA2;GNAS;ITGB8;ITGAV;ITGB7;ITGA6;ITGB6;ITGA5,2,2,G2
9,KEGG_2021_Human,Hypertrophic cardiomyopathy,13/90,2.634192657676504e-14,5.584488434274188e-13,0,0,28.078467750736657,877.9467070273631,ITGB1;TGFB1;ITGB5;ITGB4;ITGA3;LAMA1;ITGA2;ITGB8;ITGAV;ITGB7;ITGA6;ITGB6;ITGA5,2,2,G2
10,KEGG_2021_Human,Regulation of actin cytoskeleton,17/218,8.224864360164519e-14,1.5851556766862525e-12,0,0,14.464157473502055,435.79102716212753,ITGB1;ITGB5;ITGA3;ITGB4;ITGA2;ITGB2;FN1;LPAR2;CXCL12;ITGB8;ITGA6;ITGAV;ITGB7;ITGA5;ITGB6;FGFR3;FGFR1,2,2,G2
11,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,12/77,1.0479516005709525e-13,1.8513811610086826e-12,0,0,30.466153846153848,910.5348964309233,ITGB1;ITGB5;ITGB4;ITGA3;LAMA1;ITGA2;ITGB8;ITGAV;ITGB7;ITGA6;ITGB6;ITGA5,2,2,G2
12,KEGG_2021_Human,Cell adhesion molecules,14/148,1.0255314117123617e-12,1.6724050714078508e-11,0,0,17.472552491778398,482.3439675745535,ITGB1;SDC4;ITGB2;HLA-A;L1CAM;HLA-F;PTPRF;CD4;CDH1;SDC1;ITGB8;ITGA6;ITGAV;ITGB7,2,2,G2
13,KEGG_2021_Human,Amoebiasis,12/102,3.352676200480439e-12,5.0769096750132355e-11,0,0,21.975555555555555,580.6219158338322,COL1A1;LAMA5;TGFB1;LAMB3;COL4A1;LAMA1;LAMB2;ITGB2;FN1;GNAS;LAMC2;LAMB1,2,2,G2
14,KEGG_2021_Human,Axon guidance,14/182,1.7349378634441885e-11,2.4520455136677864e-10,0,0,13.912429378531073,344.71472397454136,EPHB6;ITGB1;BMPR2;SEMA4D;SEMA4C;UNC5C;L1CAM;NTN1;BMP7;GNAI2;EFNA1;CXCL12;PLXNB2;PLXNA3,2,2,G2
15,KEGG_2021_Human,Human cytomegalovirus infection,15/225,2.467759777749983e-11,3.2697817055187273e-10,0,0,12.001221001221,293.13132618472866,TRAF2;HLA-A;HLA-F;VEGFA;GNAI2;CXCL12;CCL5;GNAS;CALM3;RIPK1;ITGAV;CALR;CALM1;CALM2;B2M,2,2,G2
16,KEGG_2021_Human,MAPK signaling pathway,16/294,1.0778091393270152e-10,1.3440913972783956e-09,0,0,9.719672537831803,223.0754319335866,NGFR;CSF1R;TGFB1;INSR;TGFA;TRAF2;AREG;TGFBR1;EREG;IGF1R;VEGFA;EFNA1;ERBB3;ERBB2;FGFR3;FGFR1,2,2,G2
17,KEGG_2021_Human,Fluid shear stress and atherosclerosis,12/139,1.346045249448336e-10,1.5853421826835956e-09,0,0,15.544094488188977,353.2967507796659,HSP90AA1;BMPR2;SDC4;GPC1;GSTP1;SDC1;CALM3;ITGAV;CALM1;CALM2;HSP90B1;VEGFA,2,2,G2
18,KEGG_2021_Human,MicroRNAs in cancer,15/310,2.1546685033509967e-09,2.404156435317954e-08,0,0,8.506301607996523,169.74859864276286,NOTCH2;NOTCH3;NOTCH1;BMPR2;TNC;THBS1;VEGFA;EFNA1;ERBB3;ERBB2;TIMP3;VIM;ITGA5;FGFR3;CD44,2,2,G2
19,KEGG_2021_Human,Toxoplasmosis,10/112,3.5557700807860867e-09,3.7691162856332524e-08,0,0,15.883960141433622,309.0175868884338,ITGB1;LAMA5;TGFB1;LAMB3;LAMA1;LAMB2;LAMC2;ITGA6;LAMB1;GNAI2,2,2,G2
20,KEGG_2021_Human,Ras signaling pathway,13/232,4.6845537913105325e-09,4.729168589323014e-08,0,0,9.80150416330916,187.9830009850294,NGFR;CSF1R;INSR;TGFA;PLD1;IGF1R;VEGFA;EFNA1;CALM3;CALM1;CALM2;FGFR3;FGFR1,2,2,G2
21,KEGG_2021_Human,Phagosome,11/152,5.339602311770908e-09,5.145434954979239e-08,0,0,12.718891038039974,242.27089484315957,ITGB1;ITGB5;ITGA2;ITGB2;ITGAV;HLA-A;ITGA5;CALR;CD36;HLA-F;THBS1,2,2,G2
22,KEGG_2021_Human,Cytokine-cytokine receptor interaction,14/295,9.774974550224428e-09,9.009976541945993e-08,0,0,8.270040412570118,152.52799691426523,NGFR;CSF1R;CSF3;TGFB1;BMPR2;GDF15;BMP7;TGFBR1;CXCL10;CD4;BMP2;CXCL12;CCL5;TNFSF10,2,2,G2
23,KEGG_2021_Human,Hematopoietic cell lineage,9/99,1.892003688433801e-08,1.671269924783191e-07,0,0,16.079674796747966,285.94556962342574,CSF1R;CSF3;CD4;ITGA3;ITGA2;ITGA6;CD36;ITGA5;CD44,2,2,G2
24,KEGG_2021_Human,Adherens junction,8/71,2.1814107921628893e-08,1.84983635175413e-07,0,0,20.281618023553506,357.7821200632039,FARP2;CDH1;INSR;ERBB2;PTPRF;TGFBR1;IGF1R;FGFR1,2,2,G2
25,KEGG_2021_Human,Human immunodeficiency virus 1 infection,11/212,1.652614696768875e-07,1.3475165989038518e-06,0,0,8.895070104025327,138.90307491933947,CD4;CALM3;TRAF2;RIPK1;HLA-A;CALR;CALM1;HLA-F;CALM2;B2M;GNAI2,2,2,G2
26,KEGG_2021_Human,Prostate cancer,8/97,2.56731058150239e-07,2.0158142343648395e-06,0,0,14.337803552011598,217.57956361077237,AR;HSP90AA1;GSTP1;ERBB2;TGFA;IGF1R;HSP90B1;FGFR1,2,2,G2
27,KEGG_2021_Human,Estrogen signaling pathway,9/137,3.17175980928471e-07,2.401475284172709e-06,0,0,11.284298780487806,168.85609246510768,HSP90AA1;GNAS;TGFA;CALM3;CALM1;CALM2;ESR1;HSP90B1;GNAI2,2,2,G2
28,KEGG_2021_Human,Pertussis,7/76,6.958580392337662e-07,5.086962217846843e-06,0,0,16.068753623188407,227.8247197558246,ITGB1;ITGB2;CALM3;ITGA5;CALM1;CALM2;GNAI2,2,2,G2
29,KEGG_2021_Human,Malaria,6/50,9.232084916546548e-07,6.524006674359561e-06,0,0,21.454545454545453,298.11972139889303,CSF3;TGFB1;ITGB2;SDC1;CD36;THBS1,2,2,G2
30,KEGG_2021_Human,Lipid and atherosclerosis,10/215,1.6666608168490906e-06,1.1397809457161524e-05,0,0,7.862055177928829,104.60219467262688,HSP90AA1;RXRA;CCL5;TNFSF10;CALM3;TRAF2;CD36;CALM1;CALM2;HSP90B1,2,2,G2
31,KEGG_2021_Human,IL-17 signaling pathway,7/94,2.9528288935366987e-06,1.8969688649387275e-05,0,0,12.732597701149423,162.12094391012735,CXCL10;CSF3;HSP90AA1;TRAF2;S100A9;S100A8;HSP90B1,2,2,G2
32,KEGG_2021_Human,TGF-beta signaling pathway,7/94,2.9528288935366987e-06,1.8969688649387275e-05,0,0,12.732597701149423,162.12094391012735,BMP2;BMPR2;TGFB1;LTBP1;THBS1;BMP7;TGFBR1,2,2,G2
33,KEGG_2021_Human,Chemical carcinogenesis,10/239,4.294578071258455e-06,2.67779573854939e-05,0,0,7.029493879304174,86.87159071001527,NOTCH2;AR;HSP90AA1;RXRA;GSTP1;GNAS;ESR1;HSP90B1;VEGFA;GNAI2,2,2,G2
34,KEGG_2021_Human,Calcium signaling pathway,10/240,4.4564722783457724e-06,2.699348922883725e-05,0,0,6.998574483250178,86.23050750717464,RET;ERBB3;ERBB2;GNAS;CALM3;CALM1;CALM2;FGFR3;FGFR1;VEGFA,2,2,G2
35,KEGG_2021_Human,Breast cancer,8/147,6.008422918719086e-06,3.50701385539033e-05,0,0,9.15711301926201,110.0900017131599,NOTCH2;NOTCH3;NOTCH1;ERBB2;LRP5;ESR1;FGFR1;IGF1R,2,2,G2
36,KEGG_2021_Human,Alzheimer disease,12/369,6.231120180253403e-06,3.50701385539033e-05,0,0,5.465266106442577,65.50643053852265,APP;NCSTN;INSR;LRP5;ADAM10;CALM3;TRAF2;PSEN1;CALM1;DKK1;CALM2;RTN4,2,2,G2
37,KEGG_2021_Human,Renin secretion,6/69,6.286156910605309e-06,3.50701385539033e-05,0,0,14.969765684051398,179.2952886102628,GNAS;CALM3;CALM1;CALM2;AQP1;GNAI2,2,2,G2
38,KEGG_2021_Human,Bladder cancer,5/41,7.1866523140972925e-06,3.9065904886887845e-05,0,0,21.68853893263342,256.86354993183795,CDH1;ERBB2;THBS1;FGFR3;VEGFA,2,2,G2
39,KEGG_2021_Human,Epstein-Barr virus infection,9/202,7.955818233690346e-06,4.2165836638558834e-05,0,0,7.459244281561987,87.58351519690069,CXCL10;TRAF2;RIPK1;VIM;HLA-A;CALR;HLA-F;B2M;CD44,2,2,G2
40,KEGG_2021_Human,Pancreatic cancer,6/76,1.1039589874056033e-05,5.7082757397558015e-05,0,0,13.468027210884356,153.72436786338588,TGFB1;ERBB2;TGFA;PLD1;TGFBR1;VEGFA,2,2,G2
41,KEGG_2021_Human,Hippo signaling pathway,8/163,1.281952388431677e-05,6.326095174243667e-05,0,0,8.205202913631634,92.42784664969712,BMP2;TGFB1;BMPR2;CDH1;ITGB2;BMP7;AREG;TGFBR1,2,2,G2
42,KEGG_2021_Human,Antigen processing and presentation,6/78,1.283123077794706e-05,6.326095174243667e-05,0,0,13.092592592592592,147.47009846577356,HSP90AA1;CD4;HLA-A;CALR;HLA-F;B2M,2,2,G2
43,KEGG_2021_Human,ErbB signaling pathway,6/85,2.104008824550153e-05,0.00010137497063741648,0,0,11.928270042194091,128.45650598709722,NRG3;ERBB3;ERBB2;TGFA;AREG;EREG,2,2,G2
44,KEGG_2021_Human,Relaxin signaling pathway,7/129,2.3819875867142987e-05,0.00011221808186298474,0,0,9.063737704918031,96.48339909260272,COL1A1;TGFB1;COL4A1;GNAS;TGFBR1;GNAI2;VEGFA,2,2,G2
45,KEGG_2021_Human,Apelin signaling pathway,7/137,3.509009558094665e-05,0.00016171957093827588,0,0,8.502523076923078,87.21540967095451,NOTCH3;CDH1;CALM3;CALM1;CALM2;TGFBR1;GNAI2,2,2,G2
46,KEGG_2021_Human,Notch signaling pathway,5/59,4.365859848115248e-05,0.0001969281463405176,0,0,14.445902595508894,145.02400965652728,NOTCH2;NOTCH3;NCSTN;NOTCH1;PSEN1,2,2,G2
47,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,6/100,5.290050319576271e-05,0.00023364388911461864,0,0,10.017223910840933,98.64058260232652,COL1A1;TGFB1;COL4A1;FN1;TGFBR1;VEGFA,2,2,G2
48,KEGG_2021_Human,Chagas disease,6/102,5.911753812884319e-05,0.00025577383843499504,0,0,9.807539682539682,95.48603887689148,TGFB1;CCL5;GNAS;CALR;TGFBR1;GNAI2,2,2,G2
49,KEGG_2021_Human,Protein digestion and absorption,6/103,6.243771972330983e-05,0.00026473593162683367,0,0,9.705940108001965,93.96651574099523,COL1A1;COL18A1;COL4A1;COL6A2;COL6A1;COL9A3,2,2,G2
50,KEGG_2021_Human,"Parathyroid hormone synthesis, secretion and action",6/106,7.330119181092354e-05,0.0003047029934101136,0,0,9.413333333333334,89.62372246708458,RXRA;GNAS;LRP5;PLD1;FGFR1;GNAI2,2,2,G2
51,KEGG_2021_Human,Cellular senescence,7/156,8.006154227959379e-05,0.0003264047492937285,0,0,7.411167785234899,69.90743309462292,TGFB1;CALM3;HLA-A;CALM1;HLA-F;CALM2;TGFBR1,2,2,G2
52,KEGG_2021_Human,Central carbon metabolism in cancer,5/70,9.960050223521584e-05,0.0003984020089408633,0,0,11.994548758328284,110.52189059791851,RET;PKM;ERBB2;FGFR3;FGFR1,2,2,G2
53,KEGG_2021_Human,Human T-cell leukemia virus 1 infection,8/219,0.0001046781446773825,0.0004109586420667609,0,0,6.01039596391989,55.08299628626568,CD4;TGFB1;ITGB2;HLA-A;CALR;HLA-F;B2M;TGFBR1,2,2,G2
54,KEGG_2021_Human,Glioma,5/75,0.00013834392969422192,0.000533252965366819,0,0,11.13498312710911,98.94287373534152,TGFA;CALM3;CALM1;CALM2;IGF1R,2,2,G2
55,KEGG_2021_Human,Gastric acid secretion,5/76,0.0001473090812097228,0.0005576700931510934,0,0,10.9775978706887,96.85509995327926,GNAS;CALM3;CALM1;CALM2;GNAI2,2,2,G2
56,KEGG_2021_Human,Thyroid hormone signaling pathway,6/121,0.0001523608855761126,0.0005666755744234363,0,0,8.179296066252588,71.88994832479659,NOTCH2;NOTCH3;NOTCH1;RXRA;ITGAV;ESR1,2,2,G2
57,KEGG_2021_Human,Platelet activation,6/124,0.00017419740661865857,0.000636721555226821,0,0,7.970137207425343,68.98409898121298,COL1A1;ITGB1;FGB;ITGA2;GNAS;GNAI2,2,2,G2
58,KEGG_2021_Human,Colorectal cancer,5/86,0.0002634592084942671,0.0009466669864539768,0,0,9.61747837075921,79.26352523136094,TGFB1;TGFA;AREG;TGFBR1;EREG,2,2,G2
59,KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,7/193,0.0002982429525924697,0.0010537917658267,0,0,5.925763440860215,48.10298990843073,CALM3;TRAF2;HLA-A;CALM1;HLA-F;CALM2;VEGFA,2,2,G2
60,KEGG_2021_Human,GnRH signaling pathway,5/93,0.00037896269857716513,0.0012958079370703,0,0,8.849319971367215,69.71558677348044,GNAS;CALM3;PLD1;CALM1;CALM2,2,2,G2
61,KEGG_2021_Human,Rheumatoid arthritis,5/93,0.00037896269857716513,0.0012958079370703,0,0,8.849319971367215,69.71558677348044,TGFB1;CXCL12;CCL5;ITGB2;VEGFA,2,2,G2
62,KEGG_2021_Human,Circadian entrainment,5/97,0.0004601591847834789,0.0015484721773666,0,0,8.462855186579938,65.02805518686075,GNAS;CALM3;CALM1;CALM2;GNAI2,2,2,G2
63,KEGG_2021_Human,Gastric cancer,6/149,0.0004682635995289096,0.0015511231734395,0,0,6.568431568431569,50.35674382360865,TGFB1;RXRA;CDH1;ERBB2;LRP5;TGFBR1,2,2,G2
64,KEGG_2021_Human,Viral protein interaction with cytokine and cytokine receptor,5/100,0.0005291724539621734,0.0017259163113843,0,0,8.194363862411935,61.81988854263416,CSF1R;CXCL10;CXCL12;CCL5;TNFSF10,2,2,G2
65,KEGG_2021_Human,Melanogenesis,5/101,0.0005538200999432298,0.0017789372907267,0,0,8.108595800524935,60.80368936884631,GNAS;CALM3;CALM1;CALM2;GNAI2,2,2,G2
66,KEGG_2021_Human,Viral myocarditis,4/60,0.0006640765326966161,0.0021012570885325,0,0,11.055803571428571,80.89656575208807,LAMA1;ITGB2;HLA-A;HLA-F,2,2,G2
67,KEGG_2021_Human,Glucagon signaling pathway,5/107,0.000720274611291607,0.0022130176462872,0,0,7.629303689979929,55.2047108332081,PKM;GNAS;CALM3;CALM1;CALM2,2,2,G2
68,KEGG_2021_Human,Th17 cell differentiation,5/107,0.000720274611291607,0.0022130176462872,0,0,7.629303689979929,55.2047108332081,HSP90AA1;CD4;TGFB1;RXRA;TGFBR1,2,2,G2
69,KEGG_2021_Human,Phototransduction,3/28,0.0008158694906166332,0.0024709190287246,0,0,18.45860465116279,131.2638659154306,CALM3;CALM1;CALM2,2,2,G2
70,KEGG_2021_Human,Hepatocellular carcinoma,6/168,0.0008793209566967735,0.0026255780678833,0,0,5.792475014697237,40.75794290315221,TGFB1;GSTP1;LRP5;TGFA;TGFBR1;IGF1R,2,2,G2
71,KEGG_2021_Human,Amphetamine addiction,4/69,0.0011247119401036,0.0033116518236385,0,0,9.520673076923076,64.64754404144257,GNAS;CALM3;CALM1;CALM2,2,2,G2
72,KEGG_2021_Human,Neurotrophin signaling pathway,5/119,0.0011620372679672,0.0033746835727267,0,0,6.82207487221992,46.10072045900986,NGFR;CALM3;PSEN1;CALM1;CALM2,2,2,G2
73,KEGG_2021_Human,Non-small cell lung cancer,4/72,0.0013182394961583,0.0037765780160211,0,0,9.099264705882351,60.34139307103746,RET;RXRA;ERBB2;TGFA,2,2,G2
74,KEGG_2021_Human,Oocyte meiosis,5/129,0.0016619480059132,0.0046977730300481,0,0,6.268732537465075,40.118414254425446,AR;CALM3;CALM1;CALM2;IGF1R,2,2,G2
75,KEGG_2021_Human,Bacterial invasion of epithelial cells,4/77,0.0016906296291377,0.0047159668602262,0,0,8.47388698630137,54.08589085332617,ITGB1;CDH1;FN1;ITGA5,2,2,G2
76,KEGG_2021_Human,FoxO signaling pathway,5/131,0.0017783286865662,0.004896177682494,0,0,6.168603924509436,39.06010153213914,TGFB1;INSR;TNFSF10;TGFBR1;IGF1R,2,2,G2
77,KEGG_2021_Human,Dopaminergic synapse,5/132,0.0018387088474578,0.0049729233228426,0,0,6.119722239444479,38.54624347403765,GNAS;CALM3;CALM1;CALM2;GNAI2,2,2,G2
78,KEGG_2021_Human,Thyroid cancer,3/37,0.0018531176533234,0.0049729233228426,0,0,13.566347469220249,85.34434319824342,RET;RXRA;CDH1,2,2,G2
79,KEGG_2021_Human,Insulin signaling pathway,5/137,0.0021633793138631,0.0056621779572714,0,0,5.886423287998091,36.11958647546277,INSR;CALM3;CALM1;CALM2;PTPRF,2,2,G2
80,KEGG_2021_Human,Yersinia infection,5/137,0.0021633793138631,0.0056621779572714,0,0,5.886423287998091,36.11958647546277,ITGB1;CD4;FN1;TRAF2;ITGA5,2,2,G2
81,KEGG_2021_Human,cAMP signaling pathway,6/216,0.0031379135167057,0.0081126544578246,0,0,4.457596371882087,25.69446445891684,GNAS;CALM3;CALM1;PLD1;CALM2;GNAI2,2,2,G2
82,KEGG_2021_Human,Adrenergic signaling in cardiomyocytes,5/150,0.0032014064990601,0.008166177889046,0,0,5.355145262014662,30.760838170262367,GNAS;CALM3;CALM1;CALM2;GNAI2,2,2,G2
83,KEGG_2021_Human,Th1 and Th2 cell differentiation,4/92,0.0032356553899993,0.008166177889046,0,0,7.024147727272728,40.2731180147856,NOTCH2;NOTCH3;CD4;NOTCH1,2,2,G2
84,KEGG_2021_Human,Salivary secretion,4/93,0.0033640465227256,0.0083903277978568,0,0,6.944873595505618,39.54835153837777,GNAS;CALM3;CALM1;CALM2,2,2,G2
85,KEGG_2021_Human,Oxytocin signaling pathway,5/154,0.0035826480696092,0.0088316440785716,0,0,5.210326058236009,29.34274872985665,GNAS;CALM3;CALM1;CALM2;GNAI2,2,2,G2
86,KEGG_2021_Human,Intestinal immune network for IgA production,3/48,0.0039131320458445,0.0095354482036672,0,0,10.244444444444444,56.78922944454413,TGFB1;CXCL12;ITGB7,2,2,G2
87,KEGG_2021_Human,Aldosterone synthesis and secretion,4/98,0.0040582663936174,0.0096666722906555,0,0,6.573803191489362,36.201930186571,GNAS;CALM3;CALM1;CALM2,2,2,G2
88,KEGG_2021_Human,Inflammatory mediator regulation of TRP channels,4/98,0.0040582663936174,0.0096666722906555,0,0,6.573803191489362,36.201930186571,GNAS;CALM3;CALM1;CALM2,2,2,G2
89,KEGG_2021_Human,Necroptosis,5/159,0.0041037759724481,0.0096666722906555,0,0,5.039881378464056,27.69842078557458,HSP90AA1;TNFSF10;TRAF2;RIPK1;HMGB1,2,2,G2
90,KEGG_2021_Human,Ovarian steroidogenesis,3/51,0.0046444123644883,0.0108199496843024,0,0,9.602713178294572,51.58664350933408,INSR;GNAS;IGF1R,2,2,G2
91,KEGG_2021_Human,cGMP-PKG signaling pathway,5/167,0.0050470735627169,0.0116302129923477,0,0,4.789054146009526,25.32905210344497,INSR;CALM3;CALM1;CALM2;GNAI2,2,2,G2
92,KEGG_2021_Human,Regulation of lipolysis in adipocytes,3/55,0.0057401733149354,0.0130851262663043,0,0,8.862254025044722,45.73158701983995,INSR;GNAS;GNAI2,2,2,G2
93,KEGG_2021_Human,Shigellosis,6/246,0.0058893584215115,0.0131955849127023,0,0,3.894444444444445,19.99644643337165,ITGB1;CCL5;TRAF2;RIPK1;ITGA5;CD44,2,2,G2
94,KEGG_2021_Human,HIF-1 signaling pathway,4/109,0.005913115880692,0.0131955849127023,0,0,5.881845238095238,30.17729145059191,INSR;ERBB2;IGF1R;VEGFA,2,2,G2
95,KEGG_2021_Human,TNF signaling pathway,4/112,0.0065025128626952,0.0143597159051187,0,0,5.717592592592593,28.79131819176913,CXCL10;CCL5;RIPK1;TRAF2,2,2,G2
96,KEGG_2021_Human,Endocytosis,6/252,0.0066021835876107,0.0144295146450874,0,0,3.798296554394115,19.06879648323811,HLA-A;HLA-F;PLD1;FGFR3;TGFBR1;IGF1R,2,2,G2
97,KEGG_2021_Human,Tuberculosis,5/180,0.0068929690292111,0.0148107812057899,0,0,4.43037120359955,22.05107999534611,TGFB1;ITGB2;CALM3;CALM1;CALM2,2,2,G2
98,KEGG_2021_Human,Leukocyte transendothelial migration,4/114,0.0069163553744019,0.0148107812057899,0,0,5.613068181818182,27.9186508268576,ITGB1;CXCL12;ITGB2;GNAI2,2,2,G2
99,KEGG_2021_Human,Long-term depression,3/60,0.0073107359702342,0.0154987602568966,0,0,8.0828233374133,39.75464988407806,GNAS;IGF1R;GNAI2,2,2,G2
100,KEGG_2021_Human,Alcoholism,5/186,0.0078865017609445,0.0165538452803984,0,0,4.282202984295472,20.73700738577189,GNAS;CALM3;CALM1;CALM2;GNAI2,2,2,G2
101,KEGG_2021_Human,Sphingolipid signaling pathway,4/119,0.0080262696078436,0.016682050557479,0,0,5.367663043478261,25.89916428537077,TRAF2;S1PR3;PLD1;GNAI2,2,2,G2
102,KEGG_2021_Human,Cytosolic DNA-sensing pathway,3/63,0.008363382535761,0.0172139524037024,0,0,7.677519379844961,36.72842602996119,CXCL10;CCL5;RIPK1,2,2,G2
103,KEGG_2021_Human,Transcriptional misregulation in cancer,5/192,0.008975612390829,0.0182964406428437,0,0,4.143542886016253,19.529529118515388,NGFR;CSF1R;RXRA;ITGB7;IGF1R,2,2,G2
104,KEGG_2021_Human,Long-term potentiation,3/67,0.0098987677892598,0.0198821614780347,0,0,7.196220930232558,33.21304225556172,CALM3;CALM1;CALM2,2,2,G2
105,KEGG_2021_Human,Pathogenic Escherichia coli infection,5/197,0.0099593031967682,0.0198821614780347,0,0,4.034612860892389,18.59653194571376,ITGB1;TNFSF10;LPAR2;TRAF2;RIPK1,2,2,G2
106,KEGG_2021_Human,Osteoclast differentiation,4/127,0.0100348645195741,0.0198821614780347,0,0,5.0165142276422765,23.084442340930927,CSF1R;TGFB1;TRAF2;TGFBR1,2,2,G2
107,KEGG_2021_Human,Adipocytokine signaling pathway,3/69,0.0107238403576527,0.020857377576352,0,0,6.977448907681466,31.64472596418153,RXRA;TRAF2;CD36,2,2,G2
108,KEGG_2021_Human,Renal cell carcinoma,3/69,0.0107238403576527,0.020857377576352,0,0,6.977448907681466,31.64472596418153,TGFB1;TGFA;VEGFA,2,2,G2
109,KEGG_2021_Human,RIG-I-like receptor signaling pathway,3/70,0.0111508713647291,0.0214571461731634,0,0,6.87296077750781,30.90246491051665,CXCL10;TRAF2;RIPK1,2,2,G2
110,KEGG_2021_Human,Diabetic cardiomyopathy,5/203,0.0112346378548167,0.0214571461731634,0,0,3.911158832418675,17.556228318624683,COL1A1;TGFB1;INSR;CD36;TGFBR1,2,2,G2
111,KEGG_2021_Human,Vascular smooth muscle contraction,4/133,0.0117378558109383,0.0222180842135619,0,0,4.781734496124031,21.254504382261736,GNAS;CALM3;CALM1;CALM2,2,2,G2
112,KEGG_2021_Human,Melanoma,3/72,0.0120341126755042,0.0225772733381142,0,0,6.673070441523424,29.49503767605635,CDH1;IGF1R;FGFR1,2,2,G2
113,KEGG_2021_Human,Pathways of neurodegeneration,8/475,0.0136111647547627,0.0253119905965763,0,0,2.6802514333080056,11.516678267221396,APP;LRP5;CALM3;TRAF2;PSEN1;CALM1;DKK1;CALM2,2,2,G2
114,KEGG_2021_Human,Leishmaniasis,3/77,0.0144139617199656,0.0265718250837627,0,0,6.220615964802011,26.372662043125757,ITGB1;TGFB1;ITGB2,2,2,G2
115,KEGG_2021_Human,Apoptosis,4/142,0.01462329016688,0.0267253234084359,0,0,4.467844202898551,18.877266381369157,NGFR;TNFSF10;TRAF2;RIPK1,2,2,G2
116,KEGG_2021_Human,Signaling pathways regulating pluripotency of stem cells,4/143,0.0149691130156054,0.0271235210197295,0,0,4.435476618705036,18.63683632772952,BMPR2;FGFR3;FGFR1;IGF1R,2,2,G2
117,KEGG_2021_Human,Phospholipase D signaling pathway,4/148,0.016775685356189,0.0301393669111193,0,0,4.280381944444445,17.497451214073358,INSR;GNAS;LPAR2;PLD1,2,2,G2
118,KEGG_2021_Human,Non-alcoholic fatty liver disease,4/155,0.0195256791228362,0.0347852434793385,0,0,4.080504966887418,16.06096875289121,TGFB1;RXRA;INSR;TRAF2,2,2,G2
119,KEGG_2021_Human,Hepatitis C,4/157,0.0203595340593637,0.0359685101715426,0,0,4.026756535947713,15.681019352742094,CXCL10;RXRA;TRAF2;RIPK1,2,2,G2
120,KEGG_2021_Human,Bile secretion,3/90,0.0217676491979773,0.0381383605782743,0,0,5.287623630045442,20.2374826266668,RXRA;GNAS;AQP1,2,2,G2
121,KEGG_2021_Human,Parkinson disease,5/249,0.0248403420659501,0.0428142481136702,0,0,3.166386988511682,11.70070630475477,GNAS;CALM3;CALM1;CALM2;GNAI2,2,2,G2
122,KEGG_2021_Human,Salmonella infection,5/249,0.0248403420659501,0.0428142481136702,0,0,3.166386988511682,11.70070630475477,HSP90AA1;TNFSF10;TRAF2;RIPK1;HSP90B1,2,2,G2
123,KEGG_2021_Human,Allograft rejection,2/38,0.0260295052338323,0.0445020573352617,0,0,8.475213675213675,30.92202531046073,HLA-A;HLA-F,2,2,G2
124,KEGG_2021_Human,Phosphatidylinositol signaling system,3/97,0.0264314831300798,0.0448277953886154,0,0,4.89213260761999,17.774093433474906,CALM3;CALM1;CALM2,2,2,G2
125,KEGG_2021_Human,Protein processing in endoplasmic reticulum,4/171,0.02680983705417,0.0451086147260638,0,0,3.686564371257485,13.341626339091,HSP90AA1;TRAF2;CALR;HSP90B1,2,2,G2
126,KEGG_2021_Human,Progesterone-mediated oocyte maturation,3/100,0.0285811776295865,0.0477103122635617,0,0,4.740110285303285,16.851124783599985,HSP90AA1;IGF1R;GNAI2,2,2,G2
0,KEGG_2021_Human,ECM-receptor interaction,33/88,1.9984830076481422e-54,3.577284583690174e-52,0,0,167.67042253521126,20731.979380128792,ITGB1;LAMA5;ITGB5;SDC4;TNC;LAMC2;LAMC1;THBS2;THBS1;COMP;SPP1;ITGAV;CD36;ITGB6;LAMB3;LAMB2;ITGA2;ITGA1;FN1;HSPG2;COL1A1;COL1A2;COL4A1;COL6A2;COL6A1;COL4A6;COL4A5;COL6A3;SDC1;ITGA6;ITGA5;AGRN;CD44,3,3,G2
1,KEGG_2021_Human,Focal adhesion,34/201,1.0328127015226269e-42,9.24367367862751e-41,0,0,57.38118049615056,5547.399534130308,ITGB1;LAMA5;ITGB5;TNC;LAMC2;LAMC1;THBS2;THBS1;EGFR;COMP;ERBB2;SPP1;ITGAV;ITGB6;HRAS;LAMB3;EGF;LAMB2;ITGA2;ITGA1;FN1;VEGFB;PGF;VEGFA;COL1A1;COL1A2;COL4A1;COL6A2;COL6A1;COL4A6;COL6A3;COL4A5;ITGA6;ITGA5,3,3,G2
2,KEGG_2021_Human,PI3K-Akt signaling pathway,36/354,5.3102381246164455e-37,3.168442081021145e-35,0,0,32.593784683684795,2722.4288428566,ITGB1;LAMA5;ITGB5;TNC;LAMC2;LAMC1;THBS2;THBS1;EGFR;COMP;ERBB3;ERBB2;SPP1;ITGAV;ITGB6;HRAS;HSP90AA1;LAMB3;EGF;LAMB2;ITGA2;ITGA1;FN1;VEGFB;PGF;VEGFA;COL1A1;COL1A2;COL4A1;COL6A2;COL6A1;COL4A6;COL6A3;COL4A5;ITGA6;ITGA5,3,3,G2
3,KEGG_2021_Human,Human papillomavirus infection,33/331,1.6141399579347302e-33,7.223276311757917e-32,0,0,30.56687777672748,2307.9981337622844,NOTCH2;ITGB1;LAMA5;ITGB5;TNC;LAMC2;LAMC1;THBS2;THBS1;EGFR;COMP;SPP1;ITGAV;ITGB6;HRAS;LAMB3;EGF;LAMB2;ITGA2;FZD6;ITGA1;FN1;VEGFA;COL1A1;COL1A2;COL4A1;COL6A2;COL6A1;COL4A6;COL6A3;COL4A5;ITGA6;ITGA5,3,3,G2
4,KEGG_2021_Human,Proteoglycans in cancer,25/205,1.5235160669614382e-27,5.454187519721948e-26,0,0,34.66244725738397,2140.363713677968,ITGB1;SDC4;ITGB5;SDC2;THBS1;EGFR;ERBB3;PLAU;GPC1;ERBB2;ITGAV;HRAS;TGFB1;LUM;MMP2;ITGA2;FZD6;FN1;HSPG2;VEGFA;COL1A1;COL1A2;SDC1;ITGA5;CD44,3,3,G2
5,KEGG_2021_Human,Pathways in cancer,33/531,8.954405353712845e-27,2.6713975971909987e-25,0,0,18.10436110639742,1085.857067973942,NOTCH2;ITGB1;LAMA5;CXCL8;LRP5;LAMC2;LAMC1;EGFR;CDH1;ERBB2;ITGAV;HRAS;HSP90AA1;TGFB1;LAMB3;EGF;MMP1;LAMB2;MMP2;ITGA2;FZD6;FN1;VEGFB;PGF;VEGFA;AR;COL4A1;COL4A6;COL4A5;CALM3;ITGA6;CALM1;CALM2,3,3,G2
6,KEGG_2021_Human,Amoebiasis,15/102,4.6336351590628164e-18,1.184886704960349e-16,0,0,38.37466098411468,1531.6551343654085,LAMA5;TGFB1;CXCL8;LAMB3;LAMB2;FN1;LAMC2;LAMC1;COL1A1;COL3A1;COL1A2;COL4A1;COL4A6;COL4A5;CD14,3,3,G2
7,KEGG_2021_Human,Protein digestion and absorption,15/103,5.400787912535155e-18,1.208426295429741e-16,0,0,37.93667007150153,1508.3615020845418,COL18A1;COL16A1;COL1A1;COL3A1;COL1A2;COL5A1;COL4A1;COL6A2;COL7A1;COL5A2;COL6A1;COL4A6;COL4A5;COL8A1;COL6A3,3,3,G2
8,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,14/100,1.3059828584250466e-16,2.597454796200926e-15,0,0,35.83204134366925,1310.535612948163,TGFB1;CXCL8;MMP2;FN1;VEGFB;ICAM1;VEGFA;COL1A1;COL3A1;COL1A2;COL4A1;COL4A6;COL4A5;HRAS,3,3,G2
9,KEGG_2021_Human,Small cell lung cancer,13/92,1.4901444615269692e-15,2.6673585861332752e-14,0,0,35.835443037974684,1223.418560946792,ITGB1;LAMA5;LAMB3;LAMB2;ITGA2;FN1;LAMC2;LAMC1;COL4A1;COL4A6;COL4A5;ITGAV;ITGA6,3,3,G2
10,KEGG_2021_Human,Bladder cancer,10/41,9.095760869024816e-15,1.4801283595958565e-13,0,0,68.17089910775566,2204.0311527093854,CXCL8;CDH1;EGF;MMP1;MMP2;ERBB2;THBS1;HRAS;EGFR;VEGFA,3,3,G2
11,KEGG_2021_Human,Relaxin signaling pathway,13/129,1.3429880159495953e-13,2.003290457124813e-12,0,0,24.35960591133005,721.9872761921787,TGFB1;MMP1;MMP2;VEGFB;EGFR;VEGFA;COL1A1;COL3A1;COL1A2;COL4A1;COL4A6;COL4A5;HRAS,3,3,G2
12,KEGG_2021_Human,Fluid shear stress and atherosclerosis,13/139,3.558884266711405e-13,4.900309874933397e-12,0,0,22.41496598639456,642.5061517349709,HSP90AA1;SDC4;SDC2;MMP2;ICAM1;VEGFA;GPC1;SDC1;CALM3;ITGAV;CALM1;CALM2;BMPR1A,3,3,G2
13,KEGG_2021_Human,Malaria,9/50,4.098515714658562e-12,5.240245092313448e-11,0,0,45.8780487804878,1202.9406172184486,COMP;CXCL8;TGFB1;SDC2;SDC1;CD36;THBS2;THBS1;ICAM1,3,3,G2
14,KEGG_2021_Human,Rap1 signaling pathway,12/210,9.714156825896795e-10,1.0890001897493553e-08,0,0,12.976284584980236,269.2873177277792,ITGB1;EGF;CDH1;VEGFB;CALM3;CALM1;CALM2;THBS1;HRAS;EGFR;PGF;VEGFA,3,3,G2
15,KEGG_2021_Human,Hypertrophic cardiomyopathy,9/90,9.734079908374122e-10,1.0890001897493553e-08,0,0,23.17543859649123,480.8953987046576,ITGB1;TGFB1;ITGB5;ITGA2;ITGA1;ITGAV;ITGA6;ITGB6;ITGA5,3,3,G2
16,KEGG_2021_Human,Lipid and atherosclerosis,12/215,1.270718873494737e-09,1.3379922256209291e-08,0,0,12.653458984793318,259.1894433875645,HSP90AA1;CXCL8;MMP1;TNFSF10;TNFRSF10B;CALM3;CD14;CD36;CALM1;CALM2;HRAS;ICAM1,3,3,G2
17,KEGG_2021_Human,Regulation of actin cytoskeleton,12/218,1.487990744676194e-09,1.4797241294279931e-08,0,0,12.467285774588436,253.4080449239634,ITGB1;ITGB5;EGF;ITGA2;ITGA1;FN1;ITGA6;ITGAV;ITGA5;ITGB6;HRAS;EGFR,3,3,G2
18,KEGG_2021_Human,Dilated cardiomyopathy,9/96,1.7416370276190762e-09,1.6408054102306033e-08,0,0,21.570598911070785,435.0453373555751,ITGB1;TGFB1;ITGB5;ITGA2;ITGA1;ITGAV;ITGA6;ITGB6;ITGA5,3,3,G2
19,KEGG_2021_Human,Cell adhesion molecules,10/148,5.223924320484382e-09,4.6754122668335216e-08,0,0,15.23126734505088,290.46052616544625,ITGB1;VCAN;SDC4;CDH1;SDC2;SDC1;ITGA6;ITGAV;PTPRF;ICAM1,3,3,G2
20,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,8/77,6.363080852245599e-09,5.423768916914107e-08,0,0,23.945652173913043,451.9203828808145,ITGB1;ITGB5;ITGA2;ITGA1;ITGAV;ITGA6;ITGB6;ITGA5,3,3,G2
21,KEGG_2021_Human,Phagosome,10/152,6.760768083791671e-09,5.5008067590850417e-08,0,0,14.799220857057238,278.4048567681465,COMP;ITGB1;ITGB5;ITGA2;ITGAV;CD14;ITGA5;CD36;THBS2;THBS1,3,3,G2
22,KEGG_2021_Human,Toxoplasmosis,8/112,1.2381761460654214e-07,9.636240441117844e-07,0,0,15.85897435897436,252.2283631334636,ITGB1;LAMA5;TGFB1;LAMB3;LAMB2;ITGA6;LAMC2;LAMC1,3,3,G2
23,KEGG_2021_Human,Pertussis,7/76,1.3650745289495626e-07,1.0181180861748818e-06,0,0,20.736441057821605,327.77857278311086,ITGB1;CXCL8;CALM3;ITGA5;CD14;CALM1;CALM2,3,3,G2
24,KEGG_2021_Human,MicroRNAs in cancer,11/310,6.443122334847054e-07,4.613275591750491e-06,0,0,7.752256626029417,110.50905694141036,NOTCH2;ERBB3;PLAU;ERBB2;TNC;ITGA5;THBS1;HRAS;EGFR;CD44;VEGFA,3,3,G2
25,KEGG_2021_Human,Prostate cancer,7/97,7.337264788397293e-07,5.051424604319675e-06,0,0,15.881099656357389,224.3225896044075,AR;HSP90AA1;PLAU;EGF;ERBB2;HRAS;EGFR,3,3,G2
26,KEGG_2021_Human,Hematopoietic cell lineage,7/99,8.431028706519985e-07,5.589459772100286e-06,0,0,15.5342895562528,217.26532108387303,ITGA2;ITGA1;ITGA6;CD14;CD36;ITGA5;CD44,3,3,G2
27,KEGG_2021_Human,Gastric cancer,8/149,1.1065411344940564e-06,7.073959395515575e-06,0,0,11.675531914893616,160.12141462073828,TGFB1;EGF;CDH1;FZD6;ERBB2;LRP5;HRAS;EGFR,3,3,G2
28,KEGG_2021_Human,Glioma,6/75,2.573632073339427e-06,1.5885522107853704e-05,0,0,17.592724046140194,226.42174329031707,EGF;CALM3;CALM1;HRAS;CALM2;EGFR,3,3,G2
29,KEGG_2021_Human,MAPK signaling pathway,10/294,3.123376343411926e-06,1.863614551569116e-05,0,0,7.346418939166917,93.12758479095902,TGFB1;ERBB3;EGF;ERBB2;VEGFB;CD14;HRAS;EGFR;PGF;VEGFA,3,3,G2
30,KEGG_2021_Human,Ras signaling pathway,9/232,3.439559634542102e-06,1.9860683051065686e-05,0,0,8.357658720793014,105.1407433391082,EGF;VEGFB;CALM3;CALM1;CALM2;HRAS;EGFR;PGF;VEGFA,3,3,G2
31,KEGG_2021_Human,Calcium signaling pathway,9/240,4.5334735467666125e-06,2.535911765222574e-05,0,0,8.064935064935066,99.2311394751241,ERBB3;EGF;ERBB2;VEGFB;CALM3;CALM1;CALM2;EGFR;VEGFA,3,3,G2
32,KEGG_2021_Human,ErbB signaling pathway,6/85,5.360312375974371e-06,2.9075633796951887e-05,0,0,15.358047016274863,186.3927580080324,ERBB3;EGF;ERBB2;NRG2;HRAS;EGFR,3,3,G2
33,KEGG_2021_Human,Estrogen signaling pathway,7/137,7.413912024104274e-06,3.903206624454897e-05,0,0,10.972402854877082,129.60769383262772,HSP90AA1;MMP2;CALM3;CALM1;CALM2;HRAS;EGFR,3,3,G2
34,KEGG_2021_Human,GnRH signaling pathway,6/93,9.034104731145402e-06,4.620299276785792e-05,0,0,13.94018296973962,161.90830706826742,MMP2;CALM3;CALM1;HRAS;CALM2;EGFR,3,3,G2
35,KEGG_2021_Human,TGF-beta signaling pathway,6/94,9.60969949536371e-06,4.778156137972512e-05,0,0,13.781076066790352,159.2091557205738,TGFB1;BAMBI;INHBA;THBS1;BMPR1A;FBN1,3,3,G2
36,KEGG_2021_Human,Breast cancer,7/147,1.1762277358229518e-05,5.690399046278605e-05,0,0,10.183505154639176,115.5890258037029,NOTCH2;EGF;FZD6;ERBB2;LRP5;HRAS;EGFR,3,3,G2
37,KEGG_2021_Human,Endometrial cancer,5/58,1.270347964489002e-05,5.984007516935036e-05,0,0,18.908900323994665,213.17203320981744,CDH1;EGF;ERBB2;HRAS;EGFR,3,3,G2
38,KEGG_2021_Human,Alzheimer disease,10/369,2.2668466304352025e-05,0.00010333536686710218,0,0,5.789426895039412,61.91523289422365,APP;NCSTN;FZD6;LRP5;ADAM10;CALM3;APOE;CALM1;CALM2;HRAS,3,3,G2
39,KEGG_2021_Human,Human cytomegalovirus infection,8/225,2.3091702093207197e-05,0.00010333536686710218,0,0,7.557219662058372,80.68115840480854,CXCL8;CALM3;ITGAV;CALM1;CALM2;HRAS;EGFR;VEGFA,3,3,G2
40,KEGG_2021_Human,Axon guidance,7/182,4.652182151099391e-05,0.00020271389697682312,0,0,8.132371134020618,81.1251926436022,ITGB1;NRP1;SEMA3C;SEMA4C;PLXNB2;SEMA3F;HRAS,3,3,G2
41,KEGG_2021_Human,Pancreatic cancer,5/76,4.75641545979138e-05,0.00020271389697682312,0,0,14.102290510741216,140.36617744556432,TGFB1;EGF;ERBB2;EGFR;VEGFA,3,3,G2
42,KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,7/193,6.741655614707084e-05,0.00028064101279827165,0,0,7.647156634519455,73.44803302009183,CXCL8;CALM3;CALM1;CALM2;HRAS;ICAM1;VEGFA,3,3,G2
43,KEGG_2021_Human,Apelin signaling pathway,6/137,8.101555250207631e-05,0.0003295859976789014,0,0,9.237420158903255,87.02452905335831,CDH1;SPP1;CALM3;CALM1;CALM2;HRAS,3,3,G2
44,KEGG_2021_Human,Rheumatoid arthritis,5/93,0.00012477712232219682,0.000496335664348294,0,0,11.368227731864096,102.1887880141984,CXCL8;TGFB1;MMP1;ICAM1;VEGFA,3,3,G2
45,KEGG_2021_Human,Cellular senescence,6/156,0.00016536431653807126,0.000643482883919886,0,0,8.059591836734693,70.17776386043,TGFB1;CXCL8;CALM3;CALM1;CALM2;HRAS,3,3,G2
46,KEGG_2021_Human,Melanogenesis,5/101,0.00018402973267543817,0.0007008791946575199,0,0,10.416666666666666,89.58763773731528,FZD6;CALM3;CALM1;CALM2;HRAS,3,3,G2
47,KEGG_2021_Human,Chemical carcinogenesis,7/239,0.00025321230452741365,0.00094427088563348,0,0,6.116601493067899,50.65330351429567,NOTCH2;AR;HSP90AA1;EGF;HRAS;EGFR;VEGFA,3,3,G2
48,KEGG_2021_Human,Salmonella infection,7/249,0.0003245758692608383,0.0011856955224018,0,0,5.860867342591804,47.08029605449065,HSP90AA1;CXCL8;TNFSF10;TNFRSF10B;CD14;HRAS;S100A10,3,3,G2
49,KEGG_2021_Human,Phototransduction,3/28,0.0004070772946660061,0.0014432104246794,0,0,23.609108910891088,184.3046852468813,CALM3;CALM1;CALM2,3,3,G2
50,KEGG_2021_Human,Long-term potentiation,4/67,0.0004111940316125931,0.0014432104246794,0,0,12.592380952380951,98.1758100285217,CALM3;CALM1;HRAS;CALM2,3,3,G2
51,KEGG_2021_Human,Platelet activation,5/124,0.0004760523041558925,0.0016387185085366,0,0,8.393599864188099,64.21089481849609,COL1A1;ITGB1;COL3A1;COL1A2;ITGA2,3,3,G2
52,KEGG_2021_Human,Adherens junction,4/71,0.0005130325471433614,0.0017326948290313,0,0,11.83820895522388,89.67646036684098,CDH1;ERBB2;PTPRF;EGFR,3,3,G2
53,KEGG_2021_Human,Melanoma,4/72,0.0005410570242729545,0.0017608946789974,0,0,11.663529411764706,87.73290353881855,CDH1;EGF;HRAS;EGFR,3,3,G2
54,KEGG_2021_Human,Non-small cell lung cancer,4/72,0.0005410570242729545,0.0017608946789974,0,0,11.663529411764706,87.73290353881855,EGF;ERBB2;HRAS;EGFR,3,3,G2
55,KEGG_2021_Human,FoxO signaling pathway,5/131,0.0006114749153992576,0.001954535890294,0,0,7.924482924482924,58.63829408300237,TGFB1;EGF;TNFSF10;HRAS;EGFR,3,3,G2
56,KEGG_2021_Human,Diabetic cardiomyopathy,6/203,0.0006751299694830348,0.0021201449918853,0,0,6.122138195379675,44.695314790658415,COL1A1;COL3A1;TGFB1;COL1A2;MMP2;CD36,3,3,G2
57,KEGG_2021_Human,Bacterial invasion of epithelial cells,4/77,0.0006977158935578559,0.002153295602532,0,0,10.86191780821918,78.94114449344133,ITGB1;CDH1;FN1;ITGA5,3,3,G2
58,KEGG_2021_Human,Insulin signaling pathway,5/137,0.0007489504329790479,0.0022722394492076,0,0,7.56198347107438,54.4223681415288,CALM3;CALM1;CALM2;HRAS;PTPRF,3,3,G2
59,KEGG_2021_Human,Colorectal cancer,4/86,0.0010564487101375,0.0031517386519102,0,0,9.665365853658535,66.23522766774391,TGFB1;EGF;HRAS;EGFR,3,3,G2
60,KEGG_2021_Human,Oxytocin signaling pathway,5/154,0.0012643414025158,0.0037101165745955,0,0,6.693444512236459,44.66672017610059,CALM3;CALM1;CALM2;HRAS;EGFR,3,3,G2
61,KEGG_2021_Human,Salivary secretion,4/93,0.0014127990872274,0.0040788876873178,0,0,8.902022471910112,58.41669495979623,TRPV6;CALM3;CALM1;CALM2,3,3,G2
62,KEGG_2021_Human,IL-17 signaling pathway,4/94,0.0014697571947334,0.0041759767913853,0,0,8.802666666666667,57.41678473110847,HSP90AA1;CXCL8;MMP1;S100A8,3,3,G2
63,KEGG_2021_Human,Shigellosis,6/246,0.0018114883397367,0.005066506450201,0,0,5.014285714285714,31.65822680059884,ITGB1;CXCL8;CD14;ITGA5;EGFR;CD44,3,3,G2
64,KEGG_2021_Human,Hepatocellular carcinoma,5/168,0.0018552338197124,0.0051090285189003,0,0,6.114209580467249,38.456816340467554,TGFB1;FZD6;LRP5;HRAS;EGFR,3,3,G2
65,KEGG_2021_Human,C-type lectin receptor signaling pathway,4/104,0.0021301476651164,0.0056909915232214,0,0,7.9184,48.71054418215829,CALM3;CALM1;CALM2;HRAS,3,3,G2
66,KEGG_2021_Human,NF-kappa B signaling pathway,4/104,0.0021301476651164,0.0056909915232214,0,0,7.9184,48.71054418215829,CXCL8;PLAU;CD14;ICAM1,3,3,G2
67,KEGG_2021_Human,Tuberculosis,5/180,0.0025045829170109,0.0065550616818999,0,0,5.691486291486291,34.089914443504234,TGFB1;CALM3;CD14;CALM1;CALM2,3,3,G2
68,KEGG_2021_Human,HIF-1 signaling pathway,4/109,0.0025268114863189,0.0065550616818999,0,0,7.539428571428571,45.09179218246063,EGF;ERBB2;EGFR;VEGFA,3,3,G2
69,KEGG_2021_Human,Neurotrophin signaling pathway,4/119,0.003467012000088,0.0088656449716537,0,0,6.880347826086957,38.97346984695752,CALM3;CALM1;CALM2;HRAS,3,3,G2
70,KEGG_2021_Human,Cytokine-cytokine receptor interaction,6/295,0.0044418444210394,0.0111984528361417,0,0,4.153732081067721,22.499460661107385,TGFB1;CXCL8;TNFSF10;TNFRSF10B;INHBA;BMPR1A,3,3,G2
71,KEGG_2021_Human,Oocyte meiosis,4/129,0.0046209527976163,0.0114882020940738,0,0,6.32672,34.01975004452858,AR;CALM3;CALM1;CALM2,3,3,G2
72,KEGG_2021_Human,Natural killer cell mediated cytotoxicity,4/131,0.004879215671917,0.011964104181824,0,0,6.226456692913386,33.14200184138545,TNFSF10;TNFRSF10B;HRAS;ICAM1,3,3,G2
73,KEGG_2021_Human,Amphetamine addiction,3/69,0.0055810009936346,0.0131447260244816,0,0,8.924392439243924,46.30320286714105,CALM3;CALM1;CALM2,3,3,G2
74,KEGG_2021_Human,Renal cell carcinoma,3/69,0.0055810009936346,0.0131447260244816,0,0,8.924392439243924,46.30320286714105,TGFB1;HRAS;VEGFA,3,3,G2
75,KEGG_2021_Human,Renin secretion,3/69,0.0055810009936346,0.0131447260244816,0,0,8.924392439243924,46.30320286714105,CALM3;CALM1;CALM2,3,3,G2
76,KEGG_2021_Human,Yersinia infection,4/137,0.0057118166971181,0.0131624672484481,0,0,5.9437593984962405,30.700813896412757,ITGB1;CXCL8;FN1;ITGA5,3,3,G2
77,KEGG_2021_Human,Central carbon metabolism in cancer,3/70,0.0058091335900972,0.0131624672484481,0,0,8.79074922417615,45.25762382994262,ERBB2;HRAS;EGFR,3,3,G2
78,KEGG_2021_Human,Epithelial cell signaling in Helicobacter pylori infection,3/70,0.0058091335900972,0.0131624672484481,0,0,8.79074922417615,45.25762382994262,CXCL8;ADAM10;EGFR,3,3,G2
79,KEGG_2021_Human,Signaling pathways regulating pluripotency of stem cells,4/143,0.0066343393575295,0.0148443343124724,0,0,5.685467625899281,28.51544119036889,FZD6;INHBA;HRAS;BMPR1A,3,3,G2
80,KEGG_2021_Human,Gastric acid secretion,3/76,0.007295012532188,0.0161210770773043,0,0,8.065780550657806,39.688192467157016,CALM3;CALM1;CALM2,3,3,G2
81,KEGG_2021_Human,Phospholipase D signaling pathway,4/148,0.0074746622654426,0.016316640798954,0,0,5.486666666666666,26.86401673310212,CXCL8;EGF;HRAS;EGFR,3,3,G2
82,KEGG_2021_Human,Hepatitis B,4/162,0.010192682219849,0.0219818086428069,0,0,4.996962025316456,22.91649381709792,TGFB1;CXCL8;HSPG2;HRAS,3,3,G2
83,KEGG_2021_Human,Hippo signaling pathway,4/163,0.010408223441931,0.0221794285250673,0,0,4.9652830188679244,22.667306807288654,TGFB1;CDH1;FZD6;BMPR1A,3,3,G2
84,KEGG_2021_Human,Gap junction,3/88,0.0108890387919965,0.0229310346325573,0,0,6.922888759464182,31.29144757778988,EGF;HRAS;EGFR,3,3,G2
85,KEGG_2021_Human,Wnt signaling pathway,4/166,0.0110725121334137,0.0230462752544309,0,0,4.872592592592593,21.94269567566342,SFRP1;BAMBI;FZD6;LRP5,3,3,G2
86,KEGG_2021_Human,PD-L1 expression and PD-1 checkpoint pathway in cancer,3/89,0.0112270180519873,0.0230992670265027,0,0,6.842044669583237,30.716894829672267,EGF;HRAS;EGFR,3,3,G2
87,KEGG_2021_Human,Pathways of neurodegeneration,7/475,0.0120292264101322,0.0244685400842461,0,0,2.9957705524715834,13.242552250605488,APP;FZD6;LRP5;CALM3;CALM1;CALM2;HRAS,3,3,G2
88,KEGG_2021_Human,Influenza A,4/172,0.0124818597452921,0.0251039651056999,0,0,4.6971428571428575,20.58982664727168,CXCL8;TNFSF10;TNFRSF10B;ICAM1,3,3,G2
89,KEGG_2021_Human,Circadian entrainment,3/97,0.0141488016692794,0.0276907132441538,0,0,6.257215083210449,26.64400614220886,CALM3;CALM1;CALM2,3,3,G2
90,KEGG_2021_Human,Phosphatidylinositol signaling system,3/97,0.0141488016692794,0.0276907132441538,0,0,6.257215083210449,26.64400614220886,CALM3;CALM1;CALM2,3,3,G2
91,KEGG_2021_Human,Aldosterone synthesis and secretion,3/98,0.0145414918712316,0.0276907132441538,0,0,6.191036998436686,26.19272487484042,CALM3;CALM1;CALM2,3,3,G2
92,KEGG_2021_Human,Choline metabolism in cancer,3/98,0.0145414918712316,0.0276907132441538,0,0,6.191036998436686,26.19272487484042,EGF;HRAS;EGFR,3,3,G2
93,KEGG_2021_Human,Inflammatory mediator regulation of TRP channels,3/98,0.0145414918712316,0.0276907132441538,0,0,6.191036998436686,26.19272487484042,CALM3;CALM1;CALM2,3,3,G2
94,KEGG_2021_Human,Viral protein interaction with cytokine and cytokine receptor,3/100,0.0153453232940326,0.0289138196803352,0,0,6.06277431866898,25.323871983150248,CXCL8;TNFSF10;TNFRSF10B,3,3,G2
95,KEGG_2021_Human,Thyroid cancer,2/37,0.0158443585550002,0.0295431268890108,0,0,11.126610644257704,46.11915320840008,CDH1;HRAS,3,3,G2
96,KEGG_2021_Human,Alcoholism,4/186,0.0162032741537074,0.0299008873558106,0,0,4.332747252747253,17.86193230348106,CALM3;CALM1;CALM2;HRAS,3,3,G2
97,KEGG_2021_Human,Toll-like receptor signaling pathway,3/104,0.0170270706512324,0.0311004657813326,0,0,5.821488089403,23.71063463023117,CXCL8;SPP1;CD14,3,3,G2
98,KEGG_2021_Human,Glucagon signaling pathway,3/107,0.0183534671825019,0.0331845517744227,0,0,5.652703731911653,22.5991521282976,CALM3;CALM1;CALM2,3,3,G2
99,KEGG_2021_Human,Pathogenic Escherichia coli infection,4/197,0.019569047030729,0.035028594185005,0,0,4.083523316062176,16.06378931478253,ITGB1;CXCL8;TNFSF10;TNFRSF10B,3,3,G2
100,KEGG_2021_Human,Leukocyte transendothelial migration,3/114,0.0216662801517506,0.0383986549224095,0,0,5.294353759700295,20.28795374412773,ITGB1;MMP2;ICAM1,3,3,G2
101,KEGG_2021_Human,Human immunodeficiency virus 1 infection,4/212,0.0248104342139161,0.0435398796499117,0,0,3.786153846153846,13.995483540681333,CALM3;CALM1;CALM2;HRAS,3,3,G2
102,KEGG_2021_Human,Thyroid hormone signaling pathway,3/121,0.0252848327012242,0.0439416024613508,0,0,4.978519885886894,18.30875859926688,NOTCH2;ITGAV;HRAS,3,3,G2
103,KEGG_2021_Human,Human T-cell leukemia virus 1 infection,4/219,0.0275202061483869,0.0473665086592428,0,0,3.661581395348837,13.155456969024426,NRP1;TGFB1;HRAS;ICAM1,3,3,G2
104,KEGG_2021_Human,Cholesterol metabolism,2/50,0.0279010087799889,0.0475645768725525,0,0,8.107843137254902,29.01872002714532,CD36;APOE,3,3,G2
0,KEGG_2021_Human,Cell adhesion molecules,14/148,3.004125260238593e-16,4.926765426791292e-14,0,0,33.89699045754833,1211.5250492486964,SELPLG;ITGAM;ITGB2;HLA-B;ICAM2;HLA-C;ICAM3;HLA-A;HLA-F;ITGAL;HLA-G;CD4;PTPRC;SDC1,1,1,H1
1,KEGG_2021_Human,Phagosome,13/152,1.4149567599705072e-14,1.1602645431758158e-12,0,0,29.84660013924345,951.780987565377,ITGAM;ITGB5;ITGB2;HLA-B;HLA-C;HLA-A;HLA-F;HLA-G;THBS1;C3;ITGA5;CALR;CD14,1,1,H1
2,KEGG_2021_Human,Human T-cell leukemia virus 1 infection,13/219,1.5839513672483704e-12,8.658934140957757e-11,0,0,20.071014719699345,545.351518455759,TGFB1;SMAD3;ITGB2;HLA-B;HLA-C;HLA-A;HLA-F;ITGAL;CD3D;HLA-G;TNFRSF1A;CD4;CALR,1,1,H1
3,KEGG_2021_Human,Human papillomavirus infection,14/331,1.98529046534155e-11,8.139690907900355e-10,0,0,14.196204168175,349.8323857747871,NOTCH3;ITGB5;ITGA3;LAMB2;ITGB4;HLA-B;HLA-C;HLA-A;HLA-F;HLA-G;THBS1;TNFRSF1A;ITGA5;IFNAR1,1,1,H1
4,KEGG_2021_Human,Human immunodeficiency virus 1 infection,11/212,3.960058042846712e-10,1.2988990380537213e-08,0,0,16.865982587064675,365.1416458633341,CD4;HLA-B;HLA-C;TRAF2;CALR;HLA-A;HLA-F;CD3D;HLA-G;TNFRSF1A;GNAI2,1,1,H1
5,KEGG_2021_Human,Human cytomegalovirus infection,11/225,7.448477421434781e-10,2.0359171618588405e-08,0,0,15.830972546728972,332.73286847562457,CXCL12;CCL5;HLA-B;HLA-C;TRAF2;CALR;HLA-A;HLA-F;HLA-G;TNFRSF1A;GNAI2,1,1,H1
6,KEGG_2021_Human,Cytokine-cytokine receptor interaction,12/295,9.68026596102638e-10,2.2679480251547522e-08,0,0,13.220259128386337,274.39654614713425,CSF1R;CD4;TGFB1;CXCL12;CSF1;CCL5;CXCR3;LTB;CCL19;CCR10;TNFRSF1A;IFNAR1,1,1,H1
7,KEGG_2021_Human,ECM-receptor interaction,8/88,1.3468364281010687e-09,2.7610146776071912e-08,0,0,29.619402985074625,604.9913342958711,ITGB5;ITGA3;LAMB2;ITGB4;SDC1;ITGA5;HSPG2;THBS1,1,1,H1
8,KEGG_2021_Human,Viral myocarditis,7/60,2.579530824097368e-09,4.7004783905774275e-08,0,0,38.59711431742508,763.2833443264692,ITGB2;HLA-B;HLA-C;HLA-A;ITGAL;HLA-F;HLA-G,1,1,H1
9,KEGG_2021_Human,Hematopoietic cell lineage,8/99,3.471466214838033e-09,5.6089356723561604e-08,0,0,26.024602263408237,506.9251284227775,CSF1R;CD4;ITGAM;CSF1;ITGA3;ITGA5;CD14;CD3D,1,1,H1
10,KEGG_2021_Human,Viral protein interaction with cytokine and cytokine receptor,8/100,3.762090999751083e-09,5.6089356723561604e-08,0,0,25.74042829331603,499.320316366176,CSF1R;CXCL12;CSF1;CCL5;CXCR3;CCL19;CCR10;TNFRSF1A,1,1,H1
11,KEGG_2021_Human,Epstein-Barr virus infection,10/202,4.139964098015527e-09,5.657950933954553e-08,0,0,15.811698717948715,305.20655921789603,HLA-B;HLA-C;TRAF2;CALR;HLA-A;HLA-F;ITGAL;CD3D;HLA-G;IFNAR1,1,1,H1
12,KEGG_2021_Human,Proteoglycans in cancer,10/205,4.771030776678173e-09,6.018838825963234e-08,0,0,15.566074950690336,298.2569461608919,TGFB1;ITGB5;GPC1;ERBB2;SDC1;ITGA5;MMP9;HSPG2;THBS1;HBEGF,1,1,H1
13,KEGG_2021_Human,Pathways in cancer,14/531,9.254720128764715e-09,1.0841243579410097e-07,0,0,8.615657798776041,159.37357636053102,CSF1R;NOTCH3;TGFB1;SMAD3;ITGA3;LAMB2;GSTP1;LRP5;TRAF2;MMP9;GNAI2;CXCL12;ERBB2;IFNAR1,1,1,H1
14,KEGG_2021_Human,Antigen processing and presentation,7/78,1.672469311458568e-08,1.828566447194701e-07,0,0,28.78583264291632,515.450045830534,CD4;HLA-B;HLA-C;CALR;HLA-A;HLA-F;HLA-G,1,1,H1
15,KEGG_2021_Human,Natural killer cell mediated cytotoxicity,8/131,3.1881104188039606e-08,3.26781317927406e-07,0,0,19.22290984103871,331.8114976264048,ITGB2;HLA-B;ICAM2;HLA-C;HLA-A;ITGAL;HLA-G;IFNAR1,1,1,H1
16,KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,9/193,4.3662759199057234e-08,4.21217206390905e-07,0,0,14.630187747035572,247.9344310545588,C3;HLA-B;HLA-C;TRAF2;HLA-A;HLA-F;HLA-G;TNFRSF1A;IFNAR1,1,1,H1
17,KEGG_2021_Human,Rheumatoid arthritis,7/93,5.7353047244120324e-08,5.225499860019852e-07,0,0,23.74709302325581,395.959975643662,TGFB1;CXCL12;CSF1;CCL5;ITGB2;LTB;ITGAL,1,1,H1
18,KEGG_2021_Human,Chagas disease,7/102,1.088415979523989e-07,9.394748454838644e-07,0,0,21.487616099071207,344.518947498305,C3;TGFB1;CCL5;CALR;CD3D;TNFRSF1A;GNAI2,1,1,H1
19,KEGG_2021_Human,Allograft rejection,5/38,2.951449164070307e-07,2.4201883145376515e-06,0,0,43.056277056277054,647.3855429709622,HLA-B;HLA-C;HLA-A;HLA-F;HLA-G,1,1,H1
20,KEGG_2021_Human,Herpes simplex virus 1 infection,12/498,3.130818935629059e-07,2.4450205021103124e-06,0,0,7.618655692729766,114.1030905011509,C3;CCL5;HLA-B;HLA-C;TRAF2;ITGA5;CALR;HLA-A;HLA-F;HLA-G;TNFRSF1A;IFNAR1,1,1,H1
21,KEGG_2021_Human,Pertussis,6/76,4.028028589859478e-07,3.0027122215316104e-06,0,0,24.664596273291924,363.1817054323918,C3;ITGAM;ITGB2;ITGA5;CD14;GNAI2,1,1,H1
22,KEGG_2021_Human,Osteoclast differentiation,7/127,4.888671432483599e-07,3.378387667644763e-06,0,0,16.989583333333332,246.87860986940936,CSF1R;TGFB1;CSF1;TRAF2;LILRB2;TNFRSF1A;IFNAR1,1,1,H1
23,KEGG_2021_Human,Graft-versus-host disease,5/42,4.943981952650873e-07,3.378387667644763e-06,0,0,38.3938223938224,557.4754055408829,HLA-B;HLA-C;HLA-A;HLA-F;HLA-G,1,1,H1
24,KEGG_2021_Human,Type I diabetes mellitus,5/43,5.578218978661768e-07,3.65931165000212e-06,0,0,37.38157894736842,538.2658074237573,HLA-B;HLA-C;HLA-A;HLA-F;HLA-G,1,1,H1
25,KEGG_2021_Human,PI3K-Akt signaling pathway,10/354,7.937981541738401e-07,5.007034510942683e-06,0,0,8.757155635062611,123.00683161605605,CSF1R;CSF1;ITGB5;ITGA3;LAMB2;ITGB4;ERBB2;ITGA5;THBS1;IFNAR1,1,1,H1
26,KEGG_2021_Human,Rap1 signaling pathway,8/210,1.1932439787282346e-06,7.046215066291877e-06,0,0,11.658341953598343,159.00620142979145,CSF1R;ITGAM;CSF1;ITGB2;FPR1;ITGAL;THBS1;GNAI2,1,1,H1
27,KEGG_2021_Human,Malaria,5/50,1.2030123283912962e-06,7.046215066291877e-06,0,0,31.55555555555556,430.12373910308,TGFB1;ITGB2;SDC1;ITGAL;THBS1,1,1,H1
28,KEGG_2021_Human,Staphylococcus aureus infection,6/95,1.5138391885897305e-06,8.544902960625538e-06,0,0,19.38055691255496,259.7161613975918,C3;SELPLG;ITGAM;ITGB2;FPR1;ITGAL,1,1,H1
29,KEGG_2021_Human,Regulation of actin cytoskeleton,8/218,1.5791663567995466e-06,8.544902960625538e-06,0,0,11.209665955934613,149.74559466056493,CXCL12;ITGAM;ITGB5;ITGA3;ITGB4;ITGB2;ITGA5;ITGAL,1,1,H1
30,KEGG_2021_Human,Autoimmune thyroid disease,5/53,1.6151950718255592e-06,8.544902960625538e-06,0,0,29.578869047619047,394.4654191644695,HLA-B;HLA-C;HLA-A;HLA-F;HLA-G,1,1,H1
31,KEGG_2021_Human,Cellular senescence,7/156,1.953038087747285e-06,1.0009320199704837e-05,0,0,13.662850375049349,179.61353074480016,TGFB1;SMAD3;HLA-B;HLA-C;HLA-A;HLA-F;HLA-G,1,1,H1
32,KEGG_2021_Human,NF-kappa B signaling pathway,6/104,2.573632073339427e-06,1.2790171515989878e-05,0,0,17.592724046140194,226.42174329031707,CXCL12;TRAF2;LTB;CCL19;CD14;TNFRSF1A,1,1,H1
33,KEGG_2021_Human,Leukocyte transendothelial migration,6/114,4.391639726067362e-06,2.118320338456021e-05,0,0,15.955716586151368,196.8266545014852,CXCL12;ITGAM;ITGB2;ITGAL;MMP9;GNAI2,1,1,H1
34,KEGG_2021_Human,Focal adhesion,7/201,1.0386026182017327e-05,4.86659512528812e-05,0,0,10.469754396604005,120.14094777250176,ITGB5;ITGA3;LAMB2;ITGB4;ERBB2;ITGA5;THBS1,1,1,H1
35,KEGG_2021_Human,Viral carcinogenesis,7/203,1.1076963768946037e-05,5.046172383630972e-05,0,0,10.36186974789916,118.2355959075985,C3;HLA-B;HLA-C;TRAF2;HLA-A;HLA-F;HLA-G,1,1,H1
36,KEGG_2021_Human,Bladder cancer,4/41,1.66252578071322e-05,7.369033190188326e-05,0,0,30.282451465550057,333.24588578747864,ERBB2;THBS1;MMP9;HBEGF,1,1,H1
37,KEGG_2021_Human,Hypertrophic cardiomyopathy,5/90,2.220959197973345e-05,9.585192328095488e-05,0,0,16.672268907563026,178.64313278845043,TGFB1;ITGB5;ITGA3;ITGB4;ITGA5,1,1,H1
38,KEGG_2021_Human,Dilated cardiomyopathy,5/96,3.035417296538876e-05,0.0001276431888800963,0,0,15.56828885400314,161.95031663675692,TGFB1;ITGB5;ITGA3;ITGB4;ITGA5,1,1,H1
39,KEGG_2021_Human,Amoebiasis,5/102,4.064686112311151e-05,0.00016665213060475717,0,0,14.600883652430044,147.62353280108186,TGFB1;ITGAM;LAMB2;ITGB2;CD14,1,1,H1
40,KEGG_2021_Human,Tuberculosis,6/180,5.8844587575979816e-05,0.0002353783503039193,0,0,9.87056471764118,96.14532828701093,C3;TGFB1;ITGAM;ITGB2;CD14;TNFRSF1A,1,1,H1
41,KEGG_2021_Human,Legionellosis,4/57,6.197328638021743e-05,0.0002419909277703728,0,0,21.123571618389583,204.6622113200627,C3;ITGAM;ITGB2;CD14,1,1,H1
42,KEGG_2021_Human,TNF signaling pathway,5/112,6.359136404888637e-05,0.00024253450474458988,0,0,13.229639519359145,127.83844169565312,CSF1;CCL5;TRAF2;MMP9;TNFRSF1A,1,1,H1
43,KEGG_2021_Human,Neutrophil extracellular trap formation,6/189,7.710252121445957e-05,0.000287382124526622,0,0,9.380850558327394,88.8401686415314,C3;SELPLG;ITGAM;ITGB2;FPR1;ITGAL,1,1,H1
44,KEGG_2021_Human,Chemokine signaling pathway,6/192,8.410287089350677e-05,0.00030243590125634856,0,0,9.228143992519868,86.5920109705167,CXCL12;CCL5;CXCR3;CCL19;CCR10;GNAI2,1,1,H1
45,KEGG_2021_Human,Sphingolipid signaling pathway,5/119,8.482958205970753e-05,0.00030243590125634856,0,0,12.412907268170429,116.36934517634656,ADORA1;TRAF2;S1PR4;TNFRSF1A;GNAI2,1,1,H1
46,KEGG_2021_Human,MAPK signaling pathway,7/294,0.0001166705116075288,0.0004071056149709516,0,0,7.043758967001435,63.78938521616504,CSF1R;TGFB1;CSF1;ERBB2;TRAF2;CD14;TNFRSF1A,1,1,H1
47,KEGG_2021_Human,Fluid shear stress and atherosclerosis,5/139,0.00017620972072663065,0.0006020498791493214,0,0,10.549573560767591,91.18878032459295,GPC1;GSTP1;SDC1;MMP9;TNFRSF1A,1,1,H1
48,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,4/77,0.00020063309750197855,0.0006580765598064897,0,0,15.320856646729691,130.44227453610512,ITGB5;ITGA3;ITGB4;ITGA5,1,1,H1
49,KEGG_2021_Human,Leishmaniasis,4/77,0.00020063309750197855,0.0006580765598064897,0,0,15.320856646729691,130.44227453610512,C3;TGFB1;ITGAM;ITGB2,1,1,H1
50,KEGG_2021_Human,Complement and coagulation cascades,4/85,0.0002934773559357445,0.000943731105362002,0,0,13.802121370196488,112.26245362457216,C3;ITGAM;F10;ITGB2,1,1,H1
51,KEGG_2021_Human,Shigellosis,6/246,0.00032289600605171114,0.0010183643267784,0,0,7.132246376811594,57.33028195902112,C3;CCL5;TRAF2;ITGA5;CD14;TNFRSF1A,1,1,H1
52,KEGG_2021_Human,Hepatitis B,5/162,0.0003581536372894171,0.0011082489908578,0,0,8.993630573248408,71.36039805712241,TGFB1;SMAD3;MMP9;HSPG2;IFNAR1,1,1,H1
53,KEGG_2021_Human,Endocytosis,6/252,0.0003671308514056868,0.001114989993158,0,0,6.956168257334747,55.02184563324893,SMAD3;HLA-B;HLA-C;HLA-A;HLA-F;HLA-G,1,1,H1
54,KEGG_2021_Human,Primary immunodeficiency,3/38,0.00038878649563079895,0.0011592906415172,0,0,23.678571428571427,185.93551376748007,CD4;PTPRC;CD3D,1,1,H1
55,KEGG_2021_Human,IL-17 signaling pathway,4/94,0.0004309072892835161,0.0012619427757588,0,0,12.416275430359937,96.2213865651838,TRAF2;MMP9;S100A9;S100A8,1,1,H1
56,KEGG_2021_Human,Th17 cell differentiation,4/107,0.0007029483506405022,0.0020225180614919,0,0,10.842062081225215,78.71583336245774,CD4;TGFB1;SMAD3;CD3D,1,1,H1
57,KEGG_2021_Human,Intestinal immune network for IgA production,3/48,0.0007759707387958862,0.0021941241579745,0,0,18.40740740740741,131.82272910651656,TGFB1;CXCL12;CCR10,1,1,H1
58,KEGG_2021_Human,Toxoplasmosis,4/112,0.0008341576092878675,0.0023186753885289,0,0,10.337506520605112,73.28349542543566,TGFB1;LAMB2;TNFRSF1A;GNAI2,1,1,H1
59,KEGG_2021_Human,Lipid and atherosclerosis,5/215,0.001284506809368,0.0035109852789393,0,0,6.70578231292517,44.64294400661932,CCL5;TRAF2;CD14;MMP9;TNFRSF1A,1,1,H1
60,KEGG_2021_Human,Coronavirus disease,5/232,0.0017953164823551,0.0048267525099383,0,0,6.198237885462556,39.18881744813198,C3;ADAM17;TNFRSF1A;HBEGF;IFNAR1,1,1,H1
61,KEGG_2021_Human,Acute myeloid leukemia,3/67,0.0020424172286528,0.0054025229919203,0,0,12.930338541666666,80.08561964642477,CSF1R;ITGAM;CD14,1,1,H1
62,KEGG_2021_Human,Epithelial cell signaling in Helicobacter pylori infection,3/70,0.0023151488550091,0.0060267367019286,0,0,12.349502487562187,74.94025492672628,ADAM17;CCL5;HBEGF,1,1,H1
63,KEGG_2021_Human,Gastric cancer,4/149,0.0023865944347767,0.0061156482391154,0,0,7.685284118504128,46.40288361747014,TGFB1;SMAD3;ERBB2;LRP5,1,1,H1
64,KEGG_2021_Human,Alzheimer disease,6/369,0.0026152873576968,0.0065985711794198,0,0,4.686070188046473,27.865160133322,ADAM17;CSF1;LRP5;TRAF2;APOE;TNFRSF1A,1,1,H1
65,KEGG_2021_Human,Pancreatic cancer,3/76,0.0029258709805115,0.0072703460727861,0,0,11.331050228310502,66.10719480341469,TGFB1;SMAD3;ERBB2,1,1,H1
66,KEGG_2021_Human,Hepatocellular carcinoma,4/168,0.0036737747637132,0.0089925233022234,0,0,6.788388869804191,38.059343862049374,TGFB1;SMAD3;GSTP1;LRP5,1,1,H1
67,KEGG_2021_Human,Axon guidance,4/182,0.0048789596553384,0.011732730026593,0,0,6.250039563222029,33.26785600819984,CXCL12;EFNB3;GNAI2;EPHB3,1,1,H1
68,KEGG_2021_Human,Small cell lung cancer,3/92,0.0050078725723263,0.011732730026593,0,0,9.286516853932584,49.18830326582743,ITGA3;LAMB2;TRAF2,1,1,H1
69,KEGG_2021_Human,Th1 and Th2 cell differentiation,3/92,0.0050078725723263,0.011732730026593,0,0,9.286516853932584,49.18830326582743,NOTCH3;CD4;CD3D,1,1,H1
70,KEGG_2021_Human,TGF-beta signaling pathway,3/94,0.0053169489639688,0.0122814032407168,0,0,9.081501831501832,47.558514114647465,TGFB1;SMAD3;THBS1,1,1,H1
71,KEGG_2021_Human,Prostate cancer,3/97,0.0058016999321496,0.0132149831787854,0,0,8.790336879432624,45.2667567037336,GSTP1;ERBB2;MMP9,1,1,H1
72,KEGG_2021_Human,Transcriptional misregulation in cancer,4/192,0.0058862963565823,0.0132240082531437,0,0,5.914593946658676,30.3721986463312,CSF1R;ITGAM;CD14;MMP9,1,1,H1
73,KEGG_2021_Human,MicroRNAs in cancer,5/310,0.0061747149332926,0.0136845033656756,0,0,4.594847775175644,23.37533491101268,NOTCH3;ERBB2;ITGA5;MMP9;THBS1,1,1,H1
74,KEGG_2021_Human,T cell receptor signaling pathway,3/104,0.007033265290975,0.0151770461542092,0,0,8.178217821782178,40.5402779250076,CD4;PTPRC;CD3D,1,1,H1
75,KEGG_2021_Human,Toll-like receptor signaling pathway,3/104,0.007033265290975,0.0151770461542092,0,0,8.178217821782178,40.5402779250076,CCL5;CD14;IFNAR1,1,1,H1
76,KEGG_2021_Human,"Parathyroid hormone synthesis, secretion and action",3/106,0.0074114198532965,0.0157853617654627,0,0,8.018608414239482,39.32913526714848,LRP5;HBEGF;GNAI2,1,1,H1
77,KEGG_2021_Human,Neuroactive ligand-receptor interaction,5/341,0.0091239851556736,0.0191837636606472,0,0,4.164328231292517,19.55921922939612,C3;FPR1;ADORA1;S1PR4;ADRA2A,1,1,H1
78,KEGG_2021_Human,Relaxin signaling pathway,3/129,0.0126306409538093,0.0262205710939838,0,0,6.54728835978836,28.62231956318534,TGFB1;MMP9;GNAI2,1,1,H1
79,KEGG_2021_Human,FoxO signaling pathway,3/131,0.0131620091125108,0.0269821186806473,0,0,6.4443359375,27.906685719681,TGFB1;SMAD3;S1PR4,1,1,H1
80,KEGG_2021_Human,Salmonella infection,4/249,0.014305227481161,0.0289579378263678,0,0,4.525438344351826,19.220126088586028,PTPRC;TRAF2;CD14;TNFRSF1A,1,1,H1
81,KEGG_2021_Human,Apelin signaling pathway,3/137,0.0148321144964323,0.0289579378263678,0,0,6.1539179104477615,25.913905552735145,NOTCH3;SMAD3;GNAI2,1,1,H1
82,KEGG_2021_Human,Yersinia infection,3/137,0.0148321144964323,0.0289579378263678,0,0,6.1539179104477615,25.913905552735145,CD4;TRAF2;ITGA5,1,1,H1
83,KEGG_2021_Human,Estrogen signaling pathway,3/137,0.0148321144964323,0.0289579378263678,0,0,6.1539179104477615,25.913905552735145,MMP9;HBEGF;GNAI2,1,1,H1
84,KEGG_2021_Human,Measles,3/139,0.0154142751928821,0.0297404839015607,0,0,6.062806372549019,25.296824585072663,RACK1;CD3D;IFNAR1,1,1,H1
85,KEGG_2021_Human,Breast cancer,3/147,0.0178710342292703,0.0340796466697714,0,0,5.723668981481482,23.03532980428714,NOTCH3;ERBB2;LRP5,1,1,H1
86,KEGG_2021_Human,Regulation of lipolysis in adipocytes,2/55,0.0181254731275181,0.0341675585392296,0,0,10.272421814422332,41.19690026730335,ADORA1;GNAI2,1,1,H1
87,KEGG_2021_Human,Non-alcoholic fatty liver disease,3/155,0.0205338454363156,0.03811511609834,0,0,5.420230263157895,21.06128443391249,TGFB1;TRAF2;TNFRSF1A,1,1,H1
88,KEGG_2021_Human,Notch signaling pathway,2/59,0.0206844227606845,0.03811511609834,0,0,9.549627493391013,37.03703066274529,NOTCH3;ADAM17,1,1,H1
89,KEGG_2021_Human,Hepatitis C,3/157,0.0212318592319878,0.0386891657116222,0,0,5.349296536796537,20.60684059019312,TRAF2;TNFRSF1A;IFNAR1,1,1,H1
90,KEGG_2021_Human,Necroptosis,3/159,0.0219428150706931,0.0395452930944359,0,0,5.280181623931624,20.166679649395952,TRAF2;TNFRSF1A;IFNAR1,1,1,H1
91,KEGG_2021_Human,Hippo signaling pathway,3/163,0.0234035681156436,0.0417194040322343,0,0,5.147135416666667,19.326807812232037,TGFB1;SMAD3;ITGB2,1,1,H1
92,KEGG_2021_Human,Inflammatory bowel disease,2/65,0.0247862768799973,0.0434706616771674,0,0,8.637529897803871,31.936965611469574,SMAD3;TGFB1,1,1,H1
93,KEGG_2021_Human,cGMP-PKG signaling pathway,3/167,0.0249161109613032,0.0434706616771674,0,0,5.020579268292683,18.537186902028665,ADORA1;ADRA2A;GNAI2,1,1,H1
94,KEGG_2021_Human,Influenza A,3/172,0.0268795679829566,0.0464026226232093,0,0,4.870808678500986,17.61473812487988,CCL5;TNFRSF1A;IFNAR1,1,1,H1
95,KEGG_2021_Human,Adipocytokine signaling pathway,2/69,0.0276896999332482,0.0468155751448733,0,0,8.120220813739522,29.124753592945943,TRAF2;TNFRSF1A,1,1,H1
96,KEGG_2021_Human,Renin secretion,2/69,0.0276896999332482,0.0468155751448733,0,0,8.120220813739522,29.124753592945943,ADORA1;GNAI2,1,1,H1
97,KEGG_2021_Human,Central carbon metabolism in cancer,2/70,0.0284360118658025,0.0475867953672614,0,0,8.000402900886382,28.4822256760798,ERBB2;SLC1A5,1,1,H1
98,KEGG_2021_Human,Adherens junction,2/71,0.0291903667341638,0.0483557590343724,0,0,7.884057971014493,27.86160279121386,SMAD3;ERBB2,1,1,H1
0,KEGG_2021_Human,Pathways in cancer,46/531,3.179403982692186e-37,6.485984124692058e-35,0,0,18.941694122648528,1591.840174094424,NOTCH2;CSF1R;NOTCH3;LAMA5;NOTCH1;NOTCH4;GSTP1;LAMA4;LRP5;PDGFB;PDGFA;CXCR4;LAMC2;LAMC1;FGF1;FGF2;EGFR;LRP6;HSP90B1;GNAI2;CDH1;ERBB2;ITGAV;HRAS;PDGFRB;JAG2;PDGFRA;HSP90AA1;TGFB1;JAG1;LAMB3;EGF;LAMB2;MMP2;WNT7B;LAMB1;MMP9;VEGFA;CXCL12;GNAS;CALM3;ITGA6;IL6ST;CALM1;CALM2;FGFR1,2,2,H1
1,KEGG_2021_Human,PI3K-Akt signaling pathway,37/354,1.0252439022710808e-32,1.0457487803165022e-30,0,0,21.51598119159574,1584.819676712414,CSF1R;LAMA5;CSF1;ITGB5;ITGB4;LAMA4;PDGFB;PDGFA;LAMC2;LAMC1;FGF1;FGF2;THBS1;EGFR;HSP90B1;ERBB2;ITGB8;ITGAV;ITGB7;HRAS;PDGFRB;PDGFRA;NGFR;HSP90AA1;LAMB3;VWF;EGF;LAMB2;INSR;LAMB1;VEGFA;COL1A1;EFNA1;COL1A2;ITGA6;FGFR1;TLR2,2,2,H1
2,KEGG_2021_Human,Human papillomavirus infection,32/331,3.565755554607078e-27,2.424713777132813e-25,0,0,18.857332248636595,1148.3817684473213,NOTCH2;NOTCH3;LAMA5;NOTCH1;ITGB5;ITGB4;NOTCH4;LAMA4;LAMC2;LAMC1;THBS1;EGFR;ITGB8;ITGAV;ITGB7;HRAS;PDGFRB;JAG1;LAMB3;VWF;EGF;LAMB2;WNT7B;HLA-B;HLA-C;LAMB1;VEGFA;COL1A1;COL1A2;PKM;GNAS;ITGA6,2,2,H1
3,KEGG_2021_Human,Focal adhesion,26/201,1.900513683948949e-25,9.69261978813964e-24,0,0,24.993015873015874,1422.665023891146,LAMA5;ITGB5;ITGB4;LAMA4;PDGFB;PDGFA;LAMC2;LAMC1;THBS1;EGFR;ERBB2;ITGB8;ITGAV;ITGB7;HRAS;PDGFRB;PDGFRA;LAMB3;VWF;EGF;LAMB2;LAMB1;VEGFA;COL1A1;COL1A2;ITGA6,2,2,H1
4,KEGG_2021_Human,Rap1 signaling pathway,26/210,6.0824059375186e-25,2.136657956851551e-23,0,0,23.75966183574879,1324.8203775940017,CSF1R;CSF1;ITGB2;PDGFB;FPR1;PDGFA;FGF1;FGF2;THBS1;EGFR;GNAI2;CDH1;CNR1;HRAS;PDGFRB;PDGFRA;NGFR;EGF;INSR;VEGFA;EFNA1;GNAS;CALM3;CALM1;CALM2;FGFR1,2,2,H1
5,KEGG_2021_Human,ECM-receptor interaction,20/88,6.284288108386915e-25,2.136657956851551e-23,0,0,47.3194643711143,2636.951668765524,LAMA5;ITGB5;VWF;SDC4;LAMB3;ITGB4;LAMB2;LAMA4;LAMC2;LAMB1;LAMC1;THBS1;COL1A1;COL1A2;ITGB8;SDC1;ITGAV;ITGB7;ITGA6;CD44,2,2,H1
6,KEGG_2021_Human,Proteoglycans in cancer,22/205,7.88477126097169e-20,2.297847624626036e-18,0,0,19.546944858420268,859.8069412874715,TGFB1;SDC4;ITGB5;SDC2;MMP2;WNT7B;FGF2;MMP9;THBS1;EGFR;DCN;VEGFA;COL1A1;COL1A2;ERBB2;SDC1;TIMP3;ITGAV;HRAS;CD44;FGFR1;TLR2,2,2,H1
7,KEGG_2021_Human,Fluid shear stress and atherosclerosis,17/139,1.645652561779187e-16,4.196414032536927e-15,0,0,21.825071558678115,793.1934751293555,HSP90AA1;SDC4;SDC2;MMP2;GSTP1;PDGFB;PDGFA;MMP9;ICAM1;HSP90B1;VEGFA;PECAM1;SDC1;CALM3;ITGAV;CALM1;CALM2,2,2,H1
8,KEGG_2021_Human,Regulation of actin cytoskeleton,19/218,1.4933627190076137e-15,3.384955496417258e-14,0,0,15.136245744853298,516.7173120174358,PDGFRB;PDGFRA;ITGB5;EGF;ITGB4;ITGB2;PDGFB;PDGFA;CXCR4;FGF1;FGF2;EGFR;CXCL12;ITGB8;ITGA6;ITGAV;ITGB7;HRAS;FGFR1,2,2,H1
9,KEGG_2021_Human,Ras signaling pathway,19/232,4.713571257837111e-15,9.615685365987707e-14,0,0,14.13130395274875,466.16812583012177,PDGFRB;PDGFRA;NGFR;CSF1R;CSF1;EGF;INSR;PDGFB;PDGFA;FGF1;FGF2;EGFR;VEGFA;EFNA1;CALM3;CALM1;CALM2;HRAS;FGFR1,2,2,H1
10,KEGG_2021_Human,Breast cancer,16/147,8.705553655613345e-15,1.6144844961319297e-13,0,0,18.970727895654264,614.173810242761,JAG2;NOTCH2;NOTCH3;JAG1;NOTCH1;EGF;NOTCH4;WNT7B;LRP5;FGF1;FGF2;EGFR;LRP6;ERBB2;HRAS;FGFR1,2,2,H1
11,KEGG_2021_Human,Cell adhesion molecules,16/148,9.702228426637766e-15,1.6493788325284202e-13,0,0,18.82605583392985,607.449439562234,SDC4;SDC2;ITGB2;HLA-B;HLA-C;PTPRF;ICAM1;CD4;CDH1;PECAM1;SDC1;ITGB8;ITGA6;ITGAV;ITGB7;JAM3,2,2,H1
12,KEGG_2021_Human,Prostate cancer,13/97,2.0451676913552985e-13,3.209340069511391e-12,0,0,23.539285714285715,687.7738258865671,PDGFRB;PDGFRA;HSP90AA1;EGF;GSTP1;PDGFB;PDGFA;MMP9;EGFR;HSP90B1;ERBB2;HRAS;FGFR1,2,2,H1
13,KEGG_2021_Human,Amoebiasis,13/102,3.981432411000805e-13,5.801515798886887e-12,0,0,22.21123595505618,634.1744216474044,LAMA5;TGFB1;LAMB3;LAMB2;LAMA4;ITGB2;LAMC2;LAMB1;LAMC1;COL1A1;COL1A2;GNAS;TLR2,2,2,H1
14,KEGG_2021_Human,Melanoma,11/72,3.5204979378931832e-12,4.777104658018184e-11,0,0,27.04371584699453,713.2081968904913,PDGFRB;PDGFRA;CDH1;EGF;PDGFB;PDGFA;FGF1;FGF2;HRAS;EGFR;FGFR1,2,2,H1
15,KEGG_2021_Human,MAPK signaling pathway,18/294,3.746748751386811e-12,4.777104658018184e-11,0,0,10.21617391304348,268.7888908443773,PDGFRB;PDGFRA;NGFR;CSF1R;TGFB1;CSF1;EGF;INSR;PDGFB;PDGFA;FGF1;FGF2;EGFR;VEGFA;EFNA1;ERBB2;HRAS;FGFR1,2,2,H1
16,KEGG_2021_Human,Human cytomegalovirus infection,16/225,6.670871419262483e-12,8.00504570311498e-11,0,0,11.843725275967298,304.77778763950323,PDGFRA;HLA-B;HLA-C;CXCR4;EGFR;VEGFA;GNAI2;CXCL12;CXCR2;GNAS;CALM3;ITGAV;CALR;CALM1;CALM2;HRAS,2,2,H1
17,KEGG_2021_Human,MicroRNAs in cancer,18/310,9.086754674563778e-12,1.0298321964505615e-10,0,0,9.648493150684931,245.3052513340029,PDGFRB;NOTCH2;PDGFRA;NOTCH3;NOTCH1;NOTCH4;PDGFB;PDGFA;MMP9;THBS1;EGFR;VEGFA;EFNA1;ERBB2;TIMP3;VIM;HRAS;CD44,2,2,H1
18,KEGG_2021_Human,Bladder cancer,9/41,1.0920941604873375e-11,1.1725642565232468e-10,0,0,41.6103078358209,1050.2582724155789,CDH1;EGF;MMP2;ERBB2;THBS1;HRAS;MMP9;EGFR;VEGFA,2,2,H1
19,KEGG_2021_Human,Calcium signaling pathway,16/240,1.7722129369955378e-11,1.8076571957354486e-10,0,0,11.042182227221597,273.3625490632872,PDGFRB;PDGFRA;EGF;PDGFB;PDGFA;CXCR4;FGF1;FGF2;EGFR;VEGFA;ERBB2;GNAS;CALM3;CALM1;CALM2;FGFR1,2,2,H1
20,KEGG_2021_Human,Viral protein interaction with cytokine and cytokine receptor,11/100,1.391924086604841e-10,1.314103538450386e-09,0,0,18.50936329588015,420.07303377719785,CSF1R;CXCL12;CSF1;IL34;CXCR2;CXCR4;CCL19;IL6ST;CCL28;CCR10;CCR2,2,2,H1
21,KEGG_2021_Human,Glioma,10/75,1.417170482642573e-10,1.314103538450386e-09,0,0,22.89415847310584,519.1751510001681,PDGFRB;PDGFRA;EGF;PDGFB;PDGFA;CALM3;CALM1;HRAS;CALM2;EGFR,2,2,H1
22,KEGG_2021_Human,Toxoplasmosis,11/112,4.795150123512869e-10,4.2530896747679355e-09,0,0,16.300330033003302,349.7764903234768,LAMA5;TGFB1;LAMB3;LAMB2;LAMA4;LAMC2;ITGA6;LAMB1;LAMC1;TLR2;GNAI2,2,2,H1
23,KEGG_2021_Human,Axon guidance,13/182,6.522650929362442e-10,5.544253289958076e-09,0,0,11.649704142011837,246.3978835450859,EPHB6;CXCR4;SEMA3F;GNAI2;EFNB2;EFNA1;EFNB1;CXCL12;EFNB3;PLXNA1;HRAS;EPHB4;EPHB3,2,2,H1
24,KEGG_2021_Human,Malaria,8/50,2.3363702787212932e-09,1.9064781474365753e-08,0,0,27.95767195767196,555.6494279371611,TGFB1;SDC2;ITGB2;PECAM1;SDC1;THBS1;ICAM1;TLR2,2,2,H1
25,KEGG_2021_Human,Cytokine-cytokine receptor interaction,15/295,3.3543610425526e-09,2.6318832795412703e-08,0,0,8.193498883928571,159.87978087121093,NGFR;CSF1R;TGFB1;CTF1;CSF1;IL34;CXCR4;CD4;CXCL12;CXCR2;CCL19;IL6ST;CCL28;CCR10;CCR2,2,2,H1
26,KEGG_2021_Human,Estrogen signaling pathway,11/137,4.156201072883521e-09,3.140240810623105e-08,0,0,13.049603174603174,251.83991200493352,HSP90AA1;MMP2;GNAS;CALM3;CALM1;CALM2;HRAS;MMP9;EGFR;HSP90B1;GNAI2,2,2,H1
27,KEGG_2021_Human,Gastric cancer,11/149,1.006816859314414e-08,7.335379975005017e-08,0,0,11.907608695652174,219.26536113304692,TGFB1;EGF;CDH1;WNT7B;ERBB2;LRP5;FGF1;FGF2;HRAS;EGFR;LRP6,2,2,H1
28,KEGG_2021_Human,Gap junction,9/88,1.3407301228057284e-08,9.431342932840297e-08,0,0,16.81484980162479,304.810624978416,PDGFRB;PDGFRA;EGF;PDGFB;GNAS;PDGFA;HRAS;EGFR;GNAI2,2,2,H1
29,KEGG_2021_Human,Small cell lung cancer,9/92,1.9899547122005293e-08,1.3531692042963596e-07,0,0,16.00125876640892,283.7434229726384,LAMA5;LAMB3;LAMB2;LAMA4;LAMC2;ITGAV;ITGA6;LAMB1;LAMC1,2,2,H1
30,KEGG_2021_Human,Relaxin signaling pathway,10/129,3.0306730798635954e-08,1.994378413845721e-07,0,0,12.47109370063815,215.8982772830404,COL1A1;TGFB1;COL1A2;MMP2;GNAS;HRAS;MMP9;EGFR;GNAI2;VEGFA,2,2,H1
31,KEGG_2021_Human,Renin secretion,8/69,3.2461749573461627e-08,2.069436535308179e-07,0,0,19.23108682452945,331.6055412750528,ADCYAP1;ADORA1;GNAS;CALM3;CALM1;CALM2;AQP1;GNAI2,2,2,H1
32,KEGG_2021_Human,Alzheimer disease,15/369,6.61970326299953e-08,4.092180198945164e-07,0,0,6.456236758474576,106.72566233365391,APP;CSF1;INSR;WNT7B;LRP5;ADAM10;AGER;RTN4;LRP6;NCSTN;CALM3;APOE;CALM1;CALM2;HRAS,2,2,H1
33,KEGG_2021_Human,Phospholipase D signaling pathway,10/148,1.1185411343070865e-07,6.711246805842517e-07,0,0,10.743707093821511,171.9645318146097,PDGFRB;PDGFRA;EGF;INSR;CXCR2;GNAS;PDGFB;PDGFA;HRAS;EGFR,2,2,H1
34,KEGG_2021_Human,Leukocyte transendothelial migration,9/114,1.299996071035453e-07,7.577119956892354e-07,0,0,12.63454157782516,200.32993563463108,CXCL12;MMP2;ITGB2;PECAM1;CXCR4;MMP9;ICAM1;GNAI2;JAM3,2,2,H1
35,KEGG_2021_Human,Phagosome,10/152,1.4373910713342368e-07,7.990913815431952e-07,0,0,10.438949486392035,164.4684252568747,MRC2;ITGB5;CANX;ITGB2;HLA-B;HLA-C;ITGAV;CALR;THBS1;TLR2,2,2,H1
36,KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,11/193,1.4493324077008936e-07,7.990913815431952e-07,0,0,9.008699633699631,141.85992654882594,HLA-B;PDGFB;HLA-C;CALM3;IL6ST;CALM1;CALM2;FGF2;HRAS;ICAM1;VEGFA,2,2,H1
37,KEGG_2021_Human,Chemical carcinogenesis,12/239,1.5374448848055858e-07,8.253651486851039e-07,0,0,7.921444664895585,124.2714161882114,NOTCH2;HSP90AA1;JAG1;EGF;GSTP1;GNAS;FGF2;HRAS;EGFR;HSP90B1;VEGFA;GNAI2,2,2,H1
38,KEGG_2021_Human,Notch signaling pathway,7/59,2.061048951530401e-07,1.0780871438774403e-06,0,0,19.603365384615383,301.79146941478695,NOTCH2;JAG2;NOTCH3;NCSTN;NOTCH1;JAG1;NOTCH4,2,2,H1
39,KEGG_2021_Human,Human immunodeficiency virus 1 infection,11/212,3.725067368616301e-07,1.8997843579943137e-06,0,0,8.149253731343284,120.63349029418876,CD4;HLA-B;HLA-C;CXCR4;CALM3;CALR;CALM1;CALM2;HRAS;TLR2;GNAI2,2,2,H1
40,KEGG_2021_Human,Dilated cardiomyopathy,8/96,4.377591054486405e-07,2.1781184758907963e-06,0,0,13.312457912457912,194.91564470468796,TGFB1;ITGB5;ITGB4;GNAS;ITGB8;ITGAV;ITGB7;ITGA6,2,2,H1
41,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,8/100,5.997662897784454e-07,2.9131505503524486e-06,0,0,12.731078904991948,182.3946762872212,COL1A1;TGFB1;COL1A2;MMP2;AGER;HRAS;ICAM1;VEGFA,2,2,H1
42,KEGG_2021_Human,Central carbon metabolism in cancer,7/70,6.783548309097669e-07,3.2182415233858717e-06,0,0,16.17156862745098,229.69441674044728,PDGFRB;PDGFRA;PKM;ERBB2;HRAS;EGFR;FGFR1,2,2,H1
43,KEGG_2021_Human,Intestinal immune network for IgA production,6/48,1.1524033697667728e-06,5.342961078009583e-06,0,0,20.6621480709072,282.52720638575533,TGFB1;CXCL12;CXCR4;ITGB7;CCL28;CCR10,2,2,H1
44,KEGG_2021_Human,JAK-STAT signaling pathway,9/162,2.5356318670102525e-06,1.1494864463779813e-05,0,0,8.649692712906058,111.45187614481635,PDGFRB;PDGFRA;CTF1;EGF;PDGFB;PDGFA;IL6ST;HRAS;EGFR,2,2,H1
45,KEGG_2021_Human,Lipid and atherosclerosis,10/215,3.4427128524119148e-06,1.5267683084609362e-05,0,0,7.20777553640198,90.6684160202512,HSP90AA1;CALM3;CALM1;CALM2;AGER;MMP9;HRAS;HSP90B1;ICAM1;TLR2,2,2,H1
46,KEGG_2021_Human,Hypertrophic cardiomyopathy,7/90,3.7539007012854074e-06,1.62935264481324e-05,0,0,12.262402551382,153.19070116758,TGFB1;ITGB5;ITGB4;ITGB8;ITGAV;ITGB7;ITGA6,2,2,H1
47,KEGG_2021_Human,Human T-cell leukemia virus 1 infection,10/219,4.056510634733947e-06,1.7240170197619274e-05,0,0,7.068388675036874,87.75537004109185,CD4;TGFB1;MMP7;CANX;ITGB2;HLA-B;HLA-C;CALR;HRAS;ICAM1,2,2,H1
48,KEGG_2021_Human,GnRH signaling pathway,7/93,4.675820231028597e-06,1.9077346542596675e-05,0,0,11.832848837209305,145.22580758922186,MMP2;GNAS;CALM3;CALM1;HRAS;CALM2;EGFR,2,2,H1
49,KEGG_2021_Human,Rheumatoid arthritis,7/93,4.675820231028597e-06,1.9077346542596675e-05,0,0,11.832848837209305,145.22580758922186,TGFB1;CXCL12;CSF1;ITGB2;ICAM1;TLR2;VEGFA,2,2,H1
50,KEGG_2021_Human,Apelin signaling pathway,8/137,6.4525440310521245e-06,2.5810176124208495e-05,0,0,9.0625322997416,108.30665050399034,NOTCH3;JAG1;CDH1;CALM3;CALM1;CALM2;HRAS;GNAI2,2,2,H1
51,KEGG_2021_Human,Choline metabolism in cancer,7/98,6.628339254003629e-06,2.600348476570654e-05,0,0,11.179864253393664,133.31044848780607,PDGFRB;PDGFRA;EGF;PDGFB;PDGFA;HRAS;EGFR,2,2,H1
52,KEGG_2021_Human,Melanogenesis,7/101,8.095168148837002e-06,3.115876042193865e-05,0,0,10.821417396745932,126.8729293185567,WNT7B;GNAS;CALM3;CALM1;CALM2;HRAS;GNAI2,2,2,H1
53,KEGG_2021_Human,Chemokine signaling pathway,9/192,1.012057036972232e-05,3.823326584117321e-05,0,0,7.220699779789577,83.04483878879886,CXCL12;CXCR2;CXCR4;CCL19;CCL28;HRAS;CCR10;CCR2;GNAI2,2,2,H1
54,KEGG_2021_Human,Adherens junction,6/71,1.1752808763383017e-05,4.359223614054791e-05,0,0,13.33542953396968,151.3760388802463,CDH1;INSR;ERBB2;PTPRF;EGFR;FGFR1,2,2,H1
55,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,6/77,1.878460927081968e-05,6.842964805798597e-05,0,0,12.20479078852678,132.8183023117081,ITGB5;ITGB4;ITGB8;ITGAV;ITGB7;ITGA6,2,2,H1
56,KEGG_2021_Human,Antigen processing and presentation,6/78,2.0231211442530548e-05,7.240644095221459e-05,0,0,12.034671532846716,130.07414807592409,HSP90AA1;CD4;CANX;HLA-B;HLA-C;CALR,2,2,H1
57,KEGG_2021_Human,ErbB signaling pathway,6/85,3.30660259512996e-05,0.00011630119472526064,0,0,10.964427607872125,113.12004577971528,NRG4;EGF;ERBB2;NRG1;HRAS;EGFR,2,2,H1
58,KEGG_2021_Human,Th1 and Th2 cell differentiation,6/92,5.174895230968327e-05,0.00017892858086737944,0,0,10.068409438125954,99.36620373413474,NOTCH2;JAG2;NOTCH3;CD4;NOTCH1;JAG1,2,2,H1
59,KEGG_2021_Human,Endometrial cancer,5/58,5.885314579912357e-05,0.0002001006957170201,0,0,13.538419469510528,131.87050466911046,CDH1;EGF;ERBB2;HRAS;EGFR,2,2,H1
60,KEGG_2021_Human,Circadian entrainment,6/97,6.964836441475616e-05,0.0002329223990263977,0,0,9.512793775567498,91.05695041543294,ADCYAP1;GNAS;CALM3;CALM1;CALM2;GNAI2,2,2,H1
61,KEGG_2021_Human,"Parathyroid hormone synthesis, secretion and action",6/106,0.00011407806512860553,0.00037535363364896016,0,0,8.652700729927007,78.55464733328351,GNAS;LRP5;EGFR;FGFR1;GNAI2;LRP6,2,2,H1
62,KEGG_2021_Human,Oxytocin signaling pathway,7/154,0.00012201352222691456,0.0003950914053061996,0,0,6.901260504201681,62.18987178267904,GNAS;CALM3;CALM1;CALM2;HRAS;EGFR;GNAI2,2,2,H1
63,KEGG_2021_Human,Cellular senescence,7/156,0.00013221386837107687,0.00042143170543280754,0,0,6.807935254638768,60.80228064595009,TGFB1;HLA-B;HLA-C;CALM3;CALM1;CALM2;HRAS,2,2,H1
64,KEGG_2021_Human,Hepatocellular carcinoma,7/168,0.00020894914447237804,0.0006422140854851266,0,0,6.296675191815857,53.35437138495383,TGFB1;WNT7B;GSTP1;LRP5;HRAS;EGFR;LRP6,2,2,H1
65,KEGG_2021_Human,Gastric acid secretion,5/76,0.00021407136182837556,0.0006422140854851266,0,0,10.096958562972036,85.3112337204473,GNAS;CALM3;CALM1;CALM2;GNAI2,2,2,H1
66,KEGG_2021_Human,Pancreatic cancer,5/76,0.00021407136182837556,0.0006422140854851266,0,0,10.096958562972036,85.3112337204473,TGFB1;EGF;ERBB2;EGFR;VEGFA,2,2,H1
67,KEGG_2021_Human,Pertussis,5/76,0.00021407136182837556,0.0006422140854851266,0,0,10.096958562972036,85.3112337204473,ITGB2;CALM3;CALM1;CALM2;GNAI2,2,2,H1
68,KEGG_2021_Human,Thyroid hormone signaling pathway,6/121,0.00023547614855974172,0.0006961903522635843,0,0,7.518375119009838,62.807760896063975,NOTCH2;NOTCH3;NOTCH1;NOTCH4;ITGAV;HRAS,2,2,H1
69,KEGG_2021_Human,Tuberculosis,7/180,0.0003182007341703637,0.0009273278538679172,0,0,5.856341380482829,47.16011063576036,MRC2;TGFB1;ITGB2;CALM3;CALM1;CALM2;TLR2,2,2,H1
70,KEGG_2021_Human,PD-L1 expression and PD-1 checkpoint pathway in cancer,5/89,0.0004465530718267494,0.0012830538965162,0,0,8.528726708074535,65.79019103002082,CD4;EGF;HRAS;EGFR;TLR2,2,2,H1
71,KEGG_2021_Human,Insulin signaling pathway,6/137,0.0004587248752235203,0.0012997204797999,0,0,6.594751211901711,50.694247776142,INSR;CALM3;CALM1;CALM2;HRAS;PTPRF,2,2,H1
72,KEGG_2021_Human,Epstein-Barr virus infection,7/202,0.0006346231245118653,0.0017734673616495,0,0,5.189819004524887,38.20993468002114,HLA-B;HLA-C;VIM;CALR;CD44;ICAM1;TLR2,2,2,H1
73,KEGG_2021_Human,Regulation of lipolysis in adipocytes,4/55,0.0006440008733879005,0.0017753537590693,0,0,11.17562420651714,82.11636861678052,INSR;ADORA1;GNAS;GNAI2,2,2,H1
74,KEGG_2021_Human,Diabetic cardiomyopathy,7/203,0.0006534241255455424,0.0017773136214838,0,0,5.163077731092437,37.86231602037476,COL1A1;TGFB1;COL1A2;INSR;MMP2;AGER;MMP9,2,2,H1
75,KEGG_2021_Human,Hematopoietic cell lineage,5/99,0.0007268380923843868,0.0019509864585054,0,0,7.617560900400863,55.05064100370834,CSF1R;CD4;CSF1;ITGA6;CD44,2,2,H1
76,KEGG_2021_Human,Chagas disease,5/102,0.0008320960714578564,0.0022045142672389,0,0,7.380845659644405,52.34172942975762,TGFB1;GNAS;CALR;TLR2;GNAI2,2,2,H1
77,KEGG_2021_Human,Viral myocarditis,4/60,0.0008957298804043701,0.0023426781487498,0,0,10.175231243576569,71.40846701084777,ITGB2;HLA-B;HLA-C;ICAM1,2,2,H1
78,KEGG_2021_Human,cAMP signaling pathway,7/216,0.0009405665460106468,0.0024288047517236,0,0,4.83872783563186,33.72123052445273,ADCYAP1;ADORA1;GNAS;CALM3;CALM1;CALM2;GNAI2,2,2,H1
79,KEGG_2021_Human,Phototransduction,3/28,0.0010285118163485,0.0025997241565555,0,0,16.998857142857144,116.94605767197572,CALM3;CALM1;CALM2,2,2,H1
80,KEGG_2021_Human,Glucagon signaling pathway,5/107,0.0010322434151029,0.0025997241565555,0,0,7.017263427109975,48.25084909012185,PKM;GNAS;CALM3;CALM1;CALM2,2,2,H1
81,KEGG_2021_Human,HIF-1 signaling pathway,5/109,0.0011215564870289,0.0027902136994379,0,0,6.881619286510591,46.747100199161046,EGF;INSR;ERBB2;EGFR;VEGFA,2,2,H1
82,KEGG_2021_Human,cGMP-PKG signaling pathway,6/167,0.0012899316325442,0.0031704343739642,0,0,5.357754907739039,35.646033110185904,INSR;ADORA1;CALM3;CALM1;CALM2;GNAI2,2,2,H1
83,KEGG_2021_Human,Long-term potentiation,4/67,0.0013546666926302,0.0032899048249591,0,0,9.04145255224392,59.71155948269502,CALM3;CALM1;HRAS;CALM2,2,2,H1
84,KEGG_2021_Human,Amphetamine addiction,4/69,0.0015111787487531,0.0035846565668098,0,0,8.762368566685113,56.910403587898415,GNAS;CALM3;CALM1;CALM2,2,2,H1
85,KEGG_2021_Human,Renal cell carcinoma,4/69,0.0015111787487531,0.0035846565668098,0,0,8.762368566685113,56.910403587898415,TGFB1;PDGFB;HRAS;VEGFA,2,2,H1
86,KEGG_2021_Human,Epithelial cell signaling in Helicobacter pylori infection,4/70,0.0015939697221204,0.0037375841760065,0,0,8.62916939175932,55.5850336106473,CXCR2;ADAM10;EGFR;JAM3,2,2,H1
87,KEGG_2021_Human,Neurotrophin signaling pathway,5/119,0.0016564619823179,0.0038399800499187,0,0,6.274790236460717,40.1779291956298,NGFR;CALM3;CALM1;CALM2;HRAS,2,2,H1
88,KEGG_2021_Human,Non-small cell lung cancer,4/72,0.0017689232588371,0.0040546106157615,0,0,8.374523910283537,53.072575895472816,EGF;ERBB2;HRAS;EGFR,2,2,H1
89,KEGG_2021_Human,Platelet activation,5/124,0.0019848946995808,0.0044990946523833,0,0,6.009621239800268,37.39300166235887,COL1A1;COL1A2;VWF;GNAS;GNAI2,2,2,H1
90,KEGG_2021_Human,Osteoclast differentiation,5/127,0.0022034534380593,0.0048975471608322,0,0,5.860952720361131,35.85572279753469,CSF1R;TGFB1;CSF1;SIRPA;LILRB2,2,2,H1
91,KEGG_2021_Human,Alcoholism,6/186,0.002226323840492,0.0048975471608322,0,0,4.787591240875912,29.239751768272352,GNAS;CALM3;CALM1;CALM2;HRAS;GNAI2,2,2,H1
92,KEGG_2021_Human,Pathways of neurodegeneration,10/475,0.0022327053233205,0.0048975471608322,0,0,3.135580887703129,19.14128296359992,APP;CSF1;WNT7B;LRP5;CALM3;CALM1;CALM2;AGER;HRAS;LRP6,2,2,H1
93,KEGG_2021_Human,Endocytosis,7/252,0.002270966291497,0.0049284800368659,0,0,4.12016806722689,25.08172853666576,PDGFRA;CXCR2;HLA-B;HLA-C;CXCR4;HRAS;EGFR,2,2,H1
94,KEGG_2021_Human,Neutrophil extracellular trap formation,6/189,0.0024116052998943,0.0051786050650362,0,0,4.708388177575685,28.37963389938562,VWF;ITGB2;FPR1;HMGB1;AGER;TLR2,2,2,H1
95,KEGG_2021_Human,FoxO signaling pathway,5/131,0.002521511375198,0.005302972376705,0,0,5.673740510697033,33.945403974844055,TGFB1;EGF;INSR;HRAS;EGFR,2,2,H1
96,KEGG_2021_Human,Natural killer cell mediated cytotoxicity,5/131,0.002521511375198,0.005302972376705,0,0,5.673740510697033,33.945403974844055,ITGB2;HLA-B;HLA-C;HRAS;ICAM1,2,2,H1
97,KEGG_2021_Human,Dopaminergic synapse,5/132,0.0026059712246423,0.0054246747941535,0,0,5.628780098139907,33.490959257292715,GNAS;CALM3;CALM1;CALM2;GNAI2,2,2,H1
98,KEGG_2021_Human,Vascular smooth muscle contraction,5/133,0.002692465480439,0.0055481106869652,0,0,5.584522192028985,33.04528182836621,RAMP3;GNAS;CALM3;CALM1;CALM2,2,2,H1
99,KEGG_2021_Human,Colorectal cancer,4/86,0.0033810887566043,0.0068974210634728,0,0,6.939814002456571,39.484470834161066,TGFB1;EGF;HRAS;EGFR,2,2,H1
100,KEGG_2021_Human,Signaling pathways regulating pluripotency of stem cells,5/143,0.003675499052686,0.0074237802648313,0,0,5.177221172022684,29.02384544499695,WNT7B;IL6ST;FGF2;HRAS;FGFR1,2,2,H1
101,KEGG_2021_Human,Salivary secretion,4/93,0.0044738418546377,0.0089154317249668,0,0,6.391722576994584,34.57607290675993,GNAS;CALM3;CALM1;CALM2,2,2,H1
102,KEGG_2021_Human,Adrenergic signaling in cardiomyocytes,5/150,0.0045014189591744,0.0089154317249668,0,0,4.925537231384308,26.61446369864555,GNAS;CALM3;CALM1;CALM2;GNAI2,2,2,H1
103,KEGG_2021_Human,mTOR signaling pathway,5/154,0.0050286310736827,0.009863853259916,0,0,4.792335375936193,25.363950077763967,INSR;WNT7B;LRP5;HRAS;LRP6,2,2,H1
104,KEGG_2021_Human,Aldosterone synthesis and secretion,4/98,0.0053856434370955,0.0103648232185613,0,0,6.0502066431960815,31.60639136382187,GNAS;CALM3;CALM1;CALM2,2,2,H1
105,KEGG_2021_Human,Inflammatory mediator regulation of TRP channels,4/98,0.0053856434370955,0.0103648232185613,0,0,6.0502066431960815,31.60639136382187,GNAS;CALM3;CALM1;CALM2,2,2,H1
106,KEGG_2021_Human,Hippo signaling pathway,5/163,0.0063725443471086,0.0121495238019641,0,0,4.517290405430196,22.838320160694455,TGFB1;CDH1;WNT7B;ITGB2;FGF1,2,2,H1
107,KEGG_2021_Human,C-type lectin receptor signaling pathway,4/104,0.0066343393575295,0.0125315298975558,0,0,5.685467625899281,28.51544119036889,CALM3;CALM1;CALM2;HRAS,2,2,H1
108,KEGG_2021_Human,Wnt signaling pathway,5/166,0.0068716360803921,0.0128606767009174,0,0,4.432442164011162,22.075126861881994,MMP7;WNT7B;LRP5;RSPO3;LRP6,2,2,H1
109,KEGG_2021_Human,Th17 cell differentiation,4/107,0.0073249643489828,0.0135844793381137,0,0,5.519033317035692,27.13414512611904,HSP90AA1;CD4;TGFB1;IL6ST,2,2,H1
110,KEGG_2021_Human,TNF signaling pathway,4/112,0.0085784828976193,0.0157658604604897,0,0,5.262190247801759,25.040122819989847,JAG1;CSF1;MMP9;ICAM1,2,2,H1
111,KEGG_2021_Human,Serotonergic synapse,4/113,0.0088449524598489,0.0161104491232963,0,0,5.213649264074979,24.649655765454074,APP;GNAS;HRAS;GNAI2,2,2,H1
112,KEGG_2021_Human,Long-term depression,3/60,0.0090979236080314,0.0164245700534373,0,0,7.443609022556391,34.982796810318966,GNAS;HRAS;GNAI2,2,2,H1
113,KEGG_2021_Human,Transcriptional misregulation in cancer,5/192,0.0123914594909665,0.0221741906680454,0,0,3.811129194760909,16.73370710605998,NGFR;CSF1R;PDGFA;ITGB7;MMP9,2,2,H1
114,KEGG_2021_Human,Viral carcinogenesis,5/203,0.015436835494321,0.0273836038334042,0,0,3.597386912604304,15.00469617336398,PKM;HLA-B;HLA-C;IL6ST;HRAS,2,2,H1
115,KEGG_2021_Human,Thyroid hormone synthesis,3/75,0.0166169786227559,0.0292229624055363,0,0,5.888392857142857,24.126690458521345,CANX;GNAS;HSP90B1,2,2,H1
116,KEGG_2021_Human,Leishmaniasis,3/77,0.017817162522902,0.0310658218348036,0,0,5.728667953667953,23.072743519712382,TGFB1;ITGB2;TLR2,2,2,H1
117,KEGG_2021_Human,Complement and coagulation cascades,3/85,0.0230902224171081,0.0399186896024581,0,0,5.1676829268292686,19.47361740567939,VWF;ITGB2;TFPI,2,2,H1
118,KEGG_2021_Human,Cushing syndrome,4/155,0.0253028901192416,0.043376383061557,0,0,3.7554909714612417,13.808326864435,WNT7B;GNAS;EGFR;GNAI2,2,2,H1
119,KEGG_2021_Human,Morphine addiction,3/91,0.027541880581706,0.0468211969889003,0,0,4.81387987012987,17.29168516506597,ADORA1;GNAS;GNAI2,2,2,H1
120,KEGG_2021_Human,African trypanosomiasis,2/37,0.0287159758963512,0.0480168777283249,0,0,8.03323201621074,28.520396959496026,LAMA4;ICAM1,2,2,H1
121,KEGG_2021_Human,Thyroid cancer,2/37,0.0287159758963512,0.0480168777283249,0,0,8.03323201621074,28.520396959496026,CDH1;HRAS,2,2,H1
122,KEGG_2021_Human,Hepatitis B,4/162,0.0291243826751066,0.0483038541928597,0,0,3.58783353064384,12.687223606600003,TGFB1;MMP9;HRAS;TLR2,2,2,H1
123,KEGG_2021_Human,IL-17 signaling pathway,3/94,0.0299269995325056,0.0488408632370491,0,0,4.65447409733124,16.33252266577057,HSP90AA1;MMP9;HSP90B1,2,2,H1
124,KEGG_2021_Human,TGF-beta signaling pathway,3/94,0.0299269995325056,0.0488408632370491,0,0,4.65447409733124,16.33252266577057,TGFB1;THBS1;DCN,2,2,H1
125,KEGG_2021_Human,Allograft rejection,2/38,0.0301716473015321,0.0488493337262901,0,0,7.809692671394799,27.340583102015515,HLA-B;HLA-C,2,2,H1
126,KEGG_2021_Human,Staphylococcus aureus infection,3/95,0.0307455455222008,0.0493865455632202,0,0,4.603649068322981,16.029952811893896,ITGB2;FPR1;ICAM1,2,2,H1
0,KEGG_2021_Human,Pathways in cancer,28/531,1.2403176743877893e-22,2.4682321720317007e-20,0,0,17.424357083306614,878.9107864021659,ALK;NOTCH2;LRP5;TGFA;CXCR4;LRP6;PLD2;HSP90B1;GNAI2;RXRA;CDH1;ERBB2;ITGAV;JAG2;HSP90AA1;TGFB1;TGFB3;HGF;F2R;FN1;VEGFA;AR;COL4A1;COL4A5;CALM3;CALM1;CALM2;FGFR1,3,3,H1
1,KEGG_2021_Human,PI3K-Akt signaling pathway,24/354,6.241902967475386e-22,6.210693452638009e-20,0,0,21.57575757575757,1053.4490274677864,NGFR;HSP90AA1;ITGB5;INSR;HGF;F2R;FN1;TNC;TGFA;AREG;VEGFA;HSP90B1;COL1A1;COL1A2;RXRA;ERBB3;COL4A1;ERBB2;COL4A5;ITGAV;ITGB7;ITGA5;ITGB6;FGFR1,3,3,H1
2,KEGG_2021_Human,ECM-receptor interaction,15/88,4.5014822329419717e-20,2.589451525153793e-18,0,0,54.347945205479455,2421.0539548993984,ITGB5;SDC4;TNC;FN1;HSPG2;COL1A1;COL1A2;COL4A1;COL4A5;SDC1;ITGAV;ITGB7;ITGB6;ITGA5;CD44,3,3,H1
3,KEGG_2021_Human,Proteoglycans in cancer,19/205,5.204927688751343e-20,2.589451525153793e-18,0,0,28.377707102832048,1260.0296764746506,TGFB1;SDC4;ITGB5;HGF;SDC2;FN1;HSPG2;VEGFA;COL1A1;COL1A2;ERBB3;PLAU;ERBB2;SDC1;ITGAV;ITGA5;EZR;CD44;FGFR1,3,3,H1
4,KEGG_2021_Human,Human papillomavirus infection,18/331,7.048733559097102e-15,2.8053959565206466e-13,0,0,15.65255591054313,510.0530666667951,NOTCH2;ITGB5;FN1;TNC;HLA-B;HLA-C;PSEN1;VEGFA;HLA-E;COL1A1;COL1A2;COL4A1;MFNG;COL4A5;ITGAV;ITGB7;ITGA5;ITGB6,3,3,H1
5,KEGG_2021_Human,Cell adhesion molecules,13/148,1.177980069103282e-13,3.906967229192552e-12,0,0,24.73063973063973,736.2263233723743,VCAM1;SDC4;SDC2;ITGB2;HLA-B;HLA-C;PTPRF;HLA-E;ICAM1;CDH1;SDC1;ITGAV;ITGB7,3,3,H1
6,KEGG_2021_Human,Focal adhesion,14/201,3.143974956772391e-13,8.937871662824369e-12,0,0,19.428792569659443,559.3183789174475,ITGB5;HGF;FN1;TNC;VEGFA;COL1A1;COL1A2;COL4A1;ERBB2;COL4A5;ITGAV;ITGB7;ITGA5;ITGB6,3,3,H1
7,KEGG_2021_Human,Fluid shear stress and atherosclerosis,12/139,1.3526710522935424e-12,3.3647692425801864e-11,0,0,23.9648697758934,654.9344863197434,HSP90AA1;VCAM1;SDC4;SDC2;SDC1;CALM3;ITGAV;CALM1;CALM2;VEGFA;HSP90B1;ICAM1,3,3,H1
8,KEGG_2021_Human,Human cytomegalovirus infection,13/225,2.500030672895243e-11,5.039193173300912e-10,0,0,15.68696397941681,382.95225137649294,HLA-B;HLA-C;CXCR4;VEGFA;HLA-E;GNAI2;CCL5;CALM3;ITGAV;CALR;CALM1;CALM2;B2M,3,3,H1
9,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,10/100,2.532257876030609e-11,5.039193173300912e-10,0,0,27.52777777777778,671.6591876380966,COL1A1;TGFB1;VCAM1;COL1A2;TGFB3;COL4A1;FN1;COL4A5;VEGFA;ICAM1,3,3,H1
10,KEGG_2021_Human,Malaria,8/50,5.6287841917538696e-11,1.0182982310536547e-09,0,0,46.15098722415796,1089.1883379775345,TGFB1;VCAM1;TGFB3;HGF;SDC2;ITGB2;SDC1;ICAM1,3,3,H1
11,KEGG_2021_Human,Rap1 signaling pathway,12/210,1.7501733339108072e-10,2.902370778735421e-09,0,0,15.316239316239315,344.09671700288874,NGFR;CDH1;INSR;HGF;F2R;ITGB2;CALM3;CALM1;CALM2;VEGFA;FGFR1;GNAI2,3,3,H1
12,KEGG_2021_Human,Regulation of actin cytoskeleton,12/218,2.694817820021909e-10,4.1251442014181525e-09,0,0,14.71545929798357,324.2480870242404,ITGB5;F2R;ITGB2;FN1;ITGAX;CXCR4;ITGAV;ITGB7;ITGA5;ITGB6;EZR;FGFR1,3,3,H1
13,KEGG_2021_Human,Antigen processing and presentation,8/78,2.219445534042306e-09,3.1547832948172776e-08,0,0,27.65156794425087,550.9853760068049,HSP90AA1;CANX;HLA-B;HLA-C;KLRD1;CALR;B2M;HLA-E,3,3,H1
14,KEGG_2021_Human,Human immunodeficiency virus 1 infection,11/212,2.9281405496215007e-09,3.8846664624978584e-08,0,0,13.653189747465206,268.2701360004404,HLA-B;HLA-C;CXCR4;CALM3;CD3G;CALR;CALM1;CALM2;B2M;HLA-E;GNAI2,3,3,H1
15,KEGG_2021_Human,Human T-cell leukemia virus 1 infection,11/219,4.1155828307656474e-09,5.1187561457647736e-08,0,0,13.189021421616358,254.6600272586031,TGFB1;TGFB3;CANX;ITGB2;HLA-B;HLA-C;CD3G;CALR;B2M;HLA-E;ICAM1,3,3,H1
16,KEGG_2021_Human,Amoebiasis,8/102,1.9016938785342642e-08,2.2261004813430498e-07,0,0,20.566683964711988,365.6331859080042,COL1A1;TGFB1;COL1A2;TGFB3;COL4A1;ITGB2;FN1;COL4A5,3,3,H1
17,KEGG_2021_Human,Phagosome,9/152,2.7871815507151422e-08,3.0813840477350735e-07,0,0,15.35897435897436,267.1793400896743,ITGB5;CANX;ITGB2;HLA-B;HLA-C;ITGAV;ITGA5;CALR;HLA-E,3,3,H1
18,KEGG_2021_Human,MAPK signaling pathway,11/294,8.53591499210575e-08,8.940247807521283e-07,0,0,9.656796529051304,157.1778655346069,NGFR;TGFB1;ERBB3;TGFB3;INSR;HGF;ERBB2;TGFA;AREG;VEGFA;FGFR1,3,3,H1
19,KEGG_2021_Human,Ras signaling pathway,10/232,9.238082127563472e-08,9.191891716925654e-07,0,0,11.085585585585584,179.55707023989578,NGFR;INSR;HGF;TGFA;CALM3;CALM1;CALM2;VEGFA;PLD2;FGFR1,3,3,H1
20,KEGG_2021_Human,Calcium signaling pathway,10/240,1.2676552634944864e-07,1.201254273501918e-06,0,0,10.695652173913045,169.85686824810335,ERBB3;HGF;ERBB2;F2R;CXCR4;CALM3;CALM1;CALM2;VEGFA;FGFR1,3,3,H1
21,KEGG_2021_Human,Hypertrophic cardiomyopathy,7/90,1.6267738446326644e-07,1.47149088673591e-06,0,0,20.14646537959065,314.9194097940991,TGFB1;ITGB5;TGFB3;ITGAV;ITGB7;ITGB6;ITGA5,3,3,H1
22,KEGG_2021_Human,Dilated cardiomyopathy,7/96,2.5392534250982245e-07,2.197006224324116e-06,0,0,18.782591038310542,285.2366637382427,TGFB1;ITGB5;TGFB3;ITGAV;ITGB7;ITGA5;ITGB6,3,3,H1
23,KEGG_2021_Human,Prostate cancer,7/97,2.7268261044793333e-07,2.2609933116307804e-06,0,0,18.572958500669344,280.7294749916671,AR;HSP90AA1;PLAU;ERBB2;TGFA;HSP90B1;FGFR1,3,3,H1
24,KEGG_2021_Human,Epstein-Barr virus infection,9/202,3.189050069290254e-07,2.538483855155042e-06,0,0,11.35118019573978,169.79518239114765,CXCL10;HLA-B;HLA-C;CD3G;CALR;B2M;CD44;HLA-E;ICAM1,3,3,H1
25,KEGG_2021_Human,Gastric cancer,8/149,3.635405577718068e-07,2.782483499868829e-06,0,0,13.678602317938074,202.8177656401937,TGFB1;RXRA;TGFB3;CDH1;HGF;ERBB2;LRP5;LRP6,3,3,H1
26,KEGG_2021_Human,"Parathyroid hormone synthesis, secretion and action",7/106,5.006550941202493e-07,3.668129723704943e-06,0,0,16.876840696117803,244.8382080020485,RXRA;LRP5;PTHLH;LRP6;PLD2;FGFR1;GNAI2,3,3,H1
27,KEGG_2021_Human,Cellular senescence,8/156,5.161187550941628e-07,3.668129723704943e-06,0,0,13.027027027027026,188.5913447314335,TGFB1;TGFB3;HLA-B;HLA-C;CALM3;CALM1;CALM2;HLA-E,3,3,H1
28,KEGG_2021_Human,Lipid and atherosclerosis,9/215,5.390259020218173e-07,3.69883291387385e-06,0,0,10.627831715210355,153.39683256486356,HSP90AA1;VCAM1;RXRA;CCL5;CALM3;CALM1;CALM2;HSP90B1;ICAM1,3,3,H1
29,KEGG_2021_Human,Alzheimer disease,11/369,8.216784383100639e-07,5.450466974123424e-06,0,0,7.604554133371049,106.55437915398832,APP;NCSTN;INSR;LRP5;ADAM10;CALM3;PSEN1;APOE;CALM1;CALM2;LRP6,3,3,H1
30,KEGG_2021_Human,Pancreatic cancer,6/76,1.1906888253698054e-06,7.404596132768478e-06,0,0,20.244897959183675,276.1602192830745,TGFB1;TGFB3;ERBB2;TGFA;PLD2;VEGFA,3,3,H1
31,KEGG_2021_Human,Pertussis,6/76,1.1906888253698054e-06,7.404596132768478e-06,0,0,20.244897959183675,276.1602192830745,ITGB2;CALM3;ITGA5;CALM1;CALM2;GNAI2,3,3,H1
32,KEGG_2021_Human,Relaxin signaling pathway,7/129,1.888788701018942e-06,1.138996822735665e-05,0,0,13.679241556389492,180.2865877550585,COL1A1;TGFB1;COL1A2;COL4A1;COL4A5;VEGFA;GNAI2,3,3,H1
33,KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,8/193,2.564219038260859e-06,1.500822319452679e-05,0,0,10.40210942649967,133.91526503409685,HLA-B;HLA-C;CALM3;CALM1;CALM2;VEGFA;HLA-E;ICAM1,3,3,H1
34,KEGG_2021_Human,Estrogen signaling pathway,7/137,2.823267953875779e-06,1.605229493775086e-05,0,0,12.832252085264134,163.96558308130514,HSP90AA1;TGFA;CALM3;CALM1;CALM2;HSP90B1;GNAI2,3,3,H1
35,KEGG_2021_Human,Rheumatoid arthritis,6/93,3.905240982251443e-06,2.1587304318556583e-05,0,0,16.27504105090312,202.6761958036811,TGFB1;TGFB3;CCL5;ITGB2;VEGFA;ICAM1,3,3,H1
36,KEGG_2021_Human,Chagas disease,6/102,6.679151612895279e-06,3.570013609605011e-05,0,0,14.742559523809524,175.6799992622232,TGFB1;TGFB3;CCL5;CD3G;CALR;GNAI2,3,3,H1
37,KEGG_2021_Human,Notch signaling pathway,5/59,6.8171114153261525e-06,3.570013609605011e-05,0,0,21.62962962962963,257.3076902826053,NOTCH2;JAG2;NCSTN;MFNG;PSEN1,3,3,H1
38,KEGG_2021_Human,Viral myocarditis,5/60,7.410597315185761e-06,3.781304783902477e-05,0,0,21.235294117647054,250.84402494336055,ITGB2;HLA-B;HLA-C;ICAM1;HLA-E,3,3,H1
39,KEGG_2021_Human,MicroRNAs in cancer,9/310,1.0809617512400617e-05,5.377784712419306e-05,0,0,7.238464377999262,82.77237805050748,NOTCH2;ERBB3;PLAU;ERBB2;TNC;ITGA5;EZR;CD44;VEGFA,3,3,H1
40,KEGG_2021_Human,Leukocyte transendothelial migration,6/114,1.2670066818279248e-05,6.149617797164806e-05,0,0,13.096560846560848,147.68033378089396,VCAM1;ITGB2;CXCR4;EZR;ICAM1;GNAI2,3,3,H1
41,KEGG_2021_Human,Renal cell carcinoma,5/69,1.4771737266013717e-05,6.836222595201696e-05,0,0,18.240808823529413,202.8887743888803,TGFB1;TGFB3;HGF;TGFA;VEGFA,3,3,H1
42,KEGG_2021_Human,Renin secretion,5/69,1.4771737266013717e-05,6.836222595201696e-05,0,0,18.240808823529413,202.8887743888803,CALM3;CALM1;CALM2;AQP1;GNAI2,3,3,H1
43,KEGG_2021_Human,Tuberculosis,7/180,1.6951204985589406e-05,7.514527258401203e-05,0,0,9.62177031826729,105.69679838900414,TGFB1;TGFB3;ITGB2;ITGAX;CALM3;CALM1;CALM2,3,3,H1
44,KEGG_2021_Human,Adherens junction,5/71,1.69926495792992e-05,7.514527258401203e-05,0,0,17.686274509803923,194.2435720776249,CDH1;INSR;ERBB2;PTPRF;FGFR1,3,3,H1
45,KEGG_2021_Human,Non-small cell lung cancer,5/72,1.819634449960089e-05,7.871896859609953e-05,0,0,17.421422300263387,190.14245233564108,ALK;RXRA;HGF;ERBB2;TGFA,3,3,H1
46,KEGG_2021_Human,Gastric acid secretion,5/76,2.3689808833634712e-05,0.00010030365867858102,0,0,16.43661971830986,175.0576530433688,CALM3;EZR;CALM1;CALM2;GNAI2,3,3,H1
47,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,5/77,2.524559510971956e-05,0.00010466402972571232,0,0,16.20751633986928,171.58668810010025,ITGB5;ITGAV;ITGB7;ITGB6;ITGA5,3,3,H1
48,KEGG_2021_Human,Natural killer cell mediated cytotoxicity,6/131,2.793201253788373e-05,0.00011343817336814006,0,0,11.305714285714286,118.5487480002827,ITGB2;HLA-B;HLA-C;KLRD1;HLA-E;ICAM1,3,3,H1
49,KEGG_2021_Human,Graft-versus-host disease,4/42,3.765288515492089e-05,0.00014985848291658514,0,0,24.32313341493268,247.78221614367223,HLA-B;HLA-C;KLRD1;HLA-E,3,3,H1
50,KEGG_2021_Human,Breast cancer,6/147,5.333262231168216e-05,0.00020810180078479904,0,0,10.01469098277609,98.53416765804538,JAG2;NOTCH2;ERBB2;LRP5;LRP6;FGFR1,3,3,H1
51,KEGG_2021_Human,Small cell lung cancer,5/92,5.959487390589958e-05,0.00022806499821680803,0,0,13.402974983096689,130.3833498048494,RXRA;COL4A1;FN1;COL4A5;ITGAV,3,3,H1
52,KEGG_2021_Human,Chemical carcinogenesis,7/239,0.00010255675365641024,0.0003850715844835026,0,0,7.153406730369755,65.70471480104733,NOTCH2;AR;HSP90AA1;RXRA;VEGFA;HSP90B1;GNAI2,3,3,H1
53,KEGG_2021_Human,Hepatocellular carcinoma,6/168,0.0001116606797155372,0.0004114902826554056,0,0,8.707231040564373,79.23620239863425,TGFB1;TGFB3;HGF;LRP5;TGFA;LRP6,3,3,H1
54,KEGG_2021_Human,Axon guidance,6/182,0.0001728719694252551,0.0006254822166477412,0,0,8.008928571428571,69.38102223946096,EFNB1;SEMA4D;SEMA4C;PLXNB2;CXCR4;GNAI2,3,3,H1
55,KEGG_2021_Human,Neurotrophin signaling pathway,5/119,0.00020122894458111812,0.0007150814280650448,0,0,10.214654282765736,86.93760974386946,NGFR;CALM3;PSEN1;CALM1;CALM2,3,3,H1
56,KEGG_2021_Human,Phototransduction,3/28,0.000266079246909741,0.0009289433357024292,0,0,27.427586206896557,225.77611044675876,CALM3;CALM1;CALM2,3,3,H1
57,KEGG_2021_Human,Vascular smooth muscle contraction,5/133,0.0003370867949737409,0.0011565564172374,0,0,9.090992647058824,72.68403267219288,RAMP2;RAMP3;CALM3;CALM1;CALM2,3,3,H1
58,KEGG_2021_Human,Glioma,4/75,0.0003651608189381543,0.0012316441181134,0,0,12.996396986570586,102.8687266470888,TGFA;CALM3;CALM1;CALM2,3,3,H1
59,KEGG_2021_Human,Apelin signaling pathway,5/137,0.0003863214271315094,0.0012602944917896,0,0,8.813725490196079,69.26566567833886,CDH1;CALM3;CALM1;CALM2;GNAI2,3,3,H1
60,KEGG_2021_Human,Insulin signaling pathway,5/137,0.0003863214271315094,0.0012602944917896,0,0,8.813725490196079,69.26566567833886,INSR;CALM3;CALM1;CALM2;PTPRF,3,3,H1
61,KEGG_2021_Human,cAMP signaling pathway,6/216,0.0004333953826030666,0.0013910593731937,0,0,6.700680272108843,51.88913075489065,F2R;CALM3;CALM1;CALM2;PLD2;GNAI2,3,3,H1
62,KEGG_2021_Human,Complement and coagulation cascades,4/85,0.0005878688259759453,0.0018279046307689,0,0,11.386161355153604,84.70173083630789,PLAU;ITGB2;F2R;ITGAX,3,3,H1
63,KEGG_2021_Human,ErbB signaling pathway,4/85,0.0005878688259759453,0.0018279046307689,0,0,11.386161355153604,84.70173083630789,ERBB3;ERBB2;TGFA;AREG,3,3,H1
64,KEGG_2021_Human,Colorectal cancer,4/86,0.000614442699327743,0.0018811399564033,0,0,11.246738513896767,83.16732438985603,TGFB1;TGFB3;TGFA;AREG,3,3,H1
65,KEGG_2021_Human,Allograft rejection,3/38,0.000663266953621205,0.0019998503601609,0,0,19.58128078817734,143.3023334495559,HLA-B;HLA-C;HLA-E,3,3,H1
66,KEGG_2021_Human,GnRH signaling pathway,4/93,0.0008248605394658969,0.0023937748070457,0,0,10.358505356676249,73.54845652198753,CALM3;CALM1;CALM2;PLD2,3,3,H1
67,KEGG_2021_Human,Salivary secretion,4/93,0.0008248605394658969,0.0023937748070457,0,0,10.358505356676249,73.54845652198753,TRPV6;CALM3;CALM1;CALM2,3,3,H1
68,KEGG_2021_Human,Bladder cancer,3/41,0.0008300023200309358,0.0023937748070457,0,0,18.03266787658802,127.92522571257716,CDH1;ERBB2;VEGFA,3,3,H1
69,KEGG_2021_Human,Hippo signaling pathway,5/163,0.0008506583074318365,0.0024064581098788,0,0,7.353685778108712,51.986881820880896,TGFB1;TGFB3;CDH1;ITGB2;AREG,3,3,H1
70,KEGG_2021_Human,TGF-beta signaling pathway,4/94,0.0008585855567909456,0.0024064581098788,0,0,10.242894056847543,72.31712874533979,TGFB1;TGFB3;LTBP1;FBN1,3,3,H1
71,KEGG_2021_Human,cGMP-PKG signaling pathway,5/167,0.0009483095902504254,0.0025753686758812,0,0,7.170660856935367,49.91374789296735,INSR;CALM3;CALM1;CALM2;GNAI2,3,3,H1
72,KEGG_2021_Human,Type I diabetes mellitus,3/43,0.0009546714694705825,0.0025753686758812,0,0,17.129310344827587,119.11967855731837,HLA-B;HLA-C;HLA-E,3,3,H1
73,KEGG_2021_Human,Circadian entrainment,4/97,0.0009655885807923816,0.0025753686758812,0,0,9.910977744436108,68.80966585584474,CALM3;CALM1;CALM2;GNAI2,3,3,H1
74,KEGG_2021_Human,Endocytosis,6/252,0.0009706163351311288,0.0025753686758812,0,0,5.709639953542393,39.611079901924825,ARF1;HLA-B;HLA-C;CXCR4;PLD2;HLA-E,3,3,H1
75,KEGG_2021_Human,Melanogenesis,4/101,0.0011224187442122,0.0029389648697137,0,0,9.500359625988972,64.52900130395217,CALM3;CALM1;CALM2;GNAI2,3,3,H1
76,KEGG_2021_Human,Protein digestion and absorption,4/103,0.0012071725474574,0.0031198355447276,0,0,9.30749354005168,62.54146449090736,COL1A1;COL1A2;COL4A1;COL4A5,3,3,H1
77,KEGG_2021_Human,Intestinal immune network for IgA production,3/48,0.0013164595418251,0.0033586596002975,0,0,15.22222222222222,100.96609729146172,TGFB1;CXCR4;ITGB7,3,3,H1
78,KEGG_2021_Human,Th17 cell differentiation,4/107,0.0013899576062889,0.0035012856158417,0,0,8.944231203431926,58.83946425626155,HSP90AA1;TGFB1;RXRA;CD3G,3,3,H1
79,KEGG_2021_Human,TNF signaling pathway,4/112,0.0016445675527555,0.0040908617874795,0,0,8.527993109388458,54.66680503719077,CXCL10;VCAM1;CCL5;ICAM1,3,3,H1
80,KEGG_2021_Human,Autoimmune thyroid disease,3/53,0.0017543843654351,0.0043101541817481,0,0,13.696551724137931,86.91334912583787,HLA-B;HLA-C;HLA-E,3,3,H1
81,KEGG_2021_Human,Cytokine-cytokine receptor interaction,6/295,0.0021615393607358,0.0052456869852004,0,0,4.849480968858131,29.760947763714587,CXCL10;NGFR;TGFB1;TGFB3;CCL5;CXCR4,3,3,H1
82,KEGG_2021_Human,Diabetic cardiomyopathy,5/203,0.0022424665199628,0.0053765161141276,0,0,5.856209150326797,35.72392345723542,COL1A1;TGFB1;COL1A2;TGFB3;INSR,3,3,H1
83,KEGG_2021_Human,Platelet activation,4/124,0.0023846617099408,0.0056493771461693,0,0,7.670542635658915,46.32009051427254,COL1A1;COL1A2;F2R;GNAI2,3,3,H1
84,KEGG_2021_Human,Oocyte meiosis,4/129,0.0027513504713598,0.0064413969858895,0,0,7.361860465116279,43.40305135420065,AR;CALM3;CALM1;CALM2,3,3,H1
85,KEGG_2021_Human,Dopaminergic synapse,4/132,0.0029889779306612,0.0069163559093207,0,0,7.188226744186046,41.78389534907842,CALM3;CALM1;CALM2;GNAI2,3,3,H1
86,KEGG_2021_Human,Long-term potentiation,3/67,0.0034288146648599,0.0078429209000819,0,0,10.692887931034482,60.68792018572197,CALM3;CALM1;CALM2,3,3,H1
87,KEGG_2021_Human,Amphetamine addiction,3/69,0.0037259750372992,0.0084257844593471,0,0,10.367816091954024,57.98125159992389,CALM3;CALM1;CALM2,3,3,H1
88,KEGG_2021_Human,Melanoma,3/72,0.0042004021574726,0.0093919104419893,0,0,9.915542228885558,54.26354857766984,CDH1;HGF;FGFR1,3,3,H1
89,KEGG_2021_Human,Phospholipase D signaling pathway,4/148,0.0044963289681108,0.0099418829406006,0,0,6.384366925064599,34.50427274033352,ARF1;INSR;F2R;PLD2,3,3,H1
90,KEGG_2021_Human,Adrenergic signaling in cardiomyocytes,4/150,0.0047148701320303,0.0103105401788356,0,0,6.296272698311564,33.72934633165361,CALM3;CALM1;CALM2;GNAI2,3,3,H1
91,KEGG_2021_Human,Bacterial invasion of epithelial cells,3/77,0.0050694916746021,0.0108476219703851,0,0,9.243243243243244,48.846055051790216,CDH1;FN1;ITGA5,3,3,H1
92,KEGG_2021_Human,Leishmaniasis,3/77,0.0050694916746021,0.0108476219703851,0,0,9.243243243243244,48.846055051790216,TGFB1;TGFB3;ITGB2,3,3,H1
93,KEGG_2021_Human,Oxytocin signaling pathway,4/154,0.0051731850919037,0.0109517429073282,0,0,6.127131782945736,32.25485586184548,CALM3;CALM1;CALM2;GNAI2,3,3,H1
94,KEGG_2021_Human,Pathways of neurodegeneration,7/475,0.0056008735977793,0.0117323562732431,0,0,3.5036041602306662,18.16560139611253,APP;LRP5;CALM3;PSEN1;CALM1;CALM2;LRP6,3,3,H1
95,KEGG_2021_Human,Herpes simplex virus 1 infection,7/498,0.0071946151348621,0.0149138376233079,0,0,3.335533580349913,16.458931717268808,CCL5;HLA-B;HLA-C;ITGA5;CALR;B2M;HLA-E,3,3,H1
96,KEGG_2021_Human,Protein processing in endoplasmic reticulum,4/171,0.0074537720830555,0.0152917592219387,0,0,5.4986770644757,26.93821169418867,HSP90AA1;CANX;CALR;HSP90B1,3,3,H1
97,KEGG_2021_Human,Th1 and Th2 cell differentiation,3/92,0.0082928187220727,0.01683949924176,0,0,7.679581557535839,36.80336058111635,JAG2;NOTCH2;CD3G,3,3,H1
98,KEGG_2021_Human,IL-17 signaling pathway,3/94,0.0087950433174904,0.0176789254563696,0,0,7.510041682455475,35.549285293181995,CXCL10;HSP90AA1;HSP90B1,3,3,H1
99,KEGG_2021_Human,Phosphatidylinositol signaling system,3/97,0.0095812325071112,0.0190666526891513,0,0,7.269258987527513,33.787145340496174,CALM3;CALM1;CALM2,3,3,H1
100,KEGG_2021_Human,Aldosterone synthesis and secretion,3/98,0.0098521169582171,0.0192176100759385,0,0,7.192377495462795,33.22927978001314,CALM3;CALM1;CALM2,3,3,H1
101,KEGG_2021_Human,Inflammatory mediator regulation of TRP channels,3/98,0.0098521169582171,0.0192176100759385,0,0,7.192377495462795,33.22927978001314,CALM3;CALM1;CALM2,3,3,H1
102,KEGG_2021_Human,Alcoholism,4/186,0.009946803205134,0.0192176100759385,0,0,5.041656018400205,23.244575568936447,CALM3;CALM1;CALM2;GNAI2,3,3,H1
103,KEGG_2021_Human,Hematopoietic cell lineage,3/99,0.010127436038827,0.0193784593435249,0,0,7.117097701149425,32.68532171325279,CD3G;ITGA5;CD44,3,3,H1
104,KEGG_2021_Human,Viral protein interaction with cytokine and cytokine receptor,3/100,0.0104072034150417,0.0197241283770791,0,0,7.043370067543548,32.15479504350625,CXCL10;CCL5;CXCR4,3,3,H1
105,KEGG_2021_Human,Chemokine signaling pathway,4/192,0.0110787277902018,0.0206043628995343,0,0,4.879267689262742,21.97001731584284,CXCL10;CCL5;CXCR4;GNAI2,3,3,H1
106,KEGG_2021_Human,Transcriptional misregulation in cancer,4/192,0.0110787277902018,0.0206043628995343,0,0,4.879267689262742,21.97001731584284,NGFR;RXRA;PLAU;ITGB7,3,3,H1
107,KEGG_2021_Human,C-type lectin receptor signaling pathway,3/104,0.011571013146536,0.0211250606987217,0,0,6.763059064527142,30.15818584264637,CALM3;CALM1;CALM2,3,3,H1
108,KEGG_2021_Human,NF-kappa B signaling pathway,3/104,0.011571013146536,0.0211250606987217,0,0,6.763059064527142,30.15818584264637,VCAM1;PLAU;ICAM1,3,3,H1
109,KEGG_2021_Human,African trypanosomiasis,2/37,0.0120409245904784,0.0215868828243713,0,0,12.905844155844155,57.03665614955417,VCAM1;ICAM1,3,3,H1
110,KEGG_2021_Human,Thyroid cancer,2/37,0.0120409245904784,0.0215868828243713,0,0,12.905844155844155,57.03665614955417,RXRA;CDH1,3,3,H1
111,KEGG_2021_Human,Glucagon signaling pathway,3/107,0.0124911796757363,0.0221941496024244,0,0,6.566976127320955,28.781299763542265,CALM3;CALM1;CALM2,3,3,H1
112,KEGG_2021_Human,HIF-1 signaling pathway,3/109,0.0131273136979684,0.0231180126185462,0,0,6.44242029928432,27.91539501814072,INSR;ERBB2;VEGFA,3,3,H1
113,KEGG_2021_Human,Toxoplasmosis,3/112,0.0141157390199445,0.0246406321488505,0,0,6.264156912369503,26.688220412600337,TGFB1;TGFB3;GNAI2,3,3,H1
114,KEGG_2021_Human,Thyroid hormone signaling pathway,3/121,0.0173293859659462,0.0299873722367244,0,0,5.78375219170076,23.455148749370256,NOTCH2;RXRA;ITGAV,3,3,H1
115,KEGG_2021_Human,FoxO signaling pathway,3/131,0.0213408603747905,0.0366106139188218,0,0,5.329202586206897,20.50214429279541,TGFB1;TGFB3;INSR,3,3,H1
116,KEGG_2021_Human,Shigellosis,4/246,0.0250752254280161,0.0426493150442325,0,0,3.780126849894292,13.93307488284048,ARF1;CCL5;ITGA5;CD44,3,3,H1
117,KEGG_2021_Human,Regulation of lipolysis in adipocytes,2/55,0.0254849007450994,0.0429787732904642,0,0,8.51500857632933,31.24726411285921,INSR;GNAI2,3,3,H1
118,KEGG_2021_Human,Parkinson disease,4/249,0.0260657660248973,0.0432257286579547,0,0,3.733270052206929,13.615730434785265,CALM3;CALM1;CALM2;GNAI2,3,3,H1
119,KEGG_2021_Human,Salmonella infection,4/249,0.0260657660248973,0.0432257286579547,0,0,3.733270052206929,13.615730434785265,HSP90AA1;ARF1;HSP90B1;S100A10,3,3,H1
120,KEGG_2021_Human,Legionellosis,2/57,0.0272322650208883,0.044786948257494,0,0,8.204545454545455,29.56387179265711,ARF1;ITGB2,3,3,H1
121,KEGG_2021_Human,Endometrial cancer,2/58,0.0281236434462706,0.045873811850884,0,0,8.05762987012987,28.77496182368509,CDH1;ERBB2,3,3,H1
0,KEGG_2021_Human,Cell adhesion molecules,21/148,1.5895557882430958e-25,2.670453724248401e-23,0,0,44.19429665886359,2523.5461670269765,VCAM1;SELPLG;ITGB2;HLA-B;ICAM2;HLA-C;ICAM3;HLA-A;HLA-F;ITGAL;PTPRF;HLA-E;ICAM1;VCAN;CD4;PTPRC;CD40LG;SDC1;ITGAV;ITGB7;JAM3,4,4,H1
1,KEGG_2021_Human,Cytokine-cytokine receptor interaction,19/295,1.481415074826404e-16,1.2443886628541792e-14,0,0,17.779891304347824,648.0479452570249,NGFR;CXCL9;TGFB1;CCL21;CXCR4;IL16;TNFRSF1B;IL2RG;CXCL14;TGFBR2;CD4;CXCL12;CD40LG;CCL5;CXCR3;CXCR2;CCR7;CCL19;CCR5,4,4,H1
2,KEGG_2021_Human,Viral protein interaction with cytokine and cytokine receptor,13/100,1.3572274074940317e-15,7.600473481966578e-14,0,0,36.11354079058032,1236.2868477237237,CXCL9;CCL21;CXCR4;TNFRSF1B;IL2RG;CXCL14;CXCL12;CCL5;CXCR3;CXCR2;CCR7;CCL19;CCR5,4,4,H1
3,KEGG_2021_Human,Human immunodeficiency virus 1 infection,16/212,3.790645913640102e-15,1.592071283728843e-13,0,0,20.36579695169207,676.271540647689,HLA-B;HLA-C;CXCR4;CD3G;HLA-A;TNFRSF1B;HLA-F;CD3D;HLA-E;GNAI2;BST2;CD4;CALR;CD247;CCR5;B2M,4,4,H1
4,KEGG_2021_Human,Human T-cell leukemia virus 1 infection,16/219,6.328482783619302e-15,2.126370215296086e-13,0,0,19.656544241441665,642.6454724966858,TGFB1;ITGB2;HLA-B;HLA-C;CD3G;HLA-A;IL2RG;HLA-F;ITGAL;CD3D;TGFBR2;HLA-E;ICAM1;CD4;CALR;B2M,4,4,H1
5,KEGG_2021_Human,Epstein-Barr virus infection,15/202,3.7338867778062735e-14,1.0454882977857565e-12,0,0,19.77072192513369,611.2858420377388,HLA-B;HLA-C;CD3G;HLA-A;HLA-F;ITGAL;CD3D;HLA-E;ICAM1;CD19;VIM;CALR;CD247;B2M;CD44,4,4,H1
6,KEGG_2021_Human,Human papillomavirus infection,17/331,2.7760042899836095e-13,6.662410295960663e-12,0,0,13.59819532908705,393.1590955274612,NOTCH2;VWF;FN1;HLA-B;HLA-C;HLA-A;HLA-F;HLA-E;COL1A1;COL1A2;PKM;COL4A1;MFNG;COL4A5;ITGAV;ITGB7;ITGA5,4,4,H1
7,KEGG_2021_Human,ECM-receptor interaction,11/88,3.626451474540446e-13,7.615548096534936e-12,0,0,33.72108843537415,965.952434363241,COL1A1;COL1A2;VWF;COL4A1;FN1;COL4A5;SDC1;ITGAV;ITGB7;ITGA5;CD44,4,4,H1
8,KEGG_2021_Human,PI3K-Akt signaling pathway,17/354,8.204944507141973e-13,1.5315896413331678e-11,0,0,12.655253747241876,352.18140182847435,NGFR;VWF;FN1;TGFA;IL2RG;EREG;COL1A1;EFNA1;COL1A2;COL4A1;CD19;ERBB2;KDR;COL4A5;ITGAV;ITGB7;ITGA5,4,4,H1
9,KEGG_2021_Human,Human cytomegalovirus infection,14/225,3.168201316745076e-12,5.3225782121317276e-11,0,0,16.132233339184367,427.146969011077,HLA-B;HLA-C;CXCR4;HLA-A;HLA-F;HLA-E;GNAI2;CXCL12;CCL5;CXCR2;ITGAV;CALR;CCR5;B2M,4,4,H1
10,KEGG_2021_Human,Viral myocarditis,9/60,1.0115997572260965e-11,1.5449887201271292e-10,0,0,40.74008207934337,1031.4127073192735,CD40LG;ITGB2;HLA-B;HLA-C;HLA-A;ITGAL;HLA-F;ICAM1;HLA-E,4,4,H1
11,KEGG_2021_Human,Antigen processing and presentation,9/78,1.1637823606140584e-10,1.5290031699095894e-09,0,0,30.084934277047523,688.1680687713191,CD4;HLA-B;HLA-C;KLRD1;HLA-A;CALR;HLA-F;B2M;HLA-E,4,4,H1
12,KEGG_2021_Human,Chemokine signaling pathway,12/192,1.183157214810992e-10,1.5290031699095894e-09,0,0,15.843373493975903,362.1425152199865,CXCL9;CXCL12;CCL21;CCL5;CXCR3;CXCR2;CXCR4;CCR7;CCL19;CCR5;CXCL14;GNAI2,4,4,H1
13,KEGG_2021_Human,Proteoglycans in cancer,12/205,2.526726558949339e-10,3.0320718707392063e-09,0,0,14.76646482302266,326.3230180594621,COL1A1;TGFB1;COL1A2;ERBB2;FN1;KDR;TIMP3;SDC1;ITGAV;ITGA5;MMP9;CD44,4,4,H1
14,KEGG_2021_Human,Primary immunodeficiency,7/38,4.876145533212598e-10,5.4612829971981094e-09,0,0,50.99633431085044,1093.4376916092838,CD79A;CD4;CD40LG;PTPRC;CD19;IL2RG;CD3D,4,4,H1
15,KEGG_2021_Human,Natural killer cell mediated cytotoxicity,10/131,6.474692289373892e-10,6.7984269038425884e-09,0,0,19.23578026251823,406.9896740499762,ITGB2;HLA-B;ICAM2;HLA-C;KLRD1;CD247;HLA-A;ITGAL;HLA-E;ICAM1,4,4,H1
16,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,9/100,1.1146424450811295e-09,1.1015290045507634e-08,0,0,22.78635318170202,469.7345677557883,COL1A1;TGFB1;VCAM1;COL1A2;COL4A1;FN1;COL4A5;TGFBR2;ICAM1,4,4,H1
17,KEGG_2021_Human,Chagas disease,9/102,1.3317320696874935e-09,1.2429499317083277e-08,0,0,22.294073518379594,455.6191969437108,C3;TGFB1;CCL5;CD3G;CALR;CD247;CD3D;TGFBR2;GNAI2,4,4,H1
18,KEGG_2021_Human,Phagosome,10/152,2.774365772946125e-09,2.4531234202892057e-08,0,0,16.373653686826845,322.6075388353821,C3;ITGB2;HLA-B;HLA-C;ITGAV;ITGA5;CALR;HLA-A;HLA-F;HLA-E,4,4,H1
19,KEGG_2021_Human,Focal adhesion,11/201,3.0027396198921914e-09,2.5223012807094408e-08,0,0,13.588032581453634,266.6480287946913,COL1A1;COL1A2;VWF;COL4A1;ERBB2;FN1;KDR;COL4A5;ITGAV;ITGB7;ITGA5,4,4,H1
20,KEGG_2021_Human,Leukocyte transendothelial migration,9/114,3.5973129592727116e-09,2.813926027182173e-08,0,0,19.73421926910299,383.6939777477317,VCAM1;CXCL12;ITGB2;CXCR4;ITGAL;MMP9;JAM3;ICAM1;GNAI2,4,4,H1
21,KEGG_2021_Human,Malaria,7/50,3.684903130833798e-09,2.813926027182173e-08,0,0,36.74260042283298,713.5053512172497,TGFB1;VCAM1;CD40LG;ITGB2;SDC1;ITGAL;ICAM1,4,4,H1
22,KEGG_2021_Human,Allograft rejection,6/38,2.3900546408459352e-08,1.7457790420092046e-07,0,0,41.86727528089887,734.7440751958611,CD40LG;HLA-B;HLA-C;HLA-A;HLA-F;HLA-E,4,4,H1
23,KEGG_2021_Human,Pathways in cancer,15/531,2.9513299082696985e-08,2.065930935788789e-07,0,0,7.045421511627907,122.15651147811109,ALK;NOTCH2;TGFB1;FN1;TGFA;CXCR4;IL2RG;MMP9;TGFBR2;GNAI2;CXCL12;COL4A1;ERBB2;COL4A5;ITGAV,4,4,H1
24,KEGG_2021_Human,Graft-versus-host disease,6/42,4.4727449811650914e-08,3.005684627342941e-07,0,0,37.20786516853933,629.6567374649312,HLA-B;HLA-C;KLRD1;HLA-A;HLA-F;HLA-E,4,4,H1
25,KEGG_2021_Human,Relaxin signaling pathway,8/129,1.8282702949146395e-07,1.1679086175795216e-06,0,0,15.034862733922296,233.26176561766107,COL1A1;TGFB1;COL1A2;COL4A1;COL4A5;MMP9;TGFBR2;GNAI2,4,4,H1
26,KEGG_2021_Human,Autoimmune thyroid disease,6/53,1.876995992538517e-07,1.1679086175795216e-06,0,0,28.483863256036337,441.1701235923519,CD40LG;HLA-B;HLA-C;HLA-A;HLA-F;HLA-E,4,4,H1
27,KEGG_2021_Human,Axon guidance,9/182,2.1051900747096126e-07,1.2631140448257673e-06,0,0,11.936281758300847,183.50469420522523,EFNA1;EPHA4;CXCL12;SEMA4D;PLXNB2;CXCR4;PLXNB1;SLIT2;GNAI2,4,4,H1
28,KEGG_2021_Human,Endocytosis,10/252,3.3342017910940377e-07,1.9315375893234424e-06,0,0,9.55906660184735,142.56260342979644,CXCR2;HLA-B;HLA-C;CXCR4;HLA-A;IL2RG;CCR5;HLA-F;TGFBR2;HLA-E,4,4,H1
29,KEGG_2021_Human,Amoebiasis,7/102,5.576050471509159e-07,3.122588264045129e-06,0,0,16.58732057416268,238.85102892171412,COL1A1;TGFB1;COL1A2;COL4A1;ITGB2;FN1;COL4A5,4,4,H1
30,KEGG_2021_Human,Th17 cell differentiation,7/107,7.72343468574715e-07,4.1856033135661965e-06,0,0,15.753977272727273,221.7189000205325,CD4;TGFB1;CD3G;CD247;IL2RG;CD3D;TGFBR2,4,4,H1
31,KEGG_2021_Human,Regulation of actin cytoskeleton,9/218,9.609080334330164e-07,5.044767175523336e-06,0,0,9.862245465672638,136.64522891155735,CXCL12;ITGB2;FN1;ITGAX;CXCR4;ITGAV;ITGB7;ITGA5;ITGAL,4,4,H1
32,KEGG_2021_Human,Type I diabetes mellitus,5/43,1.8142442837640376e-06,9.236152717344192e-06,0,0,29.045321637426905,383.9745498021045,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E,4,4,H1
33,KEGG_2021_Human,ErbB signaling pathway,6/85,3.165115186603025e-06,1.5203280548720545e-05,0,0,16.918788223581284,214.24804805306687,NRG4;ERBB2;TGFA;NRG1;NRG2;EREG,4,4,H1
34,KEGG_2021_Human,Intestinal immune network for IgA production,5/48,3.16735011431678e-06,1.5203280548720545e-05,0,0,25.66149870801033,324.94168476856737,TGFB1;CD40LG;CXCL12;CXCR4;ITGB7,4,4,H1
35,KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,8/193,3.859141660339751e-06,1.8009327748252173e-05,0,0,9.8018018018018,122.18010409458353,C3;HLA-B;HLA-C;HLA-A;CCR5;HLA-F;HLA-E;ICAM1,4,4,H1
36,KEGG_2021_Human,Th1 and Th2 cell differentiation,6/92,5.024655451685047e-06,2.2814651780623995e-05,0,0,15.536190227332114,189.55944445972844,NOTCH2;CD4;CD3G;CD247;IL2RG;CD3D,4,4,H1
37,KEGG_2021_Human,Rheumatoid arthritis,6/93,5.350762908389975e-06,2.3656004437092524e-05,0,0,15.356838434715227,186.4054728820644,TGFB1;CXCL12;CCL5;ITGB2;ITGAL;ICAM1,4,4,H1
38,KEGG_2021_Human,Viral carcinogenesis,8/203,5.602454351281451e-06,2.41336495132124e-05,0,0,9.294429708222811,112.3910860753334,C3;PKM;HLA-B;HLA-C;HLA-A;CCR5;HLA-F;HLA-E,4,4,H1
39,KEGG_2021_Human,Hematopoietic cell lineage,6/99,7.688113387990783e-06,3.229007622956129e-05,0,0,14.361725262776368,169.12130898749584,CD4;CD19;CD3G;ITGA5;CD3D;CD44,4,4,H1
40,KEGG_2021_Human,Cellular senescence,7/156,9.546034837357056e-06,3.911545982136549e-05,0,0,10.546979865771812,121.91659758580222,TGFB1;HLA-B;HLA-C;HLA-A;HLA-F;TGFBR2;HLA-E,4,4,H1
41,KEGG_2021_Human,T cell receptor signaling pathway,6/104,1.0214638479934556e-05,3.990835499137222e-05,0,0,13.625544599862415,156.58051720142922,CD4;PTPRC;CD40LG;CD3G;CD247;CD3D,4,4,H1
42,KEGG_2021_Human,NF-kappa B signaling pathway,6/104,1.0214638479934556e-05,3.990835499137222e-05,0,0,13.625544599862415,156.58051720142922,VCAM1;CXCL12;CD40LG;CCL21;CCL19;ICAM1,4,4,H1
43,KEGG_2021_Human,Herpes simplex virus 1 infection,11/498,2.421611880867172e-05,9.246154454220112e-05,0,0,5.221423682409308,55.49586025508025,BST2;C3;CCL5;HLA-B;HLA-C;ITGA5;CALR;HLA-A;HLA-F;B2M;HLA-E,4,4,H1
44,KEGG_2021_Human,Complement and coagulation cascades,5/85,5.283065013816533e-05,0.0001932455063200936,0,0,13.76736111111111,135.5867413059386,C3;PROC;VWF;ITGB2;ITGAX,4,4,H1
45,KEGG_2021_Human,Fluid shear stress and atherosclerosis,6/139,5.291246006383514e-05,0.0001932455063200936,0,0,10.022133986652022,98.68666759568544,VCAM1;KDR;SDC1;ITGAV;MMP9;ICAM1,4,4,H1
46,KEGG_2021_Human,Rap1 signaling pathway,7/210,6.438004753441216e-05,0.0002301244252293881,0,0,7.720219435736677,74.50557415772478,EFNA1;NGFR;CNR1;ITGB2;KDR;ITGAL;GNAI2,4,4,H1
47,KEGG_2021_Human,PD-L1 expression and PD-1 checkpoint pathway in cancer,5/89,6.586116312677242e-05,0.0002305140709437035,0,0,13.109126984126984,126.2141714824478,ALK;CD4;CD3G;CD247;CD3D,4,4,H1
48,KEGG_2021_Human,MAPK signaling pathway,8/294,7.966702220568135e-05,0.0002731440761337646,0,0,6.307853066473756,59.531339971582575,EFNA1;NGFR;TGFB1;ERBB2;KDR;TGFA;EREG;TGFBR2,4,4,H1
49,KEGG_2021_Human,Staphylococcus aureus infection,5/95,8.989823658313635e-05,0.00030205807491933816,0,0,12.23148148148148,113.95866091171156,C3;SELPLG;ITGB2;ITGAL;ICAM1,4,4,H1
50,KEGG_2021_Human,MicroRNAs in cancer,8/310,0.00011500341455190536,0.00037883477734745294,0,0,5.968790439217478,54.140204587538335,EFNA1;NOTCH2;ERBB2;TIMP3;ITGA5;VIM;MMP9;CD44,4,4,H1
51,KEGG_2021_Human,Protein digestion and absorption,5/103,0.00013182913521748185,0.0004259095137795567,0,0,11.22845804988662,100.31508805411382,COL1A1;COL18A1;COL1A2;COL4A1;COL4A5,4,4,H1
52,KEGG_2021_Human,TNF signaling pathway,5/112,0.000195352598125352,0.0006192308770765875,0,0,10.279335410176532,87.79276554405713,VCAM1;CCL5;TNFRSF1B;MMP9;ICAM1,4,4,H1
53,KEGG_2021_Human,Neutrophil extracellular trap formation,6/189,0.00028475816902089865,0.0008859143036205736,0,0,7.265426413704181,59.313998680653086,C3;SELPLG;VWF;ITGB2;HMGB1;ITGAL,4,4,H1
54,KEGG_2021_Human,Pancreatic cancer,4/76,0.00047179149767843936,0.0014153744930353,0,0,12.108058608058608,92.73529895226524,TGFB1;ERBB2;TGFA;TGFBR2,4,4,H1
55,KEGG_2021_Human,Pertussis,4/76,0.00047179149767843936,0.0014153744930353,0,0,12.108058608058608,92.73529895226524,C3;ITGB2;ITGA5;GNAI2,4,4,H1
56,KEGG_2021_Human,Colorectal cancer,4/86,0.000753178123708609,0.0022198934172464,0,0,10.626105601715356,76.41454417726976,TGFB1;TGFA;EREG;TGFBR2,4,4,H1
57,KEGG_2021_Human,Hypertrophic cardiomyopathy,4/90,0.0008932718898448115,0.0025874082326539,0,0,10.129823664707386,71.11763811438762,TGFB1;ITGAV;ITGB7;ITGA5,4,4,H1
58,KEGG_2021_Human,Small cell lung cancer,4/92,0.0009697845642716096,0.0027614204541971,0,0,9.898601398601398,68.68081833010578,COL4A1;FN1;COL4A5;ITGAV,4,4,H1
59,KEGG_2021_Human,Dilated cardiomyopathy,4/96,0.0011364494404558,0.0031820584332762,0,0,9.46631629240325,64.1801704620759,TGFB1;ITGAV;ITGB7;ITGA5,4,4,H1
60,KEGG_2021_Human,Toxoplasmosis,4/112,0.002005672235562,0.0055238186159741,0,0,8.057387057387057,50.050683504172575,TGFB1;CD40LG;CCR5;GNAI2,4,4,H1
61,KEGG_2021_Human,Diabetic cardiomyopathy,5/203,0.0028385833177393,0.0076916451190357,0,0,5.529461279461279,32.42725021249848,COL1A1;TGFB1;COL1A2;MMP9;TGFBR2,4,4,H1
62,KEGG_2021_Human,Platelet activation,4/124,0.0029014951489587,0.0077373203972233,0,0,7.247252747252747,42.34228511612428,COL1A1;COL1A2;VWF;GNAI2,4,4,H1
63,KEGG_2021_Human,Osteoclast differentiation,4/127,0.0031620803279231,0.0083004608607983,0,0,7.069418386491558,40.69528464133551,TGFB1;SIRPA;LILRA4;TGFBR2,4,4,H1
64,KEGG_2021_Human,Lipid and atherosclerosis,5/215,0.00362863147536,0.0093786167363151,0,0,5.2103174603174605,29.276251245018656,VCAM1;CD40LG;CCL5;MMP9;ICAM1,4,4,H1
65,KEGG_2021_Human,Epithelial cell signaling in Helicobacter pylori infection,3/70,0.0045152543677582,0.0114933747542938,0,0,9.655094094743673,52.14034434693119,CCL5;CXCR2;JAM3,4,4,H1
66,KEGG_2021_Human,Adherens junction,3/71,0.004698406377385,0.0117810786776222,0,0,9.512627877237852,50.99274515455888,ERBB2;PTPRF;TGFBR2,4,4,H1
67,KEGG_2021_Human,Non-small cell lung cancer,3/72,0.0048859971615859,0.0120712871050947,0,0,9.374291115311909,49.88418294518623,ALK;ERBB2;TGFA,4,4,H1
68,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,3/77,0.0058915649401667,0.0141397558564001,0,0,8.738689776733255,44.86647486553567,ITGAV;ITGB7;ITGA5,4,4,H1
69,KEGG_2021_Human,Leishmaniasis,3/77,0.0058915649401667,0.0141397558564001,0,0,8.738689776733255,44.86647486553567,C3;TGFB1;ITGB2,4,4,H1
70,KEGG_2021_Human,B cell receptor signaling pathway,3/81,0.0067788085879237,0.0160399977855097,0,0,8.288879598662207,41.394282739000445,CD79A;CD19;LILRA4,4,4,H1
71,KEGG_2021_Human,TGF-beta signaling pathway,3/94,0.0101897737366175,0.0237761387187743,0,0,7.100095556617296,32.56366977684201,TGFB1;TGFBR2;FBN1,4,4,H1
72,KEGG_2021_Human,Tuberculosis,4/180,0.0107044506007217,0.02463490001262,0,0,4.927322677322677,22.355734433258124,C3;TGFB1;ITGB2;ITGAX,4,4,H1
73,KEGG_2021_Human,Prostate cancer,3/97,0.0110946256353179,0.0251877987396408,0,0,6.87245605920444,30.93494841965997,ERBB2;TGFA;MMP9,4,4,H1
74,KEGG_2021_Human,Transcriptional misregulation in cancer,4/192,0.0133050964163919,0.0295029122150627,0,0,4.610007014262333,19.913423768715287,NGFR;ITGB7;MMP9;TGFBR2,4,4,H1
75,KEGG_2021_Human,African trypanosomiasis,2/37,0.0133465555258617,0.0295029122150627,0,0,12.208909370199692,52.69971994295514,VCAM1;ICAM1,4,4,H1
76,KEGG_2021_Human,Bladder cancer,2/41,0.016232496842391,0.0354163567470349,0,0,10.954507857733663,45.14067945574007,ERBB2;MMP9,4,4,H1
0,KEGG_2021_Human,ECM-receptor interaction,8/88,4.453641863158811e-12,5.567052328948513e-10,0,0,66.27333333333333,1732.2059262923271,COL1A1;ITGB1;LAMB2;COL6A2;ITGA1;SDC1;ITGA5;HSPG2,5,5,H1
1,KEGG_2021_Human,Proteoglycans in cancer,9/205,1.3198017312764869e-10,8.248760820478042e-09,0,0,31.29732582688248,711.9631293987926,COL1A1;ITGB1;TGFB1;GPC1;ERBB2;SDC1;ITGA5;MMP9;HSPG2,5,5,H1
2,KEGG_2021_Human,Cell adhesion molecules,8/148,3.0116153158724086e-10,1.0547953247360604e-08,0,0,37.75619047619048,827.7430976632271,ITGB1;ITGB2;HLA-B;HLA-C;SDC1;ICAM3;HLA-A;L1CAM,5,5,H1
3,KEGG_2021_Human,Phagosome,8/152,3.72705294126051e-10,1.0547953247360604e-08,0,0,36.7,796.7655549443995,ITGB1;C3;ITGB2;HLA-B;HLA-C;ITGA5;HLA-A;CD14,5,5,H1
4,KEGG_2021_Human,Human papillomavirus infection,10/331,4.219181298944241e-10,1.0547953247360604e-08,0,0,21.8524699599466,471.7120017652889,COL1A1;ITGB1;LAMB2;COL6A2;ITGA1;HLA-B;HLA-C;ITGA5;HLA-A;TNFRSF1A,5,5,H1
5,KEGG_2021_Human,Pertussis,6/76,6.170959294334213e-09,1.285616519652961e-07,0,0,53.28214285714286,1007.2142738373032,ITGB1;C3;CXCL8;ITGB2;ITGA5;CD14,5,5,H1
6,KEGG_2021_Human,Amoebiasis,6/102,3.6675860300028995e-08,5.730603171879529e-07,0,0,38.80078125,664.3138816610085,COL1A1;TGFB1;CXCL8;LAMB2;ITGB2;CD14,5,5,H1
7,KEGG_2021_Human,Chagas disease,6/102,3.6675860300028995e-08,5.730603171879529e-07,0,0,38.80078125,664.3138816610085,C3;TGFB1;CXCL8;CCL5;CD3D;TNFRSF1A,5,5,H1
8,KEGG_2021_Human,Focal adhesion,7/201,9.0391077693953e-08,1.255431634638236e-06,0,0,23.008979048885934,373.18539854119854,COL1A1;ITGB1;LAMB2;COL6A2;ITGA1;ERBB2;ITGA5,5,5,H1
9,KEGG_2021_Human,Human T-cell leukemia virus 1 infection,7/219,1.6218591368791357e-07,2.02732392109892e-06,0,0,21.036214242239804,328.8911658183622,TGFB1;ITGB2;HLA-B;HLA-C;HLA-A;CD3D;TNFRSF1A,5,5,H1
10,KEGG_2021_Human,Shigellosis,7/246,3.565446656810704e-07,4.051643928193982e-06,0,0,18.63422864084222,276.6587834695538,ITGB1;C3;CXCL8;CCL5;ITGA5;CD14;TNFRSF1A,5,5,H1
11,KEGG_2021_Human,Tuberculosis,6/180,1.0624862474075024e-06,1.1067565077161484e-05,0,0,21.323275862068964,293.2995032698639,C3;TGFB1;ITGB2;ITGAX;CD14;TNFRSF1A,5,5,H1
12,KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,6/193,1.5949640053980165e-06,1.5336192359596313e-05,0,0,19.8278743315508,264.67554086235896,C3;CXCL8;HLA-B;HLA-C;HLA-A;TNFRSF1A,5,5,H1
13,KEGG_2021_Human,Malaria,4/50,2.395747292225211e-06,2.1390600823439385e-05,0,0,50.93606138107417,659.2051012520457,TGFB1;CXCL8;ITGB2;SDC1,5,5,H1
14,KEGG_2021_Human,Human immunodeficiency virus 1 infection,6/212,2.748825747863139e-06,2.2906881232192823e-05,0,0,17.981796116504853,230.24497263434947,BST2;HLA-B;HLA-C;HLA-A;CD3D;TNFRSF1A,5,5,H1
15,KEGG_2021_Human,Herpes simplex virus 1 infection,8/498,3.5399823812214283e-06,2.6778076322851315e-05,0,0,10.597006802721088,133.00715258077662,BST2;C3;CCL5;HLA-B;HLA-C;ITGA5;HLA-A;TNFRSF1A,5,5,H1
16,KEGG_2021_Human,Human cytomegalovirus infection,6/225,3.874906025049002e-06,2.6778076322851315e-05,0,0,16.903253424657535,210.631257474549,CXCL8;CCL5;HLA-B;HLA-C;HLA-A;TNFRSF1A,5,5,H1
17,KEGG_2021_Human,PI3K-Akt signaling pathway,7/354,4.03645217594628e-06,2.6778076322851315e-05,0,0,12.764246537138607,158.53378548138951,COL1A1;ITGB1;LAMB2;COL6A2;ITGA1;ERBB2;ITGA5,5,5,H1
18,KEGG_2021_Human,Legionellosis,4/57,4.0702676010734e-06,2.6778076322851315e-05,0,0,44.193118756936734,548.5162314220444,C3;CXCL8;ITGB2;CD14,5,5,H1
19,KEGG_2021_Human,Viral myocarditis,4/60,5.004247816512921e-06,3.127654885320575e-05,0,0,41.81932773109244,510.41423918994064,ITGB2;HLA-B;HLA-C;HLA-A,5,5,H1
20,KEGG_2021_Human,Cellular senescence,5/156,1.1039045265632407e-05,6.570860277162148e-05,0,0,19.87858719646799,226.89562552705672,TGFB1;CXCL8;HLA-B;HLA-C;HLA-A,5,5,H1
21,KEGG_2021_Human,Leishmaniasis,4/77,1.3570481443710726e-05,7.710500820290185e-05,0,0,32.05318291700242,359.2396889830151,ITGB1;C3;TGFB1;ITGB2,5,5,H1
22,KEGG_2021_Human,Hypertrophic cardiomyopathy,4/90,2.5174439988949727e-05,0.00013681760863559634,0,0,27.19015047879617,287.9350298187986,ITGB1;TGFB1;ITGA1;ITGA5,5,5,H1
23,KEGG_2021_Human,Rheumatoid arthritis,4/93,2.864901040358138e-05,0.00014921359585198636,0,0,26.269662921348317,274.7909628359514,TGFB1;CXCL8;CCL5;ITGB2,5,5,H1
24,KEGG_2021_Human,IL-17 signaling pathway,4/94,2.988166831668221e-05,0.00014940834158341104,0,0,25.97647058823529,270.6297638438778,CXCL8;MMP9;S100A9;S100A8,5,5,H1
25,KEGG_2021_Human,Dilated cardiomyopathy,4/96,3.246311761891371e-05,0.00015607268086016205,0,0,25.40920716112532,262.61447101876826,ITGB1;TGFB1;ITGA1;ITGA5,5,5,H1
26,KEGG_2021_Human,Hematopoietic cell lineage,4/99,3.663688398828788e-05,0.00016961520364948095,0,0,24.6030959752322,251.3072183176531,ITGA1;ITGA5;CD14;CD3D,5,5,H1
27,KEGG_2021_Human,Allograft rejection,3/38,5.0983396072319205e-05,0.00022208041635497216,0,0,48.800816326530615,482.34778319838193,HLA-B;HLA-C;HLA-A,5,5,H1
28,KEGG_2021_Human,Lipid and atherosclerosis,5/215,5.152265659435354e-05,0.00022208041635497216,0,0,14.25108225108225,140.70790260667985,CXCL8;CCL5;CD14;MMP9;TNFRSF1A,5,5,H1
29,KEGG_2021_Human,Regulation of actin cytoskeleton,5/218,5.50271161292238e-05,0.0002292796505384325,0,0,14.048228766538626,137.7805951564985,ITGB1;ITGA1;ITGB2;ITGAX;ITGA5,5,5,H1
30,KEGG_2021_Human,Toxoplasmosis,4/112,5.938873247607592e-05,0.00023947069546804804,0,0,21.62745098039216,210.46550706889937,ITGB1;TGFB1;LAMB2;TNFRSF1A,5,5,H1
31,KEGG_2021_Human,Bladder cancer,3/41,6.417145309345527e-05,0.00025066973864630967,0,0,44.94135338345865,433.8616729639665,CXCL8;ERBB2;MMP9,5,5,H1
32,KEGG_2021_Human,Graft-versus-host disease,3/42,6.901721319653771e-05,0.0002614288378656732,0,0,43.786813186813184,419.5282273663024,HLA-B;HLA-C;HLA-A,5,5,H1
33,KEGG_2021_Human,Type I diabetes mellitus,3/43,7.409634139154903e-05,0.0002724130198218714,0,0,42.69,405.9880644707658,HLA-B;HLA-C;HLA-A,5,5,H1
34,KEGG_2021_Human,Natural killer cell mediated cytotoxicity,4/131,0.00010918180606895216,0.00038993502167482914,0,0,18.37424733672997,167.61900003034583,ITGB2;HLA-B;HLA-C;HLA-A,5,5,H1
35,KEGG_2021_Human,Fluid shear stress and atherosclerosis,4/139,0.00013726859967362097,0.0004689891430365661,0,0,17.27843137254902,153.66695566218618,GPC1;SDC1;MMP9;TNFRSF1A,5,5,H1
36,KEGG_2021_Human,Autoimmune thyroid disease,3/53,0.00013882078633882357,0.0004689891430365661,0,0,34.13485714285714,303.19695517233794,HLA-B;HLA-C;HLA-A,5,5,H1
37,KEGG_2021_Human,Hepatitis B,4/162,0.000247010191880701,0.0008125335259233584,0,0,14.746090841399852,122.48222436499556,TGFB1;CXCL8;MMP9;HSPG2,5,5,H1
38,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,3/77,0.00042007251923727504,0.0013463862796066,0,0,23.03629343629344,179.10909801172158,ITGB1;ITGA1;ITGA5,5,5,H1
39,KEGG_2021_Human,Antigen processing and presentation,3/78,0.0004363041377333235,0.0013634504304166,0,0,22.728,175.85042235597552,HLA-B;HLA-C;HLA-A,5,5,H1
40,KEGG_2021_Human,Pathways in cancer,6/531,0.0004563704284296364,0.0013913732574074,0,0,6.941785714285714,53.3976438837808,ITGB1;TGFB1;CXCL8;LAMB2;ERBB2;MMP9,5,5,H1
41,KEGG_2021_Human,Complement and coagulation cascades,3/85,0.0005612928576068921,0.0016490273754686,0,0,20.78048780487805,155.5475154201939,C3;ITGB2;ITGAX,5,5,H1
42,KEGG_2021_Human,Epstein-Barr virus infection,4/202,0.0005697923391227778,0.0016490273754686,0,0,11.743315508021391,87.72536857504292,HLA-B;HLA-C;HLA-A;CD3D,5,5,H1
43,KEGG_2021_Human,Viral carcinogenesis,4/203,0.0005804576361649779,0.0016490273754686,0,0,11.68371268105232,87.06344861815656,C3;HLA-B;HLA-C;HLA-A,5,5,H1
44,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,3/100,0.0009010656627178086,0.0024485479965157,0,0,17.55375552282769,123.08574753825548,COL1A1;TGFB1;CXCL8,5,5,H1
45,KEGG_2021_Human,Viral protein interaction with cytokine and cytokine receptor,3/100,0.0009010656627178086,0.0024485479965157,0,0,17.55375552282769,123.08574753825548,CXCL8;CCL5;TNFRSF1A,5,5,H1
46,KEGG_2021_Human,Protein digestion and absorption,3/103,0.000981637378375214,0.0025751908721012,0,0,17.024571428571427,117.91709477173696,COL1A1;COL18A1;COL6A2,5,5,H1
47,KEGG_2021_Human,Toll-like receptor signaling pathway,3/104,0.0010094748218636,0.0025751908721012,0,0,16.855162659123057,116.27239099075166,CXCL8;CCL5;CD14,5,5,H1
48,KEGG_2021_Human,NF-kappa B signaling pathway,3/104,0.0010094748218636,0.0025751908721012,0,0,16.855162659123057,116.27239099075166,CXCL8;CD14;TNFRSF1A,5,5,H1
49,KEGG_2021_Human,TNF signaling pathway,3/112,0.0012503136702798,0.0031257841756997,0,0,15.611795543905636,104.35487450917054,CCL5;MMP9;TNFRSF1A,5,5,H1
50,KEGG_2021_Human,Leukocyte transendothelial migration,3/114,0.0013156853272945,0.0032247189394475,0,0,15.32895752895753,101.6830698940691,ITGB1;ITGB2;MMP9,5,5,H1
51,KEGG_2021_Human,Osteoclast differentiation,3/127,0.001793341739257,0.0043109176424448,0,0,13.712903225806452,86.71593653460145,TGFB1;LILRA4;TNFRSF1A,5,5,H1
52,KEGG_2021_Human,Relaxin signaling pathway,3/129,0.0018752037920586,0.0044226504529684,0,0,13.493877551020407,84.7285690515624,COL1A1;TGFB1;MMP9,5,5,H1
53,KEGG_2021_Human,Yersinia infection,3/137,0.0022258949896533,0.0051487219013859,0,0,12.68315565031983,77.4635932754753,ITGB1;CXCL8;ITGA5,5,5,H1
54,KEGG_2021_Human,MAPK signaling pathway,4/294,0.0022784332664864,0.0051487219013859,0,0,7.98052738336714,48.555661284963165,TGFB1;ERBB2;CD14;TNFRSF1A,5,5,H1
55,KEGG_2021_Human,Cytokine-cytokine receptor interaction,4/295,0.0023066274118209,0.0051487219013859,0,0,7.952698605215282,48.28853793520378,TGFB1;CXCL8;CCL5;TNFRSF1A,5,5,H1
56,KEGG_2021_Human,Non-alcoholic fatty liver disease,3/155,0.0031569053012106,0.0069230379412513,0,0,11.171052631578949,64.32474267490886,TGFB1;CXCL8;TNFRSF1A,5,5,H1
57,KEGG_2021_Human,Influenza A,3/172,0.0042273945202028,0.0091107640521613,0,0,10.038715131022824,54.87331774932685,CXCL8;CCL5;TNFRSF1A,5,5,H1
58,KEGG_2021_Human,Transcriptional misregulation in cancer,3/192,0.005739619802154,0.0121602114452415,0,0,8.96734693877551,46.27475914026221,CXCL8;CD14;MMP9,5,5,H1
59,KEGG_2021_Human,Pathogenic Escherichia coli infection,3/197,0.0061620851222328,0.012837677337985,0,0,8.7340206185567,44.45040106119308,ITGB1;CXCL8;TNFRSF1A,5,5,H1
60,KEGG_2021_Human,Diabetic cardiomyopathy,3/203,0.0066930846089323,0.0137153373133859,0,0,8.46942857142857,42.403722311812665,COL1A1;TGFB1;MMP9,5,5,H1
61,KEGG_2021_Human,Epithelial cell signaling in Helicobacter pylori infection,2/70,0.0078258434281217,0.0157779101373422,0,0,16.25326797385621,78.83361186412243,CXCL8;CCL5,5,5,H1
62,KEGG_2021_Human,Pancreatic cancer,2/76,0.0091697058780525,0.0181938608691519,0,0,14.93093093093093,70.05368929755022,TGFB1;ERBB2,5,5,H1
63,KEGG_2021_Human,Bacterial invasion of epithelial cells,2/77,0.0094030302253684,0.0183652934089228,0,0,14.731111111111112,68.74601912203012,ITGB1;ITGA5,5,5,H1
64,KEGG_2021_Human,Coronavirus disease,3/232,0.0096394396167137,0.0185373838782956,0,0,7.386026200873363,34.285138172296875,C3;CXCL8;TNFRSF1A,5,5,H1
65,KEGG_2021_Human,Salmonella infection,3/249,0.0116679594078328,0.0220984079693804,0,0,6.869686411149826,30.576347054284028,CXCL8;CD14;TNFRSF1A,5,5,H1
66,KEGG_2021_Human,Endocytosis,3/252,0.0120495856005911,0.0224805701503565,0,0,6.785886402753873,29.984965960351683,HLA-B;HLA-C;HLA-A,5,5,H1
67,KEGG_2021_Human,Small cell lung cancer,2/92,0.0132143091797527,0.0242910095216042,0,0,12.266666666666667,53.0711814284684,ITGB1;LAMB2,5,5,H1
68,KEGG_2021_Human,Staphylococcus aureus infection,2/95,0.0140449012921475,0.0254436617611368,0,0,11.869175627240145,50.62791933844144,C3;ITGB2,5,5,H1
69,KEGG_2021_Human,Prostate cancer,2/97,0.0146109514440451,0.0260909847215092,0,0,11.61812865497076,49.0980250221381,ERBB2;MMP9,5,5,H1
70,KEGG_2021_Human,Th17 cell differentiation,2/107,0.0175861325993337,0.030961501055165,0,0,10.506349206349206,42.452423270430806,TGFB1;CD3D,5,5,H1
71,KEGG_2021_Human,MicroRNAs in cancer,3/310,0.0208560493544535,0.0362084190181484,0,0,5.487668683108423,21.237888229474876,ERBB2;ITGA5;MMP9,5,5,H1
72,KEGG_2021_Human,Platelet activation,2/124,0.0231770660321675,0.0396867569043965,0,0,9.034608378870674,34.0116146279468,COL1A1;ITGB1,5,5,H1
0,KEGG_2021_Human,PI3K-Akt signaling pathway,38/354,4.115704812158334e-35,8.848765346140416e-33,0,0,24.235351689938668,1918.8501630599712,LAMA5;ITGB5;ITGB4;TNC;PDGFB;TGFA;THBS2;AREG;THBS1;EGFR;HSP90B1;FGF4;RXRA;ERBB3;ERBB2;ITGB8;ITGAV;ITGB7;ITGB6;HRAS;PDGFRB;NGFR;HSP90AA1;INSR;HGF;F2R;FN1;VEGFA;COL1A1;EFNA1;COL1A2;COL4A2;COL4A1;ITGA11;COL4A5;ITGA5;FGFR4;FGFR1,6,6,H1
1,KEGG_2021_Human,Pathways in cancer,42/531,2.2075310719526146e-33,2.3730959023490604e-31,0,0,17.89458407546672,1345.5552148216398,NOTCH2;ALK;NOTCH3;LAMA5;NOTCH1;GSTP1;LRP5;PDGFB;TGFA;CXCR4;EGFR;LRP6;HSP90B1;FGF4;PLD2;GNAI2;RXRA;CDH1;ERBB2;BDKRB2;ITGAV;HRAS;PDGFRB;JAG2;HSP90AA1;TGFB1;TGFB3;HGF;F2R;FN1;TRAF2;VEGFA;AR;COL4A2;COL4A1;GNAS;COL4A5;CALM3;CALM1;FGFR4;CALM2;FGFR1,6,6,H1
2,KEGG_2021_Human,ECM-receptor interaction,22/88,6.148178812474949e-29,4.406194815607047e-27,0,0,58.40412979351032,3793.862874835269,LAMA5;ITGB5;SDC4;ITGB4;TNC;FN1;THBS2;HSPG2;THBS1;COL1A1;COL1A2;COL4A2;COL4A1;ITGA11;ITGB8;COL4A5;SDC1;ITGAV;ITGB7;ITGB6;ITGA5;CD44,6,6,H1
3,KEGG_2021_Human,Focal adhesion,26/201,3.904134841872774e-26,2.098472477506616e-24,0,0,26.83826998689384,1570.177714767572,LAMA5;ITGB5;ITGB4;TNC;PDGFB;THBS2;THBS1;EGFR;ERBB2;ITGB8;ITGAV;ITGB7;ITGB6;HRAS;PDGFRB;HGF;FN1;VEGFA;COL1A1;COL1A2;COL4A2;COL4A1;ITGA11;COL4A5;ITGA5;VCL,6,6,H1
4,KEGG_2021_Human,Human papillomavirus infection,30/331,1.9284054286669902e-25,8.292143343268057e-24,0,0,18.570479354532512,1056.807610971205,NOTCH2;NOTCH3;LAMA5;NOTCH1;ITGB5;ITGB4;TNC;PSEN1;THBS2;TNF;THBS1;EGFR;ITGB8;ITGAV;ITGB7;ITGB6;HRAS;PDGFRB;HLA-B;FN1;TNFRSF1A;VEGFA;COL1A1;COL1A2;COL4A2;COL4A1;ITGA11;GNAS;COL4A5;ITGA5,6,6,H1
5,KEGG_2021_Human,Proteoglycans in cancer,24/205,4.2007612297149204e-23,1.50527277398118e-21,0,0,23.513812154696133,1211.5301576454217,TGFB1;SDC4;ITGB5;HGF;SDC2;FN1;TNF;HSPG2;THBS1;EGFR;VEGFA;COL1A1;COL1A2;ERBB3;PLAU;GPC1;ERBB2;SDC1;ITGAV;ITGA5;EZR;HRAS;CD44;FGFR1,6,6,H1
6,KEGG_2021_Human,Regulation of actin cytoskeleton,22/218,8.297200863387808e-20,2.5484259794691125e-18,0,0,19.537565468665345,858.3982494268912,PDGFRB;ITGB5;ITGB4;F2R;ITGB2;PDGFB;FN1;CXCR4;EGFR;FGF4;ITGA11;BDKRB2;ITGB8;ITGAV;ITGB7;ITGA5;ITGB6;EZR;FGFR4;HRAS;VCL;FGFR1,6,6,H1
7,KEGG_2021_Human,Rap1 signaling pathway,21/210,7.349068644383342e-19,1.975062198178023e-17,0,0,19.17738791423002,800.7430716818292,PDGFRB;NGFR;INSR;HGF;F2R;ITGB2;PDGFB;THBS1;EGFR;FGF4;VEGFA;GNAI2;EFNA1;CDH1;GNAS;CALM3;CALM1;FGFR4;CALM2;HRAS;FGFR1,6,6,H1
8,KEGG_2021_Human,Fluid shear stress and atherosclerosis,18/139,2.460816876186877e-18,5.878618093113096e-17,0,0,25.103623649078195,1017.8524863353952,ACVR1;HSP90AA1;VCAM1;SDC4;SDC2;GSTP1;PDGFB;TNF;ACVR2B;HSP90B1;TNFRSF1A;VEGFA;GPC1;SDC1;CALM3;ITGAV;CALM1;CALM2,6,6,H1
9,KEGG_2021_Human,MAPK signaling pathway,21/294,7.338462822150282e-16,1.5777695067623102e-14,0,0,13.219973009446694,460.69268768298775,PDGFRB;NGFR;TGFB1;TGFB3;INSR;HGF;PDGFB;TGFA;TRAF2;TNF;AREG;EGFR;FGF4;TNFRSF1A;VEGFA;EFNA1;ERBB3;ERBB2;FGFR4;HRAS;FGFR1,6,6,H1
10,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,13/100,1.446745465783365e-13,2.8277297740311227e-12,0,0,24.224043715847,716.1666456732571,TGFB1;VCAM1;TGFB3;FN1;TNF;AGER;VEGFA;COL1A1;COL1A2;COL4A2;COL4A1;COL4A5;HRAS,6,6,H1
11,KEGG_2021_Human,Amoebiasis,13/102,1.8814813467423917e-13,3.334667061195335e-12,0,0,23.677288635107757,693.7811808482528,LAMA5;TGFB1;TGFB3;ITGB2;FN1;TNF;COL1A1;COL1A2;COL4A2;COL4A1;GNAS;COL4A5;VCL,6,6,H1
12,KEGG_2021_Human,Human cytomegalovirus infection,17/225,2.0163103160715978e-13,3.334667061195335e-12,0,0,13.615099413298566,398.00117357473096,HLA-B;CXCR4;TRAF2;TNF;EGFR;TNFRSF1A;VEGFA;GNAI2;CCL5;GNAS;CALM3;ITGAV;CALR;CALM1;CALM2;B2M;HRAS,6,6,H1
13,KEGG_2021_Human,Ras signaling pathway,17/232,3.326397197353719e-13,5.108395695936069e-12,0,0,13.16712652739456,378.3141453637684,PDGFRB;NGFR;INSR;HGF;PDGFB;TGFA;EGFR;FGF4;VEGFA;PLD2;EFNA1;CALM3;CALM1;FGFR4;CALM2;HRAS;FGFR1,6,6,H1
14,KEGG_2021_Human,Calcium signaling pathway,17/240,5.775985372571809e-13,8.278912367352928e-12,0,0,12.689594892452687,357.5914813527737,PDGFRB;HGF;F2R;PDGFB;CXCR4;EGFR;FGF4;VEGFA;ERBB3;ERBB2;GNAS;BDKRB2;CALM3;CALM1;FGFR4;CALM2;FGFR1,6,6,H1
15,KEGG_2021_Human,Hypertrophic cardiomyopathy,12/90,9.524203520987992e-13,1.2798148481327615e-11,0,0,24.749218261413382,685.0526669592278,ACE;TGFB1;ITGB5;ITGB4;TGFB3;ITGA11;ITGB8;ITGAV;ITGB7;ITGB6;ITGA5;TNF,6,6,H1
16,KEGG_2021_Human,Malaria,10/50,1.143428900509029e-12,1.4461012565261247e-11,0,0,39.65,1090.2556360722754,TGFB1;VCAM1;TGFB3;HGF;SDC2;ITGB2;SDC1;THBS2;TNF;THBS1,6,6,H1
17,KEGG_2021_Human,Dilated cardiomyopathy,12/96,2.0991416391937585e-12,2.507308069036989e-11,0,0,22.97444831591173,617.7712579338081,TGFB1;ITGB5;ITGB4;TGFB3;ITGA11;GNAS;ITGB8;ITGAV;ITGB7;ITGB6;ITGA5;TNF,6,6,H1
18,KEGG_2021_Human,Prostate cancer,12/97,2.3818786874406336e-12,2.6952837778933485e-11,0,0,22.703012912482063,607.603721729282,PDGFRB;AR;HSP90AA1;PLAU;GSTP1;ERBB2;PDGFB;TGFA;HRAS;EGFR;HSP90B1;FGFR1,6,6,H1
19,KEGG_2021_Human,Axon guidance,14/182,2.3593377429384345e-11,2.5362880736588165e-10,0,0,13.56542699724518,331.9467455441754,EPHB6;NRP1;SEMA4D;SEMA4C;CXCR4;SEMA3F;GNAI2;EFNA1;EFNB1;PLXNB2;PLXNA1;PLXNB1;HRAS;EPHB4,6,6,H1
20,KEGG_2021_Human,MicroRNAs in cancer,17/310,3.4505679540599035e-11,3.5327243339184726e-10,0,0,9.623532133973509,231.8298996261945,PDGFRB;NOTCH2;NOTCH3;NOTCH1;TNC;PDGFB;THBS1;EGFR;VEGFA;EFNA1;ERBB3;PLAU;ERBB2;ITGA5;EZR;HRAS;CD44,6,6,H1
21,KEGG_2021_Human,Human T-cell leukemia virus 1 infection,14/219,2.786620556166468e-10,2.723288270799048e-09,0,0,11.09614996976416,244.1266322597452,NRP1;TGFB1;MMP7;TGFB3;ITGB2;HLA-B;TNF;TNFRSF1A;CANX;LTA;CALR;LTBR;B2M;HRAS,6,6,H1
22,KEGG_2021_Human,Alzheimer disease,17/369,5.141641528934693e-10,4.806317081395473e-09,0,0,7.986349191063174,170.8158582688553,APP;INSR;LRP5;ADAM10;TRAF2;PSEN1;TNF;AGER;RTN4;LRP6;TNFRSF1A;NCSTN;CALM3;APOE;CALM1;CALM2;HRAS,6,6,H1
23,KEGG_2021_Human,Relaxin signaling pathway,11/129,1.1866990205921414e-09,1.0630845392804602e-08,0,0,14.845338983050848,305.10274755988183,COL1A1;TGFB1;COL1A2;COL4A2;COL4A1;GNAS;COL4A5;HRAS;EGFR;GNAI2;VEGFA,6,6,H1
24,KEGG_2021_Human,Chagas disease,10/102,1.7631751630503615e-09,1.516330640223311e-08,0,0,17.19391304347826,346.5630832276484,ACE;TGFB1;TGFB3;CCL5;GNAS;BDKRB2;CALR;TNF;TNFRSF1A;GNAI2,6,6,H1
25,KEGG_2021_Human,Lipid and atherosclerosis,13/215,2.45911056178859e-09,2.0334952722482573e-08,0,0,10.372463885732836,205.6181863432966,HSP90AA1;VCAM1;TRAF2;TNF;AGER;HSP90B1;TNFRSF1A;RXRA;CCL5;CALM3;CALM1;CALM2;HRAS,6,6,H1
26,KEGG_2021_Human,Breast cancer,11/147,4.760507735560831e-09,3.7907746783169584e-08,0,0,12.868773719165086,246.60317198727492,JAG2;NOTCH2;NOTCH3;NOTCH1;ERBB2;LRP5;HRAS;EGFR;LRP6;FGFR1;FGF4,6,6,H1
27,KEGG_2021_Human,Cell adhesion molecules,11/148,5.113486533782071e-09,3.926427159868375e-08,0,0,12.774193548387096,243.8770390381729,VCAM1;SDC4;CDH1;SDC2;ITGB2;HLA-B;SDC1;ITGB8;ITGAV;ITGB7;PTPRF,6,6,H1
28,KEGG_2021_Human,Gastric cancer,11/149,5.489679412816753e-09,4.0699347370882826e-08,0,0,12.680984104721832,241.1973390610248,TGFB1;RXRA;TGFB3;CDH1;HGF;ERBB2;LRP5;HRAS;EGFR;LRP6;FGF4,6,6,H1
29,KEGG_2021_Human,Cytokine-cytokine receptor interaction,14/295,1.3083467725228634e-08,9.376485203080521e-08,0,0,8.063762830504984,146.3727488449311,ACVR1;NGFR;TGFB1;TGFB3;CXCR4;TNF;ACVR2B;TNFRSF1A;CXCL10;CCL5;LTA;LTBR;LTB;INHA,6,6,H1
30,KEGG_2021_Human,Human immunodeficiency virus 1 infection,12/212,2.1729825118216677e-08,1.5070685162634144e-07,0,0,9.592682926829267,169.25886218667506,HLA-B;CXCR4;CALM3;TRAF2;CALR;CALM1;CALM2;TNF;B2M;HRAS;TNFRSF1A;GNAI2,6,6,H1
31,KEGG_2021_Human,Melanoma,8/72,2.910613433718908e-08,1.9555684007798914e-07,0,0,19.489173228346456,338.18230964632426,PDGFRB;CDH1;HGF;PDGFB;HRAS;EGFR;FGF4;FGFR1,6,6,H1
32,KEGG_2021_Human,Estrogen signaling pathway,10/137,3.1094379803908434e-08,2.025845956921307e-07,0,0,12.433385826771651,214.9264758449956,HSP90AA1;GNAS;TGFA;CALM3;CALM1;CALM2;HRAS;EGFR;HSP90B1;GNAI2,6,6,H1
33,KEGG_2021_Human,Glioma,8/75,4.0337265645160016e-08,2.5507388569733536e-07,0,0,18.61370313785404,316.9167251527991,PDGFRB;PDGFB;TGFA;CALM3;CALM1;HRAS;CALM2;EGFR,6,6,H1
34,KEGG_2021_Human,"Parathyroid hormone synthesis, secretion and action",9/106,4.1979294829745226e-08,2.578728110970064e-07,0,0,14.556701030927837,247.26142392260024,RXRA;GNAS;LRP5;EGFR;PTHLH;PLD2;FGFR1;GNAI2;LRP6,6,6,H1
35,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,8/77,4.974451425820071e-08,2.970852934864765e-07,0,0,18.07234965194568,303.91123982204067,ITGB5;ITGB4;ITGA11;ITGB8;ITGAV;ITGB7;ITGB6;ITGA5,6,6,H1
36,KEGG_2021_Human,Chemical carcinogenesis,12/239,8.141384643431278e-08,4.730804590101958e-07,0,0,8.44009885032771,137.7738144123313,NOTCH2;AR;HSP90AA1;RXRA;GSTP1;GNAS;HRAS;EGFR;HSP90B1;FGF4;VEGFA;GNAI2,6,6,H1
37,KEGG_2021_Human,Small cell lung cancer,8/92,2.0217094918152347e-07,1.1438619493165143e-06,0,0,14.833895763029622,228.65192722334743,LAMA5;RXRA;COL4A2;COL4A1;FN1;COL4A5;ITGAV;TRAF2,6,6,H1
38,KEGG_2021_Human,TGF-beta signaling pathway,8/94,2.390599881646584e-07,1.317894806548758e-06,0,0,14.48745650979674,220.88374917294792,ACVR1;TGFB1;TGFB3;TNF;LTBP1;THBS1;ACVR2B;FBN1,6,6,H1
39,KEGG_2021_Human,Bladder cancer,6/41,3.132220430742377e-07,1.6835684815240275e-06,0,0,26.35215946843854,394.65925555911934,CDH1;ERBB2;THBS1;HRAS;EGFR;VEGFA,6,6,H1
40,KEGG_2021_Human,Renal cell carcinoma,7/69,4.1572163380013036e-07,2.1800036894397075e-06,0,0,17.467363911290324,256.6523439194216,TGFB1;TGFB3;HGF;PDGFB;TGFA;HRAS;VEGFA,6,6,H1
41,KEGG_2021_Human,Adherens junction,7/71,5.067280571918278e-07,2.593965054672452e-06,0,0,16.9197998046875,245.2574278135967,CDH1;INSR;ERBB2;PTPRF;VCL;EGFR;FGFR1,6,6,H1
42,KEGG_2021_Human,NF-kappa B signaling pathway,8/104,5.227999583639082e-07,2.613999791819541e-06,0,0,12.971784776902886,187.624763277422,VCAM1;PLAU;LTA;TRAF2;LTB;LTBR;TNF;TNFRSF1A,6,6,H1
43,KEGG_2021_Human,Non-small cell lung cancer,7/72,5.581648608156674e-07,2.727396478985648e-06,0,0,16.658653846153847,239.86148432252176,ALK;RXRA;HGF;ERBB2;TGFA;HRAS;EGFR,6,6,H1
44,KEGG_2021_Human,Phospholipase D signaling pathway,9/148,7.378502814912968e-07,3.525284678236196e-06,0,0,10.136690647482014,143.12525603655226,PDGFRB;ARF1;INSR;F2R;GNAS;PDGFB;HRAS;EGFR;PLD2,6,6,H1
45,KEGG_2021_Human,Pancreatic cancer,7/76,8.100091804627959e-07,3.705361144670236e-06,0,0,15.689764492753625,220.06809253133585,TGFB1;TGFB3;ERBB2;TGFA;EGFR;PLD2;VEGFA,6,6,H1
46,KEGG_2021_Human,Pertussis,7/76,8.100091804627959e-07,3.705361144670236e-06,0,0,15.689764492753625,220.06809253133585,ITGB2;CALM3;ITGA5;CALM1;TNF;CALM2;GNAI2,6,6,H1
47,KEGG_2021_Human,Phagosome,9/152,9.23074602775892e-07,4.134604991600349e-06,0,0,9.851148851148851,136.8871883513301,ITGB5;CANX;ITGB2;HLA-B;ITGAV;ITGA5;CALR;THBS2;THBS1,6,6,H1
48,KEGG_2021_Human,Antigen processing and presentation,7/78,9.67958991371844e-07,4.247167002958091e-06,0,0,15.246258802816902,211.13135236814855,HSP90AA1;CANX;HLA-B;KLRD1;CALR;TNF;B2M,6,6,H1
49,KEGG_2021_Human,Hepatocellular carcinoma,9/168,2.1240393903147967e-06,9.133369378353624e-06,0,0,8.852650494159928,115.63501080900502,TGFB1;TGFB3;HGF;GSTP1;LRP5;TGFA;HRAS;EGFR;LRP6,6,6,H1
50,KEGG_2021_Human,Notch signaling pathway,6/59,2.841572288491994e-06,1.1979177294623112e-05,0,0,17.38657305835893,222.04658530468168,NOTCH2;JAG2;NOTCH3;NCSTN;NOTCH1;PSEN1,6,6,H1
51,KEGG_2021_Human,GnRH signaling pathway,7/93,3.1915915046116566e-06,1.2947022141349172e-05,0,0,12.577489098837209,159.16800960403492,GNAS;CALM3;CALM1;HRAS;CALM2;EGFR;PLD2,6,6,H1
52,KEGG_2021_Human,Rheumatoid arthritis,7/93,3.1915915046116566e-06,1.2947022141349172e-05,0,0,12.577489098837209,159.16800960403492,TGFB1;TGFB3;CCL5;ITGB2;LTB;TNF;VEGFA,6,6,H1
53,KEGG_2021_Human,Viral protein interaction with cytokine and cytokine receptor,7/100,5.185808428072518e-06,2.064720022288132e-05,0,0,11.626680107526882,141.49186964751644,CXCL10;CCL5;LTA;CXCR4;LTBR;TNF;TNFRSF1A,6,6,H1
54,KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,9/193,6.611066079432736e-06,2.5843258310509785e-05,0,0,7.640139751552795,91.12215622996597,HLA-B;PDGFB;CALM3;TRAF2;CALM1;CALM2;HRAS;TNFRSF1A;VEGFA,6,6,H1
55,KEGG_2021_Human,Renin secretion,6/69,7.154113479454545e-06,2.74666856800487e-05,0,0,14.619416758951642,173.20826292553215,ACE;GNAS;CALM3;CALM1;CALM2;GNAI2,6,6,H1
56,KEGG_2021_Human,TNF signaling pathway,7/112,1.097504868863198e-05,4.139711347466448e-05,0,0,10.291666666666666,117.52966175769548,CXCL10;VCAM1;CCL5;LTA;TRAF2;TNF;TNFRSF1A,6,6,H1
57,KEGG_2021_Human,Gastric acid secretion,6/76,1.2552654227873572e-05,4.653139067228997e-05,0,0,13.152823920265782,148.43722582932205,GNAS;CALM3;EZR;CALM1;CALM2;GNAI2,6,6,H1
58,KEGG_2021_Human,Sphingolipid signaling pathway,7/119,1.63194089987789e-05,5.94690327921604e-05,0,0,9.64501953125,106.31854934499589,BDKRB2;TRAF2;TNF;HRAS;PLD2;TNFRSF1A;GNAI2,6,6,H1
59,KEGG_2021_Human,ErbB signaling pathway,6/85,2.389638620166935e-05,8.562871722264851e-05,0,0,11.64910214895496,123.96722088826152,ERBB3;ERBB2;TGFA;AREG;HRAS;EGFR,6,6,H1
60,KEGG_2021_Human,Colorectal cancer,6/86,2.5547442001975664e-05,9.004426279384866e-05,0,0,11.502906976744184,121.64293488379916,TGFB1;TGFB3;TGFA;AREG;HRAS;EGFR,6,6,H1
61,KEGG_2021_Human,Gap junction,6/88,2.9124905566926876e-05,0.00010099765640143997,0,0,11.221213840045378,117.1934247326327,PDGFRB;PDGFB;GNAS;HRAS;EGFR;GNAI2,6,6,H1
62,KEGG_2021_Human,Tuberculosis,8/180,3.08660452261028e-05,0.00010533650354939842,0,0,7.212232191906244,74.90518939263477,TGFB1;TGFB3;ITGB2;CALM3;CALM1;CALM2;TNF;TNFRSF1A,6,6,H1
63,KEGG_2021_Human,Apelin signaling pathway,7/137,4.0523543181511046e-05,0.00013613377787538867,0,0,8.301983173076923,83.96316482253641,NOTCH3;CDH1;CALM3;CALM1;CALM2;HRAS;GNAI2,6,6,H1
64,KEGG_2021_Human,IL-17 signaling pathway,6/94,4.233575501512254e-05,0.00014003365120386686,0,0,10.452959830866808,105.260036055188,CXCL10;HSP90AA1;TRAF2;TNF;S100A8;HSP90B1,6,6,H1
65,KEGG_2021_Human,Shigellosis,9/246,4.530922776670895e-05,0.00014759824196730948,0,0,5.915611814345992,59.167948436921705,ARF1;CCL5;TRAF2;ITGA5;TNF;EGFR;VCL;CD44;TNFRSF1A,6,6,H1
66,KEGG_2021_Human,Melanogenesis,6/101,6.340511528616871e-05,0.00020346417591830256,0,0,9.679314565483477,93.55992565809356,GNAS;CALM3;CALM1;CALM2;HRAS;GNAI2,6,6,H1
67,KEGG_2021_Human,Oxytocin signaling pathway,7/154,8.50576384196678e-05,0.00026893223912100847,0,0,7.335565476190476,68.75025055081817,GNAS;CALM3;CALM1;CALM2;HRAS;EGFR;GNAI2,6,6,H1
68,KEGG_2021_Human,Cellular senescence,7/156,9.223181806758e-05,0.0002841262914189836,0,0,7.23636744966443,67.23457624212213,TGFB1;TGFB3;HLA-B;CALM3;CALM1;CALM2;HRAS,6,6,H1
69,KEGG_2021_Human,Pathways of neurodegeneration,12/475,9.250623441548302e-05,0.0002841262914189836,0,0,4.088289522204077,37.97299185411598,APP;LRP5;CALM3;TRAF2;PSEN1;CALM1;CALM2;TNF;AGER;HRAS;LRP6;TNFRSF1A,6,6,H1
70,KEGG_2021_Human,Hepatitis C,7/157,9.599949644445044e-05,0.00029070270050080064,0,0,7.187760416666666,66.49517636862338,CXCL10;RXRA;TRAF2;TNF;HRAS;EGFR;TNFRSF1A,6,6,H1
71,KEGG_2021_Human,Central carbon metabolism in cancer,5/70,0.00011073685549890391,0.00032733610294582576,0,0,11.715976331360949,106.71325803431614,PDGFRB;ERBB2;HRAS;EGFR;FGFR1,6,6,H1
72,KEGG_2021_Human,cAMP signaling pathway,8/216,0.00011130826895231802,0.00032733610294582576,0,0,5.953058752271351,54.19192615373536,F2R;GNAS;CALM3;FFAR2;CALM1;CALM2;PLD2;GNAI2,6,6,H1
73,KEGG_2021_Human,Toxoplasmosis,6/112,0.000112664519153447,0.00032733610294582576,0,0,8.670030715225977,78.82008165996885,LAMA5;TGFB1;TGFB3;TNF;TNFRSF1A;GNAI2,6,6,H1
74,KEGG_2021_Human,Leukocyte transendothelial migration,6/114,0.00012421887629557166,0.00035609411204730546,0,0,8.508613264427218,76.52191913988794,VCAM1;ITGB2;CXCR4;EZR;VCL;GNAI2,6,6,H1
75,KEGG_2021_Human,Neurotrophin signaling pathway,6/119,0.00015724794972083085,0.0004448461735523504,0,0,8.13006791520889,71.20058765770717,NGFR;CALM3;PSEN1;CALM1;CALM2;HRAS,6,6,H1
76,KEGG_2021_Human,Thyroid hormone signaling pathway,6/121,0.00017225686909673704,0.0004809769721532268,0,0,7.987866531850354,69.22703517162469,NOTCH2;NOTCH3;NOTCH1;RXRA;ITGAV;HRAS,6,6,H1
77,KEGG_2021_Human,Vascular smooth muscle contraction,6/133,0.0002877139361484459,0.0007930576445117419,0,0,7.22871268998352,58.93962588756074,RAMP2;RAMP3;GNAS;CALM3;CALM1;CALM2,6,6,H1
78,KEGG_2021_Human,Salmonella infection,8/249,0.0002935033318728664,0.0007987748905400794,0,0,5.129284150684484,41.71965618898672,HSP90AA1;ARF1;TRAF2;TNF;HRAS;HSP90B1;S100A10;TNFRSF1A,6,6,H1
79,KEGG_2021_Human,Intestinal immune network for IgA production,4/48,0.0003068582908857377,0.0008246816567554201,0,0,13.75503122831367,111.2661602468319,TGFB1;CXCR4;ITGB7;LTBR,6,6,H1
80,KEGG_2021_Human,Endocytosis,8/252,0.000318055797095324,0.0008442221774752427,0,0,5.0654446882664255,40.79346328316052,ARF4;ARF1;HLA-B;CXCR4;FGFR4;HRAS;EGFR;PLD2,6,6,H1
81,KEGG_2021_Human,Insulin signaling pathway,6/137,0.00033737498819168737,0.0008845807617221072,0,0,7.00656843600213,56.01271880127128,INSR;CALM3;CALM1;CALM2;HRAS;PTPRF,6,6,H1
82,KEGG_2021_Human,Salivary secretion,5/93,0.0004201447559209904,0.0010883267773856,0,0,8.643793706293707,67.20472892207238,TRPV6;GNAS;CALM3;CALM1;CALM2,6,6,H1
83,KEGG_2021_Human,Epstein-Barr virus infection,7/202,0.00044972712317614986,0.001151087279558,0,0,5.516426282051282,42.51437774939274,CXCL10;HLA-B;TRAF2;CALR;TNF;B2M;CD44,6,6,H1
84,KEGG_2021_Human,Diabetic cardiomyopathy,7/203,0.0004632080258578193,0.0011716438301109,0,0,5.488002232142857,42.13322780205612,COL1A1;TGFB1;COL1A2;ACE;TGFB3;INSR;AGER,6,6,H1
85,KEGG_2021_Human,Circadian entrainment,5/97,0.0005099151450358353,0.0012747878625895,0,0,8.266304347826088,62.669053985615626,GNAS;CALM3;CALM1;CALM2;GNAI2,6,6,H1
86,KEGG_2021_Human,Choline metabolism in cancer,5/98,0.0005344515974762214,0.0013057624256521,0,0,8.177005789909016,61.60776441036546,PDGFRB;PDGFB;HRAS;EGFR;PLD2,6,6,H1
87,KEGG_2021_Human,Inflammatory mediator regulation of TRP channels,5/98,0.0005344515974762214,0.0013057624256521,0,0,8.177005789909016,61.60776441036546,GNAS;BDKRB2;CALM3;CALM1;CALM2,6,6,H1
88,KEGG_2021_Human,mTOR signaling pathway,6/154,0.0006278116651998344,0.0015166236855951,0,0,6.196417347580138,45.68786019764615,INSR;LRP5;TNF;HRAS;LRP6;TNFRSF1A,6,6,H1
89,KEGG_2021_Human,Endometrial cancer,4/58,0.0006351379215018689,0.0015172739235877,0,0,11.202148713599096,82.46650401149974,CDH1;ERBB2;HRAS;EGFR,6,6,H1
90,KEGG_2021_Human,Non-alcoholic fatty liver disease,6/155,0.000649525565057465,0.0015345933679929,0,0,6.154518495395661,45.16966287347973,TGFB1;RXRA;INSR;TRAF2;TNF;TNFRSF1A,6,6,H1
91,KEGG_2021_Human,Protein digestion and absorption,5/103,0.000670692137721172,0.0015673783653266,0,0,7.757849293563579,56.68815897561563,COL1A1;COL1A2;COL4A2;COL4A1;COL4A5,6,6,H1
92,KEGG_2021_Human,C-type lectin receptor signaling pathway,5/104,0.0007007943180564727,0.0016201158965821,0,0,7.679098679098679,55.77556768838297,CALM3;CALM1;TNF;CALM2;HRAS,6,6,H1
93,KEGG_2021_Human,HIF-1 signaling pathway,5/109,0.0008667192391201379,0.0019706929863843,0,0,7.308062130177515,51.52765131764256,INSR;ERBB2;LTBR;EGFR;VEGFA,6,6,H1
94,KEGG_2021_Human,Phototransduction,3/28,0.0008707713195651805,0.0019706929863843,0,0,18.036363636363635,127.08658391924652,CALM3;CALM1;CALM2,6,6,H1
95,KEGG_2021_Human,cGMP-PKG signaling pathway,6/167,0.0009582322698338492,0.002146041020982,0,0,5.692329914776831,39.564085715730506,INSR;BDKRB2;CALM3;CALM1;CALM2;GNAI2,6,6,H1
96,KEGG_2021_Human,Long-term potentiation,4/67,0.0010949931084058,0.0024270465804871,0,0,9.597479704349931,65.42608833688054,CALM3;CALM1;HRAS;CALM2,6,6,H1
97,KEGG_2021_Human,Adipocytokine signaling pathway,4/69,0.0012222680472269,0.0026544205066039,0,0,9.301233118027012,62.38380852732162,RXRA;TRAF2;TNF;TNFRSF1A,6,6,H1
98,KEGG_2021_Human,Amphetamine addiction,4/69,0.0012222680472269,0.0026544205066039,0,0,9.301233118027012,62.38380852732162,GNAS;CALM3;CALM1;CALM2,6,6,H1
99,KEGG_2021_Human,Platelet activation,5/124,0.0015413547931355,0.0033139128052414,0,0,6.382029734970912,41.32423933984256,COL1A1;COL1A2;F2R;GNAS;GNAI2,6,6,H1
100,KEGG_2021_Human,Alcoholism,6/186,0.0016642718373863,0.0035427568815649,0,0,5.08656330749354,32.545701791371506,GNAS;CALM3;CALM1;CALM2;HRAS;GNAI2,6,6,H1
101,KEGG_2021_Human,Bacterial invasion of epithelial cells,4/77,0.0018355515040819,0.0038314910036662,0,0,8.278573669350623,52.15841077799496,CDH1;FN1;ITGA5;VCL,6,6,H1
102,KEGG_2021_Human,Leishmaniasis,4/77,0.0018355515040819,0.0038314910036662,0,0,8.278573669350623,52.15841077799496,TGFB1;TGFB3;ITGB2;TNF,6,6,H1
103,KEGG_2021_Human,FoxO signaling pathway,5/131,0.0019624822952467,0.0040076075464938,0,0,6.025335775335775,37.559202478228414,TGFB1;TGFB3;INSR;HRAS;EGFR,6,6,H1
104,KEGG_2021_Human,Natural killer cell mediated cytotoxicity,5/131,0.0019624822952467,0.0040076075464938,0,0,6.025335775335775,37.559202478228414,ITGB2;HLA-B;KLRD1;TNF;HRAS,6,6,H1
105,KEGG_2021_Human,Thyroid cancer,3/37,0.0019758437205969,0.0040076075464938,0,0,13.256016042780749,82.54202742621996,RXRA;CDH1;HRAS,6,6,H1
106,KEGG_2021_Human,Dopaminergic synapse,5/132,0.0020288697813119,0.0040767009624491,0,0,5.977589339794064,37.06270610614113,GNAS;CALM3;CALM1;CALM2;GNAI2,6,6,H1
107,KEGG_2021_Human,Pathogenic Escherichia coli infection,6/197,0.0022226441193877,0.0044247082006331,0,0,4.790941190795081,29.268136397334576,ARF1;F2R;TRAF2;EZR;TNF;TNFRSF1A,6,6,H1
108,KEGG_2021_Human,Complement and coagulation cascades,4/85,0.0026349236253045,0.0051973264168852,0,0,7.457921025351051,44.29185524777077,PLAU;ITGB2;F2R;BDKRB2,6,6,H1
109,KEGG_2021_Human,Apoptosis,5/142,0.0027860934991554,0.0054455463847128,0,0,5.538461538461538,32.58340528890666,NGFR;TRAF2;TNF;HRAS;TNFRSF1A,6,6,H1
110,KEGG_2021_Human,Graft-versus-host disease,3/42,0.0028484830938718,0.0055125805727303,0,0,11.553613053613054,67.71536418059175,HLA-B;KLRD1;TNF,6,6,H1
111,KEGG_2021_Human,Signaling pathways regulating pluripotency of stem cells,5/143,0.0028716698797478,0.0055125805727303,0,0,5.498049052396879,32.17932005702284,ACVR1;FGFR4;ACVR2B;HRAS;FGFR1,6,6,H1
112,KEGG_2021_Human,Type I diabetes mellitus,3/43,0.0030471379886528,0.0057976519253129,0,0,11.264204545454543,65.25976032911598,HLA-B;LTA;TNF,6,6,H1
113,KEGG_2021_Human,Th1 and Th2 cell differentiation,4/92,0.0035068829971952,0.006589929996689,0,0,6.8622484385843165,38.7924803087868,NOTCH2;JAG2;NOTCH3;NOTCH1,6,6,H1
114,KEGG_2021_Human,Adrenergic signaling in cardiomyocytes,5/150,0.0035248462772987,0.006589929996689,0,0,5.230769230769231,29.542958061562427,GNAS;CALM3;CALM1;CALM2;GNAI2,6,6,H1
115,KEGG_2021_Human,Aldosterone synthesis and secretion,4/98,0.0043953905865089,0.0081466291043054,0,0,6.422283579665422,34.855010257944855,GNAS;CALM3;CALM1;CALM2,6,6,H1
116,KEGG_2021_Human,Necroptosis,5/159,0.0045135101989029,0.0082940572031122,0,0,4.922827172827173,26.586614814901992,HSP90AA1;TRAF2;HMGB1;TNF;TNFRSF1A,6,6,H1
117,KEGG_2021_Human,Hepatitis B,5/162,0.0048829624398267,0.0088969230895149,0,0,4.828025477707007,25.69476697425417,TGFB1;TGFB3;TNF;HSPG2;HRAS,6,6,H1
118,KEGG_2021_Human,Coronavirus disease,6/232,0.0049583214387761,0.0089583118431669,0,0,4.041778143650957,21.448455634701563,CXCL10;NRP1;ACE;TNF;EGFR;TNFRSF1A,6,6,H1
119,KEGG_2021_Human,Hippo signaling pathway,5/163,0.0050107484906313,0.0089775910457145,0,0,4.797224926971762,25.406918624987657,TGFB1;TGFB3;CDH1;ITGB2;AREG,6,6,H1
120,KEGG_2021_Human,Glucagon signaling pathway,4/107,0.0059946911174901,0.0106517238864495,0,0,5.858445119691692,29.97696661145048,GNAS;CALM3;CALM1;CALM2,6,6,H1
121,KEGG_2021_Human,Regulation of lipolysis in adipocytes,3/55,0.0061082228608514,0.0106971976285467,0,0,8.659527972027972,44.14730759733264,INSR;GNAS;GNAI2,6,6,H1
122,KEGG_2021_Human,Protein processing in endoplasmic reticulum,5/171,0.0061197921316802,0.0106971976285467,0,0,4.564179796107507,23.260096987313915,HSP90AA1;CANX;TRAF2;CALR;HSP90B1,6,6,H1
123,KEGG_2021_Human,Insulin resistance,4/108,0.0061932794847701,0.0107383474937547,0,0,5.8018203170874925,29.498140088567904,INSR;TNF;PTPRF;TNFRSF1A,6,6,H1
124,KEGG_2021_Human,Herpes simplex virus 1 infection,9/498,0.0067407806299306,0.0115115581419982,0,0,2.8302658486707566,14.150139230624408,CCL5;HLA-B;LTA;TRAF2;ITGA5;CALR;TNF;B2M;TNFRSF1A,6,6,H1
125,KEGG_2021_Human,Legionellosis,3/57,0.0067463084925199,0.0115115581419982,0,0,8.337962962962964,41.67947418732513,ARF1;ITGB2;TNF,6,6,H1
126,KEGG_2021_Human,Serotonergic synapse,4/113,0.0072519458122205,0.0122769161387985,0,0,5.534281112122698,27.264555420644133,APP;GNAS;HRAS;GNAI2,6,6,H1
127,KEGG_2021_Human,Long-term depression,3/60,0.007775244670392,0.0130599812822991,0,0,7.89792663476874,38.35873184343513,GNAS;HRAS;GNAI2,6,6,H1
128,KEGG_2021_Human,Inflammatory bowel disease,3/65,0.0096857654245055,0.0161429423741759,0,0,7.2591642228739,33.66145556047605,TGFB1;TGFB3;TNF,6,6,H1
129,KEGG_2021_Human,Chemokine signaling pathway,5/192,0.0098331049312986,0.0162624427709938,0,0,4.04730563554093,18.70664880023122,CXCL10;CCL5;CXCR4;HRAS;GNAI2,6,6,H1
130,KEGG_2021_Human,Osteoclast differentiation,4/127,0.0108323110624364,0.0177782204459834,0,0,4.900887482157264,22.177603100195125,TGFB1;TRAF2;TNF;TNFRSF1A,6,6,H1
131,KEGG_2021_Human,Oocyte meiosis,4/129,0.0114218351424128,0.0186037466334754,0,0,4.821984732824427,21.56501702880397,AR;CALM3;CALM1;CALM2,6,6,H1
132,KEGG_2021_Human,Epithelial cell signaling in Helicobacter pylori infection,3/70,0.0118465120882688,0.0190074634252074,0,0,6.715739484396201,29.78915198885873,CCL5;ADAM10;EGFR,6,6,H1
133,KEGG_2021_Human,RIG-I-like receptor signaling pathway,3/70,0.0118465120882688,0.0190074634252074,0,0,6.715739484396201,29.78915198885873,CXCL10;TRAF2;TNF,6,6,H1
134,KEGG_2021_Human,Yersinia infection,4/137,0.0139851427955874,0.0222726348226022,0,0,4.530103885668369,19.34245519699727,FN1;TRAF2;ITGA5;TNF,6,6,H1
135,KEGG_2021_Human,Thyroid hormone synthesis,3/75,0.0142627067674751,0.0225476614338762,0,0,6.247790404040404,26.553778146958265,CANX;GNAS;HSP90B1,6,6,H1
136,KEGG_2021_Human,Chronic myeloid leukemia,3/76,0.0147769600153408,0.0231901197321042,0,0,6.161892901618929,25.970444158402245,TGFB1;TGFB3;HRAS,6,6,H1
137,KEGG_2021_Human,PD-L1 expression and PD-1 checkpoint pathway in cancer,3/89,0.022414834925162,0.0349216631080422,0,0,5.227008456659619,19.85234677243492,ALK;HRAS;EGFR,6,6,H1
138,KEGG_2021_Human,JAK-STAT signaling pathway,4/162,0.0242343386976386,0.0374847684891532,0,0,3.808483911489033,14.167501870028511,PDGFRB;PDGFB;HRAS;EGFR,6,6,H1
139,KEGG_2021_Human,African trypanosomiasis,2/37,0.0258185310743292,0.0396498870070056,0,0,8.519871106337272,31.154295617627465,VCAM1;TNF,6,6,H1
140,KEGG_2021_Human,Wnt signaling pathway,4/166,0.0262037283598909,0.039956039697706,0,0,3.7136933371030074,13.524727354424504,MMP7;LRP5;PSEN1;LRP6,6,6,H1
141,KEGG_2021_Human,Parkinson disease,5/249,0.027033063820066,0.040796329598672,0,0,3.092843631778058,11.167313726429386,GNAS;CALM3;CALM1;CALM2;GNAI2,6,6,H1
142,KEGG_2021_Human,Allograft rejection,2/38,0.0271343029423725,0.040796329598672,0,0,8.2827903091061,29.875664843047307,HLA-B;TNF,6,6,H1
143,KEGG_2021_Human,Phosphatidylinositol signaling system,3/97,0.0279993615762828,0.0418046023534778,0,0,4.780222437137331,17.092037004537737,CALM3;CALM1;CALM2,6,6,H1
144,KEGG_2021_Human,Influenza A,4/172,0.0293335803551893,0.0434426990166297,0,0,3.579970919665576,12.633797323438536,CXCL10;CCL5;TNF;TNFRSF1A,6,6,H1
145,KEGG_2021_Human,Hematopoietic cell lineage,3/99,0.0295006235182695,0.0434426990166297,0,0,4.680160984848484,16.489816561729537,ITGA5;TNF;CD44,6,6,H1
146,KEGG_2021_Human,Toll-like receptor signaling pathway,3/104,0.0334366767400379,0.0489039829871303,0,0,4.447344734473448,15.112530483154517,CXCL10;CCL5;TNF,6,6,H1
